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VOORWOORD 
Beleidsmatig typeert men revalidatie vaak als een “complexe” sector. Dat is eigenaardig. 
Op zich vergt revalidatie een actieve inspanning van patiënt en van zorgverlener en in die 
zin is het een vrij arbeidsintensieve sector. Anderzijds komen er in vergelijking met andere 
domeinen van de geneeskunde weinig hoog-technologische interventies of intensieve 
medische zorgen aan te pas.   
“Complexe” sector wijst in dit geval vermoedelijk meer naar een voor beleidsmakers 
onbegrijpelijke, ondoorzichtige, en in die zin ook moeilijk bestuurbare sector –wellicht is 
het niet eenvoudig om een overzicht te krijgen van alle mogelijke revalidatie-instellingen, 
zorgverleners, en activiteiten. De multiple parallelle en overlappende 
financieringssystemen voor revalidatie zijn daar niet vreemd aan. Meerdere studies in het 
verleden, waaronder enkele van het KCE, toonden de enorme zorgvariabiliteit en het 
gebrek aan standaardisatie in behandelingsprotocollen aan. Denk maar aan leren stappen 
na het plaatsen van een heupprothese: op één plaats gebeurt dat meestal monodisciplinair 
door één kinesitherapeut, en op een andere plaats systematisch multidisciplinair door 
intensieve revalidatie. Ernstige ruggenmergletsels komen anderzijds niet steeds in 
gespecialiseerde behandelequipes terecht.  
Of dit onderzoek, in complementariteit met een recent rapport van een ministeriële 
werkgroep, een aantal zinvolle aanbevelingen kan onderbouwen, kan u zelf lezen in dit 
rapport. Eén conclusie kunnen we u wel al verklappen: de organisatie van de 
locomotorische revalidatie actualiseren zal niet lukken met enkele snelle, lukrake ingrepen 
in de reglementering en zal een werk van langere adem worden, in de revalidatie 
misschien niet eens zo vreemd.  
Tijdens dit onderzoek mochten we in de multiple contacten met externe experts 
vaststellen dat de revalidatie begonnen is aan een professionaliseringsgolf. Vele 
zorgverleners die dag na dag enthousiast patiënten terug leren functioneren en waar 
mogelijk re-integreren, zijn nieuwe wegen aan het inslaan waarbij ze de behaalde 
resultaten meer en meer ook meten. De hoeveelheid klinische studies die de meest 
efficiënte revalidatiebehandelingen onderzoeken zijn nationaal en internationaal in stijgende 
lijn. Alvast een hoopgevende beweging. 
 
 
 
 
Jean Pierre Closon     Dirk Ramaekers 
Adjunct Algemeen Directeur    Algemeen Directeur 
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EXECUTIVE SUMMARY 
DOELSTELLINGEN 
Het hoofddoel van deze studie was het bestuderen van de huidige 9.50 en 7.71 Riziv-
conventies voor musculoskeletale en neurologische revalidatie, en het formuleren van 
organisatie- en financieringsopties voor de revalidatiebehandeling van deze aandoeningen. 
METHODOLOGIE 
Een wetenschappelijke literatuurstudie werd uitgevoerd voor het formuleren van de 
definitie voor het begrip revalidatie. Een literatuurstudie aangevuld met het raadplegen van 
grijze literatuur en van nationale en internationale experts, werd gehanteerd voor de 
epidemiologische gegevens, het opstellen van het operationele concept voor de 
organisatie en financiering van revalidatie, het bestuderen van bestaande klinische paden 
binnen revalidatie, en de internationale vergelijkende studie. Belgische gegevens werden 
verzameld, enerzijds via gegevens van Riziv, FOD Volksgezondheid en mutualiteiten, 
anderzijds door het consulteren van eerdere Belgische studies over dit onderwerp. 
Verder werd in een beperkte schriftelijke bevraging bij revalidatieartsen, representatief 
verspreid, op kwalitatieve wijze gepeild naar variaties in klinische praktijkvoering. 
Vertrekkende van de internationale vergelijkende studie en de Belgische evaluatie werden 
organisatie- en financieringsmodellen voor de postacute revalidatie in België ontwikkeld. 
Gebaseerd op gegevens van 3 centra die bereid waren om gegevens ter beschikking te 
stellen, werden theoretische kosten en opbrengsten volgens het huidige 
financieringssysteem berekend voor 5 standaard behandelingsprotocollen die opgesteld 
waren door een panel van 7 revalidatie-experten. De resultaten werden vervolgens 
geëxtrapoleerd om schattingen te bekomen voor de volledige populatie.  
RESULTATEN 
DEFINITIE 
Een definitie voor het begrip revalidatie werd geformuleerd binnen het kader van de 
WHO International Classification of Functioning, Disability and Health (ICF).  
Revalidatie werd gedefinieerd als een doelgericht proces dat de mogelijkheid biedt om een 
optimaal niveau van functioneren en onafhankelijkheid te bereiken en te behouden voor 
personen met beperkingen in acticiteiten en/of maatschappelijke participatie (persoonlijke 
of omgevingsfactoren mee in aanmerking genomen); wanneer er een redelijke 
mogelijkheid is op functionele winst of verbetering van levenskwaliteit. Revalidatie omvat 4 
stappen: evalueren, formuleren van doelstellingen, aanbieden van behandeling met 
bewezen meerwaarde, herevalueren. Revalidatie wordt aangeboden in een 
multidisciplinaire setting die ingebed is in een netwerk.  
ORGANISATIE EN FINANCIERING: EPIDEMIOLOGISCHE GEGEVENS 
Epidemiologische gegevens werden verzameld voor 5 diagnostische groepen: CVA, 
ruggenmergletsel, multiple sclerose (MS), totale heupprothese en amputatie van een 
onderste lidmaat. Deze diagnoses vertegenwoordigen samen 75% van de populatie in 
locomotorische en neurologische Sp-bedden; wat goed correspondeert met de gegevens 
uit een zeer grote internationale studie (USA). Het gevonden cijfermateriaal bevatte 
nauwelijks gegevens over functionele status, wat nochtans noodzakelijk is voor de bepaling 
van revalidatienoden. De Belgische incidentie voor totale heupprothese bedraagt 
160/100.000/jaar en de prevalentie van MS 90/100.000. MS kent echter een moeilijk 
voorspelbaar verloop en dito revalidatienoden. De incidentie van ruggenmergletsel in 
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Europese landen bedraagt 1-3/100.000/jaar. Incidentie van amputatie van het onderste 
lidmaat wordt in België geschat op 12/100.000/jaar. Ongeveer de helft van de patiënten 
krijgt een prothese, met een verhouding van 1/1 voor bovenbeen- tegenover onderbeen. 
Voor CVA is de jaarlijkse incidentie in België 185/100 000, maar functionele noden zijn 
niet gekend. Ongeveer 15% dient door te stromen naar een postacute revalidatiesetting. 
Naar schatting 1/3 van de huidige musculoskeletale en neurologische revalidatie in Sp-
diensten bestaat uit CVA-patiënten. 
BELGISCHE SITUATIE 
Algemene situatie 
Voor de musculoskeletale en neurologische revalidatie  bestaat er in België een ruim 
aanbod, zowel voor eenvoudige basisrevalidatie als voor sterk gespecialiseerde en/of 
intensieve revalidatie. Bij het bestuderen van de 9.50 en 7.71 conventies, de focus van deze 
studie, dienen ook de andere financieringsmechanismen vermeld te worden waaronder de 
betreffende doelgroepen kunnen voorkomen, voornamelijk de K-nomenclatuur en de Sp-
ziekenhuisfinanciering. Deze systemen functioneren parallel, overlappen in belangrijke 
mate en worden gebruikt voor dezelfde indicaties (gebaseerd op medische diagnose), met 
uitzondering van 3 behandelingsgroepen die enkel toegankelijk zijn onder K-nomenclatuur. 
Het financieringsprincipe voor conventies en K-nomenclatuur is sterk vergelijkbaar en 
fundamenteel terug te voeren op (variaties van) een per-prestatie financiering. De 
financieringsbasis is in de verschillende systemen vooral op historische basis bepaald 
eerder dan op karakteristieken van de behandelde patiëntenpopulatie.  
Behalve de visitatiecommissies voor de Sp-diensten, is er geen kwaliteitscontrole meer 
sedert de overheveling in 1991 van het “Fonds voor Sociale Reclassering van de 
Mindervaliden” naar het Riziv. Dit Fonds maakte een duidelijk onderscheid tussen 
revalidatie met het oog op reïntegratie, en revalidatie als chronische zorg. 
Conventies en K-nomenclatuur 
Wat betreft de conventies, is er een ruime spreiding over het Belgisch grondgebied, maar 
toch valt op dat Luxemburg geen enkel revalidatiecentrum heeft dat onder conventie 
werkt terwijl het aantal in West-Vlaanderen en Brussel opvallend hoog is. De 
locomotorische en neurologische Sp-bedden zijn minder talrijk in Oost-Vlaanderen en 
Namen. De conventie 9.50 wordt voor 80% voor ambulante behandelingen gebruikt, 
terwijl de conventie 7.71 en de K-nomenclatuur voor 60% voor gehospitaliseerden 
worden toegepast. Voor de 9.50 conventie valt 64% van de behandelingen onder 
“verworven parese of hersenletsel met ernstige sekwellen”, gevolgd door 27% onder 
“vervolgbehandeling na bereiken van de maximale therapieduur”. Voor K-nomenclatuur is 
dit 38% onder “prothese van grote of middelgrote gewrichten” gevolgd door 16% 
“cerebrale letsels”. 
In 2000 werd 0,38% van het totale Riziv-budget gebruikt voor conventies en K-
nomenclatuur, in 2004 bedroeg dit 0,49%. Het grootste gedeelte van het gezamenlijke 
budget werd tussen 2000-2004 opgeslorpt door de K-nomenclatuur (68%), terwijl er naar 
7.71 conventies 18% van het budget ging en naar 9.50 conventies 14%. De groei in deze 
periode bedroeg 50% voor K-nomenclatuur, 83% voor 7.71 conventies en 45% voor 9.50 
conventies. Het aandeel voor de kost van transport bedraagt in die periode11% van het 
budget conventie 7.71 en 33% van het budget conventie 9.50. Binnen de 7.71 conventies 
liggen de Riziv-uitgaven merkelijk hoger voor diensten die enkel ambulante zorg aanbieden 
vergeleken met sommige diensten die tevens hospitalisatie aanbieden. Sedert augustus 
2004 is er een vernieuwde K-nomenclatuur in voege, de Riziv-uitgaven  stegen sedertdien 
opvallend door een shift naar K60-prestaties. Sedert augustus 2006 zijn er nieuwe 
voorwaarden ingesteld voor de 9.50 conventie, die opeenvolgend gebruik van K-
nomenclatuur en 9.50 conventie binnen één centrum moeten uitsluiten en de ongelijkheid 
in vergoeding egaliseren. 
Tenslotte is het opmerkelijk dat er nog meerdere combinatiemogelijkheden bestaan van 
multidisciplinaire therapie (K-nomenclatuur of conventie 9.50) met monodisciplinaire 
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therapie (vb. logopedie), hetgeen de transparantie bemoeilijkt. Verder worden Sp-bedden 
gefinancierd op 7/7 dagen basis, wat het doorbrengen van weekends thuis ontmoedigt. 
INTERNATIONALE VERGELIJKING 
Vijf landen werden geanalyseerd: Nederland, Frankrijk, Duitsland, Zweden en de USA. In 
alle bestudeerde landen zijn hervormingen gaande in de revalidatiesector, waarbij 
gestreefd wordt naar een duidelijk revalidatieconcept. Centraal staan telkens de noden van 
de patiënt, het bestaan van verschillende revalidatiefases en overeenkomstige 
revalidatieorganisaties, en het voorzien van continuïteit tussen de verschillende fases. 
Evenwel, bij het uitbouwen van deze principes stuit men op talrijke moeilijkheden, die 
verschillen naargelang de algemene organisatie van de gezondheidszorg verschilt. Een 
volledig uitgewerkt concept voor de postacute revalidatiesector dat al deze nieuwe 
concepten incorporeert is nog nergens volledig in voege; wel zijn een aantal initiatieven in 
de diverse landen vermeldenswaard.  
Het inschatten van patiëntennoden met name de ziekenhuisverblijfsduur met het oog op 
financiering gebeurt in de USA op basis van een PCS (patiëntenclassificatiesysteem); 
overigens gebeurt patiëntenselectie op basis van een medische beslissing die in Duitsland 
(en in Nederland voor de overgang naar de chronische fase) bekrachtigd wordt door de 
verzekeraar. In Nederland en Duitsland gebeurt een belangrijk deel van de revalidatie in 
een chronische setting, ondermeer voor de oudere populatie. Eveneens in Duitsland 
gebeurt veel revalidatie tijdens hospitalisatie; Zweden daarentegen is sterk gericht op 
revalidatie in de thuissituatie. In Duitsland wordt, enkel voor neurologische revalidatie, de 
Barthel-Index gebruikt voor transfer van de ene naar de andere fase. Netwerking is 
ondermeer voor CVA in Nederland reeds goed uitgebouwd via de ketenzorg, en er 
gebeurt benchmarking tussen de verschillende netwerken. 
In alle landen worden verschillende niveaus onderscheiden in de revalidatie: basis – 
specialistisch - hoogspecialistisch. Ondermeer de behandeling van ruggenmergletsels wordt 
nagenoeg steeds als hoogspecialistische zorg aanbevolen. 
Globale financieringsbudgetten zijn moeilijk vergelijkbaar van land tot land, aangezien een 
wisselend gedeelte van de terugbetaling geschiedt via private verzekering of geregeld 
wordt op lokaal eerder dan op nationaal niveau. Algemeen valt de introductie op van 
marktprincipes met onderhandelingen tussen zorgaanbieders en verzekeraars. O.a. in de 
USA en Duitsland is dit reeds operationeel in de revalidatiesector. 
ORGANISATIE EN FINANCIERING: PATIENTENCLASSIFICATIESYSTEMEN 
Algemene beschouwingen 
De hoger vermelde theoretische definitie dient in de praktijk gekoppeld te worden aan 
een patiëntenclassificatiesysteem (PCS). Een PCS laat toe om individuele revalidatienoden 
te evalueren (“meten”), met het oog op enerzijds adequate klinische behandeling, 
anderzijds de verwijzing naar de meest geschikte organisatie en conforme financiering. Een 
PCS dat tegelijkertijd klinische en organisatorische/financiële doeleinden dient, bestaat 
momenteel niet, evenmin als een meetinstrument dat voor beide doeleinden voldoet.  
International Classification of Functioning, Diasability and Health (ICF) 
ICF wordt momenteel in de internationale literatuur aanvaard als de meest volledige 
classificatie van mogelijke gevolgen van gezondheidsproblemen en wordt beschouwd als 
algemeen denkkader. Er is nog uitgebreid wetenschappelijk onderzoek lopende om de 
toepassing van ICF voor organisatorische doeleinden mogelijk te maken. Wel werden 
reeds de ICF items gegroepeerd die van toepassing zijn voor de acute en postacute fase 
van musculoskeletale en neurologische revalidatie. Er gaat veel aandacht naar het 
omzetten van bestaande PCS naar ICF. 
PCS voor organisatie en financiering 
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De hoekstenen van een PCS voor organisatorische en financieringsdoeleinden in 
revalidatie zijn volgens literatuuronderzoek en overleg met internationale experten 
enerzijds de medische diagnose, anderzijds informatie over de functionele status en 
mogelijkheden van de patiënt, en tenslotte additionele gegevens als leeftijd, 
comorbiditeiten en sociale situatie. Een meetinstrument dat functionele status bepaalt in 
het kader van organisatie en financiering, dient een gevalideerd meetinstrument te zijn dat 
toepasbaar is voor meerdere diagnostische groepen; in het kader van deze studie zijn dit 
de musculoskeletale en neurologische aandoeningen. Momenteel voldoen enkel de FIM-
schaal en Barthel-Index aan deze voorwaarde, ook al hebben deze schalen meerdere 
beperkingen (oa. “ceiling effect”, voornamelijk informatie over ADL-vaardigheden,...). Wat 
betreft PCS werden in twee publicaties de bestaande en reeds gebruikte PCS voor 
revalidatie onderling vergeleken. Beide publicaties weerhouden FIM-FRG en AN-SNAP als 
de beste systemen. FIM-FRG, ontworpen in de USA, wordt momenteel in meerdere 
landen gebruikt in subacute ziekenhuisrevalidatie in het kader van een prospectief 
betalingssysteem. Op basis van medische diagnose, FIM-schaal, leeftijd en comorbiditeiten 
worden 67 subgroepen onderscheiden, gekenmerkt door een homogene verblijfsduur (ipv. 
intensiteit van de revalidatiebehandeling gezien de beperkte beschikbare wetenschappelijke 
evidentie ivm. therapienoden en –intensiteit) en gekoppeld aan een bepaalde 
financieringsklasse. AN-SNAP is een afgeleide van FIM-FRG, ontworpen in Australië voor 
gebruik in een land met een kleiner bevolkingsaantal; het laat ook registratie in de 
ambulante fase toe.  
PCS voor organisatie en financiering van postacute revalidatie in België 
Hoewel deze systemen hun bruikbaarheid reeds bewezen hebben zouden ze binnen het 
specifieke kader van het Belgische gezondheidssysteem gevalideerd dienen te worden 
vooraleer implementatie mogelijk zou zijn. Hiervoor is een representatieve dataset met 
diagnose, FIM-schaal, leeftijd, comorbiditeiten en sociale situatie van Belgische patiënten 
nodig, wat momenteel niet beschikbaar is. Als geregistreerde data in België voor 
gehospitaliseerde (maar niet voor ambulante) patiënten zijn de MKG-MVG beschikbaar. 
De nieuwere MVG2 vertonen een opvallende overlap met schalen als FIM. Echter, MVG2 
is enkel ontworpen voor het registreren van verpleegkundige activiteiten, en het mogelijk 
gebruik voor registratie van revalidatienoden dient nog aangetoond te worden.  
ORGANISATIE EN FINANCIERING: THERAPIESELECTIE, –INTENSITEIT EN 
DUUR 
Organisatie en financiering worden bemoeilijkt door de zeer beperkte klinische 
wetenschappelijke bewijzen over beste behandeling evenals verantwoorde therapieduur en 
–intensiteit, hoewel er recent meer studieresultaten beschikbaar komen. Ook de studie 
van andere landen leverde hierover weinig op. Bij wijze van kwalitatieve illustratie werd bij 
negen Belgische revalidatieartsen gepeild naar variabiliteit in klinische praktijk. Deze 
variabiliteit was zeer groot, zowel voor het aantal voorgestelde therapeutische sessies als 
voor het gehanteerde betalingssysteem en de hieraan verbonden kosten. Een zoektocht 
naar klinische paden voor revalidatie leverde eveneens slechts een beperkt aantal paden 
op, veelal gekenmerkt door multidisciplinariteit maar met variabele of helemaal geen 
informatie aangaande therapie-inhoud, duur en intensiteit.  
ORGANISATIE EN FINANCIERING: KWALITEITSCONTROLE  
Het bestaan van kwaliteitssystemen werd bestudeerd in vijf andere landen: Nederland, 
Frankrijk, Duitsland, Zweden en de USA. Vooral Duitsland heeft hier al ervaring mee en 
implementeerde voor sommige aandoeningen binnen revalidatie kwaliteitsindicatoren 
gebaseerd op “evidence-based” richtlijnen. Ook in Nederland werden recent een aantal 
performantie-indicatoren ingevoerd, oa. betreffende therapieresultaten en deelname aan 
research. Zweden en Frankrijk hebben nog geen operationeel kwaliteitssyteem voor 
postacute revalidatie. De USA heeft een goed uitgebouwd accrediteringssysteem voor 23 
verschillende revalidatieprogramma’s (CARF); een Europees accrediteringssysteem zou 
volgens experts in opbouw zijn. 
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OPTIES VOOR DE ORGANISATIE VAN POSTACUTE MUSCULOSKELETALE 
EN NEUROLOGISCHE REVALIDATIE 
Als eerste model voor België wordt een «gestratifieerd» model voorgesteld. Dit omvat 3 
niveaus (Algemeen, Specifiek en Hoogspecifiek), die onderscheiden worden op basis van 
complexiteit van de revalidatienoden en doelstellingen, en tevens op incidentie/prevalentie 
van de betreffende aandoeningen. Eenvoudige revalidatie is revalidatie met doelstellingen 
op korte termijn; complexe revalidatie is revalidatie met doelstellingen op lange termijn. In 
het Algemene niveau wordt eenvoudige revalidatie aangeboden, zowel mono- als 
multidisciplinair. In het Specifieke en Hoogspecifieke niveau wordt complexe 
multidisciplinaire revalidatie aangeboden; met een hoge respectievelijk lage 
incidentie/prevalentie. Elk niveau kan zowel op ambulante als op gehospitaliseerde basis 
aangeboden worden. Via een PCS wordt de patiënt in functie van zijn revalidatie noden en 
–doelstellingen verwezen naar een bepaald niveau; afhankelijk van zijn evolutie kan hij later 
doorverwezen worden naar een ander niveau. De diensten uit de verschillende niveaus 
dienen samenwerkingsverbanden aan te gaan en zo een netwerk te vormen. Verschillende 
alternatieve opties voor dit eerste model zijn: groepering in de post-acute fase op het 
Specifieke en Hoogspecifieke niveau volgens pathologie, groepering volgens 
functiebeperking, groepering volgens pathologie doorlopend vanuit acute over post-acute 
tot chronische fase, groepering naar doelstelling (volledige maatschappelijke reïntegratie of 
functionele hertraining in geval van blijvende beperkingen); en tenslotte een model 
gebaserd op managed care.  De Belgische context in acht genomen, lijkt in de postacute 
fase het «gestratifieerde» revalidatiemodel meest plausibel. 
Cruciaal in elk van deze opties is de evaluatie van de patiënt (het PCS), op basis waarvan 
toewijzing gebeurt aan een specifiek behandelingsniveau. Cruciaal is ook aan wie deze taak 
toevertrouwd wordt: aan de arts in de acute fase, aan de revalidatiecoördinator in de 
postacute fase en/of aan een onafhankelijke derde partij (verzekering). 
Bij wijze van oefening wordt, ondanks de beperkte wetenschappelijk valide gegevens die 
als basis hiervoor kunnen dienen, een voorstel gemaakt voor het aan te bevelen aantal 
revalidatie-organisaties in België. Terwijl Algemene revalidatie breed toegankelijk zou 
moeten zijn (in acute ziekenhuizen), leiden berekeningen tot maximum 20 à 30 
revalidatiecentra op Specifiek niveau. Op Hoogspecifiek niveau zijn een drietal centra voor 
ruggenmergletsel en MS nodig, evenals enkele Hoogspecifieke centra voor zeer complexe 
CVA’s of andere niet-aangeboren hersenletsels zoals hersentrauma’s. Gezien de lage 
frekwentie van sommige  pathologieën, en de veelal dure uitrusting in deze Hoogspecifieke 
centra, worden best verschillende pathologiegroepen gecombineerd, bijvoorbeeld in 3 à 5 
centra. 
OPTIES VOOR DE FINANCIERING VAN POSTACUTE 
MUSCULOSKELETALE EN NEUROLOGISCHE REVALIDATIE 
Interpretatie van het ruwe cijfermateriaal uit dit gedeelte van de studie dient met uiterste 
voorzichtigheid te gebeuren, omwille van methodologische redenen (vb. het inschatten van 
revalidatienoden door experts, en het schatten van personeelskosten op basis van 
onvolledige gegevens). Enkel uit relatieve vergelijkingen kunnen conclusies getrokken 
worden. Het bleek dat de geaggregeerde kosten van ambulante revalidatie en revalidatie in 
het ziekenhuis niet significant verschillend zijn, maar wel de opbrengsten. Dit kan worden 
verklaard door het feit dat de huidige financieringssystemen onvoldoende zijn aangepast 
aan de kostenstructuur van multidisciplinaire revalidatie. Momenteel bestaat er 
bijvoorbeeld geen specifieke vergoeding voor groepsessies, zodat voor elke patiënt in een 
groep een individuele verstrekking kan worden aangerekend. De opbrengsten van een 
groepssessie zijn daardoor artificieel hoog en aangezien er voornamelijk in de protocollen 
van ambulante revalidatie veel groepsessies voorkomen, verklaart dit het eveneens 
artificiële verschil tussen opbrengsten voor ambulante- en ziekenhuisrevalidatie. 
Tenslotte toonde de analyse dat de budgetten die de afgelopen jaren werden besteed aan 
multidisciplinaire revalidatie ongeveer overeenkomen met het budget dat men nodig zou 
hebben indien de standaard behandelingsprotocollen gemiddeld genomen zouden worden 
gevolgd in de sector en alle revalidatie via conventie 9.50 wordt vergoed. Dit zou kunnen 
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betekenen dat de huidige revalidatieactiviteiten gemiddeld overeenkomen met de 
voorgestelde protocollen of dat de protocollen werden gedefinieerd op basis van de 
huidige praktijk in plaats van op basis van noden. 
Wat betreft financiering, wordt voor het Algemene niveau een betaling per prestatie (fee-
for-service, FFS) voorgesteld of een gemengd systeem met relatief hoge FFS-component. 
Voor niveaus met meer homogene patiëntengroepen (Specifiek of Hoogspecifiek niveau, 
pathologie- of functiespecifiek niveau, pathologiespecifieke centra) wordt een gemengd 
systeem voorgesteld met een deel forfaitfinanciering en een deel per prestatiefinanciering. 
Als alternatief kan men op het niveau van Hoogspecifieke centra (met zeer specifieke 
patiëntengroepen met zeer complexe revalidatienoden) werken met een enveloppe-
financiering, i.e. een vaste som per jaar.  
Tenslotte wordt een practisch voorstel gedaan over de verschillende implementatiefases 
van de voorgestelde veranderingen; het ontwikkelen/valideren en implementeren van een 
registratiesysteem is daarbij het meest urgent. Aanvullend op de medische diagnose 
komen in aanmerking voor een testfase: MVG2, een functionele schaal zoals FIM of Barthel 
Index aangevuld met o.a. comorbiditeiten, leeftijd; en de ICF-datasets (zogenaamde “core-
“sets) voor musculoskeletale en neurologische revalidatie.  
Een vergelijking wordt gemaakt tussen dit rapport en het recent verschenen rapport van 
de Ministeriële Wergroep Revalidatie onder leiding van Prof. Dr. A. Heilporn (april 2007). 
CONCLUSIES EN AANBEVELINGEN 
• Er is in België nood aan een coherente visie omtrent actuele verschuivingen in de 
revalidatiesector. In andere Westerse landen treedt er in revalidatiegeneeskunde een 
evolutie op naar het centraal stellen van de revalidatienoden van, en het aanbieden van 
keuzes aan de patiënt; het onderkennen van verschillende revalidatiefases; het streven 
naar continuïteit tussen de verschillende fases en tenslotte in meerdere landen ook 
een introductie van marktprincipes met onderhandelingen tussen zorgaanbieders en 
verzekeraars. België dient zich hierover te bezinnen en een globaal concept op te 
stellen, zodat van daaruit  beslissingen genomen kunnen worden. 
• Reeds meerdere studies hebben de problematiek van de musculoskeletale en 
neurologische conventies in België bestudeerd. De huidige studie hoopt de bestaande 
informatie samen te vatten en voegt een aantal cruciale elementen toe over de 
epidemiologie van de behandelde pathologieën, de bestaande situatie in België, de 
situatie in vijf andere landen, patiëntenclassificatiesystemen, therapieselectie, 
kwaliteitscontrole en tenslotte organisatie en financiering. Verdere studies lijken 
slechts zinvol na de nodige beleidsbeslissingen over de toekomstige organisatie van 
musculoskeletale en neurologische revalidatie in België. 
• De volgende aanbevelingen kunnen vanuit de voorliggende studie geformuleerd 
worden: 
• De verschillende financieringssystemen in België voor musculoskeletale en 
neurologische revalidatie (Conventie 9.50 en 7.71, K-nomenclatuur, Sp-
ziekenhuisfinanciering) functioneren parallel en overlappen in belangrijke mate. Er zijn 
geen argumenten voor het behouden van  dergelijke parallele systemen en 
differentiatie dringt zich op.  
• De financiering via deze systemen is eerder op historische basis bepaald dan op 
karakteristieken van de behandelde patiëntenpopulatie. Er moet gestreefd worden naar 
transparantie, en dit op basis van geleverde diensten in functie van de noden van de 
patiënt.  
• De Conventies zijn ruim gespreid over België, maar Luxemburg heeft geen enkel 
revalidatiecentrum onder Conventie terwijl het aantal in West-Vlaanderen en Brussel 
opvallend hoog is. Indien dit niet op basis van capaciteit per Conventie verklaard kan 
worden, is correctie aan te bevelen. De provincies Namen en Oost-Vlaanderen 
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hebben een laag aanbod van S2-S3-bedden voor musculoskeletale en neurologische 
revalidatie, ook hier is correctie aan te bevelen.  
• De mogelijkheid tot combinatie van multidisciplinaire behandeling (K-nomenclatuur of 
conventie 9.50) met monodisciplinaire nomenclatuur (vb. logopedie) bemoeilijkt ten 
zeerste de transparantie. Het lijkt logisch deze monodisciplinaire therapie onder 
toezicht van de behandelende revalidatiearts te integreren in de multidisciplinaire 
behandeling. 
• Sp-bedden zijn gefinancieerd op 7/7 dagen basis. Om binnen de revalidatie het 
doorbrengen van weekends thuis te stimuleren zou de mogelijkheid kunnen geboden 
worden van een 5/7 financiering of daghospitalisatie. 
• Internationaal wordt aanbevolen de behandeling van ruggenmergletsels zodra de 
patiënt voldoende stabiel is, toe te vertrouwen aan hooggespecialiseerde centra. 
Gezien de specificiteit van de problematiek en het beperkte aantal (200 patiënten/jaar 
in België) zouden ook in ons land een drietal dergelijke centra kunnen opgericht 
worden.      
• Gebaseerd op de bevindingen in de internationale literatuur en de Belgische evaluatie, 
wordt een «gestratifieerd» model voor de subacute revalidatie voorgesteld, met een 
Algemeen, een Specifiek en een Hoogspecifiek niveau, georganiseerd in een netwerk. 
Determinanten zijn complexiteit van de revalidatienoden en incidentie/prevalentie. 
Alternatieve opties worden eveneens voorgesteld. Cruciaal zijn in elke optie de wijze 
van selectie bij instroom en doorverwijzing van de patiënt. 
• De instroom en doorverwijzing van de patiënten in het systeem dient gebaseerd te zijn 
op een patiëntenclassificatiesysteem (PCS). Geen enkel bestaand classificatiesysteem of 
meetinstrument is tegelijk optimaal voor klinische én voor 
organisatorische/financieringsdoeleinden. Voor deze laatste doeleinden dient een 
classificatiesysteem de medische diagnose, een meetinstrument dat de functionele 
noden en mogelijkheden van de patiënt inschat, en een aantal aanvullende gegevens 
zoals comorbiditeiten, leeftijd en relevante contextuele factoren te omvatten. 
• Het huidige registratiesysteem in ziekenhuisgebonden post-acute revalidatie stelt  
registreren binnen de V 57 categorie verplicht, die informatie omvat over de 
therapeutische specialiteiten betrokken bij de revalidatie. Wanneer de onderliggende 
medische diagnoses niet vermeld worden, heeft dit echter geen consekwenties wat 
betreft terugbetaling. Nochtans gebeurt de huidige financiering op basis van medische 
diagnose. Het op korte termijn verplicht maken van registratie van de medische 
diagnose en comorbiditeiten, vb. volgens het ICD-classificatiesysteem zoals voor 
andere ziekenhuisopnames, zou reeds een zekere vooruitgang kunnen betekenen wat 
betreft evaluatie van geleverde diensten. Het zou ondermeer betere inschattingen 
mogelijk maken van incidentie en prevalentie van de respectievelijke 
terugbetalingscategorieën. 
• Momenteel zijn er in België geen gegevens gekend die systematisch informatie 
verschaffen over de functionele capaciteit van revalidatiepatiënten, wat nochtans 
onontbeerlijk is naast medische diagnose. Op korte termijn, en in afwachting dat ICF 
bruikbaar wordt als PCS voor organisatie en financiering, is het opstarten in de 
postacute fase van systematische registratie van een revalidatieschaal zoals FIM (of 
Barthel-Index) ten zeerste aanbevolen, zowel in ziekenhuisbehandeling als ambulant. 
Hoewel deze meetinstrumenten van ADL-activiteiten zeker beperkingen vertonen, zal 
dit toelaten om reeds een eerste indruk te krijgen van de aard van beperkingen van de 
behandelde revalidatiepatiënten, hetgeen nu volledig ontbreekt. Ook laat dit 
vergelijking toe met andere landen die dergelijke schaal gebruiken. Nadien kunnen deze 
gegevens uitgediept worden tijdens verder onderzoek (zie Research agenda). 
• Kwaliteitsevaluatie dient een belangrijk onderdeel uit te maken van elk organisatie- en 
financieringssysteem. Idealiter wordt hierbij niet alleen rekening gehouden met 
uitkomst van de behandeling, maar ook met levenskwaliteit, visie van de patiënt op de 
kwaliteit van zorg etc. Momenteel worden dergelijke parameters niet systematisch 
gemeten, laat staan geregistreerd. Een degelijk PCS waarbij de hoger voorgestelde 
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parameters bij instroom evenals bij uitstroom gemeten zouden worden, zou reeds een 
eerste stap kunnen betekenen in het evalueren van de geboden zorg.  
• Zelfs zonder gebruik te maken van een PCS, wordt in enkele andere landen  reeds 
systematisch gebruik gemaakt van kwaliteits- of performantie-indicatoren, oa. wat 
betreft therapieresultaten (Nederland, Duitsland). Dit zou als voorbeeld kunnen 
dienen voor België. In de USA bestaat een goed uitgebouwd accrediteringssysteem 
voor 23 revalidatieprogramma’s (CARF); een Europees accrediteringssysteem zou in 
opbouw zijn. Te noteren valt dat er in België, sedert de overheveling van het “Fonds 
voor Sociale Reclassering van de Mindervaliden” naar het RIZIV, er geen 
visitatiecommissies meer zijn in de revalidatie-instellingen, met uitzondering van de 
visitatiecommissies voor de Sp-diensten. Hervatting lijkt wenselijk. 
• Een belangrijk gegeven in de internationale literatuur betreft het streven naar 
“continuïteit in de zorg”, ondermeer door het oprichten van netwerken. Ook in België 
moeten netwerken georganiseerd worden. In Nederland bijvoorbeeld, is netwerking 
voor CVA reeds goed uitgebouwd, en er gebeurt benchmarking tussen de 
verschillende netwerken.  
• Hoewel harde wetenschappelijke evidentie hieromtrent ontbreekt, werd bij wijze van 
oefening het benodigde aantal revalidatiecentra in België ingeschat. De volgende cijfers 
kunnen in acht genomen worden bij planning van het aantal revalidatiecentra op korte 
termijn. Maximum 20 à 30 revalidatiecentra zijn nodig op Specifiek niveau. Op 
Hoogspecifiek niveau is er nood aan 3 à 5 centra, waar de revalidatie van zeer 
complexe pathologieën gecentraliseerd wordt (oa. ruggenmergletsel, MS, zeer 
complexe CVAs of andere niet-aangeboren hersenletsels zoals hersentrauma’s). 
Algemene revalidatie dient breed toegankelijk te zijn (via acute ziekenhuizen).  
• Wat betreft financiering, wordt voor het Algemene niveau een betaling per prestatie 
(fee-for-service, FFS) voorgesteld of een gemengd systeem met relatief hoge FFS-
component. Voor het Specifiek of Hoogspecifiek niveau wordt een gemengd systeem 
voorgesteld met een deel forfaitfinanciering en een deel per-prestatiefinanciering. Als 
alternatief kan men op het niveau van Hoogspecifieke centra werken met een 
enveloppe-financiering, i.e. een vaste som per jaar.  
• Momenteel bestaat geen specifiek tarief voor een revalidatiebehandeling in groep. Het 
invoeren van een onderscheid tussen individuele revalidatiebehandeling en 
groepsbehandeling, en een differentiatie qua tarief, lijkt wenselijk.  
Research Agenda 
Indien beleidsmakers beslissen om een PCS in te voeren, is het aan te bevelen om ter 
voorbereiding van een implementatie minstens de volgende items te valideren in een 
representatieve steekproef van Belgische postacute revalidatiesettings: medische diagnose 
evenals comorbiditeiten en leeftijd, MVG2, FIM of Barthel-Index, ICF-core-sets voor 
musculoskeletale en neurologische pathologie. Op basis van deze validatie-oefening kan 
dan beslist worden welke dataset het meest nuttig is met het oog op implementatie van 
een PCS. Een practisch voorstel omtrent de verschillende implementatiefases wordt 
beschreven. 
Er zijn slechts beperkte wetenschappelijke gegevens beschikbaar over indicaties, inhoud, 
intensiteit en duur van revalidatietherapie, wat het voeren van een efficiënt en 
verantwoord therapiebeleid bemoeilijkt. Wetenschappelijke vooruitgang op dit vlak dient 
nauwgezet opgevolgd te worden, en klinische research in dit domein dient gestimuleerd te 
worden. 
Een ICF gebaseerd PCS-systeem dient verder ontwikkeld te worden, idealiter in een 
internationale (vb. Europese) context. 
De methodologie in deze studie gehanteerd voor de analyse van kosten en opbrengsten, 
kan verder gebruikt worden om een meer doorgedreven economische analyse van 
postacute revalidatiecentra uit te voeren. Hiervoor zijn meer precieze cijfers in verband 
met kosten en opbrengsten van revalidatie op basis van reële noden vereist. Dit vraagt 
meer gegevens in verband met revalidatiezwaarte en prevalentie van aandoeningen die 
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multidisciplinaire revalidatie vereisen. Bovendien zijn meer precieze kostengegevens nodig 
van een groter aantal centra. 
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Introduction 
The primary aim of this project was to study the current RIZIV/INAMI (the National 
Institute of Sickness and Invalidity Insurance) conventions for “locomotor rehabilitation”. 
In the Belgian context, ”convention” refers to an agreement between the RIZIV/INAMI 
and a rehabilitation organisation concerning financing of rehabilitation services. 
As financing and payment is very much related to organisational issues, the secondary aim 
of the study was to assess the organisation and financing of musculoskeletal and 
neurological rehabilitation. 
Historical developments have lead to an unclear and problematic situation in Belgian 
musculoskeletal and neurological rehabilitation. Before 1991 the federal “Rijksfonds voor 
Sociale Reclassering van de Mindervaliden” or “Fonds Maron” regulated and financed all 
aspects of the rehabilitation facilities. Because of the Belgian political defederalisation this 
Fund was replaced by four different Regional Funds (VFSIPH, AWIPH, COCOF, 
Dienststelle der Deutschsprachigen Gemeinschaft für Personen mit einer Behinderung 
sowie für die besondere soziale Fürsorge). Acute and post-acute rehabilitation remained 
incorporated in the federal health care regulation (art. 34 of the law concerning 
compulsory health insurance) and rehabilitation services are since then financed by the 
RIZIV/INAMI, mainly with a fee for service system. 
Rehabilitation activities can be provided within two systems: 
• Rehabilitation agreements (“conventions”): different types exist which 
will be described extensively in  chapter 5. 
• Nomenclature of Physical Medicine & Rehabilitation (a fee schedule: “K”; 
art. 22 and 23 “Physiotherapy”) 
There is a substantial overlap between the different systems and it is not always clear 
which system to use. Both systems can be applied to hospitalised as well as ambulatory 
patients. 
The hospitalisation of these patients is since the early nineties mostly organised in a day-
price system of specialized beds (Sp beds, S2 musculoskeletal and S3 neurological). These 
beds are accredited by the Ministry of Public Health and the “day-price” also covers some 
therapists and infrastructure for rehabilitation. 
As the organisation and financing of rehabilitation in Belgium is very complex as well as 
heterogeneous, different studies have been performed the last five years in order to 
describe the actual situation and make recommendations for a reorganisation of the 
sector. 
• Study by the RIZIV/INAMI (Prof. Heilporn) ordered by Minister F. 
Vandenbroucke (October 2000). 
• Study ordered by the Advisory Board for Rehabilitation and the college 
of Medical Directors of the RIZIV/INAMI, in the context of the Health 
dialogues organised by Minister R. Demotte (2003-2004) (Prof. 
Heilporn). 
• Audit of the Rehabilitation sector performed by the budgetary 
commission of the RIZIV/INAMI (June 2004) (P. Verhavert) 
• Study ordered by Minister F. Vandenbroucke: Spécificité des services Sp, 
Specifieke aspecten van Sp-diensten (2003-2005) (Prof. M-C Closon) 
• The study “Réseau de Rééducation et de Réadaptation Locomotrice et 
Neurologique” by a Ministerial working group (Prof. Heilporn) in 2005-
2006, ordered by Minister R. Demotte. 
However, these reports contain only limited information based on international scientific 
literature and data.  
For this study two main questions were raised: 
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- First question: what frame of reference and what criteria should be used for 
the evaluation of the usefulness, efficacy, efficiency and quality of rehabilitation 
programmes in terms of structure, process and outcome? 
In order to define a frame of reference and criteria, the domain of musculoskeletal and 
neurological rehabilitation had to be identified, so a  conceptual definition of 
musculoskeletal and neurological rehabilitation was developed. 
In the next phase the conceptual definition was made operational. This was done by the 
development of an outcome model, mainly based on outcome measures and a patient 
classification system which could ideally be used for resource allocation as well as clinical 
decision making. 
A separate small chapter focused on how workload could be monitored. As the 
rehabilitation sector in Belgium is currently not using targeted measures, a quick scan was 
done on how existing registrations (minimum nursing data, FIM, Barthel Index) could be 
used for profiling the different rehabilitation services.  
- Second question: how can the need for rehabilitation services at country level 
be estimated and what are the financial implications of choices made in the 
health services organisation model? 
A description is made of the current Belgian financing systems for musculoskeletal and 
neurological rehabilitation: RIZIV/INAMI nomenclature, conventions and also the 
hospitalisation beds for diagnosis and therapy of musculoskeletal and neurological 
disorders were taken into account (Sp beds: S2 and S3). 
Five pathologies were selected as representative examples for the scope of this study: 
Stroke, Multiple Sclerosis, Total Hip Replacement, Spinal Cord Injury and Lower Extremity 
Amputation. For these five selected pathologies, an epidemiologic study was performed. 
Belgian clinical practice was investigated and compared to clinical pathways developed in 
several countries. 
A separate chapter focused on how other countries have developed experiences in 
organising and financing post-acute musculoskeletal and neurological rehabilitation. The 
Netherlands, France, Germany, Sweden and the US were chosen to cover a broad range 
of health care models.  
The following chapters conclude by presenting different conceptual organisation models. 
Suggestions were made on patient referral and clinical practice. Recommendations were 
made with regard to a financing system for the proposed organisation model, taking into 
account aspects of quality control. In addition costs, revenues (for the rehabilitation 
centres) and RIZIV/INAMI expenditures were calculated in order to simulate the 
budgetary impact. 
Finally, some propositions are made on how to implement the recommendations and a 
comparison is made with the report of the Ministerial subworkgroup on musculoskeletal 
and neurological rehabilitation (report 2007 Prof. A.Heilporn). 
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1 CONCEPTUAL DEFINITION OF 
MUSCULOSKELETAL AND NEUROLOGICAL 
REHABILITATION 
1.1 DEVELOPMENT OF A CONCEPTUAL DEFINITION OF 
MUSCULOSKELETAL AND NEUROLOGICAL 
REHABILITATION 
1.1.1 Introduction 
In this part of the report, the researcher describes the method to identify the domain of 
rehabilitation and all of its related aspects, to avoid a too limited view on rehabilitation 
while answering the questions formulated by the minister of health care. First, the 
literature search for existing definitions of rehabilitation is described, followed by a 
proposal for the development of a conceptual definition for musculoskeletal and 
neurological rehabilitation based on existing literature.  
In Belgium the term ‘locomotor’ is used instead of ‘musculoskeletal and neurological’. The 
researchers will use the term “musculoskeletal and neurological rehabilitation”. Besides, 
musculoskeletal rehabilitation can not be seen disconnected of neurological rehabilitation 
because many patients have to contend with musculoskeletal and neurological problems at 
the same time. Within this project musculoskeletal as well as neurological rehabilitation 
will be discussed. 
1.1.2 Critical view on the current published literature 
Looking for a definition of rehabilitation in the literature, the researchers ascertained that 
most of the existing definitions are developed around a specific pathology. No definitions 
for musculoskeletal and neurological rehabilitation were found. Papers which contain a 
description of a scientific approach in the development of a definition of rehabilitation are 
scarce. 
A lot of definitions refer to the International Classification of Functioning, Disease and 
Health (ICF) or components of the ICF. However, ICF is still a theoretical framework. ICF 
did not yet prove any additional value on relevant data collection about rehabilitation, 
organisational design for rehabilitation or simulation of the financial impact of 
rehabilitation. 
“ICF is a multidimensional system across which the individual codings are not mutually 
exclusive and can vary across raters so that “core sets” for different clinical conditions 
must be agreed upon by users.” 1 
1.1.3 Methodology 
The objective of the search of the literature was to formulate a definition of 
musculoskeletal and neurological rehabilitation. 
The search of the literature for existing definitions of rehabilitation was preceded by 
asking some questions. Does a definition for rehabilitation have to be built around a type 
of patients (pathology, age,…), the different therapies, the concerned professional groups 
or the goals to achieve? The researchers agreed on a patient centred approach. The 
definition is built around the outcome and goals because different diagnostic conditions 
may share the same type of rehabilitation needs. The appropriateness of a therapy is 
function of the needs and related aims whereas the appropriateness of a specific 
professional is function of the therapy.  
As a result two main questions were formulated before the start of the search: 
• How can goals be achieved? 
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• How are patients assessed and/or selected? 
The researchers collaborated with the Belgian Centre for Evidence Based Medicine 
(CEBAM) to respect the principles of evidence based medicine during their search for 
definitions. Because the general acknowledged Oxford Centre for Evidence-based 
Medicine Levels of Evidence speaks only to the validity of evidence concerning prevention, 
diagnosis, prognosis, therapy, harm, differential diagnosis, symptom prevalence study and 
economic and decision analyses, the researchers decided to identify a proper hierarchy for 
evidence related to the objective of the study. By preference guidelines were explored 
presuming that no guideline concerning rehabilitation practices can be developed without 
an agreement on a definition of rehabilitation. In the second instance also systematic 
reviews were included supposing that systematic reviews of published definitions of 
rehabilitation exist. No meta-analyses were included for the reason that the focus on 
clinical practice was expected without any statement of general definition. The researchers 
searched Medline, Embase, PEDro and relevant websites (NHS Guidelines Finder, National 
Guidelines Clearinghouse, the website of the Disability and Rehabilitation Team of the 
WHO, the UN website, the website of the New Zealand Guidelines Group).  Papers of 
particular interest were those that analyse and discuss functional outcomes and contained 
a definition for rehabilitation. CEBAM validated the search methodology as well as the final 
development of the definition. See for a detailed description of the search algorithms. 
Information from the several sources was incorporated into an Excel format intended to 
maximally facilitate decision-making. Information such as title, author, year of publication, 
the inclusion of a definition of rehabilitation, the mention of the use of assessment tools, 
the consideration of a specific pathology or therapy and the identification of outcomes was 
registered.  
Analysing the existing definitions and the opinion of their developers the main point during 
rehabilitation would be the individual centred approach. The importance of this focus 
induced an additional search looking for papers concerning the study of individuals’ needs 
and demands related to rehabilitation and the value of these needs as a predictive factor 
for the outcome of the rehabilitation process. The objective of this additional search was 
not to make up an exhaustive list of papers reporting individuals’ needs and demands but 
rather to perform a global survey to know if something was published yet. 
Because no definitions for musculoskeletal and neurological rehabilitation were found, the 
project team agreed on the incorporation of the criterion that the musculoskeletal and/or 
the neurological system must be affected. 
1.1.4 Definition of musculoskeletal and neurological rehabilitation 
The project team agreed on some conditions related to the content of the definition after 
consultation of an expert panel. The content of the definition must be clear and 
meaningful, precise and unambiguous, not related to a specific functional disorder or 
disease nor coloured by the opinion of a professional group. All different aspects of the 
rehabilitation process must be covered. The domain of rehabilitation must be bordered to 
obtain a clear distinction between acute as well as chronic care. For that reason, the 
definition must contain criteria to select and follow up individuals for rehabilitation, to 
define rehabilitation services, to identify the type of involved professionals and to organise 
rehabilitation. To cover these aspects four main question nouns were answered in the 
definition. 
Four main question nouns of the definition: 
• What?   Æ Individual and Outcome 
• How?   Æ Services  
• Who?   Æ Professionals 
• Where?   Æ Organisation 
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DEFINITION 
Rehabilitation is a process 2-10 comprising a range of goal-oriented activities 2 providing 
opportunities 6 to achieve and maintain 11 an optimal level of independence 2, 6, 12, 8, 13 and 
functioning {, 1997 #107 for individuals with impaired body structures or functions related to the 
musculoskeletal and/or the neurological system causing activity limitations and/or 
participation restrictions, considering the relevant contextual factors (personal and 
environmental) 2, 14 for whom there is a reasonable expectation of functional gain and/or 
increase in quality of life. 
Rehabilitation comprises four core phases 5: 
• Identification of the individual’s needs, preferences and capabilities by use 
of a recognised functional assessment measure 15; 
• Collaborative goal setting in partnership with the patient or his/her 
advocates and the team members, focused on the restoration of function 
as well as prevention of activity limitations and participation restrictions, 
including an indicative time frame 15; 
• Evidence based activities with proven added value to achieve the 
predefined goals; 
• Assessment of the progress against the agreed goals by means of the 
functional assessment measure used in step 1) and defining the necessity 
to reiterate the rehabilitation cycle. 
Different types of professionals can be involved in the performance of the rehabilitation 
process. Professionals must have accredited skills and expertise, appropriate as related to 
the required interventions in order to achieve the predefined goals.  
Rehabilitation services are provided in a specialist rehabilitation organisation 15 accredited 
as such by a recognised instance. The most appropriate rehabilitation organisation is 
determined by criteria inherent to the individual’s characteristics, the complexity of the 
individuals’ needs and goals, the different professionals involved and the infrastructure and 
equipment required for the activities. 16 A rehabilitation organisation is part of a network 
which meets the demand for rehabilitation at all levels of specialisation and in all phases of 
the process.  
1.1.5 Interpretation rules for the definition of musculoskeletal and neurological 
rehabilitation 
For each component of the definition of musculoskeletal and neurological rehabilitation, 
we shortly explain the keywords.  
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1.1.5.1 What? 
Rehabilitation Interpretation 
…is a process… Rehabilitation is considered as a process because 
an ‘input’ has to be transformed to an ‘output’. 
…comprising a range of goal-oriented activities… During this process many different activities can be 
performed but always related to predefined goals. 
…providing opportunities… The patient has to take the initiatives and has to 
participate actively to the activities. 
…to achieve and maintain… Rehabilitation stands out from chronic care 
process because the rehabilitation process ends 
when goals are achieved. From the moment goals 
are achieved patients are followed up to control 
the maintenance of the achieved goals.  
…an optimal level… Optimal is function of an individual’s preferences. 
…of independence and functioning … Specially functioning is supported during the 
rehabilitation process. Independence stands for 
self reliance. 
…for individuals… Individuals are used instead of patients because 
rehabilitation covers a wider range then only 
medical issues such as social, educational, and 
vocational (cfr. WHO definition for rehabilitation, 
1969). 
… with impaired body structures or functions … Impaired body structures or functions indicate that 
a certain level of dysfunction exists as a result of a 
health condition (cfr. ICF). This distinguishes 
rehabilitation from acute care.  
No diseases or injuries are mentioned for the 
reason that rehabilitation starts based on a certain 
level of dysfunction. Different diagnostic 
conditions may share the same type and amount of 
rehabilitation needs. 
… related to the musculoskeletal and/or the 
neurological system … 
The underlying diagnosis specifies the type of 
rehabilitation. All ICD-9 codes within the Medical 
Diagnosis Category (MDC) of disorders and 
diseases related to the musculoskeletal system, the 
nervous system and the connective tissues can 
induce a musculoskeletal and neurological 
rehabilitation process if the impairment criteria 
are fulfilled. 
… causing activity limitations and participation 
restrictions, considering the relevant contextual 
factors (personal and environmental)… 
Besides the impaired body structures or functions 
the other components of the ICF model are also 
included. ICF is useful to understand and measure 
health outcomes and is recognised as such by the 
WHO. No other classification was found that 
comprised so many outcomes. Participation refers 
amongst others to social reintegration, an essential 
goal of any rehabilitation process. 
…for whom there is a reasonable expectation of 
functional gain and/or increase in quality of life. 
The possibility to improve the functional level 
and/or the quality of life must be realistic. 
A distinction between improvement of functional 
level and quality of life is relevant. Different 
measures are used to evaluate both. Rehabilitation 
can result in a significant progress measuring the 
quality of life without a significant progress 
measuring functional level. 17 
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1.1.5.2 How? 
Rehabilitation Interpretation 
…comprises four core phases… By describing four core phases a reference to the 
Rehab-CYCLE 14, 18 is made. The Rehab-Cycle is a 
structured approach to rehabilitation 
management that includes all tasks, from 
problem analysis to the assessment of the effects, 
thereby involving the patient in clinical decision 
making. Emphasis is drawn on the patients' 
perspective (e.g. through patient-rated 
questionnaires), taking into account the patient's 
needs and preferences, and discussing therapy 
goals by means of the ICF Sheet 19. 
1) identification of the individual’s needs, 
preferences and capabilities … 
The particular differences between individuals’ 
needs and aspirations, the nature of individual 
professional interactions, and individuals’ 
rehabilitation readiness could diminish the 
chance of success.  Therefore it is advised to 
take the opinion of the professional as well as 
the opinion of the concerned individual or his 
advocates into account. 
… by use of a recognised functional assessment 
measure; 
The use of a recognised functional assessment 
measure makes it possible to assess individuals in 
a standardised way, to compare them and 
compose homogeneous groups. 
2) collaborative goal setting in partnership  with 
the patient or his/her advocates and the team 
members, focused on the restoration of function 
and prevention of activity limitations and 
participation restrictions, … 
There is a desire to meet the patient’s 
expectations and to achieve his or her 
commitment, but always taking into account 
practical and evidence-based knowledge of the 
rehabilitation team (e.g. aspects of secondary and 
tertiary prevention). Thus, this process of 
defining the target problems is usually the result 
of consent between the patient and the health 
care team. 
… including an indicative time frame; In order to avoid that rehabilitation becomes 
chronic care, an indicative time frame is 
desirable. 
3) evidence based activities with proven added 
value to achieve the predefined goals; 
Rehabilitation interventions may include 
measures to provide and/or restore functions, or 
compensate for the loss or absence of a function 
or a limitation. 
4) Assessment of the process against the agreed 
goals by means of the functional assessment 
measure used in step 1) and defining the 
necessity to reiterate the rehabilitation cycle. 
It is important to assess the output of the 
process in order to measure the efficacy and 
efficiency of the interventions. The possibility to 
reiterate the process is essential if goals appear 
not attained or if the health condition changes 
and new goals are defined. 
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1.1.5.3 Who? 
Rehabilitation Interpretation 
Different types of professionals can be involved 
in the performance of the rehabilitation process. 
An exhaustive list of professionals is not included 
in the definition. The involvement of a certain 
type of professional depends on the required 
rehabilitation activities as a function of 
individuals’ needs and goals. 
A multidisciplinary team intervenes in a 
coordinated interdisciplinary way in case of the 
presence of goals which require rehabilitation 
activities belonging to the unique domain of 
several disciplines. To do this in a coordinated 
way, a coordinator must be appointed. Because 
of the need for integration of medical 
information, such as diagnosis and prognosis, 
with paramedical, personal and environmental 
information, this coordinator is a physician 
specialised in rehabilitation medicine. 
A rehabilitation process is considered as mono-
disciplinary when there are goals requiring 
rehabilitation activities belonging to the domain 
of only one type or goals that can be equally 
performed by several types of disciplines.  
Professionals must have accredited skills and 
expertise, appropriate as related to the required 
interventions in order to achieve the predefined 
goals.  
The skills and expertise of these professionals 
must comply with specified quality requirements. 
1.1.5.4 Where? 
Rehabilitation Interpretation 
… services are provided in a rehabilitation 
organisation …. 
A rehabilitation organisation is a group of 
persons associated as members in a formally 
defined framework of interaction. The 
association is regarded as an entity because 
members share and interact in order to realise 
(at least some common) rehabilitation aims. 
A rehabilitation organisation is generally 
organised around different rehabilitation (and 
other) services. In the most practical terms a 
health care organisation is observable as a 
rehabilitation facility, a physical entity in which 
care, treatment or rehabilitation for the sick or 
the injured are provided by a group of specially 
trained people.  
… accredited as such by a recognised instance. Outcome of services as well as the rehabilitation 
organisation must comply with specified quality 
requirements. 
The most appropriate rehabilitation organisation 
is determined by criteria inherent in the 
individual’s characteristics, … 
Individual’s characteristics are personal (e.g. the 
presence of co-morbidities, age, gender) and 
environmental (e.g. social factors, geographical 
factors) 
… the complexity of the individual’s needs and 
including aims, … 
The aspect of different levels of complexity 
which induces the need for different levels of 
specialisation, could result in a stratified 
rehabilitation organisation. 
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… the different professionals concerned, … An interdisciplinary coordination in case of a 
multidisciplinary rehabilitation service includes 
some specific requirements for a rehabilitation 
organisation. 
… and the infrastructure required for the 
activities. 
Hospital facilities, therapy rooms, meeting-
rooms, equipment,… 
A rehabilitation organisation is part of a network 
which meets the demand for rehabilitation on all 
levels of specialisation and in all phases of the 
process. 
Rehabilitation must be organised along the 
continuum of care (in the acute, post-acute as 
well as the chronic phase). Close collaboration 
between the different facilities is necessary. It 
might be possible that geographical aspects affect 
the design of this network. 
1.1.6 Discussion 
The proposed definition which we will use as a framework during this project, is very 
comparable to the WHO definition of rehabilitation. 
Currently, the WHO defines rehabilitation as: "A progressive, dynamic, goal-oriented and 
often time-limited process, which enables an individual with an impairment to identify and 
reach his/her optimal mental, physical, cognitive and/or social functional level. 
Rehabilitation provides opportunities for the individual, the family and the community to 
accommodate a limitation or loss of function and aims to facilitate social integration and 
independence." 6 
Both definitions (Project & WHO) contain a clear reference to the ICF. Although there is 
only limited experience related to the use of the ICF in practice, there is an agreement on 
the more global approach on functioning covered by the different components of the ICF 
model.  
We recognise the imperfections of the newly developed definition. A term as ‘reasonable 
expectation’ is still too vague. A public discussion is necessary to identify clear criteria to 
consider reasonability because it concerns the allocation of public resources. We tried to 
describe ‘appropriate’ by incorporating a logical relation between individual’s needs, goals, 
interventions, professionals, infrastructure and equipment but this might still be 
insufficient. Also our attempt to distinct rehabilitation from chronic care by specifying that 
functional gain and/or increase in quality of life must be expected, can be insufficient. 
1.2 CONCLUSIONS 
This chapter contains a definition of musculoskeletal and neurological rehabilitation. 
A definition of musculoskeletal and neurological rehabilitation is developed based on a 
systematic search of the published literature. The researchers agreed on a patient centred 
focus. The definition is built around the outcome and goals of rehabilitation. Four main 
questions are answered in the definition: what, how, who and where.  
The definition of rehabilitation is a critical issue to be resolved in recommending both a 
patient classification system and options for the organisation model and financing system 
of rehabilitation. In the next chapter this conceptual definition will be made operational. 
With the new definition, the researchers recommend implicitly the move from a 
classification of rehabilitation programmes to a classification of rehabilitation patients. It 
will be a challenge to select a patient classification system which supports patient referral 
(clinical decision making) as well as resource allocation. 
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Key points 
• Policy makers need a global vision on rehabilitation for decision-making 
concerning organisation (and financing) of musculoskeletal and neurological 
rehabilitation. Therefore a conceptual framework as well as a definition are 
essential.  
• Four main questions have to be answered in the definition: what (individual 
and outcome), how (services), who (professionals) and where (organisation). 
• The WHO International Classification of Functioning, Disability and Health 
(ICF) is worldwide acknowledged as an international framework to describe 
health and disability. Its applicability will depend on its compatibility with 
currently used outcome measures and on the improvement of its 
practicability. 
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2 SELECTION OF PATHOLOGIES AND 
EPIDEMIOLOGY 
2.1 SELECTION OF DIAGNOSES 
Diagnosis as well as information about level of functioning, personal and environmental 
criteria are important for clinical decision-making and resource allocation in rehabilitation. 
20 a 
To formulate advice on organisation and financing musculoskeletal and neurological 
rehabilitation, some diagnoses were selected because of a lack of available information 
concerning the level of functioning. For these diagnoses epidemiological data were 
collected, clinical practice patterns were investigated and critical pathways of different 
countries were analysed and compared. 
The selection criteria for the diagnoses were: 
• Criterion A: The diagnoses have to induce a musculoskeletal and/or 
neurological rehabilitation process; 
• Criterion B: The diagnoses have to differ mutually concerning 
characteristics of concerned individuals (e.g. age), progress, impaired 
body structures and functions causing activity limitations and/or 
participation restrictions; 
• Criterion C: The diagnoses have to be of high incidence and prevalence; 
Children were excluded because of the specificity of the approach. 
The researchers could have used the Minimal Clinical Data sets (Minimale Klinische 
Gegevens = MKG; Résumé Clinique Minimum = RCM) which contain the ICD-9 codes per 
hospital admission in Belgium to determine the medical diagnoses inducing an admission in 
a rehabilitation unit.  Because of time restrictions the researchers looked for existing 
medical rehabilitation databases which were used to build a classification system. 
The Uniform Data System for medical rehabilitation (UDSmr) seems a reliable source of 
data to select medical diagnoses which meet the selection criteria. In 1988, UDSmr began 
data collection and reporting services for facilities that provide comprehensive medical 
rehabilitation services for adults. The UDSmr is used by approximately 60% of the 
rehabilitation facilities in the United States and by facilities in Australia, Canada, France, 
Germany, Italy, Japan, Portugal, and Sweden. Currently, this database includes over 13 
million patient assessments. The centrepiece of the system is the Functional Independence 
Measure (FIM), which measures the functional ability of individuals for 18 items across the 
motor, cognitive, and self-care domains. FIM is the most widely accepted functional 
assessment measure in use in the rehabilitation community. The UDSmr also contains 
impairment codes (= diagnoses). The UDSmr was used for the development for the FIM-
FRGs. 
The FIM-FRGs were developed in 1994 by Margaret Stineman 21 based on 36.980 patient 
records from 57 freestanding rehabilitation hospitals and 68 units from 35 states in the 
United States that subscribe to the UDSmr. In the first version only 18 impairment 
categories were defined. A second version of this model was developed in 1997 22 which 
includes two new impairment categories as well as separate groups for patients admitted 
for evaluation only. 
In the FIM-FRG, the patient impairment category, functional status at admission to 
rehabilitation, and patient age were used to develop groups that were homogeneous with 
respect to length of stay. In the FIM-FRG the functional status and age are criteria of 
distinction between different groups. 
                                                
a  http://www.who.int/classifications/icf/en/ 
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The FIM-FRG include probably most of the impairment groups which can induce a 
rehabilitation process ((+) Criterion A). The FIM-FRG are compounded taking into 
account impairment group, functional status and patient age ((+) Criterion B). 
For the selection of diagnoses some principles were respected, which are represented in 
Figure 2.1 and Figure 2.2. Only diagnoses within the Medical Diagnostic Categories of 
disorders and diseases related to the neurological system or the musculoskeletal system 
and the connective tissues were withheld ((+) Criterion A) (Figure 2.1 = green dots). 
Within these only the top 5 of well defined diagnoses with a high incidence were kept ((+) 
Criterion C) (Figure 2.2 and Figure 2.1 = green left-right lines). An exception was made 
for the two impairment categories of spinal cord which were also retained for the reason 
that a small group of individuals with very specific rehabilitation needs might require a 
special approach related to organisation and financing (Figure 2.2 and Figure 2.1 = blue 
right-left lines). Even though traumatic brain injury (TBI) requires a specific rehabilitation 
service, traumatic brain injury was not included for the purpose of the study due to 
overlap concerning patients’ profile with spinal cord injury and the clinical characteristics 
with stroke patients. Moreover, they appear even less frequent than spinal cord injury. 
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Figure 2.1: Link of the UDSmr Impairment groups to the FIM-FRG 
Impairement categories (Version 1994) and the Major Diagnostic Groups 23. 
Major Diagnostic Categories FIM-FRG Impairment Categories (Version 1.1) UDSmr Impairment Group Codes
Left body (right brain)
Right body (left brain)
Bilateral
No paresis
Other stroke
2) Brain dysfunction, nontraumatic Other brain
Open injury
Closed injury
Paraplegia incomplete
Paraplegia complete
Quadriplegia incomplete C1-4
Quadriplegia incomplete C5-8
Quadriplegia complete C1-4
Quadriplegia incomplete C5-8
Other non-traumatic SC
Paraplegia incomplete
Paraplegia complete
Quadriplegia incomplete C1-4
Quadriplegia incomplete C5-8
Quadriplegia complete C1-4
Quadriplegia incomplete C5-8
Other traumatic SC
Multiple sclerosis
Parkinsonism
Polyneuropathy
Other neurologic
Single lower extremity above the knee
Single lower extremity below the knee
Double lower extremity above the knee
Double lower extremity above/below the 
knee
Double lower extremity below the knee
Single upper extremity above the elbow
Single upper extremity below the elbow
Other amputation
9) Osteoarthritis Osteoarthritis
Rheumatoid arthritis
Other arthritis
Status post hip fracture
Status post femur (Shaft) fracture
Status post pelvic fracture
Status post major multiple fracture
Status post hip replacement
Status post knee replacement
13) Other orthopedic Other orthopedic
Chronic obstructive pulmonary disease
Other pulmonary
4. Diseases and disorders of the 
circulatory system
15) Cardiac Cardiac
Brain + spine cord
Brain + multiple fracture/amputation
Spinal cord + multiple 
fracture/amputation
Other multiple trauma
Neck pain
Back pain
Extremity pain
Other pain
Burns
Spinabifida
Other congenital
Other disabling impairments
3. Diseases and disorders of the 
respiratory system
2. Diseases and disorder of the 
musculoskeletal system and the 
connective tissues
1. Disease and disorders of the nervous 
system
17) Pain
11) Orthopedic: Lower extremity fracture
12) Orthopedic: Lower extremity joint 
replacement
14) Pulmonary
6) Neurological conditions (otherwise not 
classified)
7) Lower extremity amputation
8) Other amputation
18) Otherwise not classified
No direct equivalent
No direct equivalent
5. Major multiple trauma 16) Major multiple trauma
10) Other arthritis
1) Stroke
3) Brain dysfunction, traumatic
4) Spinal cord injury, nontraumatic
5) Spinal cord injury, traumatic
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Figure 2.2: Number of cases per FIM-FRG Impairment category 22. 
Impairment category N Number of FRGs Variables R²
Stroke 26183 9 M,C,A .26
Nontraumatic brain 2513 4 M,A .24
Traumatic brain 3214 5 M,C .32
Nontraumatic spinal cord 2609 4 M .23
Traumatic spinal cord 1831 4 M .30
Guillain-Barré 388 2 M .30
Neurological 3558 2 M .13
Lower extremity fracture 12445 4 M,C .09
Joint replacement 12658 7 M,C,A .16
Other orthopedic 3715 2 M .08
Lower limb amputation 3256 2 M .07
Other amputation 211 1 - -
Osteoarthritis 1651 2 M .12
Rheumatoid arthritis 1469 2 M .10
Cardiac 1038 2 M .15
Pulmonary 1075 3 M .19
Pain 1591 2 M .02
Major multiple trauma (MMT) 534 2 M .18
MMT with brain/spine injury 435 3 M,C .37
Miscellaneous 4163 3 M .15
Evaluation only 910 2 M .08
Overall System 85447 67 .32
Cross-validation R²
M = Motor-FIM; C = Cognitive-FIM; A = Age
Characteristics of FIM-FRGs Version 2.0
 
This selection of diagnoses was discussed with an expert panel. Lower extremity fractures 
were considered as too variable related to rehabilitation needs and goals. For that reason, 
they were excluded from the selection. Within the group of neurological conditions only 
multiple sclerosis was withheld because it affects a rather young population and is 
characterised by a specific course of recurrent acute episodes. Within the group of lower 
extremity joint replacements, the total hip replacements were withheld. Finally five 
diagnoses were selected: stroke, multiple sclerosis, total hip replacement, spinal cord 
injury and lower extremity amputation. For these diagnoses incidence and prevalence 
numbers were searched. 
To check if the selected diagnoses were representative for Belgium, we analysed the 
results of the Pathos-Aggir-Socios project coordinated by Prof. Marie-Christine Closon in 
200524. During this project a compilation of different measurement tools was tested in a 
sample of Belgian hospitals and, amongst other aspects, the diagnoses requiring 
rehabilitation was registered.  
It seemed that of all individuals with musculoskeletal and/or neurological lesions admitted 
on a Sp facility (for a list of all diagnoses causing musculoskeletal and/or neurological 
lesions see attachment) 75% was diagnosed with one of the five selected diagnoses. Sp 
facilities are facilities for specialised care and are not bound to respect an average length 
of stay (in contrast with acute beds). Therefore, individuals with rehabilitation needs are 
mostly admitted to such a facility and not to an acute care facility. These results are an 
indication that the chosen diagnoses are fairly representative. 
It is interesting to compare the percentages in Figure 2.3 with the percentages per FIM-
FRG impairment category as presented in Figure 2.1 and 2.2. In Figure 2.3, on a total of 85 
447 patient cases, Stroke accounts for 30.6%; Neurological conditions not otherwise 
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specified for 4.1%; SCI for 5.2%; Joint replacement (knee and hip) for 14.8% and LEA for 
3.8%. 
Figure 2.3: Pathos-Aggir-Socios: Diagnoses which underlie rehabilitation needs 
(Inpatient) 
Of all patients with musculoskeletal and/or 
neurological lesions, admitted on a Sp 
service
Stroke 28%
MS 10%
SCI 8%
THR 26%
LEA 3%
Selected diagnoses 75%
Musculoskeletal and 
neurological lesions 100%
 
2.2 EPIDEMIOLOGY 
2.2.1 Methodology 
In the literature search for epidemiologic data, the focus was on incidence, prevalence and 
mortality. If available, data on the degree of dependence were collected but because of 
unclear use of validated scales, these data were only mentioned in the attachments. See 
also the attachments to consult more details. 
Initially, the researchers searched the Pubmed database for studies published after January 
1, 2000 that might contribute to an up-to-date view on incidence and prevalence data of 
the selected diagnoses in Belgium, The Netherlands, Germany, France and Great Britain. 
Pubmed was searched using the MeSH terms “Epidemiology”, “Incidence”, “Prevalence”, 
“Statistics and numerical data” and “Trends”, combined with the diagnoses and the 
mentioned country names or the MeSH term “Rehabilitation”. Reference lists of incidence 
or prevalence studies were also examined. If for certain diagnoses only few articles were 
published after January 1, 2000 the search was extended to the period before January 1, 
2000 without mentioning country names. 
Earlier research for incidence and prevalence data for amputations and spinal cord injuries 
was done by a team of the Federal Centre of Expertise for the Health Care Sector25. The 
studies selected by this team were included additionally.  
Finally, the researchers asked Belgian experts whether they were aware of any relevant 
papers. 
Only papers reporting incidence or prevalence data of the total population of a region 
were scanned. In other words, papers that only consider individuals presenting a certain 
pathology or treated with a specific therapy were excluded. However, there is a difference 
in population selection between the papers. Some papers contain data collected at the 
level of a facility, other papers contain data collected at the level of a community. The first 
type of data selection might be less complete because not all individuals reach a facility 
after for example a traffic accident or a stroke. 
The search algorithms and results can be found in the attachments. 
2.2.2 Results 
28 relevant publications were found for ‘Stroke’, 11 for ‘Total Hip Replacement’, 10 for 
‘Multiple Sclerosis’, 10 for ‘Lower Extremity Amputation’ and 18 for ‘Spinal Cord Injuries’. 
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2.2.2.1 Stroke 
INCIDENCE 
For Belgium, crude incidence data for stroke (first ever AND recurrent) vary from 200 to 
230 per 100 000 inhabitants per year 26, 27. After age adjustment more males (196 per 100 
000) than females (163 per 100 000) are affected by stroke (first ever AND recurrent) 28. 
Age and gender adjusted incidence for stroke (first ever AND recurrent) is situated 
around 185 per 100 000 inhabitants per year 29, 30. In a recent (2006) review using the 
structure of WHO’s stroke component of the WHO InfoBase, studies on stroke 
epidemiology published in peer-reviewed journals were analysed. It concerned 44 
incidence studies and 12 prevalence studies. Data for Belgium are presented in Figure 
2.4.31 
Figure 2.4: Stroke incidence estimates for Belgium 31 
Men Women
25–34 19 12
35–44 37 23
45–54 139 84
55–64 312 186
65–74 812 550
75–84 1446 1237
85+ 1754 1661
Age
Belgium
 
Internationally, crude incidence for stroke (first ever AND recurrent) ranges from 174 to 
224 per 100 000 inhabitants per year 32, 33. Crude incidence for first ever stroke is situated 
around 280 per 100 000 inhabitants per year 32 , 34, 35, that is a large number compared to 
the other data obtained and as a consequence to consider with reserves. And, as in 
Belgium, more males (280 per 100.000) than females (200 per 100 000) were affected 36. 
Age adjusted incidence for stroke (first ever AND recurrent) ranges from 101 to 285 per 
100 000 inhabitants per year for males and from 47 to 198 per 100 000 inhabitants per 
year for females 37. Age adjusted incidence for first ever stroke ranges from 100.4 to 182 
per 100 000 inhabitants per year 38, 33, 39-41. 
Age and gender adjusted incidence for stroke (first ever AND recurrent) ranges from 220 
to 269 per 100 000 42, 43. Age and gender adjusted incidence for first ever stroke ranges 
from 161 to 208 per 100.000 inhabitants per year 33, 42, 35 
KCE reports 57 Musculoskeletal & Neurological Rehabilitation 25 
PREVALENCE 
Belgian data on stroke prevalence were obtained via a recent review using the structure of 
WHO’s stroke component of the WHO InfoBase. Studies on stroke epidemiology 
published in peer-reviewed journals were analysed. It concerned 44 incidence studies and 
12 prevalence studies. See Figure 2.5. 31 
Figure 2.5: Stroke prevalence rates for Belgium 31 
Men Women
25–34 114 65
35–44 218 124
45–54 1072 804
55–64 2185 1476
65–74 5052 3568
75–84 7830 6260
85+ 9403 8362
Age
Belgium
 
Internationally, large differences in prevalence data of stroke appeared. In one publication 
the prevalence of stroke was estimated at 750 per 100 000 43. In another publication the 
prevalence was estimated about 100 per 100 000 44 what is probably an underestimation 
in comparison with the incidence data. 
MEAN AGE AND MORTALITY  
The mean age at onset for males is 63.3 years, for females 71.4 years 36. Yearly stroke 
mortality ranges at 28 days from 15.9% to 33% and at 1 year from 26.3% to 37.3% 45, 33 , 41 , 
35 . 
2.2.2.2 Total Hip Replacement 
INCIDENCE 
The crude incidence of total hip replacement in Belgium was about 160 per 100 000 
inhabitants in 2004 46. 
Internationally, the crude incidence of total hip replacement ranges from 58 to 126 per 
100 000 47, 48 .  
Age standardized incidence of total hip replacement (primary and revision) ranges from 
112 to 113 per 100 000 49. Age standardized incidence of primary hip replacement show a 
higher incidence for females (87.1 per 100 000) then for males (65.5 per 100 000 50. The 
same counts for the hip revisions (females: 21.0 per 100 000; Males: 16.6 per 100 000) 51. 
Age and gender standardised incidence of primary hip replacement ranges from 134 to 
193 per 100 000, of revisions from 21.1 to 43 per 100 000 52, 53. 
In 2004, 16 599 THR were registered in Belgium 46. 
PREVALENCE 
An estimation of the prevalence of hip disease severe enough to require surgery was 1520 
per 100 000 aged 35-85 54  
MEAN AGE AND MORTALITY 
The mean age of the population undergoing a primary hip replacement is 68.6 years and 
71.8 years within the population undergoing a revision 51 
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Mortality within 90 days after a total hip replacement is 1100 per 100 000 47 
2.2.2.3 Multiple Sclerosis 
INCIDENCE 
No Belgian data were found. 
Crude incidence of multiple sclerosis ranges from 4.3 to 6.1 per 100 000 55 , 56 , 57; 58. 
A recent review contains an estimation of the mean multiple sclerosis incidence in Europe 
of 4 to 4.2 per 100 000. In this review the estimation is based on data from Croatia, 
Denmark, Finland, France, Greece, Hungary, Iceland, Italy, Malta, Norway, Poland, Spain, 
Sweden, Ukraine and the U.K. 59 , 60 
PREVALENCE 
In Belgium there is a prevalence of 87.5 to 87.9 per 100 000 population 61; 62. More 
females (101.3 per 100 000) have multiple sclerosis than males (73.8 per 100 000) 62 
Internationally, the prevalence of MS ranges from 87.5 to 149.1 per 100 000 63 , 64, 56 , 61 , 57 ; 
58. For females this ranges from 11 to 282 per 100 000. For males this ranges from 10 to 
123 per 100 000 60. Female/Male ratio: from 1.1 to 3.4 60 
MEAN AGE AND MORTALITY 
The incidence peaks for females in the age interval 25 years – 29 years, for males in the 
age interval 30 years – 34 years 58.  
Mean survival time after onset ranges from 30 to 45 years 60 
2.2.2.4 Lower Extremity Amputation 
INCIDENCE 
In Dutch Limburg, a southern province of the Netherlands, the crude incidence of major 
lower extremity amputation is 17.1 per 100 000 inhabitants per year 65. In the north of 
The Netherlands, the incidence of major lower extremity amputation is about 19 per 100 
000 inhabitants 66. 
Internationally, the crude incidence of lower extremity amputation ranges from 15.4 to 34 
per 100 000 67, 68 , 69 , 70 ; 65. Only one report speaks about a major amputation rate that 
ranges from 20 to 50 per 100 000 inhabitants per year 71. The below-knee/above knee 
ratio varied from 0.76 to 0.78 67, 70 . In one report a ratio of 2.5 was mentioned but it is 
unclear if only major amputations were withheld as below-knee amputations 71. Crude 
incidence of the major lower extremity amputations ranges from 8.8 to 11.7 per 100 000 
69 , 72. Belgian RIZIV/INAMI data (see chapter 10) point towards 12 per 100.000. 
The incidence of lower extremity amputations was 10 times higher in diabetic subjects 
compared to non-diabetic subjects 73. For people with diabetes the crude incidence ranges 
from 383 to 440 per 100 000 68 , 73. For people without diabetes the crude incidence is 
situated around 38 per 100 000 73. 
The age adjusted incidence of all major Lower Extremity Amputations ranges for males 
from 3.7 to 58.7 per 100 000 and for females from 0.5 to 32.0 per 100 000 74. 
PREVALENCE 
No prevalence data were found. 
MEAN AGE AND MORTALITY 
No data about mean age were found. 
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Early hospital mortality after major lower extremity amputation is 7.6%, after minor lower 
extremity amputation 0.8% 72. 
2.2.2.5 Spinal Cord Injury 
INCIDENCE 
In literature, it was not always explained that only spinal cord injuries surviving the acute 
phase were included. This may influence the incidence data. Additionally, it was not always 
mentioned whether it concerned traumatic or non-traumatic spinal cord injuries. Looking 
at Figure 2.2, a difference in incidence of both causes is suspected. Indeed, the traumatic 
spinal cord injuries represent 67.5%, the non-traumatic 32.5% 75. 
A recent (2006) review of the literature published since 1995 on Pubmed was performed. 
The incidence of spinal cord injury in Europe ranges from 1.04 to 2.97 per 100 000 (based 
on data of 7 studies). This is the lowest incidence compared to other continents, South-
America and Africa being excluded because no studies from these continents were found. 
76. 
Incidence rates for males are consistently higher for females 77; 78. 
In older publications, the crude incidence of SCIs ranges from 1.21 to 5.78 per 100 000 79 
;80, 81, 77 ; 82; 83; 78. The crude incidence of SCIs surviving the acute phase ranges from 1.04 to 
4.43 per 100 000 79; 77. The crude incidence of traumatic spinal cord injury : 1.27 per 100 
000 population per year 84. Some caution with the interpretation is needed because it 
concerns an old publication (1978). 
The age adjusted incidence rate is 1.45 per 100 000 per year 85, 86, 83, 87. The age and gender 
adjusted incidence rate ranges from 2.71 to 7.1 per 100 000 85; 81. 
The results concerning mean incidence of SCI in a European survey (experts were 
contacted in 21 countries), published in the December 2006 Newsletter of ISCOS 
(International Spinal Cord Society), showed an incidence of 1.75 per 100 000 inhabitants. 
PREVALENCE 
A recent (2006) review of the literature published since 1995 on Pubmed was performed. 
The prevalence of SCI ranges from 28 to 68.1 per 100 000. These data are based on the 
results of only 2 studies: Australia and Finland. 76 
In older publications, the prevalence of SCI ranges from 7.2 to 112 per 100 000 80, 88, 81, 82  
The prevalence of traumatic SCI ranges from 25 per 100 000 84. 
MEAN AGE AND MORTALITY 
Spinal cord injuries appear mostly in the age interval 33 years to 50 years 78, 76. Limited to 
traumatic spinal cord injuries, the mean age is situated around 29 years 84, 89. 
2.3 CONCLUSION 
Diagnoses were identified respecting some well defined criteria. During discussions with 
an expert panel, stroke, total hip replacement, multiple sclerosis, lower extremity 
amputation and spinal cord injury were selected to investigate more in detail in the course 
of this project. 
Of the five selected pathologies, stroke has the highest incidence but affects the oldest 
part of the population (mostly after retirement) and has the highest mortality rate within 
the first year after the incident. Moreover, stroke has a high recurrence rate. Of the 
survivors, less then 50% is independent for activities of daily living afterwards. Only one 
report presents data related to LOS and discharge destination which is too limited to 
make conclusions. 
Total hip replacement also affects a rather large population and concerns mostly older 
individuals (after retirement). The crude incidence in Belgium is about 160 per 100 000 
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per year. As will be described in the chapter concerning clinical pathways, loss of level of 
functioning is limited in time. 
Multiple sclerosis is characterised by a low incidence. Because of a long mean survival 
time, the prevalence in Belgium ranges between 87.5 and 87.9 per 100 000. Individuals are 
usually affected by the first symptoms at young age (35y-49y). The progress of the disease 
requires different types and intensity of therapy depending on the stage. 
Lower extremity amputation has a low incidence and affects especially diabetics. No data 
about the median age were reported. Above knee amputations were performed more 
often than below knee amputations (4/3). Prosthetic fitting is less frequent among patients 
with above knee amputations. 
Spinal cord injury has the lowest incidence compared to the other pathologies in our 
selection (1-3 per 100 000 per year). The most important cause of spinal cord injury is  
trauma. Moreover, spinal cord injury is often associated with other lesions. Length of stay 
is significantly higher after traumatic SCI compared to non-traumatic spinal cord injury. 
Very young individuals are affected. Earlier research showed that life expectancy is not 
significantly reduced under the condition that complications are prevented. As a 
consequence, prevalence numbers up to 112 per 100 000 are mentioned. 
Information concerning incidence and prevalence is relevant in the organisation and 
financing of rehabilitation services. 
Key points 
• For the organisation and financing of rehabilitation services, information on 
specificity and frequency of rehabilitation needs for a certain diagnostic 
category is necessary. However, this information is scarse in literature. As a 
consequence, only incidence and prevalence of diagnostic categories was 
looked for. 
• Of the five selected pathologies stroke and THR have the highest incidence, 
MS and lower extremity amputation are less frequent and SCI has the lowest 
incidence. 
• Stroke occurs more frequently with increasing age and has a high mortality 
and recurrence rate. Incidence (about 185/100 000 per year) and prevalence 
numbers for Belgium are available, but this is not a clear indicator for 
rehabilitation needs. In Belgium 1/3 of inpatient rehabilitation services are 
delivered to stroke patients. 
• THR is a temporary condition; the incidence found for Belgium is about 160 
per 100 000 per year.  
• MS occurs at young age and is usually progressive; its fluctuating nature 
makes it difficult to predict rehabilitation needs. The prevalence in Belgium 
is about 90 per 100 000 per year. 
• SCI occurs at young age. The incidence in European countries is about 1 to 3 
per 100 000 per year. 
• Lower limb amputation has an incidence rate of 12 per 100 000 per year in 
Belgium; the incidence rate of major limb amputation in Western countries 
is estimated from 8.8 to 11.7 per 100 000 per year. The below/above knee 
ratio is about ¾; prosthetic fitting is less frequent in the latter so that 
roughly the same number of prostheses is provided for below/above knee 
amputations. 
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3 OUTCOME MEASURES, OUTCOME MODELS 
AND PATIENT CLASSIFICATION SYSTEMS 
3.1 INTRODUCTION 
This chapter contains a translation of the conceptual definition of musculoskeletal and 
neurological rehabilitation into practice. The principal goal is to have tools available to 
support decisions to the four main questions: 
• What?   Æ Individual and Outcome 
• How?   Æ Methods  
• Who?   Æ Professionals 
• Where?   Æ Organisation and Infrastructure 
Outcome measures are necessary to explore individuals’ needs and capabilities and are 
essential to assign an individual to an appropriate rehabilitation programme (What?). By 
one outcome measure only a limited set of outcomes is measured. To have an integrated 
view on the patients’ needs, preferences and capabilities a compilation of all possible 
outcomes into an outcome model such as the International Classification of Functioning, 
Disability and Health (ICF) is essential. 
To structure inflow of individuals (What?) and determine the type and intensity of 
required interventions (How?), the professionals to be involved (Who?) and the preferred 
organisation (Where?), a patient classification system is required. Patient classification 
systems (PCS) should contain groups of individuals, homogeneous related to outcome and 
required resources. Such a PCS can serve as a patient selection and referral tool, a 
framework for selection of therapy as well as for a financing system. In existing patient 
classification systems individuals are homogeneously grouped related to resource 
consumption (length of stay (LOS)) but they can not serve for patient referral purposes 
because they lack sufficient information for clinical decision making. 
The final outcome of the rehabilitation process is the main quality criterion. Accreditation 
requirements for professionals and services are necessary in creating the possibility to 
deliver services of high quality. 
This chapter describes internationally used tools or tools that are applied to a large 
population. Internationally applied tools make it possible to compare the Belgian situation 
with the situation in other countries by use of common parameters. If relevant, these 
tools will be proposed for each selected pathology (Spinal Cord Injury, Lower Extremity 
Amputation, Stroke, Multiple Sclerosis and Total Hip Replacement). Outcome measures 
can differ for different pathologies. For the purpose of this study though, one PCS for all 
musculoskeletal and neurological rehabilitation indication is preferable. 
3.2 OUTCOME MEASURES 
3.2.1 Introduction 
Outcome measures inform about individuals’ needs, preferences and capabilities at the 
start and the end of the rehabilitation process. In daily practice, the results of outcome 
measures are used to orient health care professionals towards an appropriate type and 
intensity of therapy. Each outcome measure covers a limited set of outcomes. A 
compilation of several outcome measures is often required to have enough information 
for a tailored therapy. Some outcome measures serve in a patient classification system as a 
relative parameter for allocation of resources (e.g.: Functional Independence Measure 
(FIM), Barthel Index (BI)). 
A search on outcome measures was performed on Pubmed with the algorithm "Outcome 
Assessment (Health Care)"[MeSH] AND "Rehabilitation"[MeSH] published later than 1999 
and delivered 4780 results. A search on Google with the keywords “the use of outcome 
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measures in rehabilitation” delivered a link to the Pro-Esor-study “The use of outcome 
measures in physical medicine and rehabilitation in Europe” 90. The aim of the study was to 
survey the use of outcome measures in rehabilitation within Europe. The survey focused 
on nine diagnostic groups: hip and knee replacement, low back pain, lower limb amputees, 
multiple sclerosis, neuromuscular disorders, rheumatoid arthritis, spinal cord lesions, 
stroke and traumatic brain injury. It identified a relatively small number of dominant 
outcome assessments for each diagnostic group and some variation in the preference for 
measures across regions. The five diagnostic groups selected for this project were 
included although the described methodology can be extended to other pathologies. A 
comparable study was performed in Australia “Outcome measurement in Australian 
rehabilitation environment” 91. For this study the original survey questionnaire of the Pro-
Esor study was used. Three of the five diagnostic groups selected for our project were 
included. 
3.2.2 Outcome measures used in rehabilitation 
The results of the Pro-Esor Study and the Australian study for the 5 selected pathologies 
are included (See Appendix to chapter 3). For each pathology the most frequently applied 
outcome measures are listed based respectively on a survey of 418 rehabilitation centres 
across Europe and 440 across Australia.  
3.2.3 Discussion 
An outcome measure supports by preference clinical decision making as well as resource 
allocation. This outcome measure must be applicable for most diagnostic groups and must 
be useful to groups of individuals needing comparable resources.  
FIM is the only instrument used for outcome measurement in each diagnostic group. 
Barthel Index is used in nearly each diagnostic group. In literature both outcome measures 
are considered as competing instruments 92, 93 . Appropriateness and responsiveness of 
outcome measures such as FIM and BI requires an extensive search of the literature. 
FIM and BI are tools measuring level of dependence related to activities of daily living. The 
results of this measurement can be used to estimate workload. But neither FIM nor 
Barthel Index measure rehabilitation needs. Nevertheless, they are currently used to 
classify patients into homogeneous groups related to resource consumption during 
rehabilitation (LOS).  
3.3 OUTCOME MODELS 
3.3.1 International Classification of Functioning, Disability and Health (ICF) 
For this project, the concept of an outcome model is used. Several interpretations of this 
term exist. Within the framework of this project an ‘outcome model’ is considered as a 
structured compilation of all possible outcomes as a consequence of a health condition. 
An outcome model is required to identify individuals with different types of disabilities or 
to examine the effect of interventions. One common classification system for clinical 
decision making as well as resource allocation could not be found in literature. The reason 
might be that clinical relevant outcomes can differ from one health condition to another 
and thus give rise to many subgroups. Within a payment model, subgroups need to be 
limited, otherwise the model becomes impractical . 
ICF is an ‘outcome model’. The project team as well as the expert panel agreed on the use 
of this model because it is a member of the WHO Family of international classifications 
and it is internationally considered as the most complete set of possible outcomes as a 
consequence of a health condition. The WHO worked previously with the International 
Classification of Impairments, disabilities and handicaps (ICIDH) b (= the model preceding 
ICF), a model proposed by Saad Nagi from the Institute of Medicine and the National 
Advisory Board on Medical Rehabilitation Research model 94 95.  
                                                
b  http://www.cdc.gov/nchs/about/otheract/icd9/icfhome.htm 
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For information on the ICF, the website of the WHO c, the website of the International 
Classification of Functioning, disability and health d , and the website of ICF Research 
Branch, WHO FIC Collaborating Center (DIMDI), Institute for Health and Rehabilitation 
Sciences, Ludwig-Maximilian University in Munich e, were consulted. Publications of Prof. 
Gerold Stucki, MD, MS, director of the ICF Research Branch of the WHO, were searched 
on Pubmed. Opinions about the use of the ICF were collected by expert contacts. Expert 
selection was based on references mentioned in publications or on references of 
contacted experts. 
The International Classification of Functioning, Disability and Health is the result of the 
revision of the ICIDH. ICF is endorsed by the World Health Assembly as a member of the 
WHO Family of International Classifications in 2001. It is the generally accepted 
framework to describe functioning in rehabilitation. 
The joint use of ICF and the International Classification of Diseases ICD-10, needs to be 
addressed when applying the ICF to rehabilitation medicine. WHO considers the ICF and 
the ICD-10 to be distinct but complementary classifications.  
ICF is structured around the following broad components (Figure 3.1): 
Figure 3.1: ICF model 
ICF 2001
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Functioning and disability are viewed as a complex interaction between the health 
condition of the individual and the contextual factors (environmental an personal). The 
picture produced by this combination of factors and dimensions is of "the person in his or 
her world". Within ICF these dimensions are considered as interactive and dynamic rather 
than linear or static. It allows an assessment of the degree of disability, although it is not a 
measurement instrument. It rather defines “what to measure”. ICF can contribute to the 
integration of the results of different outcome measures. 
ICF must be compatible with these measures. Items of assessment instruments used in 
rehabilitation should be linked to ICF domains. ICF linking rules 96 are being developed to 
link technical and clinical measures, health-status measures and interventions to ICF. It will 
be essential to know how scores from a specific assessment instrument can be mapped to 
the scores used in the ICF. ICF scores represent ‘performance’ in real life or ‘capacity’ 
(with or without assistance), typically in a rehabilitation test situation. However, the most 
widely used instruments in acute and sub-acute rehabilitation, including FIM, measure 
                                                
c  http://www.who.int/classifications/icf/en/ 
d  http://www3.who.int/icf/icftemplate.cfm 
e  http://www.icf-research-branch.org/aboutus/history.htm 
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assistance. It will be a challenge to link the grading of assistance related to performance 
and capacity. 
Core sets per pathology will improve applicability because ICF covers hundreds of 
different outcomes. It is not possible to score every individual related to all outcomes. 
Condition specific core-sets can be defined as a selection of ICF domains including the 
least number of domains but as many as required to be sufficiently comprehensive to 
cover the prototypical spectrum of limitations in functioning and health encountered in a 
specific condition. Scientifically based condition-specific core-sets are currently being 
developed in a collaborative project of the University of Munich with the Classification, 
Assessment, Surveys and Terminology Group (CAS) of WHO 14, 18. Core-sets are yet 
validated for several health conditions such as rheumatoid arthritis, osteoarthritis, stroke, 
chronic pain and osteoporosis. 
ICF success depends on its compatibility with measures used in rehabilitation and on the 
improvement of its applicability. It is expected to see the development of ICF, based on 
versions of currently used measurements, and on the development of ICF core sets.14, 18 
By several experts, it has been claimed that ICF may also be used for the development of 
prospective payment systems. While current systems such as the FRGs are based on the 
FIM, future concepts may prefer to base their predictive models on more comprehensive 
and condition or context-oriented ICF-based sets of domains (See attachments). 
3.3.2 Conclusion 
ICF can be used as a conceptual framework although the operational application of ICF is 
still experimental. In terms of clinical utility and long-term consistency of ICF, it makes 
sense to select relevant parameters from ICF respecting the requirements for developing 
a scientific classification, then to examine the coverage of these parameters provided in 
existing instruments. Once the clinical records are back-coded, resource use can be linked 
to the resulting ICF profiles.  
3.4 ‘ASSESSMENT’ INSTRUMENTS 
Several outcome measures, patient classification systems and an outcome model are 
discribed in this chapter. Besides these, two ‘assessment’ instruments were identified. 
‘Assessment’ instruments are outcome measures which include a classification of 
individuals. One is the Minimal Data Set for Post-Acute Care, detected during the search 
for patient classification systems as discussed in the next chapter. The other instrument is 
“Pathos-Aggir-Socios”24, developed durring a previous study ordered by the Belgian 
government. These instruments, combine information on outcome with information on 
clinical status, treatment, management and resource consumption. 
3.4.1 Minimal Data Set - Post Acute Care (MDS-PAC) 
The first instrument is the Minimum Data Set – Post Acute Care (MDS-PAC) 97. In 1999-
2000, the Centres for Medicare and Medicaid Services (CMS), formerly the Health Care 
Financing Administration, developed the MDS-PAC, an original and very detailed 
assessment instrument for all post-acute care settings. The MDS-PAC is not (yet) used in 
practice. 
MDS-PAC is a comprehensive data collection tool, with over 400 items, including socio-
demographic information, pre-admission history, advance directives, cognitive and 
communication patterns, mood and behaviour patterns, functional status, bladder/bowel 
management, diagnoses, medical complexities, pain status, oral/nutritional status, 
procedures/services, functional prognosis, and resources for discharge. 
It has been assessed extensively and includes a functional status assessment as informative 
as FIM, because it uses similar items, and it shows similar validity and inter-observer 
reliability. In addition, MDS-PAC provides information on treatment, management, and 
clinical status. However, the implementation of MDS-PAC, both as an assessment and a 
reimbursement tool, was halted in 2002 and CMS instead proposed the Inpatient 
Rehabilitation Facilities – Patient Assessment Instrument (IRFs-PAI), which includes FIM as 
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a measure of patient functional status and is a variation on the FIM-FRG. Implementation 
of the instrument was halted because it consists of over 400 data elements, many of which 
simply did not apply to the care and management of many patients 98.  
With MDS-PAC it seemed possible to estimate actual rehabilitation costs and define 
reliable regression models to predict costs based on individual patient characteristics. An 
Italian team defined comprehensive measures of clinical status and detailed measures of 
resource consumption by use of MDS-PAC but they concluded that a direct comparison 
with the long-established FIM-FRGs is needed 97. 
3.4.2 Pathos-Aggir-Socios 
Pathos-Aggir-Socios was adapted in Belgium by Prof. M.-C. Closon and Dr. L. Habimana 
(Centre Interdisciplinaire en Economie de la Santé, UCL). It combines three instruments 
originally applied in geriatric settings: Pathos, Socios, Aggir. f 
Pathos-Aggir-Socios estimates the workload related to the care for the rehabilitation 
population. It maps the population of different rehabilitation facilities, based on the 
perception of the health providers. It can not be used for the planning of a rehabilitation 
programme at the level of an individual or for an estimation of required resources ex ante. 
No studies report on the Pathos-Aggir-Socios used in a rehabilitation setting or in 
comparison to other outcome measures but it might be interesting to look at the data 
gathered during this Belgian project. Currently, this instrument is being studied in 
Switserland. 
3.4.3 Conclusion 
Both mentioned assessment instruments, MDS-PAC and  Pathos-Aggir-Socios, have 
important disadvantages to be used as tools to support clinical decision-making and 
resource allocation. MDS-PAC concerns a too extensive set of items to score (+/- 400). 
Pathos-Aggir-Socios makes it possible to estimate workload related to rehabilitation 
services but does not contain criteria to predict required financial resources. 
3.5 PATIENT CLASSIFICATION SYSTEMS 
Patient selection and referral is by preference done with a Patient Classification System 
(PCS) including all predictive criteria for outcome and resource utilisation. 
Publications related to the use of a PCS were searched. Patient Classification System is not 
included in the MeSH taxonomy. Instead, the keyword ‘triage’ was used, that is defined as 
the sorting out and classification of patients or casualties to determine priority of need 
and proper place of treatment. "Triage"[MeSH] AND "Rehabilitation"[MeSH] resulted in 
30 publications. None of them were considered as relevant. 
Searching Google with the keywords Patient Classification System and rehabilitation, 
resulted in publications of MG Stineman about case-mix of patients for rehabilitation and 
of K Eagar about the comparison of existing Patient Classification Systems and the 
development of a new PCS 15. The consultation of another study including a comparison of 
Patient Classification Systems 99 was found based on a search in the grey literature 
(Google). During expert contact it seemed that investigations are being performed in the 
U.S. to develop a Uniform Patient Assessment for Post-Acute Care 100. For all mentioned 
PCS Pubmed was searched using the name of the PCS to find reports describing the 
principles of these systems. 
3.5.1 Inpatient or Outpatient Rehabilitation? 
Some classifications have been developed specifically for rehabilitation medicine, while 
others have a broader perspective and contain rehabilitation as only one branch or one 
class. Often a distinction is made between inpatient and outpatient classification systems 15; 
99; 1; 22. As a consequence, it is necessary to decide if an individual is a candidate for 
                                                
f  http://www.belspo.be/belspo/home/publ/pub_ostc/agora/ragff083ann_fr.pdf 
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inpatient or outpatient rehabilitation before classifying this individual. Criteria for inpatient 
rehabilitation have also an organisational impact. 
Pubmed was searched by (Inpatients (MeSH) AND Patient selection (MeSH) AND 
Rehabilitation (MeSH)) (N=2), by (Inpatients (MeSH) AND Criteria (All Fields) AND 
Rehabilitation (MeSH)) (N=47), by (Medical Rehab (Free text) AND Criteria (Free Text) 
AND (Admission OR Hospitalisation)) (N=4), by (Rehabilitation (Free text) AND Criteria 
AND (Admission OR Hospitalisation)) (N=1765), by ("Rehabilitation"[MeSH] AND 
"standards"[Subheading] AND "Patient Admission"[MeSH] (N=45). No relevant papers 
were detected.  
The absence of scientific papers about inpatient rehabilitation criteria suggests a large 
variability in the selection and use of these criteria. This presumption is confirmed for 
stroke rehabilitation in a recent European project 101. This study showed significant 
differences in case-mix at intake in four European stroke rehabilitation units. 
By lack of scientific papers reporting inpatient rehabilitation admission criteria,  the 
researchers explored Google using the keywords “Inpatient rehabilitation admission 
criteria”. Only the first ten results were withheld as no additional information seemed to 
be found by scanning more results. Comparing countries, no remarkable differences in 
admission criteria were detected.  
A synthesis of all inpatient rehabilitation admission criteria (See attachment) is made: 
• Have inability or decreased ability in at least two areas diagnosed by a 
physician and listed below:  
o complete activities of daily living; 
o move self from place to place; 
o manage elimination needs; 
o communicate or understand information;  
o cognitively process information, memory, and reasoning; 
• Be medically stable; 
• Need for continued close medical supervision by a physician with 
specialized training or experience in rehabilitation. The intensity may not 
be as great as acute care but 24 hour availability of a physician with 
special training or experience in the field of rehabilitation is required; 
• Need for twenty-four hour rehabilitation nursing;  
• Need for an intensive programme with multiple services (physical 
therapy, occupational therapy, speech pathology); 
• Be capable of participating cognitively and behaviourally in a programme; 
• Be able to physically tolerate programme activity including three hours of 
therapy per day; 
• Have a discharge plan. 
Via Google a report of the GTA Rehab Network about ‘Inpatient Rehab Referral 
Guidelines’ was also found. The GTA Rehab Network is made up of publicly-funded 
hospital and community-based organisations from across the Greater Toronto Area 
(GTA) that are involved in the planning and provision of rehabilitation services. This 
report contains a quick reference guide for inpatient rehabilitation referrals. The 
development of the Inpatient Rehab Referral Guidelines has resulted in the standardization 
of best practice for the inpatient rehabilitation referral process to improve patient flow 
through the system. 
All admission criteria were formulated for rehabilitation patients in general and no specific 
criteria for musculoskeletal and/or neurological rehabilitation patients were found. 
However, in a few papers the need for more specific criteria was discussed, specially 
concerning orthopaedic patients. 
In a report of the Centres for Medicare and Medicaid Services (CMS) the application of 
the 75 percent rule was discussed. To develop the list in the 75 percent rule in 1983, 
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Centres for Medicare and Medicaid Services (CMS) relied on information from the 
American Academy of Physical Medicine and Rehabilitation, the American Congress of 
Rehabilitation Medicine, the National Association of Rehabilitation Facilities, and the 
American Hospital Association (See also attachment). A control of the admissions in 
Inpatient Rehabilitation Facilities in 2003 showed that fewer than half of all Inpatient 
Rehabilitation Facilities Medicare patients in the fiscal year 2003 were admitted for 
conditions on the list in the 75 percent rule. Nearly half of the patients admitted for 
conditions not on the list were admitted for orthopaedic conditions. Experts, including 
those of the Institute of Medicine, generally agreed that condition alone is insufficient for 
identifying appropriate types of patients for inpatient rehabilitation, since within any 
condition only a subgroup of patients require the level of services of an Inpatient 
Rehabilitation Facility, and contended that functional status should also be considered. 
Further, the experts agreed on the fact that two basic requirements must be met if 
inpatient hospital stays for rehabilitation services are to be covered: (1) the services must 
be reasonable and necessary, and (2) it must be reasonable and necessary to furnish the 
care on an inpatient hospital basis, rather than in a less intensive facility, such as a Skilled 
Nursing Facility (SNF), or on an outpatient basis.” 20 
All these conditions are subject for a discussion with experts. An agreement on more 
specific criteria must be formulated. For example if ‘being medically stable’ is one of the 
conditions than ‘medically stable’ must be judged using objective indicators. 
3.5.2 Inpatient classifications 
3.5.2.1 Functional Independence Measure - Functional Related Groups (FIM-FRG) 15, 98 
Origin: Patients were classified into FRGs (Functional Related Groups) following their 
development in 1993 by Harada 102. These were refined twice by M Stineman: first in 1994 
with the Functional Independence Measure Functional Related Groups (FIM-FRG) 21 and 
further in 1997 22. In the U.S. the FIM-FRGs are known as Cost Management Groups 
(CMGs). 
Outcome measure: Classes are formed based on the Rehabilitation Impairment Code, the 
motor and cognitive subscales of the FIM at admission and patient age.  This data are 
collected by the Centres for Medicare and Medicaid by use of the Inpatient Rehabilitation 
Facility – Patient Assessment Instrument (IRF-PAI). 
Implementation: By the Centres for Medicare and Medicaid (CMS) Cost Management 
Groups (CMGs) are compounded for Prospective Payment by use of the Inpatient 
Rehabilitation Facility – Patient Assessment Instrument (IRF-PAI). This is also in Canada 
the current national standard. 
3.5.2.2 Resource Utilisation Groups (RUG-III) 103 
Origin: The RUG-III model was developed for nursing home patients and groups these 
patients into one of eight hierarchies on the basis of patient conditions and services 
required. The RUG-III classification system has eight major classification groups: 1) 
Rehabilitation Plus Extensive Services, 2) Rehabilitation, 3) Extensive Services, 4) Special 
Care, 5) Clinically Complex, 6) Impaired Cognition, 7) Behaviour Problems, 8) Reduced 
Physical Function. The eight groups are further divided into 44 RUG-III-groups by the 
intensity of the resident’s activities of daily living (ADL) needs, and in the Clinically 
Complex category, by the presence of depression. 
Outcome measures: Minimum Data Set Assessment Instrument (MDS). 
Implementation: Prospective payment to nursing homes within CMS. 
3.5.2.3 Australian National Sub-acute and Non-acute Patient classification15, 104 
Origin: In 1995 the Centre for Health Service Development at the University of 
Wollongong was commissioned by the Commonwealth to develop a national classification 
of sub-acute and non-acute care, including rehabilitation. The resultant classification – the 
Australian National Sub-Acute and Non-Acute Patient (AN-SNAP) classification - was 
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released in 1997. The AN-SNAP system, based on analysis of over 30 000 episodes of 
care, defines four case types of subacute care (palliative care, rehabilitation, 
psychogeriatric care, and geriatric evaluation and management) and one case type of non-
acute care (maintenance care), and classifies both overnight and ambulatory care. 
Outcome measure: Concerning rehabilitation the classification is built on impairment 
groupings, functional status as measured by FIM (Functional Independence Measure) or by 
Barthel Index as an alternative, and age. 
Implementation: The AN-SNAP classification is implemented in NSW, South Australia, 
Queensland and the Northern Territory for a mixed payment model (an episode 
component and a per diem component). Victoria and Western Australia are taking 
different approaches whilst no classifications are in use in Tasmania or the ACT. (1999) 
3.5.2.4 Casemix Rehabilitation and Funding Tree(CRAFT) 15  
Origin: July 1999, Victorian Department of Human Services implemented CRAFT (Case-
mix Rehabilitation and Funding Tree). 
Outcome measure: This model groups patients based on impairment category and 
according to their functional status as measured by the Barthel Index. 
Implementation: This model classifies patient episodes of care in designated rehabilitation 
units and is being progressively introduced for funding purposes. The Victorian 
Rehabilitation Classification and Funding System (VicRehab) funding model (Victoria, 
Australia) is based on the Case-mix Rehabilitation and Funding Tree (CRAFT) 
classification. 
3.5.2.5 Diagnostic Related Groups (DRG) 105 
Origin: The system was created by Robert Barclay Fetter and John Devereaux Thompson 
at Yale University 106, 107 with the material support of the former Health Care Financing 
Administration (HCFA), now called the Centres for Medicare and Medicaid Services 
(CMS), a federal agency with the United States Department of Health and Human 
Services. 
Outcome measure: DRGs are assigned by a "grouper" programme based on ICD 
diagnoses, procedures, age, sex, and the presence of complications or comorbidities. 
Implementation: Many variations of the DRGs exist. All of them are used for Prospective 
Payment (Medicare, Belgian Hospital Financing System). 
In 1983, DRGs were implemented in all acute care, non-specialty hospitals throughout the 
United States. They were implemented to contain the costs for the Medicare Programme. 
Instead of hospital reimbursement being based on retrospective charges (after the delivery 
of care), the reimbursement system changed to a DRG fixed payment or "prospective 
payment" system, meaning hospitals are compensated for a patient's care based on the 
qualifying DRG. 
3.5.2.6 Diagnose Behandel Combinaties (DBC) 
(See also study of rehabilitation in The Netherlands in chapter 8) 
Origin: The DBCs are developed in the Netherlands as a variation and ‘enrichment’ of the 
DRGs. 
Outcome measure: The DBCs group all activities and interventions in a hospital 
performed by a medical specialist on demand of a patient with a certain diagnosis. All steps 
in the patient’s care process are mentioned. 
Implementation: Currently DBCs are used in acute hospital care. From January 1st 2007, 
DBCs will be gradually introduced for the funding of rehabilitation settings. 
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3.5.2.7 Programme de Médicalisation du Système d'Information  – Soins de Suite et de 
Réadaptation 99 
Origin: PMSI-SSI has been developed in France in 1998. It not only includes post-acute 
rehabilitation, but also geriatric care, palliative care, alcoholabuse, and rehabilitation for 
children. Psychiatric care and long-term (“chronic”) care are excluded. It is based on 
medical diagnosis combined with an assessment of functional impairment and a description 
of resource utilisation (time attributed to physiotherapy, speech therapy…). Evaluation of 
the patient has to be completed once every week (instead of once per care episode). The 
system has been criticised on three points: the large inclusion criteria which weakens its 
ability to predict costs per category, the large time investment (to be completed once 
every week); the fact that resource utilisation (and not only patient characteristics) is 
taken into account to develop case-mix groups.  
Outcome measure: Diagnosis, a measure for dependence and a measure for the utilisation 
of resources. 
Implementation: Funding of rehabilitation in France. 
3.5.2.8 TAR-FIM 99 
Origin: TAR-FIM was developed by a team in Switzerland specific for neurological 
rehabilitation.   
Oucome measure: Diagnosis, a measure for dependence and a measure for the 
consumption of resources. 
Implementation: TAR-FIM was subject of an experiment. It is not clear if it was 
implemented. 
3.5.3 Outpatient classifications 
3.5.3.1 Home Health Resource Groups 98, 108  
Origin: The implementation of the prospective payment system for home health care in 
October 2000 in the USA. 
Outcome measures: Outcome and Assessment Information Set (OASIS). OASIS is 
developed by the Centre for Health Services Research at the University of Colorado in 
the late 1980s and early to mid 1990s. The Oasis items were designed to measure, assess, 
and encourage improvement in care outcomes over time using Outcome-Based Quality 
Improvement processes. 
Implementation: With the implementation of the prospective payment system for home 
health care in October 2000, information collected via OASIS was used for case-mix 
adjustment in establishing Medicare reimbursement. Overall, OASIS is used for outcome 
monitoring, payment, and as a core but not comprehensive clinical assessment. 
3.5.3.2 Ambulatory Visit Groups 109-111  
Origin: Ambulatory Visit Groups (AVGs) were developed in the 1980’s by the Health 
Systems research group at Yale University (USA). 
“Ambulatory care has particular problems in the construction of appropriate case-mix 
measures, and day-case surgery provides an opportunity to test two existing measures, 
one inpatient (Diagnosis Related Groups) and one ambulatory (Ambulatory Visit Groups). 
These grouping systems were applied to the same data to compare the case-mix patterns 
that they produce. The findings show that Ambulatory Visit Groups appear to have 
advantages over the Diagnosis Related Groups with respect to their underlying 
assumptions and labelling of the groups; in particular, they assign greater weight to 
procedures. However, Diagnosis Related Groups are more developed, easier to use, more 
familiar and allow direct comparisons with inpatient care. Nevertheless, a proper 
evaluation of these issues requires further data collection and analysis, together with a 
fundamental examination of the uses of ambulatory case-mix.” 109 
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Outcome measures: AVG is a visit-based grouping methodology with 570 groups, which 
each categorizes visits with similar types and amounts of resource use. 
Implementation: unknown 
3.5.3.3 Ambulatory Patient Groups 112 
Origin: APG were developed by researchers at 3M Health Information Systems, Inc.(USA). 
Outcome measures: Visits are grouped into 297 categories based on significant 
procedures, medical, and ancillary services provided. 
Implementation: In the U.S., APG are the basis for Medicare’s ambulatory prospective 
payment system. 
3.5.3.4 Ambulatory Care Groups 113 
Origin: Adjusted Clinical Group (ACG) is a population/patient case-mix adjustment system 
developed by researchers at Johns Hopkins University School of Hygiene and Public 
Health in Baltimore, Maryland, U.S.  
Outcome measure: ACG measures health status by grouping diagnoses into clinically 
cogent groups. The goal of ACG is to assign each individual a single, mutually exclusive 
ACG value, which is a relative measure of the individual's expected or actual consumption 
of health services. The primary conceptual basis is the expected persistence or recurrence 
of the condition over time. Other considerations included (in decreasing order of 
priority): Likelihood that the patient would have a return visit for the condition; 
Likelihood of a specialty consultation or referral; Expected need and cost of diagnostic and 
therapeutic procedures associated with the condition; Likelihood of an associated 
hospitalization; Likelihood of associated disability; and likelihood of associated decreased 
life expectancy. 
Implementation: Only in experimental setting. 
3.5.3.5 Duke Casemix System 
Origin114: Dumix was developed in the U.K. to cater for the wide variety amongst patients 
encountered in geriatric medicine. Rehabilitation is part of the system. 
Outcome measure: Dumix combines age, gender, patient-reported perceived and physical 
health status, and provider-reported or auditor-reported severity of illness to classify 
patients by their risk of high future utilization. 
Implementation: Only in experimental setting. 
3.5.3.6 Australian National Sub-acute and Non-acute Patient classification 15 
See Inpatient classifications 
3.5.3.7 Other 
Admission Casemix System for the Eldery (ACME), Australian Ambulatory Classification 
(AAC), Victorian Ambulatory Classification and Funding System, Efficient model. 
3.5.4 Discussion 
Only general information is available concerning the patient classification systems, the 
underlying rules are never published in detail. Anyway, no Belgian data set is available to 
test the applicability of the system to the Belgian situation. 
A common feature of all mentioned inpatient classification systems, is that all of them use 
the results of a measurement of activities of daily living (FIM or Barthel Index) as main 
criterion for classifying patients and that all of them are used for financing of rehabilitation. 
The mentioned outpatient classification systems all use different criteria for grouping 
individuals and not systematically measure for activities of daily living. 
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For a further assessment of the advantages and disadvantages of the listed patient 
classification systems, the results of other research teams were summarised.  
Concerning PCS for inpatient rehabilitation, the team at the University of Wollongong  
(see  3.5.2, Australian National Sub-acute and Non-acute Patient classification) concluded 
that the more variables were used to classify patients, the better the predictive value of 
the required resources. Of the compared PCS, FIM-FRG and AN-SNAP scored best. 
Selection of the ‘best’ classification involves a trade-off between simplicity and accuracy 
and whether the classification is already in use elsewhere, in order to benchmark. 
Concerning PCS for outpatient rehabilitation, this team concluded the preferred option 
was highly dependent on the model selected for the classification of inpatient care to 
facilitate transfers and follow up of individuals. 15 
A report was found including a comparison of Patient Classification Systems using 
predefined selection criteria without testing these instruments with a data set {Rapport 
rédigé par les membres du CoPil sur la base d'un travail de recherche de M.Nicolas 
Jeanprêtre, 2002, 104}. For this comparison, no distinction was made between in- and 
outpatient classification systems. MDS-PAC, AN-SNAP, PMSI-SSR, TAR-FIM and RUG-III 
were compared and AN-SNAP was selected model as the best patient classification 
system. The main comment on this system was that it does not include prognostic 
indicators for the medical evolution. 
The preference for one or another patient classification system depends on the application 
possibilities. Ideally, a Patient Classification System supports patient referral to the most 
appropriate rehabilitation programme which is determining the required resources. The  
PCS currently used to support resource allocation show the important restriction that 
not the real rehabilitation needs are covered but rather the care needs by using the FIM 
and Barthel Index. The International Classification of Functioning, disability and health is 
not yet tested on validity related to patient referral and/or resource allocation, and as 
such is not ready to use yet. However, scientific work on this subject is going on, including 
research on how to convert the existing PCS to the future ICF-based PCS. Another 
problem is that for most PCS, it will be a challenge to tune an inpatient to an outpatient 
classification. 
3.6 FRAMEWORK FOR SELECTION OF THERAPY 
3.6.1 Introduction 
In the definition of rehabilitation two conditions for therapy are: 
• Interventions must be evidence based; 
• Interventions must have a proven added value to achieve the defined goals. 
Criteria to evaluate therapy concerning evidence, proven added value and quality are 
essential. 
First, the focus is on criteria for the selection of interventions to compound a 
rehabilitation programme. Numerous factors influence the individuals’ decision-making 
when planning care across the continuum. Patient, environment and disease related factors 
are critical. Taking these factors into account is essential in selecting appropriate 
intervention strategies in any disease stage. 115 
In chapter 8 models for quality assessment will be discussed. Current clinical practice in 
Belgium will be compared to clinical pathways developed in different countries (chapter 6 
and 7). 
The complexity and interaction of the criteria which determine a therapy plan for an 
individual, requires a framework permitting a health professional to have a detailed view 
on the individuals’ situation. This is in contrast with the framework used for resource 
planning, which has to be easy manageable for financial analysts and policy-makers. 
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3.6.2 International Classification of Functioning, Disability and Health 
The ICF model earlier mentioned, is probably the best candidate to serve as a framework 
for therapy planning. Studies reporting the application of ICF for therapy planning, were 
searched.  One study of the application of ICF was performed for a well described 
pathology 116. No papers are available, which report the application  of these models for 
the whole set of pathologies requiring rehabilitation. An attempt was made through the 
development of linking rules to link the outcomes of ICF to useful interventions 96. These 
linking rules are only a first step in the use of ICF as a connecting framework between 
interventions and outcome measures.  A lot of study work is necessary to apply these or 
comparable rules in clinical practice. 
3.6.3 The 3-hour rule 
The US also struggles with the problem of therapy planning. The Centres for Medicare 
and Medicaid Services (CMS’s) solved the problem by implementing a simple “3 hour 
rule”. Strictly speaking the 3 hour rule is not a rule at all. The 3 hour rule is not specified 
in any regulation, and, therefore, it does not have the force of law. Nevertheless, CMS’s 
viewpoint, that the “general threshold for establishing the need for inpatient hospital 
rehabilitation services is that the patient must require and receive at least 3 hours a day of 
physical and/or occupational therapy” has achieved such general acceptance that it has 
become a virtually unquestioned part of the rehabilitation services culture in the US. 
CMS’s guidance on the 3 hour rule notes that the daily component of the rule may be 
answered by therapy services 5 days a week. Also, while most patients will answer the 3 
hour rule through physical or occupational therapy, CMS recognizes that other therapies, 
such as speech therapy or prosthetic-orthotic services, may be required, within the 3 
hours. Furthermore, if the patient has a secondary diagnosis or medical complication that 
rules out 3 hours of therapy a day, inpatient hospital care may nevertheless be the only 
reasonable means by which even a low-intensity rehabilitation programme can be safely 
carried out. However, in such cases, CMS requires justification of the existence and extent 
of complicating conditions affecting the carrying out of a rehabilitation programme. 
3.6.4 Discussion 
At long term ICF might be a good framework for therapy planning but not enough 
evidence is available yet to implement this now. This opinion is shared by some experts 
contacted (see attachments). 
3.7 ACCREDITATION OF PROFESSIONALS AND SERVICES 
3.7.1 Commission on Accreditation of Rehabilitation Facilities (CARF) 
Because in scientific literature no information on the development and use of 
accreditation systems was found, grey literature was searched. The study of rehabilitation 
in The Netherlands, Germany, France, Sweden in a next chapter and the US will also focus 
on the use of quality systems in the concerned countries. 
The CARF-system was identified as an internationally used accreditation system 
(Commission on Accreditation of Rehabilitation Facilities) g. CARF was formed in 1966 in 
the US by two national organisations - the Association of Rehabilitation Centres (ARC) 
and the National Association of Sheltered Workshops and Homebound Programmes 
(NASWHP) - that had been developing standards for their respective memberships for 
about a decade. In September 1966, the two organisations agreed to pool their interests 
in setting standards, and they formed the Commission on Accreditation of Rehabilitation 
Facilities, now known as CARF. In the years since its formation, CARF has steadily grown 
in size and stature. 
                                                
g  http://www.carf.org/ 
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The CARF family of organizations currently accredits more than 4,800 providers at more 
than 17,000 locations in the United States, Canada, Western Europe, and South America. 
More than 6.3 million persons of all ages are served annually by CARF-accredited 
providers. 
After an organisation applies for accreditation of its services or programmes, CARF sends 
professionals in the field to conduct an on-site survey to determine the degree to which 
the organisation meets the standards. CARF surveyors also consult with staff members 
and offer suggestions for improving the quality of services. 
CARF-accredited programmes and services have demonstrated that they substantially 
meet internationally recognized standards. CARF accreditation means that you can be 
confident that an organization has made a commitment to continually enhance the quality 
of its services and programmes, and its focus is on consumer satisfaction. 
3.7.2 Accreditation systems in Belgium 
In Belgium there are requirements for rehabilitation services, requirements for services 
related to a hospital stay during rehabilitation and accreditation criteria for physicians. 
Requirements for rehabilitation services are included in the description of financing 
principles and differ per type of payment system (K30/K60, convention 9.50, convention 
7.71). Requirements are related to team composition, opening hours, equipment and 
buildings. These requirements are discussed in detail in chapter 5. 
Requirements for services related to a hospital stay are also conditions to be paid (B1 and 
B2: see chapter 5). Requirements include data registration concerning the activities related 
to social services and discharge management, participation to projects which contribute to 
the improvement of social services and discharge management, specific numbers of 
required full time equivalents (FTE) and some infrastructural issues. 
Accreditation criteria for physicians influence the price of the honoraria and include a 
minimum participation to further training courses. 
All these requirements and criteria are related to structure or process but no outcome 
measurement is performed. 
3.7.3 Discussion 
Accreditation or quality systems for professionals and services will be further discussed in 
the chapter concerning the international comparison of the five selected countries 
(chapter 8). 
3.8 CONCLUSION 
In this chapter, existing outcome measures, outcome models, assessment instruments, 
patient classification systems, criteria for the selection of therapy and accreditation of 
professionals and services, were discussed. 
Exploring the published literature an ideal interaction between outcome measures, an 
outcome model and a patient classification system as a framework for the mapping of a 
rehabilitation programme as well as for resource allocation, was designed. 
As proposed in Figure 3.2, outcome measures supply information to an outcome model. In 
this outcome model data related to diagnosis as well as level of function and 
environmental factors, should be covered. Starting from this outcome model a patient 
classification is built. One level in the hierarchy of this patient classification system serves 
as a framework for resource allocation (rehabilitation budget). Another level serves as a 
framework for the composition of rehabilitation programmes (rehabilitation services). The 
rehabilitation programme determines the resource allocation. Resource allocation as well 
as rehabilitation programmes must be controlled by a quality system. 
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Figure 3.2: Principles of an ideal Patient Classification System 
Patient Classification System
Outcome
measures
Outcome
model
Patient
classification
system
Managerial level
Clinical level
Rehabilitation
Services
Rehabilitation
Budget
Quality system
 
This model is not applied (yet). Outcome measures, outcome models and patient 
classification systems exist. But no links are made yet between outcome measures and 
outcome models, nor links between outcome models and patient classification systems. 
Outcome measures are as such used in clinical practice. It should be kept in mind that 
existing patient classification systems group patients related to resource allocation (Length 
Of Stay), hence they are not satisfying to manage clinical patient referral. They can serve 
as a relative indicator to distribute the rehabilitation budget over resources independent 
of care needs and indeed are mostly used for financing purposes. These PCS are usually 
built upon the results of tools measuring dependence for activities of daily living, like FIM 
and the Barthel Index, which cover a very limited set of outcomes that are not fully 
representative for rehabilitation needs. However, because a lot of research is going on to 
convert the results of the FIM and the Barthel Index  to ICF scores 117, it might be an 
option to implement  FIM or Barthel Index at short term in Belgium, in order to line up 
with international tendencies. Also, it would allow to get some- although limited- 
information on the severity of functional impairment of patients treated in Belgian 
rehabilitation centres. Nowadays this information is not available.  
ICF is widely accepted as the most complete instrument to describe functional impairment 
and rehabilitation needs. It can already be used as a conceptual framework although the 
application of ICF in clinical practice and for financing purposes only fits long term vision. 
The current main restrictions of ICF are the huge set of items to score, the lack of clear 
definitions to distinguish the content of the items mutually and the difficulty to convert the 
results of measurement tools to ICF scores. ICF core sets and ICF linking rules are 
already valuable attempts to compensate these restrictions. It can be considered to start a 
validation project using ICF core sets versus FIM or Barthel Index. Elements common to 
ICF core sets and FIM or Barthel Index are described in the Appendix to chapter 4. 
An other option is to consider a novel research project in which an alternative approach 
should be developed to the objective of using ICF as the basis for a PCS which supports 
patient referral as well as resource allocation. In this research project, one should (instead 
of starting with the selection of existing tools) start with the selection of ICF items related 
to each of the ICF components (Health condition; Body function and structure; Activities; 
Participation; Environmental factors and Personal factors), which are supposed to be 
relevant for patient referral and/or resource allocation in rehabilitation. Next, one should 
identify measurement tools which cover one or more of these ICF items. Then, a new 
measurement tool for ICF items which are not covered by one or another existing 
measurement tool should be developed. Next, start registering the results of the selected 
measurement tools, and  use the linking rules (still under development) to translate the 
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results of these measures to ICF scores. Finally, analyse the collected data on their utility 
in a PCS. Groups within this PCS must be homogeneous related to required rehabilitation 
services and indirectly to required resources. A comparable approach was respected by 
the Division of Health Care Policy and Research at the University of Colorado at Denver 
for the development of a Uniform Patient Assessment instrument for Post-Acute Care. 
Their instrument is intended to cover the population in different rehabilitation settings and 
must facilitate placement decision-making, enhancement of safety and quality of care 
transitions through transmission of core information to a receiving provider and provision 
of baseline information for longitudinal follow up of health and function 100. 
Key points 
• The conceptual definition of musculoskeletal and neurological rehabilitation 
has to be translated into practice to facilitate decisions on the organisation 
and financing of rehabilitation. 
• A patient classification system is required to structure inflow of individuals 
(What?) and determine the type and intensity of required interventions 
(How?), the professionals to be involved (Who?) and the preferred 
organisation (Where?).  
• Outcome measures, outcome models and patient classification systems 
exist. But no links are made between outcome measures and outcome 
models, or between outcome models and patient classification systems. 
• ICF can already be used as a conceptual framework for an outcome model 
but the application of ICF in clinical practice and for financing purposes only 
fits long term vision. A lot of research is going on about this subject. 
• ICF’s success depends on its compatibility with measures used in 
rehabilitation and on the improvement of its applicability. 
• FIM and Barthel Index are tools measuring the level of dependence related 
to activities of daily living, but neither FIM nor Barthel Index measure 
rehabilitation needs. However, in some countries they are used in Patient 
Classification Systems implemented for resource allocation. 
• Most of the existing PCS are specific for inpatient or for outpatient care. An 
exception is the Australian AN-SNAP, derived from the FIM-FRG-system. 
• In order to test existing PCS in Belgium, datasets from Belgian rehabilitation 
patients are necessary. 
• A short term option could be to implement the registration of FIM or 
Barthel Index in Belgian rehabilitation centres, in order to get some –
although limited- information on the severity of functional impairment of 
rehabilitation patients. 
• To line up with international tendencies, it could be considered to start a 
validation project using ICF core sets versus FIM or Barthel Index. 
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4 REGISTERED DATA AND PATIENT PROFILES 
4.1 BACKGROUND 
In chapter 3 an extensive description has been made of the different scales used to 
measure outcomes of rehabilitation within the scope of organizational/financing purposes. 
Rehabilitation scales and/or datasets are already in use in some countries in order to 
classify patients for organizational/financing purposes.  
The approval of ICF as an internationally accepted classification of functioning, has 
stimulated the analysis of existing measures and scales. Major efforts on this part are being 
done by the “ICF branch of WHO”. A systematic review by this group 118 made an inventory 
of different measures used in acute and post-acute rehabilitation and compared it to ICF. 
The authors conclude that at this stage no real standard validated scales measuring (clinical 
and functional) characteristics of rehabilitation patients are readily available that cover 
most/all aspects of ICF. At the same time ICF-concepts covered by the individual 
rehabilitation scales vary a lot. This means that currently, no existing validated 
rehabilitation scale is able to differentiate rehabilitation units and pathologies on basis of 
the (clinical and functional) characteristics of patient populations, and at the same time fit 
to the ICF-model.  
The use of ICF itself as a managerial and financial tool is still under development (see 
chapter 3); and many problems still have to be solved. 
Taking into account these observations, this chapter has a practical purpose. In Belgium, 
the only formal registration system currently used in the hospital sector, including 
indicators of functionality of the patient, is the minimum nursing data set.  A quick scan of 
literature was performed to assess to what degree current nursing registration systems 
could be used to describe and compare patient populations in rehabilitation settings and 
to what degree these datasets could be used for rehabilitation managerial purposes. In a 
second part we illustrate how profiles of Belgian minimum nursing data can differentiate 
the characteristics of rehabilitation facilities. A third part brings some examples of 
internationally accepted. Rehabilitation scales that are in use in some Belgian rehabilitation 
centres and sometimes are already used for organizational purposes at the level of the 
own hospital. 
4.2 A QUICK SCAN OF AVAILABLE LITERATURE 
4.2.1 Methods  
A quick scan of the databases Medline (through PubMed), CDC, CRD, Econlit and Cinahl 
was done in November 2006.  
Following search terms were used: Rehabilitation, Rehabilitation Science, Rehabilitation 
research, Rehabilitation centers, Disability evaluation, Severity of disability, International 
classification of functioning, disability and health or disability, Patient classification, 
minimum data set, Research instruments, Rehabilitation or Clinical assessment tools, 
outcome assessment, Functional assessment , Rehabilitation patients,  FIM(keyword), 
subacute care, Barthel Index, Disability evaluation, Functional status, Functional 
assessment, Instrument validation, Clinical assessment tools, Brain injuries,  or Cerebral 
Vascular accident or Activities of daily living, Physiotherapy, Physical therapy. 
The search was general. The selection of the articles was based on the title and abstract. 
As could be expected, the majority of literature found on nursing data sets focuses on the 
use of datasets for nursing issues and on the ability to use large clinical nursing datasets to 
assess the effectiveness of nursing interventions. There is an extensive literature on 
nursing terminology, on information models and standards for nursing datasets h . All 
                                                
h  The FOD-MVG 2 report makes an extensive overview of internationally available nursing data sets and scales 
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articles solely reflecting on nursing issues were excluded, if no reference is made to 
functionality, levels of dependency, as a measuring issue. 
Additional documents, especially on the Belgian situation, were retrieved through web-site 
search, and contacts with individual experts dealing with minimum nursing data. 
4.2.2 Minimum nursing data and rehabilitation: the literature 
It has been argued that outcome measures are an important tool in quality assurance 
procedures, also in the accountability process of justifying expenses and resources. But it 
has been demonstrated too, that there is a great heterogeneity of outcome measures over 
Europe 90. Numerous available measures try to assess aspects of functioning, but they vary 
greatly in underlying dimensions and constructs 18.  
A systematic review of measures used in rehabilitation 118 compared available measures to 
the ICF. The review finds that the FIM, Barthel Index and Glasgow coma scale are the 
most cited assessment instruments. All other formal assessment instruments, were applied 
in less than 10% of the studies selected. A recent exercise validated the ICF core sets for 
early post-acute rehabilitation facilities, comparing it with FIM, Functional Assessment 
Measures (FAM) and Barthel Index (BI), 117. (See also Appendix for comparison of ICF 
core sets, FIM and BI). The authors conclude that FIM and Barthel code abilities to the 
level of independence and need of assistance, without explicit reference to the 
environment. Many aspects of human functioning are not measured by FIM, FAM and BI. 
The authors recommend that, especially for acute neurological conditions, additional items 
(besides the ones coded in FIM and BI), need to be coded if the scores are to be used for 
prospective payment aims. 
Only few articles have focused on a comparison of nursing datasets and rehabilitation 
outcome scales, mainly from an American background. The American Minimum Data Set 
(Version 2.0) is an American, federally mandated nursing assessment conducted on every 
resident of a skilled nursing facility. Authors have argued that it could be used as a simple 
tool to collect data and measure outcomes for individuals who receive rehabilitation in the 
skilled nursing facility. 
In 1998 a “crosswalk” was developed between the FIM, measured in acute rehabilitation 
settings and the American minimum dataset (MDS) developed for nursing homes. 119. A 
pseudo-FIM was developed rescaling MDS-items to correspond to FIM-items. Pseudo-
items could be defined for 12 of the 18 FIM items (8 motor and 4 cognitive items). Based 
on the testing of the instruments it was argued that FIM and MDS items can be used to 
predict item and subscale scores between the two instruments with reasonable accuracy. 
It could thus be used to compare case-mix between acute rehabilitation and nursing home 
rehabilitation on the level of effectiveness (degree of improvement among similar patients) 
and efficiency (cost of care to obtain a given degree of improvement) of rehabilitation care 
in different types of settings.  
Morris et al. 120 assessed the validity of standardized assessment data collected with the 
Minimum Data Set (MDS) in post-acute care settings. This assessment was done for the 
development of performance indicators. Performance indicators derived from information 
collected with the MDS demonstrate convergent validity with data collected with other 
research or standardized assessment instruments. Results were most favorable for areas 
of physical functioning, cognitive and communicative functioning, and clinical complexity.  
Bryant et al 121 compared the medical outcomes short form SF 36, the MDS for Nursing 
Home Resident Assessment and Care Screening which is a major component of the RAI 
(Resident Assessment Instrument for long-term care), FIM and IRF-PAI (Inpatient 
Rehabilitation Facility-Patient Assessment Instrument). They observed that all evaluated 
datasets include items that assess ADL, ambulation and locomotion, and 
neuro/emotional/behavioral status (primarily cognition and depression). All except the SF-
36 contain items concerning sensory status (eg, vision, hearing, speech), (in)continence, 
and some measure of physical ability. But the instruments do not specify the data items 
identically or have identical response options. Items differ in perspective; qualification; 
source (patient and/or caregiver); and action versus outcome or tool (eg, walking vs 
wheelchair). Time periods covered also vary considerably. Based on this observational 
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analysis of the scales, obstacles are seen to the development of a standardized approach to 
post-acute care quality assessment related to the potentially different characteristics in 
patient populations served by different types of providers. Bryant et al conclude that it 
may not be possible to construct a single dataset that by itself meets all needs in each 
setting. However, a single core set of measures applicable to all settings is considered to 
be useful for assessing quality, facilitating transfers between providers, and minimizing any 
data collection burden for healthcare professionals.  
4.3 THE BELGIAN NURSING MINIMUM DATA SETS 
4.3.1 Background 
The Belgian Nursing Minimum Data Set (BNMDS) is a registration of nursing activities 
implemented nationally in 1988. Four times per year, during a two-week period, patients 
in hospitals are scored on the level of nursing activities. The results of these scores are 
presented as so called “fingerprints” of hospital departments, projected on a national map. 
The reference for this national comparison is the “average” Belgian nursing unit. 
4.3.2 Fingerprints of rehabilitation departments 
The fingerprints identify the nursing care on a nursing department organised around 23 
activities (see Appendix to chapter 4) The fingerprint is presented as horizontal 
histogrammes for each of the 23 dimensions. Each variable is scored between -0,5 and 
+0,5. A score 0 implies that the department scores identical to the average Belgian nursing 
department. The calculations of the scores are based on a Ridit-analysis. 
• Example: The reference value 0 for the dimension “hygiëne”, is based on 
the observation that 35% of the patients in general hospitals is not 
getting help in hygienic care, 30% is receiving supportive help, 20% partial 
help, 15% full help. Each nursing unit is then compared to this reference 
point. A higher percentage patients needing a higher level of care, will 
lead to a positive score on the fingerprint. A lower percentage of 
patients needing more care will lead to a negative score 
Figure 4.1 is an example of a 1998 fingerprint of an average Belgian “locomotor”  
rehabilitation department, and Figure 4.2 of an average Belgian “neurological” 
rehabilitation department. These average departments are characterized by a large (always 
compared to the average nursing unit) amount of basic nursing care (hygiene, mobility, 
excretion and nourishment), a lot of day clothing tasks, comfort care (special mouth care 
and pressure ulcer care), and training for independency (programme). The units have little 
technical nursing care. Figure 4.2 shows a similar fingerprint of an average Belgian 
neurological rehabilitation department. 
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Figure 4.1: Fingerprint of an average Belgian “locomotor”  rehabilitation 
department (1998) 
(Source: Federale Overheidsdienst (FOD) Volksgezondheid, Veiligheid van de Voedselketen en Leefmilieu: 
https://portal.health.fgov.be/portal/page?_pageid=56,698710&_dad=portal&_schema=PORTAL#fb2000) 
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Figure 4.2: Fingerprint of an average Belgian “neurological”  rehabilitation 
department (1998) 
 
(Source: Federale Overheidsdienst (FOD) Volksgezondheid, Veiligheid van de Voedselketen en 
Leefmilieu: 
https://portal.health.fgov.be/portal/page?_pageid=56,698710&_dad=portal&_schema=PORTAL#fb20
00) 
Each individual hospital department can be compared to this general picture. Figure 4.3 
presents (as an example) the fingerprint of the locomotor and neurological rehabilitation 
departments of a large academic university centre.  
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Figure 4.3: Fingerprint of the locomotor (left) and neurological (right) 
rehabilitation departments of a large Belgian academic university centre 
(1998).  
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The graphs show a small difference of the units on detailed aspects, but the overall picture 
for the different rehabilitation units remains the same. This graph illustrates that hospital 
units can be profiled using the minimal nursing data. As such it could be considered to 
reflect further on this profiling in order to get more rehabilitation specific information.  
4.3.3 Revision of the Belgian Nursing Minimum Data Set 
Due to important changes in hospital practices, and percieved shortcomings of the original 
BNDMS, a revision of the data set is prepared . The process of revising the (B-NMDS) 
started in 2000.  
The Nursing Interventions Classification (NIC) was selected as a framework for the 
revision of the original BNMDS. Different items were seen as priorities for the revised 
BNMDS: hospital financing, nurse staffing allocation, assessment of the appropriateness of 
hospitalisation, and quality management. The revised version (MVG-RIM2) will allow a 
more detailed profile of the patients. The instrument is built on 4 levels. It is an open 
registration of 76 items (as opposed to the 23 in the MVG-RIM1). Each of the 76 items 
hold two or more aspects. These 76 items are grouped in 21 classes and 6 domains. (see 
Appendix to chapter 4) 
Nationwide implementation of the new MVG is foreseen the earliest by January 2008. 122 
MVG-RIM2 (see Appendix to chapter 4) is expected to be able to respond in a more 
exhaustive way to document the nursing care needs of the patients, including cognitive 
aspects. It would also enable to compare “what has to be done” with “what is done”. It is 
also expected that MVG-RIM2 is a registration that enables to document the intensity of 
nursing care both needed and offered. 
However, the MVG-RIM2 is not a tool enabling to score for other paramedical 
(occupational training, physical therapy, psychology,…) and social needs and activities. 
Moreover an ongoing preliminary analysis of potential use of MVG-RIM2 on geriatric 
wards (KCE), seems to indicate that MVG-RIM2 is not a tool to monitor or assess the 
effectiveness of therapy and different aspects of rehabilitation activities. Last but not least, 
it is developed for use in hospitals, and does not allow to collect information on 
ambulatory services (except some specific day hospital activities). 
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4.4 INTERNATIONALLY ACCEPTED REHABILITATION SCALES 
USED FOR ORGANISATIONAL AND FINANCING PURPOSES 
As already pointed out in chapter 3, specific organisational and payment systems in 
rehabilitation medicine use FIM and Barthel-Index. These scales are considered  to be 
suitable for organisational and financing purposes in rehabilitation. FIM and Barthel-Index 
(BI) are used for clinical purposes in some Belgian rehabilitation centers. The scales are 
not used in all rehabilitation facilities. 
As mentioned117 these scales do not cover all the domains proposed by ICF, accepted 
internationally and endorsed by WHO as a general framework in rehabilitation medicine. 
(See Appendix to chapter 4 for comparison of ICF core sets for post-acute rehabilitation, 
FIM and BI). However, the use of ICF itself as an organizational and financial tool is still 
under development; and many problems still have to be solved. Until this work has 
proceeded, some initiatives could be launched to use the FIM and Barthel Index at a more 
generalised level in Belgium, alike some other countries. 
Figure 4.4 shows the kind of information that can be generated by a systematic use of 
these scales. Average FIM and/or BI are shown for 2 Belgian rehabilitation services (one 
tertiary referral hospital and one secondary level general hospital) that already use these 
scales for clinical purposes. It are illustrations for those specific hospitals and should not 
be generalized to all Belgian rehabilitation centres.  
Figure 4.4 X represents the average outcome for patients admitted to the rehabilitation 
ward (BI at admission compared to average BI at discharge).  
Figure 4.4 Y is a longitudinal comparison (two years) of the average BI for a rehabilitation 
ward.  
Figure 4.4 Z represents average FIM-scores at admission and at first follow-up evaluation 
for 2 patient groups: stroke and spinal cord injury (SCI). In this last example, it would be 
even more appropriate to compare the subscales of the FIM-score (motor and cognitive 
subscale), which on average is very different for these 2 pathologies, but this is beyond the 
scope of this exercise.  
Figure 4.5 represents the average disability level for different months of the year in three 
different rehabilitation wards in the same hospital, measured by BI.  
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Figure 4.4: Average disability level of patients for different months of the year 
in 3 different rehabilitation wards in the same hospital, measured by Barthel 
Index. 
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Fig. (X): Average Discharge Barthel Index for a given Admission Barthel Index.
(Source: Rehabilitation Service (S2 beds), Virga Jesse Hospital, Hasselt)
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Fig. (Y): Barthel Index (BI): Average Admission BI (all patients) and Average
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Fig. (Z): Average Total FIM Score for Stroke/Spinal Cord Injury (SCI) at
admission and first follow-up. 
(Source: Rehabilitation Service, University Hospital Pellenberg-Leuven, Pro-Esor Study
(1999-2000)).
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Source: Rehabilitation Service, University Hospital Pellenberg-Leuven, 2005 
Figure 4.5: Average disability level of for different months of the year in 3 
different rehabilitation wards in the same hospital, measured by BI 
0,00
2,00
4,00
6,00
8,00
10,00
12,00
14,00
16,00
Ja
nu
ary
Fe
bru
ary
Ma
rch Ar
pil Ma
y
Ju
ne Ju
ly
Au
gu
stu
s
Se
pte
mb
er
Oc
tob
er
No
ve
mb
er
De
ce
mb
er
KCE reports 57 Musculoskeletal & Neurological Rehabilitation 53 
4.5 CONCLUSIONS 
Currently, rehabilitation activities are not registered. Even more, the Belgian health care 
system is not using validated measures enabling to differentiate the different profiles of 
rehabilitation facilities, especially not for pathology specific characteristics. Since literature 
is offering some indications that minimum nursing data sets could potentially, with the 
necessary critical attitude, be used and further adapted for comparing rehabilitation units, 
it could be considered to use MVG-RIM2 as an intermediate profiling tool, using the 
fingerprints. It would be an intermediate tool during the period that more detailed 
rehabilitation registration systems are developed. The fingerprints could be used as a 
proxy to monitor and compare the condition of the patients within the units.  
However, the necessary reluctance is needed if MVG-RIM2 is intended to be used for 
other than nursing purposes. MVG-RIM2 is not intended for measuring rehabilitation 
specific purposes. Moreover, MVG-RIM2 is not allowing for pathology specific 
comparisons without a coupling with other datasets (MKG-RCM). If considered, the use of 
MVG-RIM2 should go hand in hand with thorough scaling comparisons with focused 
rehabilitation measures, as MVG-RIM2 is developed for nursing and not for rehabilitation 
purposes. The “cross-walk” exercise described in the literature, could be an example of 
how to deal with this issue. Last but not least, it should be kept in mind that MVG-RIM2 is 
developed for inpatient registration and not for routine registration of outpatient or 
ambulatory services. 
A more laborious strategy to exploit existing datasets, could consider the coupling of 
MVG-RIM2 with Minimal Clinical Data (MKG-RCM) and Minimal Financial Data (MFG-
RFM) sets, for identifying rehabilitation activities. The MKG-RCM is a tool to differentiate 
on therapeutic activities. But some particular limitations have to be taken into account. 
The minimal clinical data set is limited to a registration of physical therapy activities, (as 
defined in art 7 of K.B. 18.12.2002). Medical acts that are provided in the framework of 
multidisciplinary rehabilitation (art. 22 K.B. 17.07.1992) will require a coupling with 
Minimal Financial data.  
Moreover there are some methodological issues to consider, when coupling datasets. To 
make accurate analyses of MKG-RCM data for rehabilitation purposes, one should only 
take into account stays in both acute and rehabilitation phases for which rehabilitation 
activities are done under K-nomenclature, or convention 9.50 or 7.71. It is the only 
strategy that enables to trace back the main diagnosis (via the “number of stay” 
(verblijfsnummer)). Only focusing on the registration data in rehabilitation units makes it 
almost impossible to trace back to the causes for rehabilitation. Code V57(.x), used for 
the registration for rehabilitation activities, does not require a registration of the original 
problem. Some secondary diagnosis for “late effect” coding is theoretically possible, but 
often not registered in daily practice, as this has no impact on the financing. 
Congruent with the international agenda, further efforts are needed to develop a specific 
rehabilitation registration system. In order to avoid over-registration on the ward and 
guarantee accurate exploitation of these date, some reflections and validation exercises 
are needed to fit this specific registration module in other registration models. As already 
mentioned in chapter 3, other countries use specific rehabilitation scales like FIM and 
Barthel Index for organisational and financing purposes in rehabilitation facilities. These 
scales, although not routinely registered in Belgium, are used in some Belgian hospitals for 
clinical purposes. It could be an option to introduce one of these scales in the Belgian 
registration system, to validate it for Belgium and to compare this exercise with 
experiences at the international level. An advantage of this approach would enable an 
international comparison of the Belgian situation, from the clinical point of view as well as 
from the organisational and financing point of view. One of the disadvantages however, 
could be the augmentation of the administrative burden that is already high in this part of 
medical practice.  
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Key points 
• In literature some efforts have been described to assess the use of minimum 
nursing data in post-acute rehabilitation. Different American datasets, used 
for different settings providing post-acute rehabilitation care (acute 
rehabilitation hospitals, nursing homes), all include items that assess ADL, 
ambulation and locomotion, and neuro/emotional/behavioural status. 
Although the instruments do not specify all data items identically, it seems 
to be possible to construct a single dataset that makes it possible to 
compare post-acute rehabilitation needs in different settings. 
• In Belgium only MVG-RIM includes functional items. It could be considered 
to use MVG-RIM as an intermediate profiling tool of post-acute 
rehabilitation, using the “fingerprints”.  
• However, the necessary reluctance is needed before starting to use MVG-
RIM: it is not a tool developed to score for therapeutic (occupational 
training, physical therapy, psychology,…) activities, neither to monitor or 
assess the effectiveness of therapy or different aspects of rehabilitation 
activities. Validation will be necessary. It could be an option to validate MVG-
RIM with FIM or Barthel Index, or with other instruments currently tested in 
other countries. It should be kept in mind that MVG-RIM can only be used 
for inpatient registration, and not for outpatients. 
• The coupling of MVG-RIM with Minimal Clinical Data (MKG-RCM) and 
Minimal Financial Data (MFG-RFM) sets could be included in this validation 
exercise. But there are important methodological issues to take into 
account, related to the particularities of these Belgian registrations 
concerning the field of rehabilitation. 
• Congruent with the international agenda, further efforts are needed to 
develop a specific rehabilitation registration system, enabling to monitor the 
patient-profiles and rehabilitation activities in post-acute care. One should 
line up with international efforts and initiatives to develop validated 
registration instruments in line with the ICF-concept, and to integrate these 
with existing registration systems.  
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5 DESCRIPTION OF THE CURRENT 
ORGANISATION AND FINANCING OF 
MUSCULOSKELETAL AND NEUROLOGICAL 
REHABILITATION IN BELGIUM 
5.1 DESCRIPTION OF THE BELGIAN FINANCING SYSTEM FOR 
MUSCULOSKELETAL AND NEUROLOGICAL 
REHABILITATION 
5.1.1 Introduction 
In order to understand the complex Belgian financing system, first a typology for provider 
payment systems is presented, which is then applied to the financing system of 
rehabilitation in Belgium, concerning hospital stay as well as rehabilitation activities. Then, 
the different payment systems in Belgium are described in detail.  In the final section of 
this chapter a summary of the different actual payment systems, classified according to the 
typology model (focussing on financial incentives created by these payment mechanisms) is 
presented. 
5.1.1.1 Typology for provider payment systems in health care123 
This section is based on (health) economic literature on the incentives created by different 
payment reimbursement mechanisms. Consequently, typical assumptions (and the 
associated terminology) from economic theory will be used. 
Ideally a payment scheme should incorporate the right incentives for providers (e.g. 
physicians and hospital management) to ensure good quality of the health care provided 
on the one hand and to contain overall health care costs on the other hand.  Payment 
mechanisms should therefore seek to resolve quite distinct (and sometimes contradictory) 
challenges facing the players in the health care system, i.e. patients, physicians, hospitals, 
insurers and government. 
It has often been argued that it is therefore necessary to separate the financial self-interest 
of the physician (and other health care providers) from his role as patient advocate.  
Otherwise a physician’s clinical judgement about patient care and the subsequent course 
of treatment may not only depend on the well-being of the patient, but also on his own 
financial interest.  Another potential conflict could arise between the micro and the macro 
level : what is best for an individual patient is not always best for society 124. 
A review of the literature on physician payment methods and health services 
reimbursement schemes reveals four major payment systems : fee-for-service (FFS), 
capitation, salaried and fee-for-time (FFT) 125 126. These four basic payment or 
reimbursement systems can also be mixed in various ways.  Each of these pure methods 
has its own characteristics with specific consequences which will lead to a distinct type of 
practice setting and which will create different incentives.  A FFS system will often lead to 
excessive consultations, interventions and prescriptions, while a capitation system could 
potentially lead to a selection of good risks, implying that (on average) the level of health 
services provided will be suboptimal.  From a cost point of view, a capitation payment 
mechanism will create incentives to adopt a cost-conscious way to treat patients 127.  On 
the macro level and focussing on policy and budget, it can be argued that the lack of 
control and accountability in an open-ended system (especially FFS) makes planning 
difficult and will often lead to a chronic overrunning of the budget.  It should be noted that 
under (risk-based) capitation financing and supply-side cost-sharing, policy makers should 
be concerned that the incentives resulting from these mechanisms may distort a 
physicians’ clinical judgement 124.  
An underlying assumption of the majority of classical economic models is that the level of 
all outputs is determined exogenously, i.e. by the demand of the patients. This assumes 
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that physicans are perfect agents for their patients and, consequently, that they have full 
information about their patients’ utility function and that their own preferences are not 
influencing the course of the treatment.   
Closely related is the issue of supplier induced demand (SID).  Notwithstanding the fact 
that the SID hypothesis has been the subject of numerous (health economics) studies, its 
exact definition is still open to debate.  However, after examining different possible 
definitions, McGuire (2000)128 suggests the following definition : “SID exists when the 
physician influences a patient’s demand for care against the physician’s interpretation of 
the best interest of the patient”.  It is the amount of demand created by the supplier 
(doctor), who is acting as agent for the consumer (patient), which exists beyond what a 
fully informed patient would have chosen freely i .  Crucial elements of SID are the 
existence of asymmetric information regarding the patient’s health status and need for 
health care, combined with an imperfect agency relationship between patient and 
physician j .  If physicians then maximise their own profit instead of the utility of the 
patients, they will induce a shift in demand curve.  Additional favourable conditions for SID 
are a fee-for-service reimbursement system and excess supply.  Although numerous 
studies have found empirical support in favour of the existence of SID, there is no 
conclusive empirical evidence (e.g. McGuire (2000)128 and Ferguson (2002)130). 
A typology to classify provider payment systems from an incentive point of view is 
developed by a Belgian team of experts in health economics k.  Following the typology 
model for provider payment systems in health care by Jegers et al. (2002)123, which was 
based on an extensive study of the literature until 2000, the different current financing 
systems for musculoskeletal and neurological rehabilitation in Belgium will be classified.  
Incentives created by the various reimbursement mechanisms will be highlighted.  In a 
standard health economics setting it is assumed that providers will try to maximise profits 
implying that different payment mechanisms create incentives that may change the clinical 
behaviour of health care providers.  From the point of view of the sponsor (insurers, 
government, …) non-appropriate reimbursement mechanisms may lead to undesired 
behaviour of providers.  The typology model classifies payment systems according to two 
dimensions: on the one hand fixed versus variable systems and on the other hand 
retrospective versus prospective systems (Figure 5.1).   
                                                
i  Opponents of the SID assumption argue that doctors believe in the efficacy of their treatments and believe that 
more of them are better.  From this perspective SID is nothing more than the use of medical capacity to its 
limit129. 
j  The principal-agent framework is often used in health economics to describe the patient-doctor relationship.  
The specialised agent (physician) who has superior medical information makes treatment decisions on behalf of 
the uninformed principal (patient). 
k  Marc Jegers (Free University of Brussels (VUB), Micro Economics of the Profit and Non Profit Sectors), Katrien 
Kesteloot (University Hospitals, Leuven; Catholic University of Leuven (KU Leuven), Center for Health Services 
and Nursing Research), Diana De Graeve (University of Antwerp (UFSIA), Department of General an Public 
Economics) and Willem Gilles (Catholic University of Leuven (KU Leuven), Center for Health Services and 
Nursing Research) 
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Figure 5.1: Typology for provider payment systems in health care. 
 
Source: Jegers, Kesteloot, et al. – 2002 123 
The macro level is the level of the sponsor. A closed-end system is a financing system that 
is fixed at the macro-level. Policy-makers (insurers, politicians) determine a ceiling of 
expenditures, which may not be exceeded during a certain period. Corrections are made 
if the budget is overrun (or is likely to be overrun): a distinction is made between a ‘hard 
cap’ and a ‘soft cap’. In case of a ‘hard cap’ no exceeding of the ex ante defined budget is 
possible. In case of a ‘soft cap’ exceeding of the budget is possible but corrections, for 
example in prices, are applied in this case. An open-end system is a financing system 
without any budget limits either on a global level or for certain health care expenditures. 
The micro level is the level of the individual provider.  The distinction between a fixed and 
a variable payment system is based on the (absence of a) relationship between activities 
(production) of a provider and the payment (income) he receives.  In a variable system, 
the provider has an ability to influence his earnings by varying his activities, contrary to 
fixed systems where the provider receives a lump sum determined ex ante and not related 
to his production.  In a profit maximising setting, economic theory predicts that providers 
will produce until the marginal revenue equals the marginal cost of production.  
Production (e.g. number of consultations, activities, …) will therefore depend on the fee 
and on the cost of providing an additional unit.  Consequently variable systems with 
relatively generous fees will probably lead to overproduction.  In a fixed payment system 
where the provider receives a lump sum per unit (e.g. patient, period, …), marginal 
benefits of production within the unit are zero.  Therefore providers will have strong 
incentives to reduce marginal cost (e.g. by reducing the number or intensity of activities 
per unit or by selecting good risks).  However, providers can still attempt to increase the 
number of units in order to gain more income (e.g. within a fixed per diem payment 
increasing activities does not generate additional payments, however an additional day 
produces an extra income). 
The second dimension to classify reimbursement mechanisms is the distinction between 
retrospective and prospective reimbursements, pointing to the link (or absence of a link) 
between income of the provider and his actual cost of producing a service.  In a 
retrospective system, ex post reimbursement is based on real costs, implying that 
incentives to reduce costs are very weak.  In a prospective payment system 
reimbursement rates (e.g. Belgian nomenclature fees) are determined ex ante, without any 
link to real cost of an individual provider, creating incentives to increase efficiency and 
contain cost on the one hand and to select good risks and to provide a suboptimal level of 
care on the other hand. 
Not all interactions between the several systems and between the micro and the macro 
level are possible.  A closed end system at the macrolevel, on the one hand, can be 
achieved, both by means of a fixed and a variable reimbursement system at the microlevel.  
A closed end system further requires prospective funding and is not compatible with 
retrospective reimbursement.  
An open-ended system at the macro level, on the other hand, is not compatible with fixed 
reimbursement at the microlevel – but only with variable payment systems. Open ended 
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systems can work both with prospective and retrospective reimbursement.  Each of the 
possible combinations has its advantages and disadvantages. Figure 5.1 shows that, at the 
microlevel, fixed payment systems are not compatible with retrospective reimbursement 
(but only with prospective reimbursement). Variable payment systems can be applied both 
in retro- and in prospective ways.  A summary of the possible combinations and their main 
financial incentives is presented in Figure 5.2. 
Figure 5.2: A summary of characteristics and incentives (assuming profit 
maximisation) in payment systems according to the retrospective/prospective 
and variable/fixed dimensions. 
 
Source: Jegers, Kesteloot, et al. – 2002 123 
Variable reimbursement systems for health care providers can further be classified 
according to the unit of financing (Figure 5.3).   
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Figure 5.3: Variable payment : Unit of reimbursement 
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The unit used, e.g. item-of-service, diem, case, episode, patient or period indicates the 
intensity of the link between the provider’s production costs and his return. The financial 
risk varies per unit of financing.  As the ‘unit’ of payment becomes more extensive (i.e. 
covers a broader set of health care activities), the financial risk for the provider increases, 
to the advantage of the sponsor, whose financial risk decreases. 
5.1.2 Financing of rehabilitation in Belgium 
Financing of musculoskeletal and neurological rehabilitation in Belgium is split up in 
services related to a hospital stay (a small part for therapists payment is included) and 
rehabilitation activities (nomenclature and conventions). Each part has its own typology of 
payment systems (Figure 5.4). 
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Figure 5.4: Typology of the Belgian payment system for rehabilitation 
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5.1.2.1 Hospital stay 
In Belgium the payment of services related to a hospital stay is done via a hospital funding 
system, which can be classified as a closed-end budget with a ‘hard cap’ at the 
governmental level. For the description of the coverage by the hospital day price we refer 
to “De Belgische ziekenhuisfinanciering ontcijferd. Walter Sermeus. ISBN 90-334-5277-4”. 
There is no link between the price and the real costs related to the delivered services 
during a hospital stay. Hence, funding of the stay component in Belgian hospitals can, at 
the microlevel, be classified as a prospective, variable payment system. 
The main parts in the hospital day price are B1 (financing of general services) and B2 
(financing of clinical services), which represent 85% of the budget. For acute services B1 is 
yearly calculated related to units of work and B2 is yearly calculated related to justified 
activity.  
For organisations providing musculoskeletal and neurological rehabilitation a specific 
system exists (Specialized or Sp-beds) where B1 and B2 are not recalculated every year, 
but set at their historical price level, annually adjusted for inflation.  Historical prices 
depend on the history of the beds in these organisations. l Within the group of Sp-beds it 
concerns S2 beds for hospital stays during specialised musculoskeletal rehabilitation and S3 
beds for specialised neurological rehabilitation. These beds can issue from beds for 
chronic care (V bed), for psychogeriatric care (Vp bed), for specialised rehabilitation (S 
bed), for surgical interventions (C bed), for acute medical services (D bed) or for the 
treatment of multiple sclerosis and its consequences (H bed). The historical price is higher 
for acute (C and D) beds than for V and S beds. 
The budget to which an Sp-service or hospital is entitled is calculated, based on the 
historical price levels (cf. supra) and on the number of stay days in 2000 and the quotum 
                                                
l  Source: Koen Schoonjans Federal Governmental Service for Health Care 
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(expected number of stay days, based on a hypothetical occupancy rate of the beds) of 
2002. m 
If the actual number of stay days in year t for instance is lower (higher) than the quotum in 
2002, the budget for year t is reduced with the B1+B2-part of the budget for the (non-
realised) stay days below quotum (increased with 25% of the B1+B2 part of the budget for 
each stay day on top of the reference number). 
Moreover, the budget is paid to the institution, based on two parameters: 
• monthly ‘advance payments’ (this method is used for 80% of B1+B2) 
• a payment per stay day (this method is used for 20% of B1+ B2 and 
for all other parts of the budget). The price paid per stay day for year 
t is calculated on the basis of the actual number of stay days in t-2. 
Hence if the actual number of stay days in year t is larger (smaller) 
than the actual number of stay days in t-2, the institution will receive 
a (slightly) larger  (smaller) budget than expected. 
Hence, it can be concluded that, at the microlevel, also the hospital budget for Sp-services 
is prospective (i.e. not based on the actual costs of the institution) and slightly variable (i.e. 
small annual variations, depending on the evolution of the number of stay days, relative to 
the number of stay days in the reference period). 
These beds are financed on a 7/7 days basis. Part-time hospitalisation (e.g. 5/7 days) is not 
provided within the system. This is contradictory as one of the main rehabilitation goals is 
reintegration in the home environment and patients should be encouraged to spend the 
weekends home as soon as possible. A funding system of “week day” hospitalisation is not 
applicable in Belgium – but inspiration may be found in the funding for partial 
hospitalisation in psychiatric hospitals (funding for day- or night hospitalisation in acute 
psychiatry (Ad, An), chronic psychiatry (Td, Tn) or child psychiatry (Kd, Kn), whereby the 
funding is based on an expected utilisation of the ‘partial hospital beds’ during weekdays 
(i.e. expected occupancy of 80% of the capacity during 251 days per year – or 56% per 
year).n Neither is there reimbursement for travel expenses to go home in the weekend 
(see further: transport convention). On the other hand there are no clearly defined 
criteria justifying hospitalisation. 
As demonstrated during the Pathos-Aggir-Socios project, coordinated by Prof. M-C 
Closon in 2003-2005 (“Spécificités des services Sp/Specifieke aspecten van de Sp 
diensten”), there is a large variability in characteristics of patients staying in organisations 
providing musculoskeletal or neurological rehabilitation services at the level of: 
• Independence 
• Rehabilitation needs 
• Age 
• Number of pathologies and the interaction 
The current Minimal Clinical Data (MKG/RMS) registration includes a registration of main 
pathology (principal diagnosis), degree of severity, main co-morbidities, principal 
interventions and some other data but does not provide enough information to map the 
variability at all mentioned levels. However, this variability influences the intensity of care 
and indirectly the financial needs. o 
Summarised, financing of services related to a hospital stay is characterised by: 
                                                
m  In this section, the overall characteristics of the Sp-hospital funding system are described. No details are added 
and the specifics of an acute hospitals with an Sp-service (whereby patients may have part of their stay in an Sp-
unit and part of their stay elsewhere in the hospital) are not incorporated either. 
n  This funding system for partial hospitalisations is not automatically transferable to Sp-beds, since  it covers 
daytime or nighttime hospitalisations (i.e. patients do not stay overnight or only overnight), whereas patients in 
Sp-beds do stay overnight (during weekdays). But it is a precedent of a hospital funding system, based on a 5/7 
days per week hospitalisation.  
o  Analyse de la spécificité des services Sp. Rapport Mars 2003. D. Thimus, M.C. Closon 
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• A large variability mainly explained by historical factors 
• A yearly price correction limited to the price index; 
• Absence of a link with “working units” or “justified activity” 
• Absence of a link with the large variability of patient characteristics. 
5.1.2.2 Rehabilitation activities 
The payment of rehabilitation activities varies as a function of provider activities within an 
a priori defined budget. The budget can be exceeded but in case of a significant overrun, 
corrective measures – such as an adjustment in the fee schedule or an increase in co-
payment – can be undertaken.  There is no link between the price and the real cost of 
therapy (prospective payment).  
Rehabilitation activities are financed by two different systems: nomenclature and 
conventions. Nomenclature covers mono-disciplinary as well as multidisciplinary activities 
(R for mono-disciplinary speech therapy, M for mono-disciplinary physical therapy and K 
for physical medicine & rehabilitation).  The systems for multidisciplinary rehabilitation 
activities, scope of this study, will be analysed in detail in the following paragraphs (K-
nomenclature and conventions). 
There are no significant differences between the nomenclature and the conventions, nor 
from a financial point of view, nor concerning accessibility, content, intensity or duration 
of therapy (Figure 5.5). 
Figure 5.5: Variable payment: Unit of reimbursement 
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The unit of reimbursement is per item-of-service for both systems. However, the unit of 
reimbursement is for some cases within the conventions rather per diem because the 
item-of-service is a 6 hours therapy session, while the item-of-service within the K-
nomenclature is limited to a 1 or a 2 hours therapy session. 
The beneficiary of the budget differs. For K-nomenclature the physiatrist is the paid 
provider whereas for conventions the paid provider is the institution. However, the 
received budget must in both cases be distributed over physiatrist, therapists and 
institution. 
The type of beneficiary has an impact on: 
• The position of the physiatrist in the discussion concerning 
distribution of the budget 
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• The relation between physiatrist and therapists 
• The relation between physiatrist and patients 
• The guarantees for optimal supply of care to the patients. 
Financing of rehabilitation activities is characterised by two different payment systems 
which differ little concerning the type of financed rehabilitation activity (both 
multidisciplinary for nearly the same diagnoses), or the unit of payment. The price as well 
as the paid provider differ. 
Due to a differentiation of rehabilitation organisations in function of the access to different 
payment systems, the income of rehabilitation organisations, the distribution of 
responsibilities and positions of authorities within these organisations differ without a 
formal link to delivered rehabilitation services. 
The current double payment system appears irrational. The concern is that different 
payment systems are applied while patients in one setting of care may, in some instances, 
be similar to patients in other settings of care. 
5.1.3 Payment systems for musculoskeletal and neurological rehabilitation 
activities 
As mentioned above, two main systems exist for (multidisciplinary) musculoskeletal and 
neurological rehabilitation: 
• Hospital day price of Sp-beds: S2 musculoskeletal and S3 neurological 
(inpatients only) 
• Rehabilitation activities (in- as well as outpatients): 
o Rehabilitation agreements (“conventions”) between the 
RIZIV/INAMI and the health care provider . 
o Nomenclature of Physical Medicine & Rehabilitation (a fee 
schedule: “K”) 
There is a substantial overlap between the different systems and it is not always clear 
which system should be used. The two systems (nomenclature and conventions) for 
rehabilitation activities could even be used sequentially for a certain number of pathologies 
until very recently (rules changed August 1st 2006, as will be explained in chapter 5.1.5). 
Nomenclature acts are physician’s fees whereas conventions are agreements between 
RIZIV/INAMI (Insurance committee) and the health care providers (institutions). Hospital 
day prices are also paid to the hospitals (except for the “fee for supervision” which is 
again a fee for the physician). 
In order to understand the existence of the different payment systems in Belgium, a short 
historical review seems necessary. In 1963 the National Institute of Sickness and Invalidity 
Insurance (RIZIV/INAMI) was founded by the Ministry of Social Affairs, as well as the 
“Rijksfonds voor Sociale Reclassering van de Mindervaliden” or “Fonds Maron” (further 
called “National Fund”) by the Ministry of Employment and Work. Most aspects of 
rehabilitation resorted under the “National Fund” and the main objective was to promote 
employment of persons with a disability. Therefore the maximum age for subscription was 
set at 65 years.  
Due to the changing governmental structure of Belgium, the “National Fund” was 
abolished in 1991 and replaced by four different Regional Funds (VFSIPH, AWIPH, 
COCOF, Dienststelle der Deutschsprachigen Gemeinschaft für Personen mit einer 
Behinderung sowie für die besondere soziale Fürsorge. Note that since April 2006 the 
VFSIPH (Vlaams Fonds voor Sociale Integratie van Personen met een Handicap) is called 
VAPH (Vlaams Agentschap voor Personen met een Handicap)). These funds are 
responsible for accreditation and subsidies of the Rehabilitation centres. In 1995 though, 
the subsidies for the intramural (in a hospital) rehabilitation centres were abolished by the 
Flemish Fund (VFSIPH). On the other hand these funds finance measures promoting social 
and/or professional integration of disabled persons, as well as individual material or 
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personal assistance. Whereas the national fund organised quality control through 
inspection visits of the centres, this is no longer organised by the regional funds. 
Rehabilitation services are since 1991 financed by the RIZIV/INAMI. Rehabilitation is part 
of the health care provisions system (art.34 of the law concerning compulsory health 
insurance) which is mainly a fee for service system.  
Most of the rehabilitation agreements have been established on a temporary basis in 1991 
and since then been prolonged year by year. For musculoskeletal and neurological 
rehabilitation, the subject of this study, there are different types of agreements: 46 “type 
conventions 950” (28 in the region of Flanders, 13 in Wallonia and 5 in Brussels) and 7 
“specific conventions 7.71” (2 in Flanders, 3 in Wallonia and 2 in Brussels). There are also 
agreements with six reference centres for neuromuscular diseases (NMRC-convention) 
7.89.2 (3 in Flanders, 1 in Wallonia and 2 in Brussels). Recently, reference centres for 
cerebral palsy and spina bifida as well as for chronic fatigue and chronic pain were 
introduced as well. 
In the nomenclature (a fee schedule) of Physical Medicine & Rehabilitation (art. 22 and 23 
“Physiotherapy”) three nomenclature codes for rehabilitation acts were established in 
1991, and have been revised in August 2004. Since then the nomenclature includes more 
specific criteria and a limitative list of pathologies. However, there is a great overlap 
between these pathologies and those included in the agreements. 
The nomenclature, as well as the 9.50 and 7.71 conventions, can be applied in both 
hospitalised and ambulatory patients. 
Rehabilitation for hospitalised patients is mostly organised in a day-price system of 
specialized beds (Sp beds, musculoskeletal and neurological). Accreditation of hospital 
beds is organized by the Ministry of Public Health. Again, both systems can be used 
simultaneously (Sp bed/nomenclature or Sp bed/agreement). These beds exist since the 
early nineties and the norms were published in 1993. The “day-price” also covers some 
therapists and infrastructure for rehabilitation. Their historical background can be very 
different. Many of them, mainly the beds in isolated services (also called “categoral” 
hospitals), originated from the formal R- or V-beds (hospital law 1985). Others are 
reconverted acute beds (C- or D-beds) in general hospitals. The financing is depending on 
the formal day-price of the original bed-type (acute or chronic, general or “categoral” 
hospital) and varies substantially. The day-prices are mainly set historically and there are 
no objective criteria to differentiate between them. The last decade we saw a spectacular 
growth of the number of Sp-beds. For instance, the number of S2 beds (Sp beds for 
“musculoskeletal” disorders) increased between 2003 and 2005 from 1.775 to 1.996. 
5.1.3.1 Conventions  
Within the convention system, the following conventions are relevant for musculoskeletal 
and neurological rehabilitation.  
•  “Convention 7.71: Specific and type conventions – Institutions for 
motor rehabilitation”: these conventions exist under two distinct 
forms (described as such in the “Riziv Audit Revalidatiesector June 
2004”): 
o “Specific reference centres for important orthopaedic and/or 
neurological rehabilitation”. These reference centres provide 
rehabilitation to patients with highly complex disorders and 
provide treatments of at least half a day. 
o “Specific categoral centres”: category specific rehabilitation 
centres specialised in one pathology such as multiple sclerosis 
or traumatic brain injury. 
•  “Convention 9.50: Type convention – Institutions for ‘locomotor’ 
rehabilitation”: 48 (since 2005 only 46) general rehabilitation centres 
located across the different regions. The 9.50 centres provide 
rehabilitation to patients with complex disorders or more important 
impairments and disabilities and lasting problems. This convention 
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was renewed in a different form July 1st 2005 (and is applied since 
August 1st 2006) . 
• “Convention 7.89.2: Type convention - Reference centres for 
patients with neuromuscular disorders”. This type of convention is 
different from the 9.50 and 7.71 in the sense that the fee covers the 
coordination and follow-up of the services provided to these patients 
during one year  
• Additionally, for wheelchair bound patients there exists a “transport-
convention“ in order to pay for the travelling expenses for 
ambulatory rehabilitation. 
To be complete the following conventions have to be mentioned: 
• “Convention 7.89.4: Reference centres for chronic fatigue 
syndrome.” 
• ”Convention 7.89.5: Reference centres for cerebral palsy and spina 
bifida (CP-SB)”.  
• “Convention 7.89.6: Reference centres for chronic pain.” 
As these conventions have been applied only since very recently we did not perform any 
analyses on the data. In concept they are very similar to the convention 7.89.2. 
Based on the scope of this study, a detailed analysis is performed on the 9.50 convention 
(paragraph 5.1.4), the 7.71 convention (paragraph 5.1.5) and to a lesser extent the 
convention 7.89.2 (paragraph 5.1.7). 
5.1.3.2 Nomenclature   
Within the nomenclature system, three nationally established fee schedules are relevant 
for musculoskeletal and neurological rehabilitation:  
• K-nomenclature: nomenclature for Physical Medicine and 
Rehabilitation (PM&R): applied in the departments for PM&R, present 
in most of the Belgian hospitals, where a team of multi-disciplinary 
practitioners provide general and acute rehabilitation, under the 
supervision and coordination of a specialist in PM&R 
• M-nomenclature: nomenclature for mono-disciplinary physical 
therapy 
• R-nomenclature: nomenclature for mono-disciplinary speech therapy 
(to be distinguished from R30/R60 applied for convention 9.50. There 
is no relation between the two R-codes.). 
For other disciplines such as occupational therapy and psychotherapy there currently is no 
nomenclature when performed mono-disciplinary. 
Based on the scope of this study, a detailed analysis is performed on the K nomenclature 
(paragraph 5.1.6).  
5.1.3.3 Hospital day price 
Regarding the fee for hospitalisation the assumption is that most of the inpatients reside in 
Sp-beds: S2 beds (allocated for musculoskeletal disorders) and S3 beds (allocated for 
neurological disorders).  
As rehabilitation activities for inpatients also take place in other settings (geriatric beds, 
Sp-beds for chronic disorders, acute beds, psychiatric beds…) the expenses for S2 an S3 
beds are probably an underestimation of the “fee for hospitalisation for musculoskeletal 
and neurological rehabilitation”. 
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5.1.3.4 Other payment systems 
In addition to the financial arrangements for the different rehabilitation modalities, some 
centres can benefit from other sources of income such as subsidies from the Regional 
Funds  (VFSIPH, AWIPH,…) and Institutions (VIPA, CRAC, COCOM), for example for 
buildings. 
VIPA (Vlaams Infrastructuurfonds voor Persoonsgebonden Aangelegenheden): Flemish 
public institution. As a financing instrument VIPA provides financial support to welfare and 
health provisions for infrastructural works in e.g. hospitals and elderly care institutions in 
Flanders. 
CRAC (Centre régional d'aide aux communes): Walloon public institution that supervises 
financial issues of the municipalities and the hospitals in Wallonia. 
COCOM (Commission communautaire commune): public institution of the region of 
Brussels-capital, responsible for health policy and health institutions. 
Moreover, specific products and materials (e.g. pharmaceuticals, devices,…) can be 
reimbursed separately, both for hospitalised and for ambulatory patients. 
5.1.3.5 Sources of data  
All data concerning the different systems (descriptions and expenditures) were supplied by 
the RIZIV/INAMI (National Institute of sickness and invalidity insurance) and the FOD 
Volksgezondheid (Federal Service of Health, Food Chain Safety and Environment 
Organisation of Health Care Establishments). 
5.1.4 Inventory of different rehabilitation services 
5.1.4.1 Departments of Physical Medicine and Rehabilitation 
Surprisingly there exists no central register of the departments of physical medicine and 
rehabilitation. It is presumed that most of the acute/general hospitals in Belgium dispose of 
such a department. 
5.1.4.2 Rehabilitation centres with a convention (9.50 or 7.71) 
In Figure 5.6 an overview is given of the geographical distribution of the 46 rehabilitation 
centres with a 9.50 convention and the 7 rehabilitation centres with a 7.71 convention 
mentioning: 
• the number of 9.50 centres in each of the 10 Belgian provinces and 
the Brussels region 
• the different locations of the 7.71 centres 
This inventory is based on data from RIZIV/INAMI. 
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Figure 5.6: Geographical location of the 9.50 and 7.71 centres (2006) 
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Figure 5.7 shows population data for the 10 provinces and the Brussels region, as well as the concentration of conventioned centres per province. 
Figure 5.7: Population data (Belgium provinces and Brussels region) and number of 9.50 and 7.71 conventions/100 000 inhabitants 
Source: Nationaal Instituut voor de Statistiek – 2005 
Provinces
Number of 
9.50 
conventions
Number of 
7.71 
conventions Population Population / km²
 Number of 9.50-
7.71 conventions  
/ 100.000 
Inabitants
West Vlaanderen 10 0 1.138.503 364 0,88
Oost Vlaanderen 6 1 1.380.072 463 0,51
Vlaams Brabant 3 1 1.037.786 493 0,39
Antwerpen 6 0 1.676.858 585 0,36
Limburg 3 0 809.942 334 0,37
Brabant Wallon 1 1 363.776 333 0,55
Hainaut 6 0 1.286.275 340 0,47
Liège 5 1 1.034.024 268 0,58
Luxembourg 0 0 256.004 58 0,00
Namur 1 1 455.863 124 0,44
Brussels Hoofdstedelijk gewest -  Région de Bruxelles- Capitale
Brussels Hoofdstedelijk gewest 5 2 1.006.749 6238 0,70
Totals 46 7 10.445.852 342 0,51
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The “absolute” number of 9.50 / 7.71 conventions as an indicator for rehabilitation 
activity has some limitations because: 
• Some of the 9.50 conventions might not be in use and represent no 
rehabilitation activities. 
• The number of institutions with a 9.50 convention is not proportional 
to the number of musculoskeletal and neurological rehabilitation 
activities. The volume (number) of rehabilitation activities depends on 
the capacity of the institution (for inpatients and outpatients). 
In the distribution of centres over the country different factors can be of importance 
such as: 
• Geographical distribution (distance) 
• Transport issues such as public transportation facilities, traffic density 
(traffic jams) 
• Density of population (in order to obtain a minimum volume of 
patients/activities per centre) 
• Language issues 
Nevertheless, the following conclusions can be drawn 
• There are no institutions with a 9.50 or 7.71 convention in the 
province of Luxembourg. As a consequence, inhabitants of 
Luxembourg need to travel to the neighbouring provinces. 
Luxembourg is characterized by the lowest number of inhabitants, the 
biggest area in km², resulting in the lowest population density (58 
inhabitants / km²).  
• In the Walloon region, provinces with the lowest number of 
inhabitants (Namur, Luxembourg, Brabant wallon) do have the lowest 
number of rehabilitation centres with a 9.50 and/or 7.71 conventions.  
These institutions are concentrated in the provinces of Liège and 
Hainaut, which have the highest number of inhabitants. 
• In the Flemish region, West Flanders has a significantly higher number 
of 9.50 conventions, as compared with the other provinces.  
• The Brussels region has a high number of 9.50/7.71 conventions per 
100 000 inhabitants whereas it is characterised by a very high density 
of 6312 inhabitants / km². 
• On the whole, 9.50 and 7.71 conventions considered together, they 
are rather homogeneously distributed compared to the density of 
population in a certain area. There are two exceptions: Luxembourg 
has no conventions at all, whereas West-Vlaanderen has a high number 
of 9.50 conventions. It should be taken into consideration however, 
that the number of conventions is not necessarily  proportional to the 
number of musculoskeletal or neurological rehabilitation activities 
since their capacity can differ.  
5.1.4.3 Inventory of Sp Beds  
In order to have a more precise view on rehabilitation activities, compared with the 
number of 9.50 conventions and/ or 7.71 conventions, we give an overview of the 
number of beds, which are allocated to musculoskeletal and neurological rehabilitation.  
Based on the scope of the study, the inventory is limited  to S2 and S3 beds. 
• S2 beds are defined as beds for the treatment and rehabilitation of 
“musculoskeletal” disorders.  
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• S3 beds are defined as beds for the treatment and rehabilitation of 
“neurological” disorders. 
Practically, there is some overlap between both bed-types for an important number of 
disorders that have “neurological” as well as “musculoskeletal” aspects.  For instance, a 
patient with a stroke, MS or a spinal cord lesion can be admitted in a S2 as well as in a 
S3 unit. However, patients without a neurological disorder such as amputees or patients 
with THR (total hip replacement) will only stay in S2 beds. 
Limitations of this approach are:  
• Focus lies on rehabilitation activities for inpatients, as the number of S2 
and S3 beds gives an indication of rehabilitation activities in a hospital 
setting.  
• Musculoskeletal and neurological rehabilitation activities are also given 
to patients who are hospitalized in other beds such as G (geriatric) 
beds, S5 beds (beds for chronic disorders), K beds (neuropsychiatry 
for children), C beds (surgery), D (internal medicine), … 
As a consequence, an inventory of S2 and S3 beds, as an indicator for musculoskeletal 
and neurological rehabilitation in hospital setting might be an underestimation of the 
real activity. On the other hand, due to waiting lists for instance in nursing-homes, some 
patients stay longer than necessary in the Sp-bed. 
5.1.4.4 Results 
As shown in Figure 5.8 there are currently 3321 S2 and S3 beds in Belgium. The S2 
beds, allocated for rehabilitation of musculoskeletal disorders represent 60 %, the S3 
beds for neurological disorders 40 %.  
Figure 5.8: General overview of S2 and S3 beds 
S2 S3 S2 + S3
Flemish region 1069 702 1771
Walloon region 672 437 1109
Brussels region 278 163 441
Total 2019 1302 3321  
Sourcep: https://portal.health.fgov.be – updated 29-05-2006 
                                                
p  There are two different databases for the inventory of S2/S3 beds. The first database gives an overview of the 
total number of beds at a certain point in time (e.g. figure 4), the second source calculates a year-to-date 
average of the total number of beds and takes into account the variation per institution in this given year (e.g. 
figure 30). These databases diverge for the indicator “total number of beds” given their different calculation. 
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Figure 5.9 shows the geographical distribution of the S2 and S3 beds over the 10 provinces and the Brussels region. 
Figure 5.9: Geographical repartition of S2 and S3 beds in Belgium 
Number Beds / institution S2 S3 Total S2 S3 Total S2 S3 Total S2 S3 Total S2 S3 Total S2 S3 Total S2 S3 Total S2 S3 Total S2 S3 Total S2 S3 Total S2 S3 Tota
Institution 1 20 20 40 26 27 53 59 20 79 26 60 86 20 20 40 56 27 83 20 21 41 20 31 51 20 20 24 20 44 20 55 75
Institution 2 30 25 55 20 23 43 30 123 153 60 20 80 20 120 140 42 42 24 20 44 20 56 76 32 32 26 26 24 88 112
Institution 3 20 50 70 20 20 30 134 164 55 40 95 30 30 26 20 46 31 30 61 30 30 20 20 29 20 49
Institution 4 20 20 40 24 24 20 20 100 100 22 22 24 81 105 20 100 120 22 22
Institution 5 22 22 30 30 26 26 20 20 20 9 29 20 20 24 24
Institution 6 60 60 20 20 20 20 20 22 42 30 30 20 20
Institution 7 125 125 22 22 40 40 20 20 47 47
Institution 8 20 20 30 30 21 21 20 20 38 38
Institution 9 22 22 24 24 30 30
Institution 10 0 22 22 24 24
Totals 317 115 432 140 50 190 139 277 416 361 120 481 112 140 252 98 27 125 241 173 414 181 217 398 82 0 82 70 20 90 278 163 441
Population 
(Number Beds / 
inhabitants) * 100.000 27,8 10,1 37,8 10,1 3,6 13,7 13,3 26,5 39,8 21,4 7,1 28,5 13,7 17,2 30,9 26,7 7,4 34,1 18,7 13,4 32,1 17,5 20,9 38,4 31,7 0,0 31,7 15,3 4,4 19,6 27,3 16,0 43,3
1.018.804458.574258.5471.036.588
Antwerpen Vlaams BrabantOost VlaanderenWest Vlaanderen
1.141.866 1.688.4931.044.1331.389.450 1.290.079366.481814.658
Brussels NamurLuxembourgLiègeHainautBrabant WallonLimburg
 
Source: https://portal.health.fgov.be – updated 29-05-2006  
 
72  Musculoskeletal & Neurological Rehabilitation KCE reports 57  
The following information is included in the table: 
• Number of S2 and S3 beds in every province and the Brussels region – 
taking into account the repartition of these beds over several 
institutions. For example: In West-Vlaanderen there are 317 S2 beds 
and 115 S3 beds. The 317 S2 beds are spread over 8 institutions. The 
115 S3 beds are spread over 4 institutions 
• Population (number of inhabitants) of every province and the Brussels 
region 
• Ratio Number of beds / 100.000 inhabitants. For example: in West-
Vlaanderen there are 27.8 S2 beds / 100.000 inhabitants and 10.1 S3 
beds / 100 000 inhabitants.  
Remarks:  
• The number of S2 and S3 beds does not always represent general 
rehabilitation capacity because some centres are focusing on one 
specific pathology. For example the 134 S3 beds in Vlaams-Brabant are 
mainly for multiple sclerosis patients and do not represent general 
neurological rehabilitation. 
• The differentiation between “musculoskeletal” and “neurological” is 
not always very clear. Many neurological patients also present 
musculoskeletal problems. For example stroke patients can also be 
admitted in musculoskeletal beds. 
• Rehabilitation activities for inpatients are not only linked to S2 and S3 
beds. Many musculoskeletal and neurological rehabilitation activities 
take place in G (geriatric) beds,  K (neuropsychiatry beds for children) 
beds, S5 (bed for chronic diseases), C (surgical beds), D (internal 
medicine beds), ….  
Nevertheless, the following conclusions can be drawn: 
• The number of institutions with S2 beds is higher than the number of 
institutions with S3 beds. As a consequence geographical coverage is 
higher for musculoskeletal rehabilitation than for neurological 
rehabilitation (average distance to a S2 centre is smaller than the 
average distance to a S3 centre for the patients).  This remark is 
applicable on all the provinces and the Brussels region. This seems 
logical though as most of the neurological disorders can also be 
treated in musculoskeletal beds. 
• At the national level there are 19 S2 beds / 100 000 inhabitants and 
12.4 S3 beds / 100 000 inhabitants meaning that musculoskeletal 
rehabilitation is more important in terms of infrastructure (beds) than 
neurological rehabilitation. 
o The ratio “number of S2 beds / 100 000 inhabitants” varies 
from 10,1 in Oost-Vlaanderen  to 31.7 in Luxembourg.  
o The ratio “number of S3 beds / 100.000 inhabitants” varies 
from 0 in Luxembourg to 26.5 in Vlaams-Brabant  
• In Wallonia, the two provinces with the highest number of inhabitants 
(Liège and Hainaut) are characterized by a medium ratio of “number of 
S2 beds/100 000 inhabitants” and a high ratio “number of S3 beds/100 
000 inhabitants”. 
o The ratio “number of S2 beds/100 000 inhabitants is 18.7 in 
Hainaut and 17.5 in Liège (national average 19.2) 
o The ratio “number of S3 beds / 100 000 inhabitants  is 13.4 
in Hainaut and 20.9 in Liège (national average 12.4) 
Based on this information, it seems that neurological rehabilitation in the Walloon 
region is concentrated in the provinces Liège and Hainaut..  
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• In Wallonia, the three provinces with the lowest number of inhabitants 
(Namur, Luxembourg, Brabant wallon) are characterized by a low ratio 
concerning “number of S3 beds/100 0000 inhabitants” 
o The ratio “number of S3 beds/100 000 inhabitants is 4.4 in 
Namur, 0 in Luxembourg and 7.4 in Brabant wallon 
(national average 12.4) 
o The ratio “total number S2 + S3 beds/100 000 inhabitants” 
is only low in Namur.  
Combining this information with the results of the previous paragraph (number of 9.50 
and 7.71 conventions) we conclude that  
o The low number of 9.50 and 7.71 conventions in 
Luxembourg does not correlate with the infrastructure of 
S2 beds (musculoskeletal rehabilitation).  
o The low number of 9.50 and 7.71 conventions and the low 
ratio of S3 beds/100 000 inhabitants confirms the 
concentration of neurological rehabilitation in the other 
provinces Liège and Hainaut. Especially in Luxembourg and 
Namur, that cover a much larger area than Brabant wallon, 
it might be a long distance to travel to obtain appropriate 
neurological rehabilitation.  
• In Flanders all provinces (except Oost-Vlaanderen) are characterized 
with one ratio above and one ratio below the national average (S2 or 
S3 beds/10 000 inhabitants). 
o Oost-Vlaanderen is characterized by a ratio of 10.1 S2 
beds/100 000 inhabitants and 3.6 S3 beds / 100.000 
inhabitants. Both indicators are below the national average. 
Based on the information of the previous paragraph (six 
9.50 conventions and one 7.71 convention), we did not 
expect this result. A partial explanation is the fact that only 
20 beds of the rehabilitation centre of the University 
hospital of Ghent are included in the overview as S2 beds.  
Combining this information with the results of the previous paragraph (number of 9.50 
and 7.71 conventions) we conclude that  
o “West-Vlaanderen, that was characterised by a high number 
of 9.50/7.71 conventions, has an S2 ratio of 27.8 which is 
above the national average of 19 and a S3 ratio below the 
national average of 12.4.  
o Oost-Vlaanderen has a low ratio total number S2 + S3 
beds/100 000 inhabitants but an average number of 9.50 and 
7.71 conventions. 
• In the Brussels region, the ratio number of S2 beds/100 000 inhabitants 
is 27.3 and the ratio number of S3 beds / 100 000 inhabitants is 16. 
Both ratios are above the national average. Combining this information 
with the results of the previous paragraph (number of 9.50 
conventions/7.71 conventions) we conclude that both musculoskeletal 
and neurological rehabilitation beds are abundantly represented in the 
Brussels region.  
5.1.4.5 Conclusion 
The geographical distribution of 9.50 and 7.71 conventions and S2-S3 beds is relatively 
homogeneous in Belgium. Only the provinces of Luxembourg and Namur tend to show 
a relatively low supply of neurological rehabilitation services, whereas there is a 
relatively high supply of rehabilitation services in the Brussels region and West-
Vlaanderen.  
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5.1.5 Convention 9.50: Type convention – Institutions for ‘locomotor’ 
rehabilitation 
5.1.5.1 Cost model 9.50 convention 
The cost of the rehabilitation activity, specified in the 9.50 convention is determined by 
the contract with RIZIV/INAMI and is equal for the 46 rehabilitation centres that 
subscribed to the 9.50 convention.  
The  focus lies on the “new” 9.50 agreement that should have been applied since July 
1st 2005, but only started August 1st 2006 (KB 22-06-2006). All sessions in the 9.50 
conventions have to be multidisciplinary (at least 2 disciplines), in contrast to K-
nomenclature, which can also offer mono-disciplinary sessions.   
In the “new 9.50 convention” two rehabilitation prices are applied: 
• During the first 60/120 sessions (depending on the underlying 
pathology) a uniform price per rehabilitation session is paid. This is 
called R30/R60, where R30 stands for one hour and R60 for two hours 
of multidisciplinary rehabilitation activities (comparable to K30/60). 
The exact price is €30.58 for R30 and €61.15 for R60 (Oct. 2006) 
(comparable to the prices of K30/60, see further). 
• After these 60/120 sessions, the price per session is in relation to the 
underlying pathology, without any relation with duration of the session. 
• The accumulation of diagnostic with treatment honoraria or an 
accumulation of K-nomenclature with rehabilitation fees (9.50) is 
forbidden during the first 60/120 sessions (exception for speech 
therapy). After this first period one extra fee can be cumulated (e.g. M-
nomenclature for physical therapy or R-nomenclature for speech 
therapy). Also, the “new 9.50 convention” cannot be preceded any 
more by K30/60, at least in the 46 existing  9.50 rehabilitation centres. 
Of course, centres without convention 9.50 can first apply K-
nomenclature, and then refer the patient to a 9.50 convention centre. 
The convention-centre receiving such a patient has to discount the 
amount of K-sessions already delivered from the 60 or 120 sessions 
they can deliver using R30/R60. A problem with regard to referral 
between different services is that after R30/R60, K30/K60 cannot be 
applied anymore in services without a convention. 
The price is subject to indexation. 
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5.1.5.2 Target groups 9.50 convention 
Figure 5.10: Target groups convention 9.50 
9.50 
Group A2 
- Acquired para or tetraplegia 
- Brain injury that causes severe neuromotor impairments or speech- and language impairments or 
other severe neuropsychological impairments 
Group A2bis 
- Chronic evolutive diseases of the brain and/or spinal cord, with motor or intellectual sequels, during 
the intensive rehabilitation phase after an episode of deterioration 
Group A4 
- Amputation of an upper or lower limb 
Group B3 
- Cerebral palsy 
- Congenital diseases of the spine and/or spinal cord 
- Dysmelia en phocomelia 
Group B4 
- Myopathies: progressive hereditary muscular dystrophies, Thomson's myotonia congenita and 
autoimmune polymyositis 
- Mucoviscidosis 
- Severe musculoskeletal and psychological impairments due to rheumatoid arthritis in a Steinbrocker 
stadium III and IV 
Art. 5 paragraph 3 
After the allowed maximal duration of a patient, there is a possibility to extend treatment with a 
more limited cost per treatment. 
Source: RIZIV/INAMI 2006 
In Figure 5.11 the different pathology groups are linked to: 
• Maximum number of sessions (limited to one treatment per day) 
• Number of extra sessions that are allowed after the maximum number 
of sessions are reached 
• Maximum duration of the total rehabilitation program  
• Price  of the session (€) after R30/60 
• Maximum duration of the treatment interval (if specified) 
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Figure 5.11: Target groups and treatment criteria (convention 9.50)  
Maximum number of 
sessions
Extra sessions after 
maximum
(one session / day) (art. 5)
Groep A2
460 
(max. 120 R30-R60) 2 year 150/year 39
Groep A2 bis every period of illness 150/year 39 3 months
Groep A4
195 
(max. 60 R30-R60) 1 year 37
36
9 treatments 
of 6 months
69
3 treatments 
of 6 months
144/year years 6 to 18 100/year 21
Groep B4
30/maand 
(max.  120 R30-R60) 6 months 100/year 43
Pathology
Maximum duration 
of the total 
rehabilitation program
Price of the 
session after 
R30/60 (€)
Maximum 
duration 
of interval
Groep B3
230 
(max. 120 R30-R60) 100/yearyears 1 to 6
 
Source: RIZIV/INAMI 2006 
Remark: Group B3 has different reimbursements depending on type of treatment (not 
pathology). 
In the convention a maximum duration (time between the start date and end date of all 
treatment sessions) and a maximum number of sessions is specified for each pathology 
group.  
All pathology groups except group A4 (amputation of an upper or lower limb) can be 
the subject of an extension of the normal duration time (see art. 5 paragraph 3) at a 
reduced price of €5,87.  
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Figure 5.12: Relative distribution of expenditures and number of treatments 
within the 9.50 convention per pathology 
Red : percentage of expenditures Green : percentage of cases 
Source: RIZIV / INAMI 2006 
As shown in Figure 5.12 group A2 (acquired para- or tetraplegia , brain injury that 
causes severe neuromotor impairments or speech- and language impairments or other 
severe neuropsychological impairments) is the most important pathology group,  
representing  81 % of the expenditures and 64 % of the cases.  The art. 5 par. 3 
represents the extension of rehabilitation activities after the normal duration time at a 
reduced price of 5,87 €. This group represents 7% of the expenditures and 27 % of the 
cases. All other pathology groups represent a rather limited proportion of expenditures 
and cases. Note that these numbers relate to expenditures and cases before 
introduction of the above explained “new 9.50 convention”. 
5.1.5.3 Requirements 
 Team 
Management Unspecified 
Team Physician in Rehabilitation Medicine 
Multi-disciplinary team (unspecified) 
Experts General practitioner 
Nurse 
Social worker 
Infrastructure 
Opening hours Unspecified 
Volume Unspecified 
%
81%
5%
2%
4%
1%
7%
64%
4% 2% 3% 1%
27%
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A2 A2bis A4 B3 B4 Art. 5 par. 3
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5.1.5.4 Detailed overview expenditures evolution convention 9.50 
Figure 5.13: Expenditures evolution of the convention 9.50 between 2000 
and 2004 in Euro. 
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Source: RIZIV/INAMI 2006 
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Figure 5.14: Detailed expenditures growth of the convention 9.50 between 
2000 and 2004 in Euro. 
Source: RIZIV/INAMI 2006 
We notice that in absolute terms (€), A2 pathology (para- and tetraplegia/brain injury) 
is responsible for the largest part of the growth.  
Other pathology groups have a rather marginal influence on the expenditures growth in 
the 9.50 conventions; they also represent a limited number of cases in the 9.50 
convention.  
5.1.5.5 Conclusion Convention 9.50 
This convention can be applied in 46 Belgian rehabilitation organisations for a limited list 
of acute or chronic neurological and musculoskeletal disorders. The fee (per item-of-
service) is different for a number of different groups of pathologies. 
The largest group of patients, at least before the changes to the “new convention 9.50”, 
is A2 pathology (para- and tetraplegia/brain injury). Possibly a lot of patients in this 
group are stroke patients, however, no further diagnostic details are available. 
Art 5 par. 3 is registered frequently (27% of cases), which means that many patients are 
chronic patients. This is probably linked to the transport convention and the relatively 
important group of outpatients in the 9.50 conventions. In practice this rather small fee 
is often cumulated with mono-disciplinary K or M-nomenclature. 
The system recently (August 2006) changed to the “new convention 9.50”, so new 
evolutions are to be followed up. 
5.1.6 Convention 7.71: Specific and type conventions – Institutions for motor 
rehabilitation 
5.1.6.1 Cost models 7.71 conventions 
The cost model analysis was done based on the different conventions 7.71 that exist 
between the RIZIV/INAMI and the seven 7.71 centres.  
€
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Two different convention models were identified for the 7.71 centres. Although a 
typology exists, each centre has an individual agreement that stipulates the exact price 
of a treatment (depending on the convention model and individual criteria). 
Conventions 7.71 do not allow any cumulation with other nomenclature on the same 
day, whereas 9.50 does in the second phase of the convention (see 5.1.5.1).  
Two centres are specific for multiple sclerosis patients. Two other centres are specific 
for traumatic brain injury patients. The three other centres can accept patients as 
defined on the pathology list (important orthopaedic and /or neurological rehabilitation) 
and one of these centres is also specific for epilepsy patients. 
5.1.6.2 First type of 7.71 conventions (specific categoral rehabilitation centres) 
For the first type of 7.71 conventions (centres 1 to 4 treating MS and TBI), the 
“price/full equivalent treatment” is calculated based on: 
• Normal production capacity 
• Personnel and operating costs 
These elements are negotiated between the RIZIV/INAMI and the centres individually.  
Figure 5.15 shows an overview of these data for the four centres. The tables on the left 
side focus on normal production capacity, the tables in the middle focus on the 
personnel and operating cost. The table on the right side focuses on the result 
(price/full equivalent treatment). 
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Figure 5.15: Cost model for centres 1 to 4 (7.71 conventions)  
In/Out Eq. Pl. Days Util. Distr. Cap. Costs Index No Index Total € Equivalent 1 (3h) 0,83 (2h30) 0,66 (2h)
In 1 15 250 90% 43% Personnel 93% 1.111.618     Price 153 127 101
In 0,66 5 250 90% 9% Other 3% 4% 83.421          
Out 0,66 25 250 90% 47% 1.195.039     
In/Out Eq. Pl. Days Util. Distr. Cap. Costs Index No Index Total € Equivalent 1 (3h) 0,66 (2h)
In 1 30 250 90% 36% Personnel 84% 2.858.670     Price 180 119
In 0,66 12 250 90% 9% Other 10% 6% 556.267        
Out 0,66 70 250 90% 55% 3.414.937     
In/Out Eq. Pl. Days Util. Distr. Cap. Costs Index No Index Total € Equivalent 1 (6h) 0,5 (3h)
Out 1 10 236 90% 100% 2124 Personnel 83% 423.149        Price 239 120
Other 7% 9% 84.925          
508.074        
In/Out Eq. Pl. Days Util. Distr. Cap. Costs Index No Index Total € Equivalent 1 (6h) 0,5 (3h)
Out 1 10 236 90% 100% 2124 Personnel 81% 374.207        Price 219 109
Other 10% 9% 90.527          
464.734        
Centre 3
eq. = 6h
Centre 4
eq. = 6h
7830
18927
Centre 1
eq. = 3h
Centre 2
eq. = 3h
 
Source: RIZIV/INAMI 2006 
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Normal production capacity (activity) 
• Capacity is limited. To calculate the normal production capacity the 
following indicators are used:  
• An agreed number of places (Pl.), linked to equivalents (eq). For 
example: centre 1 has 15 places with equivalent 1 (3 hours treatment) 
for inpatients, 5 places with equivalent 0,66 (2 hours treatment) for 
inpatients (In) and 25 places with equivalent 0,66 (2 hours treatment) 
for outpatients (Out).  
• Equivalents stand for a defined number of “treatment” hours. These 
equivalents are however not the same for centres 1-2 (3 hours) and 
centres 3-4 (6 hours), which hampers comparability. 
• Working days/year (days). E.g. centre 1 has 250 working days , centre 
3 has 236 working days 
•  The hypothesis of 90% utilization  
• The above mentioned indicators determine the normal total capacity 
(formula Æ equivalent x places x working days x utilization rate (Util) 
= normal total capacity). 
• If a centre exceeds normal capacity the reimbursements of 
expenditures is limited to a reduced percentage. If the centre exceeds 
a second threshold value (maximum capacity), the reimbursements of 
expenditures is limited to the lowest reimbursement (“overcap”). 
• It must be remarked that for centre 2, where the duration of an 
equivalent therapy session is defined as 3 hours and a 0,66 eq. as 2 
hours, the actual treatment time for the patient is 4 repsectively 2,5 
hours, as part of the therapy is given in group sessions. 
Costs  
• Personnel and operating costs incurred by the centres in the treatment 
activities are submitted to RIZIV/INAMI. These costs have to be 
negotiated and accepted by RIZIV/INAMI. Yearly, working costs are 
partly indexed, personnel costs are fully indexed. 
Cost / full equivalent treatment  
• To determine the cost for the “full equivalent” treatment, total costs 
are divided by normal total capacity. Equivalents are used to determine 
the cost of other levels of (limited) treatments. 
SECOND TYPE OF 7.71 CONVENTIONS 
The second type 7.71 convention does not have an explicit cost model (Centres 5, 6 & 
7, limitative list of pathologies). The prices are set in negotiation with RIZIV/INAMI. 
Additional information on this (implicit) cost model was not found. 
Full equivalents are based on a full day (6 hour) treatment. 
KCE reports 57 Musculoskeletal & Neurological Rehabilitation 83 
 
Figure 5.16: Cost model centres 5 to 7 (7.71 conventions) 
Equivalent 1 (6h) 0,5 (3h)
Cost Hosp. 117 62
Cost Amb. 102 54
Equivalent 1 (6h) 0,5 (3h)
Cost Hosp. 119 63
Cost Amb. 103 56
Equivalent 1 (6h) 0,5 (3h)
Cost Hosp. 122 66
Cost Amb. 106 58
Center 7
Center 6
Center 5
 
Source: RIZIV/INAMI 2006 
Centres 5, 6 & 7 do not have to limit production capacity and are as a consequence not 
directly subjected to limited expenses. Nevertheless they have to report production 
data for follow up to the RIZIV/INAMI. 
BOTH TYPES OF 7.71 CONVENTIONS 
Overall, the 7.71 system lacks transparency and important differences exist between 
pricing structures for the different centres.  
Treatment sessions, even for the same underlying pathologies, is reimbursed differently 
for each centre (Figure 5.17). The comparison is based on theoretical (hourly) 
equivalents as stated in the different conventions. 
Figure 5.17: Comparison of the cost per session for the 7.71 centres 
Source: RIZIV/INAMI 2006 
One can argue that this might be justified by the complexity of the treatment, personnel 
involved and infrastructure used but these differences mainly seem to be the result of 
historical negotiations rather than based on objective quality indicators. 
Other minor differences exist between the individual conventions: 
• Centres 3 & 4 accept only outpatients. Centres 1 and 2 (and 5, 6 and 
7) treat in- and out patients. The price of the outpatients conventions 
is significantly higher than for inpatient. The assumption is that the 
financing is supposed to be partly covered by hospitalisation ‘day-price’. 
• The total number of expected working days (used for calculating the 
required staffing levels) is different for centres 1-2 (250 days) versus 
centres 3-4 (236 days); they are not specified for the centres 5-7; 
• The percentage of the costs that are indexed vary between the 
institutions (Centres 1 to 4) because of: 
Centre 1               2             3           4           5           6              7             
Baseline (1h) 50             60           40         36         21         21            22           
1h
2h 101           119           
3h 153           180           120           109           62             63             66             
6h 239           219           117           119           122           
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o A different repartition of the personnel costs (fully indexed) 
between centres 
o A different repartition of indexed and non indexed other 
costs between centres 
Yearly indexation exists for each agreement. The centres 1 to 4 can also request update 
of prices through the negotiation of the personnel and working cost and through the 
negotiation of production capacity standards.  
5.1.6.3 Target groups for the 7.71 Convention 
Figure 5.18: Pathologies for the 7.71 convention 
Source: RIZIV/INAMI 2006 
Pathologies 1 2 3 4 5 6 7
Paraparesis X X X
Tetraparesis X X X
Paraplegia X X X
Tetraplegia X X X
Traumatic brain injury X X X X X
Neurosurgical intervention on the brain X X X
Guillan-Barré syndrome X X X
amyotrofic lateral sclerosis X X X X X
Wilson's disease X X X X X
Friedreich's ataxia X X X X X
olivopontocerebellar atrophy X X X X X
multiple sclerosis X X X X X
leukodystrophy X X X X X
Arnold-Chiari deformity X X X X X
syringomyelia X X X X X
Hemiplegia/hemiparesis with severe neuropsychological impairments that can be 
shown objectively X X X
Complete monoplegia of an upper limb X X X
Amputation of an upper limb above the hand X X X
Amputation of an lower limb at the thigh in the proximal 1/3 or with desarticulation of 
the hip X X X
Amputation of both lower limbs at the tibia or femur X X X
rheumatoïd arthritis in a Steinbrocker stadium III and IV X X X
spondylitis with peripheral lesions in a Steinbrocker stadium III en IV, with eventual 
neurological complications X X X
Multiple trauma: bone-, articular or neuromuscular lesions at several limbs, or 
complex wounds at the head, trunk or pelvis with lesions of the internal organs X X X
Epilepsy X
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5.1.6.4 Requirements (7.71 conventions) 
In this table we list common requirements for all accredited 7.71 centres, with an 
explanation of small differences in requirements. 
Team 
Management All centres have a managerial position 
Support All centres have a support team (secretary, maintenance) 
Team All centres have a multidisciplinary team led by a Physician in Rehabilitation 
Medicine. The team composition is adapted to the target group of the 
centres. 
The team and the accepted personnel cost is agreed per centre with the 
RIZIV/INAMI. 
Experts All centres have the possibility to involve external experts in the 
rehabilitation program. 
Availability 
Opening hours Centres accepting inpatients have a 7/7, 24h scheme, others accept only 
outpatients (centres 3 & 4). 
Capacity Capacity is limited for centres 1 to 4. The other centres have no formally 
limited capacity in the convention agreement, but have to submit 
production data for follow up. 
Infrastructure  
Equipment Each centre has the obligation to provide the necessary equipment for all 
rehabilitation programs and extra-treatment activities. Given the large 
diversity in core competences of the different centres, these requirements 
depend on the rehabilitation context and are only implicitly stipulated. 
Buildings Each centre has to provide the necessary buildings to accommodate 
patients. 
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5.1.6.5 Detailed overview expenditures evolution convention 7.71 
Figure 5.19: Expenditures evolution 7.71 conventions in Euro for the 7 
centres between 2000 and 2004. 
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Source: RIZIV/INAMI 2006 
As the only classification of expenditures in the accounting system is in- and outpatients, 
a detailed overview of the expenditures evolution (real growth) in the conventions 7.71 
based on in- and outpatients is provided. 
Figure 5.20: Detailed expenditures evolution for in versus outpatients 7.71 in 
Euro for the 7 centres between 2000 and 2004. 
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Source: RIZIV/INAMI 2006 
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The majority of the expenditures growth is attributed to outpatient treatment. Only 
2003 has a negative overall growth in expenditures, for which there is no clear 
explanation. 
Although the majority of treatment sessions is in the segment of inpatients (See Figure 
5.20: 62%), growth in the period 2001-2004 is mainly explained by the outpatient 
segment (cfr. infra). 
5.1.6.6 Conclusion convention 7.71 
This specific convention can be applied in 7 Belgian rehabilitation organisations for a 
limited list of mostly acute neurological and musculoskeletal disorders. Price setting is 
different for each convention. The fee is higher than in the 9.50 convention and the 
requirements more specified. This convention informally aims at patients with more 
complex rehabilitation needs even though the pathologies overlap with 9.50 as well as 
nomenclature. 
5.1.7 K-Nomenclature 
5.1.7.1 Cost model 
The rehabilitation nomenclature is part of the nomenclature for medical interventions 
(chapter V, part 10, art.22 and 23). In the K-nomenclature there are diagnostic acts, 
therapeutic acts, rehabilitation acts and rehabilitation treatments (complex mono-
disciplinary or multidisciplinary). For the scope of this study we only included 
rehabilitation acts and rehabilitation treatments. 
The price of the sessions in the K-nomenclature is negotiated at a national level within 
the following actors: 
• Medicomut 
• Technical Medical Board (TGR / CTM) 
Nomenclature can be subject to indexation if negotiated between a representation of 
the physicians and RIZIV/INAMI. Prices are set at a national level. 
K-nomenclature is applicable on in and out-patients and is subject to indexation. K-
nomenclature is a “fee for service” system where one fee covers the personnel and 
operating costs of a treatment session. 
K-nomenclature makes a distinction between “rehabilitations acts (K15/20)” and 
“multidisciplinary rehabilitation treatments (K30/60)”. 
• Rehabilitation acts: treatment session supervised by a physician 
specialised in PM&R (mono-disciplinary treatment allowed). 
• Multidisciplinary rehabilitation treatments: administered by different 
therapists (at least two disciplines, under the supervision of a physician 
specialised in PM&R). The unit of payment is based on hourly 
treatment (K-30: 1 hour; K-60: 2 hours and in the futureK-45: 1,5 
hours). 
So in K30 and K60 the duration of the treatment session is defined as respectively one 
or two hours whereas K15 and K20 activities have no specified duration per session. 
The “new nomenclature”, in application since August 2004, introduced new 
rehabilitation acts and treatments (all acts and treatments listed in Figure 5.21 under 
post-2004). A limitative list of pathologies (Figure 5.22) for the acts concerning 
multidisciplinary rehabilitation treatment (K30/60, more specifically codes 558810, -21, -
32, -43) was also introduced in 2004.  Another important difference is that while before 
August 2004 a preliminary agreement on behalf of the mutual insurance was necessary, 
whereas in the new nomenclature a notification is enough, which might lower the 
threshold for initiating multidisciplinary therapy. Figure 5.21 shows a general overview 
of the “new” K nomenclature: 
88  Musculoskeletal & Neurological Rehabilitation KCE reports 57  
 
Figure 5.21: Overview new K-nomenclature since Augustus 2004 
K Amb. Hosp. Description Cost (€)
Max. number 
of treatments
20 558795 558806 20 18
15 558390 15 30
15 558423 15 unspecified
30 558456 558460 Complex incontinence 31 60 / 1/2 year
60 558994 Spine disorders 61 36
30 558810 558821 31 60
60 558832 558843 61 120
15 558434 558445 Ex-post (Treatment) 15 104
Rehabilitation act
Post-2004 treatments (Nomenclature change)
Pre-2004 treatments
Multidisciplinary 
Rehabilitation
 
Source: RIZIV/INAMI 2006 
5.1.7.2 Target groups K nomenclature 
Based on the scope of the study, an overview of the target groups for the K30 and K60 
nomenclature (multidisciplinary treatment) is shown in the table below. K30 
intervention represents an expenditure of €31, K60 intervention represents an 
expenditure of €61 per treatment session. In February 2007 the Technical Medical 
Board (TGR/CTM) agreed on replacing K60 by K45 (ca €46) for code 402A: prosthesis 
of large + intermediate joints of the limbs. This adaptation has up to date not been 
implemented yet. 
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Figure 5.22: Limitative list of pathologies in K-nomenclature (K30/ K60)  
K-Nomenclature Cost (€)
Max. number 
of treatments
Central Nervous System
101 A Cerebral lesions with neurological deficits 61 120
102 A Spinal cord injury/paraplegia-paresis/tetraplegia-paresis 61 120
103 A Progressive neurological disease after a clear change in functional autonomy 61 120
Peripheral Nervous System
201 A Peripheral nerve lesion/radiculopathy/plexus lesion 61 120
202 A Polyneuropathy after a clear change in functional autonomy 61 120
Muscular system
301 A Myopathy/myositis after a clear change in autonomy 61 120
Orthopedic diseases
401 A Algodystrophy (Südeck), Frozen Shoulder (complex regional pain syndrome) 61 120
402 A Prosthesis of large + intermediate joints of the limbs 61 60
403 A Amputations UL/LL (except finger D2-D5) 61 60
404 A Orthopedic-functional impairment concerning the large + intermediate joints of 
the limbs 61 60
405 B Functional impairments due to severe tendon lesions with partial or complete 
interruption of continuity 31 60
406 B Vertebral crush fractures 31 60
407 B Fractures of the pelvis with ilio- and ischiopubic fracture with sacroiliacal 
dislocation after surgical correction 31 60
-Varia-
501 B Postoperative or postintensive rehabilitation after an intervention  >K180 or N 
300 or after a stay of > 7 days in Intensive Care 31 60
501 A Scars of widespread burns with functional impairments during evolutive phase 
or after surgical/plastic correction 61 60
503 A Chronic rheumatic-evolutive joint diseases after a clear change in functional 
autonomy 61 60
504 B respiratory rehabilitation for obstructive of restrictive respiratory  insufficiancy 
with a FEV1 < 60 % and/or proven desaturation, at demand of the pneumologist 31 60  
Source: RIZIV/INAMI 2006 
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Figure 5.23: Relative distribution of pathologies treated with K30/60-
nomenclature amongst the members of the Christian Mutuality (CM),during 
one year (1/8/2004 until 31/7/2005).  
K30 - K60 (2004-2005) 
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Source: Christelijke Mutualiteit 2005, dr. J.Boly 
Figure 5.23 represents the relative distribution of pathologies treated with K-
nomenclature during one year amongst the members of the Christian Mutuality (CM), 
one of the largest mutual insurances in Belgium. The information of the CM was used 
since this information is not available at the national level.  
Group 402 A (prosthesis of large and intermediate joints of the limb) represents 38 % 
of the patients. Group 101 A (cerebral lesions with neurological deficits) has a patient 
proportion of 16 %, followed by group 404 A (orthopaedic functional impairment 
concerning the large and intermediate joints of the limbs) and group 501B (the 
postoperative or post intensive rehabilitation after an intervention > K180 or N300, or 
after a stay of > 7 days in intensive care). 
The exact numbers of patients concerned in the different groups are respectively 8589, 
3594, 2954 and 2628. 
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5.1.7.3 Requirements (only valid for multi-disciplinary treatment K30/60) 
Team 
Management - 
Team Physician in PM&R (Supervision) 
Physical Therapist (Permanent) 
Occupational Therapist (Permanent) 
Available experts Speech therapist 
Clinical psychologist 
Infrastructure 
Opening hours - 
Volume - 
5.1.7.4 Detailed overview expenditures evolution K nomenclature 
The K-nomenclature changed in august 2004. As a result different new codes were 
introduced. Because the old K-15 code was used for the new K-20 treatment, a 
comparative analysis on codes is impossible (different kind of treatments using the same 
nomenclature number). Therefore Figure 5.24 shows data for the period January – May 
2004 (before introduction of the new K nomenclature) and January – May 2005 & 2006 
(after introduction of the new K nomenclature) and it is expected that these data 
reflect the evolution of expenditures for the corresponding years. The data used are 
not the data based on the bills (invoices) for a certain month, but on the actually 
delivered treatment session during each of the corresponding months.  
The old K-15 now is listed at the bottom of the table. Only K30 and K60 sessions are 
still under the same code. Colour code: orange is migrated to new nomenclature code / 
blue is new type of treatment / green is no change. 
Figure 5.24: Effect on the expenditures evolution since the new K-
nomenclature (2004-2006) 
Amb. Hosp. K Expenditures Cases K Expenditures Cases K Expenditures Cases
558795 558806 15 11.578.610    953.369    20 13.659.870    865.637    20 14.109.236    905.661    
558390 15 717.496         61.767      15 703.343         60.482      
558423 15 729.449         59.331      15 799.231         65.397      
558456 558460 30 416.951         14.971      30 457.250         16.467      
558810 558821 30 5.923.618      194.882    30 2.740.072      97.872      30 3.467.961      123.887    
558832 558843 60 22.660.162    373.921    60 29.103.125    519.468    60 32.398.290    578.547    
558994 60 3.291.218      59.600      60 5.398.214      97.765      
558434 558445 15 352.829         29.998      15 690.858         57.579      
2006/01-052005/01-052004/01-05
 
Source: RIZIV/INAMI 2006 
Based on this sample of limited K codes, expressing the change in the K nomenclature 
in Augustus 2004, there is a 27% total growth in expenditures versus a 12% total 
growth in number of cases from 2004 to 2005. In 2006, as compared with 2005, we 
notice a 14% total growth in expenditures versus a 12% total growth in cases. This 
disparity suggests that the changes in the K nomenclature did not introduce any savings, 
on the contrary, expenses increased. 
Within K30/60, we notice that the number of K30 (61.997 cases) decreased with over 
50 %, while K60 (52.429 cases) increased with approximately 28 %, indicating a shift of 
K30 to K60, explaining an increase in total expenditures larger then the increase in 
cases. 
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Figure 5.25: Expenditures evolution of the K-nomenclature in Euro (2000-
2004) 
S
o
u
r
c
e
:
 
R
I
Z
I
V
/
I
N
A
M
I
 
2
0
06 
Figure 5.26: Detailed overview expenditures growth K-nomenclature (2000-
2004) 
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Source: RIZIV/INAMI 2006 
Because K30 and K60 treatments sessions are the only longitudinally comparable data, 
and since multidisciplinary therapy is the focus of this study, we excluded all other 
treatments from this graph. 
K60 accounts for the largest part of the growth in expenditures (€) and has no negative 
growth during the period under review. The expenditures for K30 increased in the 
period 2001 – 2004 with a negative growth in 2004 as well for ambulatory care out 
patients) as hospitalized patients (in patients). 
As mentioned in 5.1.7.2, the Technical Medical Board proposed a measure in order to 
control this grow’th in K60 expenditures by replacing K60 for code 402A, which is the 
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largest pathology group in Figure 5.23, by K45. This measure will probably be 
implemented in the second half of 2007. 
5.1.7.5 Conclusions K-nomenclature 
For K-nomenclature, the largest diagnostic categories between 2000-2004 (before the 
revision) were: cerebral lesions with neurological deficits, prosthesis of large and 
intermediate joints of the limb, orthopaedic functional impairment concerning the large 
and intermediate joints of the limbs, and the postoperative or post intensive care 
rehabilitation. 
The limitative list for treatment in K-nomenclature is roughly the same as the list with 
indications for the conventions, extended with some groups of orthopaedic disorders 
or postoperative status. 
For the multidisciplinary part of K-nomenclature, the revision in 2004 caused an 
increase in cases as well as expenditures, especially due to an increase in use of K60. As 
such, the aim of the revision, expenditures reduction, was not reached. An explanation 
might be that only notification to the mutual insurance is now required whereas before 
a preliminary agreement on behalf of the mutual insurance was necessary. A first 
measure taken in 2007  to reverse this increase is the replacement for code 402A 
(prosthesis of large + intermediate joints) by K45. 
5.1.8 Neuromuscular Reference Centre (NMRC) 
5.1.8.1 Introduction NMRC 
A neuromuscular reference centre (NMRC) is an organizational/functional unit, 
characterised by the following aspects:  
• specific expertise related to neuromuscular disorders and 
• multidisciplinary teamwork  
The aim of an NMRC is to develop for and in collaboration with the patient and his/her 
advocates longitudinal (in all stages of the disease starting with diagnosis) optimal care, 
including rehabilitation, taking into account medical, paramedical, psychological and 
social aspects.  
A NMRC is led by a specialised physician coaching a team of different specialised 
physicians, therapists and a multidisciplinary rehabilitation team.  
The four “core medical disciplines” for neuromuscular diseases are: neurology, 
neuropaediatrics, genetic medicine and rehabilitation medicine. Besides these core 
disciplines, many other medical disciplines need to be represented in the NMRC 
(cardiology, ophthalmology, internal medicine…). 
5.1.8.2 The rehabilitation activities of a NMRC 
The NMRC rehabilitation programmes are customised programmes, starting from a 
detailed medical, paramedical, psychological, medical-technical, social and pedagogical or 
professional evaluation of the disorders of a patient and the related limitations and 
disabilities.  
The programme is initially set up for the multidisciplinary rehabilitation team but all 
stakeholders (GP, institutions, ..) benefit from the written plan. 
Every programme is “target” focused, taking into account and describing the related 
timeframe.  
5.1.8.3 Cost model 
The rehabilitation activities suppose execution of activities during a timeframe of one 
year.  
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Individual rehabilitation programmes require the set-up of a programme that needs to 
be communicated and discussed with the patient. At least two interventions of 1 hour 
by the rehabilitation team are necessary during the implementation phase.  
Yearly price of the agreement was set at BEF44 738 (€1109.02). Ninety-five % of this 
amount is linked to the index (121.92 on October 1st, 1997). 
This price does not include fees for other rehabilitation agreements sessions or 
activities as described in the nomenclature of medical activities.  
The payment of this amount of money depends on:  
• The condition to have at least 50 patients on a yearly basis for whom 
an approval was given; 
• The minimum requirements of the rehabilitation team, specified in the 
section below; 
• A non medical therapeutic intervention of 12 hours and a medical 
intervention of 4 hours (outside nomenclature) / patient / year.  
5.1.8.4 Target groups NMRC 
The most important neuromuscular disorders are:  
• Muscular dystrophies 
• Congenital myopathies 
• Inflammatory myopathies 
• Neuromuscular junction disorders 
• Myotonic syndromes and periodic paralyses 
• Motor neuron disorders 
• Inflammatory neuropathies 
• Hereditary neuropathies 
• Metabolic and mitochondrial disorders 
• Degenerative (often hereditary) neurological disorders 
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5.1.8.5 Requirements  
Team 
Management NMRC: specialist physician (expertise and experience in diagnosis and 
treatment of neuromuscular disorders) 
Multidisciplinary rehabilitation team as a specified entity in a NMRC: 
Medical rehabilitation specialist 
Team The multidisciplinary rehabilitation team is composed of at least: 
Physician specialised in Rehabilitation medicine (0.5 FTE) 
Nurse (1 FTE) 
Physical therapist  (0.5 FTE) 
Occupational Therapist (0.5 FTE) 
Psychologist (part time) 
Dietician (part time) 
Social worker (part time) 
Administrative worker (0.5 FTE) for every 50 patients included in the 
NMRC agreement  
Experts Besides the above mentioned core disciplines the rehabilitation team must 
prove they can rely on rehabilitation technicians at all times 
Infrastructure 
General Infrastructure needs to be adapted for wheelchair bound patients 
(accessibility of rooms) 
Volume Minimum capacity to ensure expertise with Neuromuscular disorders 
NMRC (general): min of 100 patients / year 
Multidisciplinary rehabilitation team: min of 50 patients / year 
Opening hours  
5.1.8.6 Detailed cost evolution 
Figure 5.27: Cost evolution of NMRC (2000 – 2004) 
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The expenditures are multiplied with a factor six (2000-2004), this is due to the recent 
introduction of this convention (start year 2000) which explains that new patients are 
added every year (2000: 232 patients; 2004: 1 379). 
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5.1.8.7 Conclusion 
This type of rehabilitation agreement is different from the conventions 9.50 and 7.71. A 
fixed yearly price is paid for multidisciplinary follow up of a very specific group of 
patients, mostly in the chronic phase. This type of convention can be cumulated with 
fees for sessions of rehabilitation treatment. 
The same type of convention also exists for chronic fatigue syndrome, cerebral palsy 
and spina bifida and chronic pain. 
5.1.9 Evolution of the expenditures in musculoskeletal and neurological 
rehabilitation 
The expenditures for musculoskeletal and neurological rehabilitation are mainly 
composed of the following components: 
• Rehabilitation activities: 
K-nomenclature: rehabilitation activities performed in 
departments of physical medicine and rehabilitation 
Rehabilitation activities performed in centres with a 
convention 9.50 
Rehabilitation activities performed in centres with a 
convention 7.71 
• Expenditures for transport convention 
• Expenditures for reference centres (NMRC: convention 7892) 
• Expenditures for mono disciplinary physical therapy (M-nomenclature) 
and speech therapy (R-nomenclature) 
• Expenditures for hospitalisation, limited to Sp-beds (S2 and S3). 
Before analyzing the trends in the expenditure evolution for musculoskeletal and 
neurological rehabilitation, a general overview of the Belgian healthcare budget is given. 
This permits to look at the detailed expenditures from an accurate perspective. 
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Figure 5.28: RIZIV/INAMI Healthcare Budget Breakdown (2000-2004) 
2000 2001 2002 2003 2004
13.774.374 14.162.558 15.383.682 16.771.433 17.332.173
4.344.032 4.291.476 4.623.615 5.062.599 5.222.722
52.872 61.960 67.251 76.862 84.323
39.369 45.026 47.306 55.889 60.475
13.503 16.934 19.945 20.973 23.848
5.454 6.511 6.738 7.904 7.886
7.786 9.613 12.030 11.557 14.269
263 810 1.177 1.511 1.693
390.657 406.213 368.336 362.870 388.654
8.986.814 9.402.909 10.324.480 11.269.102 11.636.474Other expenses
Thousand €
M-nomenclature
Convention 771
Convention 950
K-nomenclature
Rehabilitation
Honoraria
Health Care Budget
Convention 7892
Convention total
Healthcare Budget Breakdown - 2000
13.774 Million €
62,41%
31,54%
2,84%
0,38%
0,29%
0,10%
Other Honoraria M-nomenclature Rehabilitation K-nomenclature Convention
Healthcare Budget Breakdown - 2004
17.332 Million €
64,91%
30,13%
2,24%
0,49%
0,35%
0,14%
Other Honoraria M-nomenclature Rehabilitation K-nomenclature Convention
 
Source: RIZIV/INAMI 2006 
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Figure 5.28 details the total RIZIV/INAMI expenditures for the years 2000 to 2004. As 
the focus of this report is on musculoskeletal and neurological rehabilitation, only those 
expenditures that are relevant for the analysis are detailed. The pie charts give an 
overview of the percentage shares of the following expenditures clusters (for the year 
2000 and 2004): 
• Other expenses: total for all other expenditures (e.g. medicines, etc.) 
• Honoraria: total of all medical honoraria  
• Rehabilitation: sum of K-nomenclature and Convention expenditures 
• K-nomenclature: all therapeutic expenditures  
• Convention: all therapeutic expenditures (9.50 & 7.71); and NMRC 
expenditures (7892) 
• M-nomenclature: all expenditures (hospitalized and ambulantory) 
The first conclusion based on this analysis is the relatively small proportion of 
musculoskeletal and neurological rehabilitation in the total health care budget: 0.38 in 
2000 and 0.49 % in 2004. Furthermore, the growth in absolute figures (M€31) for 
rehabilitation expenditures is small as compared to the growth of all medical honoraria 
(M€879). However, the relative increase is higher with 59% for rehabilitation against 26 
% for the whole budget. Furthermore the expenditures in the M-nomenclature have 
stagnated in the period 2000-2004. 
5.1.9.1 Expenditures for the rehabilitation therapeutic activities (K, 9.50, 7.71) 
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Figure 5.29 shows the expenditures (2000-2004) for the rehabilitation activities in K 
nomenclatureq , convention 9.50 and convention 7.71. K-nomenclature mops up the 
largest part of the budget. This seems logical because K can be applied in every 
department of PM&R, and before August 2004 also by physicians of other specialties 
with the supplementary specialisation in rehabilitation medicine, and thus the access is 
much wider than to conventions. Also, the fee for K60 was until August 2006 higher 
than for 9.50 (A2 and A2bis), which implies that most of the 9.50 centres first “used” K-
nomenclature, and then only switched to convention. We presume that the proportion 
K/9.50 will now substantially change as 9.50 centres can no longer apply K30/60 for the 
concerned pathologies. 
The expenditures for mono-disciplinary physical therapy (M-Nomenclature: mono-
disciplinary physical therapy without supervision of a specialist in physical medicine and 
rehabilitation) and speech therapy (R-Nomenclature: same mono-disciplinary setting) 
are listed separately below in 
                                                
q  K-nomenclature is underestimated for 2004 due to newly introduced nomenclature codes, for more 
information please consult the K-nomenclature paragraph 
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Figure 5.29. As it was not possible to allocate a part of these expenditures to 
musculoskeletal and neurological rehabilitation (data not linked to pathology), these 
expenditures are not included in the total musculoskeletal rehabilitation expenditures. 
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Figure 5.29: Overview of expenditures of K nomenclature, 9.50 / 7.71 
conventions, M and R nomenclature 
€ 2000 2001 2002 2003 2004
K-Nomenclature 39.369.316 45.025.801 47.306.026 55.888.616 60.475.118
Convention 950 5.453.798 6.510.803 6.738.129 7.904.463 7.886.151
Convention 771 7.785.951 9.613.495 12.029.734 11.557.395 14.269.210
Total 52.609.064 61.150.099 66.073.889 75.350.475 82.630.479
M-Nomenclature 390.656.558 406.212.975 368.336.322 362.870.404 388.653.569
M - hospitalised 32.597.175 33.921.709 32.969.281 36.344.202 40.734.890
R-Nomenclature 29.838.549 34.937.563 37.253.976 41.704.034 46.587.119
R-hospitalised 601.166  
Source: RIZIV/INAMI 2006 
The expenditures evolution of the K nomenclature, M nomenclature (limited to 
hospitalised patients) and the conventions 9.50 and 7.71 is visualized in the Figure 5.30.  
When the expenditures are compared for K and M nomenclature with the expenditures 
for the conventions 9.50 and 7.71, the latter only represent a small part. 
Figure 5.30: Evolution of the expenditures (in absolute figures) for the 
subsectors of musculoskeletal rehabilitation 
 
Source: RIZIV/INAMI 2006 
The evolution of the expenditures for each subsector in musculoskeletal and 
neurological rehabilitation shows that in absolute terms the K-Nomenclature accounts 
for the largest part of the expenditures growth (Figure 5.31).  
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Figure 5.31: Yearly expenditures growth (absolute figures) for the subsectors 
of musculoskeletal rehabilitation 
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Source: RIZIV/INAMI 2006 
Figure 5.32 shows the net growth (absolute) for each subsector from 2000 to 2004. 
The K-nomenclature expenses increase throughout 2000-2004 (net growth of €21 105 
802). The convention 9.50 has a positive but relatively small growth of €2 432 354 for 
2000-2004, the convention 7.71 shows a more significant growth in three out of four 
years, representing €6 483 259. 
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Figure 5.32: Trend analysis of the expenditures of the subsectors of 
Rehabilitation (%) 
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Source: RIZIV/INAMI 2006 
The expenditures evolution in percentage points (2000 = 100 %) shows (Figure 5.32): 
• K nomenclature: a growth of 50% during the period 2000 – 2004 with 
a slowdown in growth in the period 2001-2002. 
• Convention 9.50: a growth of 45 % during the period 2000 – 2004 with 
a slow down in growth in the period 2003-2004 
• Convention 7.71: a growth of 83 % during the period 2000 – 2004 with 
negative growth in the period 2002 – 2003.  
The effect of the new K-nomenclature in August 2004 and the new convention 9.50 in 
July 2005 are analysed in the previous paragraphs. 
Explanatory factors for the increase of the expenditures in the different subsectors 
might be the following: 
During the last decade the length of stay (LoS) decreased significantly in the acute 
departments of the Belgian hospitals, due to the “PAL/NAL” system (a system in which 
a hospital is financially penalized if there are a “positive number of hospitalisation days”, 
as compared to the country’s average, taking into account differences in pathology 
between hospitals). This system was applied until July 2002. Since then, the system of 
“justified beds” has similar incentives. Patients are transferred to rehabilitation centres 
much sooner now. This had as a consequence that several acute beds were converted 
into Sp-beds (cf. KB 12-06-2002). So the number of Sp-beds grew over the last years. 
For instance, between 2002 and 2005 the number of neurological Sp beds increased 
from 1203 to 1304 and of musculoskeletal Sp beds from 1582 to 1915. 
The number of departments PM&R grew the last decades and only few hospitals do not 
have a specialist in PM&R nowadays. 
Another hypothesis is that due to ‘progress in medicine’, an increasing number of very 
severely ill (e.g. critically ill patients staying several months in intensive care) or severely 
disabled patients (e.g. high tetraplegics dependent on artificial ventilation) survive. So, 
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even though prevention for road traffic and working accidents improves, the need for 
rehabilitation seems to increase. 
Part of the growth in expenditures is due to inflation. However, comparing the growth 
in the expenditures for rehabilitation to the overall growth in RIZIV/INAMI 
expenditures in Figure 5.28, it is clear that the growth in rehabilitation expenditures is 
larger than the overall growth in RIZIV/INAMI expenditures. 
5.1.9.2 Relation between subsectors and in- versus outpatients 
An analysis of the treatments, given to in- and outpatients in the different systems 
(based on the RIZIV-INAMI data from 2000-2004) gives following results: 
Figure 5.33: Overview of treatments for in- and outpatients (cumulative for 
years 2000 to 2004)  
Treatments
K-nomenclature 3.303.654 63% 1.920.117 37%
Convention 9.50 249.351 22% 897.667 78%
Convention 7.71 312.134 62% 188.805 38%
Inpatient Outpatient
 
Source: RIZIV/INAMI  2006 
The proportion of treatment sessions, given to inpatient / outpatient is different for all 
systems: 
• In the 9.50 convention the majority of the treatments focuses on 
outpatients 
• In K nomenclature and 7.71 convention the majority of the treatments 
focuses on inpatients 
The fact that in the 9.50 population there are substantially more outpatients, might be 
explained as follows: 
• The transport convention is mostly linked to the convention system 
(mostly 9.50). 
• It often happens that if a patient is a candidate for reimbursement of 
the expenditures for transport (only for wheelchair bound patients), 
he is “switched” from K to 9.50 when he is discharged from hospital 
and starting ambulatory rehabilitation. (This mechanism is impossible 
since the “new” 9.50 convention (cf. chapter 1.6), starting  August 1st 
2006.) 
• Some centres with a 7.71 convention also have a transport convention. 
As they usually deal with severely impaired patients in an early post-
acute phase, the majority of the patients is hospitalised. In the 
ambulatory phase they can be referred to a regional 9.50 centre, closer  
to the patients home.  
• Some other 7.71 centres deal with chronic patients (mostly MS) and 
then thus often treat ambulatory patients 
5.1.9.3 Expenditures of the “transport convention” 
A specific expenditure that has to be added for the musculoskeletal and neurological 
rehabilitation sector is the expenditures of the “transport convention”. This allows 
wheelchair bound patients to travel with reimbursement between their home and the 
rehabilitation centre. Several centres with a convention 9.50/7.71 have this transport 
agreement with RIZIV/INAMI. 
The total fees (Source: RIZIV/INAMI 2006) account for the following cumulated (2000-
2004) expenditures: 
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• Convention 7.71: €6 940 586 
• Convention 9.50: €16 714 566 
Based on the aggregated data (expenditures for transport were only available for the 5 
years period 2000-2004 as a whole) is concluded: 
• For the convention 7.71 transport fees account for 11% of the total 
expenditures (therapy + transport);  
• For the convention 9.50 transport fees account for 33% of the total 
expenditures (therapy + transport). 
This difference can be explained by the large proportion of outpatients in the 9.50 
convention (78%) versus the lower proportion of outpatients in the 7.71 convention 
(38%) 
5.1.9.4 Total expenditures for musculoskeletal and neurological rehabilitation 
The total expenditures for musculoskeletal and neurological rehabilitation is calculated 
based on: 
• K-Nomenclature: all treatment expenditures  
• Convention 9.50 / 7.71: all treatment expenditures + transport fees 
(the total transport expenditure was distributed equally over the 5 
years as only aggregated data were at our disposal) 
Figure 5.34: Total expenditures for musculoskeletal and neurological 
rehabilitation (K nomenclature, 9.50/ 7.71 convention incl. transport fees) 
€ 2000 2001 2002 2003 2004
K-Nomenclature 39.369.316 45.025.801 47.306.026 55.888.616 60.475.118
Convention 950 8.796.711 9.853.716 10.081.042 11.247.376 11.229.064
Convention 771 9.174.068 11.001.612 13.417.851 12.945.513 15.657.327
Total (incl. transport) 57.340.095 65.881.129 70.804.919 80.081.505 87.361.509  
Source: RIZIV/INAMI  2006 
As indicated before, these total expenditures are an underestimation of the total 
expenditures for musculoskeletal and neurological rehabilitation because the part of the 
M-nomenclature and R-nomenclature cannot be allocated to musculoskeletal and 
neurological rehabilitation (due to lacking data). 
The total expenditures for musculoskeletal and neurological rehabilitation, as defined 
above, over a five year period (2000-2004) are visualised in Figure 5.35. 
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Figure 5.35: Evolution of the estimated total expenditures for 
musculoskeletal and neurological rehabilitation (Euro) 
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Source: Riziv/Inami 2006 
The evolution of the expenditures for musculoskeletal and neurological rehabilitation 
has a high year-to-year growth rate that slows down from 2001 to 2002, but picks up in 
2003. 
The total expenditures growth for the three sub sectors in the period 2000 – 2004 is 
52 %. 
5.1.9.5 Expenditures for the Sp hospitalisation day price 
Another expenditure that was not included in the above calculation is the day price that 
hospitals receive for a hospitalised patient. Musculoskeletal and neurological 
rehabilitation patients however can stay in different types of “beds” (cf. S2/S3) and will 
not always be in Sp-beds (also acute, geriatric, paediatric etc.). Therefore we include the 
total expenditures of the Specialist beds (Sp) as an indication, without including this in 
the total expenditures for musculoskeletal rehabilitation. The years do not correspond 
to those in the other paragraphs concerning K nomenclature and conventions but due 
to organisational changes at the Federal Public Service of Public Health (FOD 
Volksgezondheid/SPF Santé Publique) it was more coherent to analyse the data starting 
with the year 2003. 
KCE reports 57 Musculoskeletal & Neurological Rehabilitation 107 
 
Figure 5.36: S-beds per type 
2003 2004 2005
S310 CARDIO-PULMONAIRES 426 463 449
S311 AFFECTIONS NEUROLOGIQUES 1219 1240 1304
S312 AFFECTIONS LOCOMOTRICES 1776 1856 1915
S313 AFFECTIONS CHRONIQUES 1084 1052 1021
S314 Service de soins palliatifs 369 373 385
S315 PSYCHO-GERIATRIE 1027 1029 1014
Total 5899 6013 6088  
Sourcer: FOD Volksgezondheid/SPF Santé Publique 2006 
Figure 5.36 shows that the proportion of S2/S3 to the total number of Sp-beds is 
approximately half of the total number of beds for the different years. 
Figure 5.37: Total expenditures for Sp-beds 
2003 2004 2005
€ € €
Total hospital expenditures 10.190.433.459     10.645.257.850     10.516.129.503     
Sp-beds expenditures 290.319.961          299.240.812          303.088.961          
% of Sp-beds expenditures in total 2,85% 2,81% 2,88%
Average expenditure (day price) 217                        204                        212                        
Minimum expenditure (day price) 60                          47                          47                          
Maximum expenditure (day price) 911                        473                        683                        
 
Source: FOD Volksgezondheid/SPF Santé Publique 2006 
The total expenditures of S-beds increase with 4% in 3 years. This is in line with the 
overall expenditure growth of hospital financing, where we notice a 3% growth in 3 
years (Figure 5.37). Earlier data (2000-2002) are not comparable to later years, due to a 
change in the reimbursement scheme (ex-post to à priori). 
The norms for specialist beds (cf. regulation on specialist bedss) stipulate that with an 
80% occupancy ratio, the hospital has to provide additional therapeutic personnel. This 
does not cover other interventions financed by RIZIV/INAMI or other third parties.  
• For every 30 S2/S3 beds, with 80% occupancy: 2 FTE occupational 
therapist, speech therapist or paramedical with relevant rehabilitation 
experience; availability of a psychologist 
The requirements include minimal staffing for nurses and physicians. The day pricet is 
composed of different elements (infrastructure, nurses, etc.). 
5.1.9.6 Proportion cases/expenditures in the different subsectors 
We notice in Figure 5.38 that the proportion of cases to the total expenditures is 
different for each sub sector (due to different pricing of the treatments). 
                                                
r  There are two different databases for the inventory of S2/S3 beds. The first database gives an overview of the 
total number of beds at a certain point in time (e.g. figure 4), the second source calculates a year-to-date 
average of the total number of beds and takes into account the variation per institution in this given year (e.g. 
figure 30). These databases diverge for the indicator “total number of beds” given their different calculation. 
s  Koningklijk Besluit / Arrêté Royale – 21 October 1998 
t  FPS Public Health 2006 
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Figure 5.38: Cases and expenditures in the different subsectors 
Source: RIZIV/INAMI 2006 
Case (as mentioned in the table above) or unit of treatment, is different for the three 
systems. The figure is therefore only included as an indication, but the different systems 
cannot be compared. 
Until 2004, when the system of K-nomenclature was revised, the expense/case was 
significantly higher for the K-nomenclature than for the 9.50 nomenclature. The reason 
is not obvious. The expense/case is highest for the 7.71 conventions, in which a lot of 
highly specialized and intensive rehabilitation is provided.  
5.1.10 Comparative analysis of the expenditures in the different systems 
The comparability of the treatments and prices in the different systems is questionable. 
Comparing the fixed prices (equivalent of a 1 hour treatment, see table) in the different 
systems is not as transparent as seems at first. One should take into account that a 
treatment session can be provided with different intensity, different infrastructure and 
different multidisciplinary teams. 
Figure 5.39: treatment expenditures for 7.71 / 9.50 conventions and K 
nomenclature 
950 K-nom
Centre 1               2              3            4           5           6           7           A2
Baseline (1h) 50             60            40           36         21         21         22         13-39 31
1h 31
2h 101           119           61
3h 153           180           120           109           62             63             66             
6h 239           219           117           119           122           
Locomotor Rehabilitation
771
 
Source:  RIZIV/INAMI 2006 
• Convention 9.50: Expenses refer to the treatment for pathology group 
A2 after R30/60- the duration of a treatment session is unspecified. 
Therefore we give a range from 13€ (price/hour in case of 3h 
treatment) to 39€ (price/hour in case of 1h treatment) as a baseline 
expenditure.  
• K-nomenclature: Expenses refer to K30 and K60 
• Convention 7.71: Expenses refer to different treatment sessions (full 
day / half day, maintenance / intensive) and is recalculated to 1h in 
order to compare with the 9.50 convention and the K nomenclature 
2000 2001 2002 2003 2004
Cases 72.672             85.693             110.610           111.034           120.930           
Expenditures (€) 7.785.951         9.613.495         12.029.734       11.557.395       14.269.210       
Cases 191.278           222.516           221.051           260.563           251.610           
Expenditures (€) 5.453.798         6.510.715         6.738.129         7.904.463         7.881.553         
Cases 860.448           972.456           1.003.236         1.139.764         1.237.337         
Expenditures (€) 39.369.316       45.025.801       47.306.026       55.888.616       60.475.118       
7.71
9.50
K-nom
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5.1.11 Comparative analysis of the current financing system  
Table 1 in the Appendix to chapter 5 contains a comparative analysis of the current 
financial system. 
Following items are compared: 
• Price setting 
• Price per hour of therapy 
• Duration of therapy sessions 
• Duration of the rehabilitation program 
• Items covered by the price 
• Payment system 
The comparative analysis is made on the basis of the different pathologies as defined in 
the different systems, this may be directly, or indirectly by comparability of pathology 
(e.g. K: Chronic rheumatic progressive joint disease after a clear change in functional 
autonomy; 9.50: Severe musculoskeletal and psychological impairments due to 
rheumatoid arthritis in a Steinbrocker stadium III and IV; 7.71: Rheumatoid Arthritis in a 
Steinbrocker stadium III and IV).  
It is important to know that per financial system (K, 9.50 or 7.71), the pathologies which 
are mentioned on their limitative list, are indicated in the table in bold. 
* Bold = mentioned on the limitative list of this financial system; 
* Standard = indirectly a candidate for this financial system because of comparability 
with a pathology that is mentioned on the limitative list. 
* (Standard) in parentheses = indirectly a candidate for this financial system because of 
comparability with a pathology that is mentioned on the limitative list, but under certain 
conditions (See remarks per row). 
The different financing systems for musculoskeletal and neurological rehabilitation in 
Belgium that were discussed extensively in the previous sections of this chapter will 
now be classified according to the typology model by Jegers et al. (2002) 123. Figure 5.40 
summarises the results focusing on the type of reimbursement (fixed or variable and 
retrospective or prospective).  Taking into account the unit of reimbursement, all 
systems could be classified as more or less variable and prospective.  Hence the financial 
risk is shared by the sponsor and the provider.  The incentives are based on combining 
the unit of reimbursement, the type of reimbursement and the assumption on the 
height of marginal revenue compared to marginal cost.  An arrow up (down) means that 
the financing mechanism creates incentives to increase (decrease) the respective items. 
In spite of the fact that a considerable number of financing mechanisms for rehabilitation 
co-exist in the Belgian context, it is clear from this table that all systems are to a certain 
degree variable and prospective.  Hence, they generate similar incentives : increasing the 
number of units of reimbursement (e.g. days, sessions, patients) and decreasing the 
intensitiy of care (and the cost) within the unit of payment.  In addition, an incentive for 
selecting good risks is produced.  
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Figure 5.40: Incentives of the current reimbursement system for rehabilitation  
REHABILITATION 
SERVICE/ACTIVITY 
UNIT OF 
REIMBURSEMENT 
TYPE OF REIMBURSEMENT ASSUMPTION MARG. REVENUE (MR) VS. 
MARG. COST (MC) 
INCENTIVES REMARKS 
Hospital stay  
(Sp : S2, S3) 
Patient-day Variable – 
Prospective 
MC<MR - Inpatient Days ↑ 
- Cost/day ↓ 
- Intensity of care* ↓ 
- Risk selection 
Day price based on historical prices, adjusted 
for inflation 
K-nom. Item Variable – 
Prospective 
 
MC<MR - Sessions /acts ↑ 
- Cost/session ↓ 
- Intensity of care*↓ 
- Risk selection  
- Upcoding**  
 
MC<MR - Sessions ↑ 
- Cost/session ↓ 
- Intensity of care* ↓ 
- Risk selection 
First 60/120 sessions : uniform price per 
session (R30/R60) 
After 60/120 sessions : price related to 
pathology (no relation with duration) 
Conv. 9.50 Treatment session Variable – 
Prospective 
 
MC>MR - Sessions ↓ 
- Cost/session ↓ 
Maximum number of sessions and duration is 
determined, additional sessions (>max.) at 
reduced price 
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REHABILITATION 
SERVICE/ACTIVITY 
UNIT OF 
REIMBURSEMENT 
TYPE OF REIMBURSEMENT ASSUMPTION MARG. REVENUE (MR) VS. 
MARG. COST (MC) 
INCENTIVES REMARKS 
   - Intensity of care* ↓ 
- Risk selection 
- Accumulation with K, M 
Conv. 7.71 
 
Treatment session 
 
Variable – 
Retrospective 
Type 1: soft cap 
Type 2 : no cap 
MC<MR - Sessions ↑ 
- Cost/session ↓ 
- Intensity of care* ↓ 
- Risk selection 
Price per full equivalent treatment is 
negotiated with RIZIV/INAMI  
Type 1 :using cost model 
Type 2 : no cost model 
Conv. 7.89.2 
(NMRC) 
Patient-year Variable – 
Prospective 
 
MC<MR - Patients ↑ 
- Cost/patient ↓ 
- Intensity of care* ↓ 
- Risk selection 
- Accumulation with nom. 
Prospective (indexed) price per patient (one 
year), subject to minimum requirements on 
team and volume 
Remarks   Generally, it is assumed that 
MC<MR, except for the 
additional sessions (> maximum 
number) in Conv. 9.50, financed 
at a strongly reduced price 
* Within the unit of 
reimbursement (e.g. day, 
session, …) 
** Declaring more or higher 
fees than justified by actual 
activities 
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5.1.12 Conclusion 
• Different financing systems exist for musculoskeletal and neurological 
rehabilitation  in Belgium. 
o One is linked to hospital stay with specialised beds (Sp 
beds) for diagnosis and treatment of musculoskeletal (S2) 
and neurological disorders (S3). 
o Others are linked to rehabilitation activities and concern 
mainly nomenclature (K, M and R) and rehabilitation 
agreements (also called conventions). These systems are 
mainly fee for service systems. 
• Sp-beds 
o The number of S2 and S3 beds gives an indication of the 
rehabilitation infrastructure, but is probably an 
underestimation as patients treated in the context of 
musculoskeletal and neurological rehabilitation can also stay 
in G, C, D, … beds. On the other hand, not all patients 
staying in S2/S3 beds need inpatient rehabilitation. 
o S2 and S3 beds are relatively well spread over the different 
Belgian provinces except for East Flanders and Namur 
where the number per 100 000 inhabitants is relatively low. 
o Price setting is mainly historical and not in correlation to 
the patient’s needs for nursing care or rehabilitation 
activities. Sp beds account for about 3 % of the total 
hospital expenditure over the period 2003-2005. 
• Mono-disciplinary nomenclature only exists for physical therapy (M) 
and speech therapy (R). No data are available concerning the part of 
these expenses in relation to musculoskeletal and neurological 
rehabilitation. 
• K-nomenclature (Physical medicine and rehabilitation) explains the 
largest part of the expenditures for musculoskeletal and neurological 
rehabilitation, at least until 2004. The expenses increased with 50 % 
between 2000 and 2004. 
o K15/20: rehabilitation acts under the supervision of a 
physiatrist, can be mono- or multidisciplinary, duration of 
the session is not defined 
o K30/60: multidisciplinary rehabilitation sessions under the 
supervision of a physiatrist during respectively one or two 
hours. Limitative list of pathologies and 60 or 120 sessions 
can be reimbursed depending on the pathology 
• A revised K-nomenclature was introduced in August 2004. The main 
changes are the limitative list of pathologies and the fact that an 
agreement on behalf of the sickness fund is no longer required, only a 
notification. The expenditures continued to increase, more than the 
number of cases, which is due to a shift from K30 to K60 (based on 
data of January-March  2004-2005). 
• The most relevant conventions concerning post-acute rehabilitation 
activities are 9.50 (type convention, similar for all organisations) and 
7.71 (specific convention for each organisation, three groups are 
recognisable).  
• For the more chronic phase a specific type of convention for 
“reference centres” has been developed. Multidisciplinary follow up, as 
financed with these conventions is only foreseen for a very limited 
number of mostly progressive disorders. 
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• The geographical distribution of 9.50 and 7.71 conventions is relatively 
homogeneous in Belgium. Only the province of Luxembourg lacks a 
convention, and Brussels as well as West Flanders have a higher 
number of conventions, even corrected for number of inhabitants. 
• Travelling expenses represent 11 % of the total expenditures linked to 
the 7.71 convention, 33 % of the total expenditures linked to the 9.50 
conventions and is therefore not negligible. It is included in the 
convention 9.50 and 7.71 expenditures as discussed  in the paragraphs 
below. 
• The expenditures of the musculoskeletal and neurological 
rehabilitation sector as calculated in paragraph 5.1.9, are probably 
underestimated. Because there is no link between the M-
nomenclature, R-nomenclature and their specific segment of 
musculoskeletal and neurological rehabilitation treatments it is not 
possible to allocate this part of the expenses. 
• Total expenditure of musculoskeletal and neurological rehabilitation 
2000-2004 is mainly explained by the K nomenclature (+/-68%), the 
7.71 conventions (+/-18 %) and to a lesser extent by the 9.50 
conventions (+/-14%). 
• In the period 2000 – 2004 we noticed an expenditures growth (travel 
expenses included) of 52 % for musculoskeletal rehabilitation. In 
absolute data (€) this growth is mainly caused by the K-nomenclature 
(70%), but also the 7.71 conventions (20%) and the 9.50 conventions 
(10%). 
• Looking at the three subsectors separately, there is a percentage 
growth of 50% for the K nomenclature, 45 % for the 9.50 conventions 
and 83 % for the 7.71 conventions.  
• As shown in paragraph 5.1.10, the prices for each unit of payment, as 
well as per hour of therapy are very variable depending on the system. 
• No link was identified between cost models and treatment. In general 
the only criteria used are the duration and total number of sessions, 
the target groups and some limited team requirements.  
• As shown in Table 1 (see Appendix) (comparative analysis), the 
overlap in pathologies between the different systems (convention 9.50, 
convention 7.71 and K nomenclature), indicates that there is no clear 
mandate for the different subsectors. Most of the patients and 
pathologies (except for three pathologies from the limitative K30/60 
list) can be treated in the three different systems. This has implications 
for the expenditures per treatment, the expertise of the team and the 
maximum number of treatments. This is changing August 1st 2006, 
with the application of the “new” 9.50 convention and the creation of 
a R30/60. A centre with a 9.50 convention can no longer use K30/60 
for the patients included in the convention. In exchange an R30/60 has 
been created with the same conditions as K30/60. This should limit 
overlap and clarify the situation. 
• No clear criteria for patient referral exist (patient classification 
system), which worsens the overlap situation. A referral system based 
on clinical criteria could increase the transparency of the system. 
• Indicators such as severity, complexity, age, co-morbidity, 
rehabilitation needs and goals, etc. are not included in the cost model. 
• Except for the inspection visits controlling quality in Sp services (in 
Flanders), there are no other explicit quality or accreditation systems 
in musculoskeletal rehabilitation in Belgium. 
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The mix of the different types of rehabilitation centres guarantees a range from very 
general to highly specialised treatment in the Belgian rehabilitation landscape. However, 
due to a lack of formalised coordination and patient classification system with criteria 
for referral between the different levels of rehabilitation and a good description of the 
roles and tasks of all types of rehabilitation, the system lacks transparency. 
Key points 
• The organisation and financing of musculoskeletal and neurological 
rehabilitation in Belgium lacks transparency and clinical coherence. 
• Several parallel payment systems exist but are mostly based on historical 
factors rather than on criteria related to patients’ rehabilitation needs and 
goals. 
• One payment system is linked to hospital stay with specialised beds (Sp 
beds) for diagnosis and treatment of musculoskeletal (S2) and neurological 
disorders (S3). 
• Other systems are linked to rehabilitation activities and concern mainly 
nomenclature (K, M and R) and rehabilitation agreements (also called 
conventions). These systems are mainly fee for service systems. 
• Several combinations (parallel as well as sequentially) of the different 
payment systems are possible, inducing a very heterogeneous 
rehabilitation landscape in Belgium. 
• The different payment systems overlap significantly. 
• There are no clear criteria for patient referral to the different types of 
rehabilitation organisations and the only characteristic on the limitative 
lists is the medical diagnosis. 
• There are no criteria justifying an inpatient treatment. 
• Patients’ rehabilitation needs and goals are not formally assessed. 
• Sp-beds are financed on a 7/7 days basis, discouraging week-ends home. 
Neither is there reimbursement for travel expenses for week-ends home 
(see further: transport convention).  
• There is no systematic registration of data concerning the performed 
rehabilitation activities. 
• There is no accreditation system and only very limited formal quality 
control. 
• The different rehabilitation organisations are geographically relatively well 
spread, but there is no convention in the province of Luxemburg. The 
number of conventions, corrected for population density is high in the 
region of Brussels capital and West Flanders. The number of Sp beds (S2 
and S3) is relatively low in the provinces of East Flanders and Namur. 
• There is nomenclature for mono-disciplinary physical therapy and speech 
therapy, but not for other disciplines such as occupational therapy or 
psychotherapy. 
• Reimbursement for travel expenses is only provided for wheelchair bound 
patients and only for ambulatory treatment.  
• The RIZIV/INAMI expenditures for (multidisciplinary) musculoskeletal and 
neurological rehabilitation were 0.38 % in 2000 and 0.48 % in 2004. 
• In absolute figures the expenditure for musculoskeletal and neurological 
rehabilitation grew about 50 % over a five year period, 2000-2004. 
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• K-nomenclature and  convention 9.50 changed significantly in 2004 and 
2006. It is too early to estimate the impact of these changes but there is a 
trend towards increased expenses for multidisciplinary K-nomenclature. 
• A payment system for follow up of patients with permanent functional 
impairments due to musculoskeletal or neurological disorders in the 
chronic phase, exists only for a very limited number of pathologies (such as 
neuromuscular disorders). 
• Price setting for each unit of payment, as well as per hour of therapy 
depends on the system, is not transparent and mainly based on historical 
facts. 
• Within the convention 7.71 the reimbursement per hour for organisations 
with ambulatory treatment only is higher than for some organisations with 
hospitalisation. 
• All financing mechanisms can be qualified as variable and prospective, 
generating similar incentives : increasing the number of units of 
reimbursement and decreasing the intensitiy of care (and the cost) within 
the unit of payment.  In addition, an incentive for selecting good risks is 
produced. 
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6 SURVEY CONCERNING CLINICAL 
PRACTICE IN BELGIUM (FIVE CASES) 
6.1 INTRODUCTION 
In a previous chapter the current Belgian organisational and payment system is 
described. In this part of the report possible rehabilitation paths out of Belgian daily 
practice are presented. The scenarios will be indicative but not exhaustive, and serve as 
a qualitative illustration. This will be done for five patient cases. In each case an 
individual is described with functional impairments as a consequence of one of the five 
earlier selected pathologies: amputation of a lower extremity, multiple sclerosis, spinal 
cord injury, stroke and total hip replacement. Information on daily practice is collected 
by means of a questionnaire interview, addressed to twelve practitioners. 
Practice pattern variations are expected based on the results of the analysis of the 
current Belgian organisation and payment system for neurological and musculoskeletal 
rehabilitation (chapter 5), and of previous reportsu concerning the Belgian situation. 
These analyses demonstrate that differences in rehabilitation supply, as well as in 
payment systems exist, depending on the type of rehabilitation organisation. Practice 
pattern variations can induce a difference in cost for the government, private insurers 
and patients, and maybe also variability in outcome and/or quality of care. Data on 
differences in outcome or quality are not available. 
6.2 METHODOLOGY 
A questionnaire was developed, containing five parts. Each part includes a case of a 
patient with functional impairments as a consequence of one of the earlier selected 
pathologies: spinal cord injury, multiple sclerosis, amputation of a lower extremity, 
stroke and total hip replacement. Each patient is described by a medical diagnosis, co-
morbidities, a rehabilitation diagnosis, the level of functioning by use of the ‘SAMPC’ 
(“Somatisch, ADL, Maatschappelijk, Psychisch, Communicatief” or “Somatic, activities of 
daily living, social, psychological, communicative”)-model 136 and the level of dependence 
by use of the FIM (Functional Independence Measure). The letter, the cases and an 
example of the questionnaire are included in attachment. 
As the difference between a medical diagnosis and a rehabilitation diagnosis might be 
unclear, we give an example: “An individual with the medical diagnosis of coxarthrosis 
has after a surgical intervention during which a total hip was implanted, a rehabilitation 
diagnosis of total hip replacement.” 
For each patient case a part with closed answers and a part with open answers was 
developed. 
The goal of the part with closed answers was an identification of the current practice. 
This part contained a multiple choice table representing the duration of each phase of 
the rehabilitation process (according to the responder of the questionnaire) as well as 
the possible combinations of treatment packages, as identified by payment systems. For 
each phase in the rehabilitation process a choice for a payment system could be made. 
Each practitioner was asked to indicate a programme comparable to the programmes in 
his/her daily practice. 
The goal of the part with open answers was to formulate propositions to optimise the 
current practice. In the part with open answers each practitioner could propose an 
ideal programme for the patient without the restrictions of the current accessibility to 
payment systems and the current Belgian organisational model, but still based on her or 
his experiences. 
                                                
u  Referenties 131; 132; 133; 134; 135. 
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Because of time constraints our questionnaire was not validated for use in practice and 
because it was not our objective to compose an exhaustive list of possible rehabilitation 
programmes, only a limited set of practitioners was selected. The questionnaire was 
sent to six practitioners of the Dutch speaking part of Belgium and six practitioners of 
the French speaking part of Belgium. Of the Dutch speaking practitioners 1 works in a 
rehabilitation organisation with convention 7.71, 3 work in a rehabilitation organisation 
with convention 9.50, 2 work in a rehabilitation department without any convention. Of 
the French speaking practitioners 1 works in a rehabilitation organisation with 
convention 7.71, 2 work in a rehabilitation organisation with convention 9.50, 1 works 
in a rehabilitation organisation with conventions 7.71 and K-nomenclature, 1 works in a 
rehabilitation department without any convention. The response rate was 75% (9/12). 
One of the twelve practitioners preferred not to participate because of the fact that 
he/she had not enough experience in the several domains. Two others did not respond 
at all. 
The results of the closed answer part of the questionnaire are represented in graphs. 
Of the open answer part of the questionnaires a synthesis of the propositions was 
made. 
6.3 RESULTS 
6.3.1 Actual rehabilitation programmes 
6.3.1.1 Notifications 
There are differences in duration of sessions. For example a session under K30 goes on 
for 60 minutes and a session under K60 goes on for 120 minutes. In the graphs, we only 
took into account the number of sessions and not the duration of the sessions because 
the duration of sessions is not asked in the questionnaire. This is a shortcoming of our 
questionnaire because only K-nomenclature includes a strict identification of duration of 
sessions, within the conventions 7.71 the duration of sessions can vary from 2 to 6 
hours, within the 9.50 conventions there is not at all a definition of duration of sessions 
included. 
There can be differences in the “composition” of the team responsible for the 
treatment in the different systems as discussed in chapter 5. A team usually includes a 
physician specialised in rehabilitation medicine, a physical therapist, an occupational 
therapist, a speech therapist, a psychologist and a social worker.  
The conditions for the payment modalities can differ. For example a polytrauma patient 
can be treated under K60 or Convention 7.71 but not under Convention 9.50. 
For a detailed description of the duration of sessions, the composition of the team and 
the conditions for certain payment modalities, we refer to chapter 5.  
To understand the graphs it is important to know that every rehabilitation programme 
is defined by 2 digits and 1 letter. For example: ‘11a’: 
• The first digit = the reference to the pathology (1= Lower Extremity 
Amputation; 2= Stroke; 3= Multiple Sclerosis; 4= Spinal Cord Injury; 
5= Total Hip Replacement); 
• The second digit = the reference to a rehabilitation organisation, these 
organisations are kept anonymous; 
• The letter = the differentiation of optional programmes in one 
rehabilitation organisation, for example: a = one optional programme; 
b = a second optional programme, as proposed by the specialist of the 
concerned rehabilitation organisation. 
A rehabilitation process consists of several phases. The distinction between the phases 
is based on a difference in treatment packages. Examples of phases are: 
• An inpatient rehabilitation in an acute care service or in a Sp-service; 
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• An outpatient rehabilitation in a rehabilitation organisation, in a 
service for physical medicine and rehabilitation, in a private physical 
therapy practice or at home. 
These phases are in relation to the progress of a health condition. 
For each separate respondent, the number of rehabilitation sessions per rehabilitation 
phase is calculated by [duration of a rehabilitation phase (months) * Sessions per week * 
4]. If several payment systems are drawn on during one phase, the sum of the number 
of rehabilitation sessions of each payment system is calculated. 
The reimbursement per rehabilitation programme is calculated by [the number of 
rehabilitation sessions * price per session]. The cost of equipment for example is not 
calculated (see chapter 5)! 
6.3.1.2 Sum of rehabilitation sessions per patient case and per respondent 
Each of the next five graphs represents a possible number of rehabilitation sessions for 
one patient case. The values on the X-axis are explained under “Notifications” (see 
6.3.1). The values on the Y-axis represent the number of sessions.  
Figure 6.1: Sum of rehabilitation sessions per patient case and per 
respondent - Lower extremity amputation 
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Figure 6.2: Sum of rehabilitation sessions per patient case and per 
respondent – Stroke 
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Figure 6.3: Sum of rehabilitation sessions per patient case and per 
respondent – Multiple Sclerosis 
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Figure 6.4: Sum of rehabilitation sessions per patient case and per 
respondent – Spinal Cord Injury 
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Figure 6.5: Sum of rehabilitation sessions per patient case and per 
respondent – Total Hip Replacement 
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Key Points 
• There is a clear variability in number of rehabilitation sessions per patient 
case as proposed by the different respondents. For example: A patient with 
an amputation of a lower extremity gets less than 100 sessions in one 
rehabilitation organisation and more than 400 sessions in another 
organisation. 
• For all respondents, the number of rehabilitation sessions is higher for 
patients after stroke, spinal cord injury and multiple sclerosis then for 
individuals after amputation of a lower extremity or a total hip 
replacement. 
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6.3.1.3 Type of payment system drawn on per phase in the rehabilitation process 
Each of the next five graphs represents some possible types of payment systems drawn 
on per phase in the rehabilitation process, for one patient case. 
The numbers mentioned on the X-axis refer to the phases as well as to the payment 
systems. Per phase we applied a different colour. The payment systems (K30, K60, M, 
7.71, 9.50) are discussed in detail in chapter 5. 
The numbers mentioned on the Y-axis refer to the frequency a financing system is 
proposed by responders per phase in the rehabilitation process. Per phase the total 
number depends on the number of rehabilitation programmes proposed and not 
directly to the number of respondents.  
 
Figure 6.6: Type of payment system drawn on per phase in the rehabilitation 
process – Amputation of Lower Extremity 
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Figure 6.7: Type of payment system drawn on per phase in the rehabilitation 
process – Stroke 
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Figure 6.8: Type of payment system drawn on per phase in the rehabilitation 
process – Multiple Sclerosis 
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Figure 6.9: Type of payment system drawn on per phase in the rehabilitation 
process – Spinal Cord Injury 
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Figure 6.10: Type of payment system drawn on per phase in the 
rehabilitation process – Total Hip Replacement 
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Key points 
• Most of the practitioners preferred to charge a K60 in the first phase(-s) 
for each of the five patient cases. 
• However, for each of the five patient cases there is a large variability in 
payment systems applied per phase. Probably a part of the variability can 
be explained by the fact that the access to some payment systems is 
reserved for specific rehabilitation organizations (For more detailed 
information on this issue see chapter 5).  
6.3.1.4 Treatment packages identified by payment systems in terms of percentage of 
the complete rehabilitation process 
Each of the next graphs represents payment system in terms of percentage of the 
complete rehabilitation process. 
The values on the X-axis are explained under “Notifications” (see 6.3.1). On the Y-axis, 
payment systems are reflected in terms of percentages of the complete rehabilitation 
process. The rehabilitation process in total represents 100%. 
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Figure 6.11: Treatment packages identified by payment systems in terms of 
percentage of the complete rehabilitation process – Amputation of Lower 
Extremity 
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Figure 6.12: Treatment packages identified by payment systems in terms of 
percentage of the complete rehabilitation process – Stroke 
0,00%
10,00%
20,00%
30,00%
40,00%
50,00%
60,00%
70,00%
80,00%
90,00%
100,00%
21a 22a 22b 23a 24a 24b 25a 26a 27a 28a 29a
Cerebrovascular Accident
M
K60
9.50
7.71
 
KCE reports 57 Musculoskeletal & Neurological Rehabilitation 125 
 
Figure 6.13: Treatment packages identified by payment systems in terms of 
percentage of the complete rehabilitation process – Multiple Sclerosis 
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Figure 6.14: Treatment packages identified by payment systems in terms of 
percentage of the complete rehabilitation process – Spinal Cord Injury 
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Figure 6.15: Treatment packages identified by payment systems in terms of 
percentage of the complete rehabilitation process – Total Hip Replacement 
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Key points 
• Between the different respondents, there is a large difference in use of 
mono- (M, K15 and K20) versus multidisciplinary treatment (K30, K60, 
convention 9.50, convention 7.71). The contribution of the payment 
systems differs accordingly.   
• For all described patient cases, except for total hip replacement, every 
single payment modality (M, K, convention 9.50, convention 7.71) seems to 
be under consideration at least once during the rehabilitation process.   
6.3.1.5 Reimbursement for each optional rehabilitation programme per patient case 
Because the number of sessions and the used payment systems differ between 
rehabilitation organisations a difference in reimbursement per optional rehabilitation 
programme per patient case is expected. For the calculation of the reimbursement see 
“Notifications” (see 6.3.1). 
The next graph shows possible reimbursements of a rehabilitation programme for the 
five patient cases. 
On the X-axis the patient cases are classified by underlying pathology as well as the 
optional rehabilitation programmes. On the Y-axis the reimbursement (Euro) is 
represented. 
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Figure 6.16: Reimbursement for each optional rehabilitation programme per 
patient case 
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The reimbursement of possible rehabilitation programmes differs per patient case. It 
would be interesting to have quality and outcome indicators available to check if 
differences in number of sessions, differences in payment systems and as a consequence 
differences in reimbursement, induce a difference in quality of care and outcome. 
Rehabilitation after stroke seems to be the most expensive of the five selected 
pathologies, whereas rehabilitation after total hip replacement seems to be the least 
expensive. Spinal cord, multiple sclerosis and amputation of lower extremity are 
situated in-between. 
6.3.1.6 Average number of sessions per patient case 
The next graph shows the average number of sessions per patient case. The number of 
optional rehabilitation programmes differs between the patient cases because some 
respondents described more options per patient case then others. In case of more 
optional programmes, the total number of rehabilitation sessions might be higher. 
The X-axis represents the five patient cases. The Y-axis represents the average number 
of sessions per case. 
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Figure 6.17: Average number of sessions per patient case 
Most of the rehabilitation sessions are provided to an individual after stroke or spinal 
cord injury or to the individual with multiple sclerosis rather then to individuals after 
amputation of a lower extremity or a total hip replacement, which seems logical when 
the complexity and the chronic character of the consequences of the different 
pathologies is considered. 
In order to detect trends in the number of sessions per respondent a graph reflecting 
the average number of sessions per patient case per respondent completes the analysis. 
No outliers are detected though. 
Figure 6.18: Average number of sessions per patient case per respondent 
6.3.2 Optimised rehabilitation programmes 
A second part of the questionnaire asks the respondents to describe ideas for 
optimising rehabilitation programmes for each of the five patient cases, independent of 
their own working situation, the current payment systems and the Belgian organisation 
model. Concrete recommendations, such as included in a report of the GTA (Greater 
Toronto Area) Rehab Network 137, (see chapter 3.5.1) were hoped for.  In that report 
recommendations were made for patients after hip replacements such as: 
• Standardize the model of care to achieve equitable access to best care; 
• Identify and track appropriate outcome measures; 
• Develop appropriate triage tools; 
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• Improve the quality and quantity of available hip replacement data. 
However, every respondent formulated recommendations at the individual patient level 
or ‘micro’-recommendations instead of more general or ‘macro’-recommendations. 
Most of these recommendations are still dominated by the characteristics of the 
current payment systems and organisation. 
A synthesis of the recommendations has been made. 
6.3.2.1 Spinal Cord injury (SCI) 
Acute care unit 
• Stay as short as possible; 
• Stay until medical stabilisation; 
• Acute care unit must be specialised in spinal cord lesions; 
• Rehabilitation (physical therapy, occupational therapy) can start in this 
unit. 
• As soon as possible transfer to a rehabilitation organisation for a 
multi-disciplinary rehabilitation programme. 
Reference organisation specialised in spinal cord injuries 
• Multidisciplinary rehabilitation programme 
• One price per medical team for multidisciplinary interventions 
(neurologist, orthopaedist, physiatrist, urologist, … ). 
• The physiatrist is the coordinator during the stay in a rehabilitation 
organisation.  
• ADL-training, mapping of required equipment, sphincter training, … 
General rehabilitation organisation 
When the individual can perform transfers, is independent for ADL and adaptations at 
home are performed, outpatient rehabilitation in the rehabilitation organisation can 
start. 
When functioning at home is without problems, rehabilitation at home can start. 
Rehabilitation at home 
• Physical therapy 
6.3.2.2 Stroke 
Acute care unit 
• Start multidisciplinary rehabilitation programme 
Rehabilitation organisation specialised in stroke or non-congenital cerebral lesions 
• Continue the multidisciplinary rehabilitation programme 
After six months of rehabilitation in a rehabilitation organisation specialised in stroke or 
non-congenital cerebral lesions, an assessment of dependence must be performed. 
Depending on the results of the assessment the patient can stay in the specialised 
organisation or can be transferred to a general rehabilitation organisation. 
General rehabilitation organisation 
Duration of the stay in a rehabilitation organisation depends on the level of recovery 
and the social situation. If there is recovery of function and difficulties concerning social 
situation exist, early transfer to a nursing home with maintenance physical therapy is 
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preferred. If recovery and/or acceptable social situation are present, the duration of the 
stay in a rehabilitation organisation is by preference 3 months but can be prolonged. 
Rehabilitation at home 
• Physical therapy + Speech therapy. 
Payment related to the patients’ characteristics. 
6.3.2.3 Multiple Sclerosis (MS) 
Therapy planning is performed during a short stay in a “categoral” rehabilitation 
organisation. 
Multidisciplinary medical follow-up (neurologist, physiatrist, urologist, … ). 
Only in case of complication or relapse, a short stay in a rehabilitation organisation for 
intensification of the rehabilitation programme is essential. In all the other cases 
outpatient rehabilitation in a rehabilitation organisation or at home is preferred. 
Rehabilitation “categoral” organisation (Inpatient/Outpatient depending on the 
geographical situation) 
Locoregional rehabilitation organisation 
Rehabilitation at home: physical therapy + speech therapy 
Maintenance physical therapy 
6.3.2.4 Lower Extremity Amputation (LEA) 
Start production of prosthesis 15 – 21 days after amputation. 
Rehabilitation “reference” organisation with a technical department for rehabilitation 
equipment OR IF older patient or patient without professional occupations THEN 
locoregional rehabilitation organisation 
• An inpatient rehabilitation during the first 8 – 12 weeks seems less 
fatiguing and more efficient than an outpatient rehabilitation. 
• Ù Admission as short as possible (only: ADL-training, handling 
and adapting the prosthesis, preparation of home care). 
• During the inpatient phase social reintegration must be prepared.  
• Admission in an rehabilitation organisation where a surgeon, a 
reconstructive surgeon, paramedics, orthopaedic technicians, … are 
available. 
• As soon as the patient is independent for ADL: monodisciplinary 
rehabilitation at home. 
Rehabilitation at home 
• Physical therapy 
6.3.2.5 Total Hip Replacement (THR) 
Before the intervention informative lessons and exercises must be provided. 
Acute care unit 
• After surgical intervention progressively start physical therapy. 
Department for physical medicine and rehabilitation 
• Physical therapy + Occupational therapy (maximum one month). 
• Length of stay depends on the social situation.  
Rehabilitation at home 
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• Physical therapy (maximum 3 months). 
6.4 CONCLUSION 
A large variability in current rehabilitation programmes appears per patient case. A link 
to the type of rehabilitation organisation was not made in order to guarantee the 
anonymity of the respondents. Duration of therapy was very different between 
respondents. Furthermore, for all but one case every possible payment system was 
suggested at least once in the proposed rehabilitation programmes. This accentuates the 
overlap, related to accessibility as well as content, between the different payment 
systems as described in chapter 5. Possibly the variability can be explained by a lack of 
criteria permitting a uniform interpretation of the individuals’ needs. Another possibility 
is that the variability in rehabilitation programmes is related to the preferences of the 
practitioner and to the accessibility of payment systems which differs between 
rehabilitation organisations. Important is the remark that it is not known whether this 
variability induces differences in quality and/or outcome. In Belgium, as in many other 
Western countries, there is no systematic registration of quality and outcome 
information. 
Concerning the propositions to optimise rehabilitation programmes independent of the 
own working situation, the current payment systems and the Belgian organisation 
model, only recommendations at the level of an individual patient were given 
comparable to the content of a clinical pathway. Another important fact is that most 
recommendations still seem inspired by the characteristics of the current payment 
systems and organisation model. 
Key points 
• A small exploratory survey shows a large variability in current 
rehabilitation practice in Belgium for five patient cases (LEA, MS, SCI, 
stroke and THR). 
• The variability concerns duration of the rehabilitation programmes 
(expressed as a number of treatment sessions), type of therapy (mono- 
versus multidisciplinary) as well as payment system (M- or K-
nomenclature, 9.50 or 7.71 convention). 
• Rehabilitation organisations have a different access to payment systems. 
• The variability in rehabilitation programmes is probably rather explained 
by the type of rehabilitation organisation (and associated financing system) 
locally available, and not by patient’s rehabilitation needs and goals. Except 
for medical diagnosis, no patient referral criteria are available. 
• Quality and outcome parameters, measuring the impact of the variability 
in clinical practice are not registered systematically. 
• Recommendations of practitioners for optimising rehabilitation 
programmes are mostly inspired by the characteristics of the current 
payment system and organisation model.  
• Most practitioners recommend different steps in the organisational setting 
(e.g. acute setting, specialised centres, general centres, home care), thus 
subscribing a network of organisations. 
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7 CLINICAL PATHWAYS FOR 
REHABILITATION 
7.1 INTRODUCTION 
A limited research on rehabilitation practice in Belgium (See chapter 6) indicated that a 
large variability is possible related to intensity and duration of therapy for patients with 
comparable characteristics. An additional question to find out whether this variability is 
also represented in the currently used clinical pathways, was formulated. The goal of 
this chapter was an identification and comparison of clinical pathways for rehabilitation 
after amputation of lower extremity, multiple sclerosis, spinal cord injury, stroke and 
total hip replacement. Guidelines and the results of randomised clinical trials were 
considered as out of scope for this chapter, as they are not necessarily reflected in 
clinical practice. 
Due to a lack of scientific reports containing evidence to support all clinical decisions in 
rehabilitation,  the content of a clinical pathway is often influenced by the opinion of 
stakeholders and the financing and organisational aspects of the health care system in a 
country. A comparison of  clinical pathways developed in different countries, might 
neutralise these influences and might result in a more neutral description of the 
‘optimal’ clinical pathway. 
At a macroscopic level, the clinical pathways can be used to discuss current variability in 
rehabilitation practice in Belgium. Besides, these clinical pathways can be used to argue 
certain choices related to the future supply of rehabilitation services. 
This chapter was performed by a collaboration between the “Centrum voor 
Ziekenhuis- en Verplegingswetenschap, Leuven” (CZV) and the department of Physical 
Medicine and Rehabilitation, Leuven (PMR). 
The CZV offered an introduction course on clinical pathways and continuous support 
during this (sub-)project. The CZV provided a network of contacts concerned with the 
development of clinical pathways, in different countries. 
PMR composed a team of residents of Physical Medicine and Rehabilitation. 
Clinical pathways were searched, analysed and compared by use of a general template 
(Figure 7.1) in which the most relevant parameters were integrated. It was not the 
objective to analyse the type of interventions in detail. 
KCE reports 57 Musculoskeletal & Neurological Rehabilitation 133 
 
Figure 7.1: Template for analysis and comparison of clinical pathways 
Method of outcome measurement
Conditions to end this phase
Length of phase
Method of outcome measurement
Conditions to end this phase
Length of phase
Phase …
Phase …
End of phase
End of phase
Involved professionals
Type of therapy (physical therapy, vocational therapy, …)
Intensity of therapy
Expected outcomes
Conditions to start this phase
Type of therapy (physical therapy, vocational therapy, …)
Acute care/Post-acute care/Maintenance
Inpatient/Outpatient
Mono-/Multidisciplinary
Intensity of therapy (X Hours/Day/Week)
Expected outcomes
Delay after onset pathology
Method of identification of patient needs
Acute care/Post-acute care/Maintenance
Inpatient/Outpatient
Mono-/Multidisciplinary
Involved professionals
Title
Delay after onset pathology
Method of identification of patient needs
Conditions to start this phase
Publication year
Author
General information of the clinical pathway
Content of the clinical pathway
Pathology
Origin (Country/City/Hospital/Institute/Organisation/...)
Objective (Clinical practice/Resource allocation/…)
Method used in the development of the clinical pathway
Focus on outcome/Focus on process
* Focus on outcome: Tasks depend on outcomes
* Focus on process: Tasks depend on delay, availability of resources, ...
Search algorithm
Source (Website/Journal)
 
7.2 LOWER EXTREMITY AMPUTATION (LEA) 
7.2.1 Methodology 
The literature for rehabilitation pathways after LEA was explored. 
First examples of pathways were searched on the website of evidence based medicine 
of KU Leuven. 
There was a link to the website www.consorta.com. The combinations “clinical pathway 
and amputation”, “clinical pathway and amputee”, “critical pathway and amputation” and 
“critical pathway and amputee”, were searched. No results were found. 
The website of NHS in the U.K. v was searched on the topic: “Protocols and Care 
pathways”. Under the heading “Clinical Department” one reference to “amputation leg” 
was found. This clinical pathway was included. But the authors remarked that the 
document does not allow for Care Pathway Variance recording. The origin of the 
                                                
v  www.library.nhs.uk 
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pathway is UK, West Yorkshire, Keighley, Airedale General Hospital. The year of 
publication was not traced.  
The website of the American Association of Physical Medicine and Rehabilitation 
(www.aapmr.org) was consulted and 7 articles in the period 2000-2006 were found. 
We excluded 2 articles by abstract and read 5 articles in full text. We only kept 1 
clinical pathway as relevant. 
The Pubmed database was searched with the keywords critical pathways, integrated 
care pathway, amputation, amputees and rehabilitation. (See Appendix to chapter 7) 
The Cinahl database was searched using the keywords amputation care, critical path, 
amputation stumps, below knee amputation and above knee amputation. (See Appendix 
to chapter 7) 
International experts were contacted on this topic (See Appendix to chapter 7). Two 
reactions were received which seemed useful. It concerned only one real clinical 
pathway. The other one concerned a theoretical protocol. 
One clinical pathway was received via the CZV (Centrum voor Ziekenhuis- en 
Verplegingswetenschap, Leuven). The origin is the Shangi General Hospital, Shangai . 
All these search algorithms were double checked by a second reader to avoid a 
selection bias. 
7.2.2 Results 
Four existing critical pathways concerning rehabilitation of patients who had an 
amputation of the lower extremity, above or below the knee, were selected. 
Origin Country Number of pathways 
United Kingdom 1 Europe 
Belgium  1 
America USA 1 
Asia Shangai 1 
7.2.2.1 Patient characteristics 
All these pathways concerned planned amputations on a vascular basis, and therefore 
can not be used for traumatic amputees.  
7.2.2.2 Delay after LEA 
All pathways start in the pre-operative phase, when the decision for amputation is 
made. For this phase, there are almost no differences between the different pathways.  
The day of the intervention is only in one path considered as part of the post-acute 
phase.  
One pathway indicates that rehabilitation therapy starts at the day after surgery, in two 
other pathways on day two after surgery. In the other pathway no concrete timing is 
given. 
The maintenance phase after therapy starts in the week following surgery (2 pathways), 
depending on the progression (criteria are discussed in detail in the Appendix) (1 
pathway), or is not explicitly described (1 pathway).  
7.2.2.3 Method of identification of patient needs 
Patients’ needs are determined by a multidisciplinary team and comprise medical 
assessment, level of amputation and premorbid lifestyle, performed. The medical 
assessment includes a physical examination and evaluation of the mental state. No 
further detail on the eventual use of standardised assessment instruments is given. 
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An assessment is performed in the pre-operative phase. In the other phases no 
assessments are mentioned. 
7.2.2.4 Conditions to start rehabilitation 
The start of the pre-operative phase is related to the planning of an amputation of the 
lower extremity. 
The start of the post-operative phase depends on the patient’s physical evolution, 
wound healing, stump-modelling, three points march, motivation and cooperation, as 
mentioned in one pathway. 
The follow-up factors during all phases of rehabilitation are pain control and a good 
physical status (criteria not described in detail). 
7.2.2.5 Duration of rehabilitation 
In one pathway the post-operative phase is continued until the day of discharge, 4 
weeks after surgery. The pathway stops at the day of discharge. 
In one pathway, the different phases are based on the patients’ progression (criteria for 
patient progression are described in the Appendix). The pathway is divided in a pre-
prosthetic training, a prosthetic training and the community integration. A long term 
follow-up is foreseen until 18 months after surgery. 
The other pathways contain no exact numbers of days or weeks of each phase following 
surgery.  
7.2.2.6 Involved professionals 
All rehabilitation programs are organised by a multidisciplinary team. This team includes:  
• Physicians: orthopaedic (all pathways) and vascular surgeons (all 
pathways), physical therapist (all pathways) and anaesthesiologist (only 
1 pathway in the pre-operative phase); 
• Nurses (all pathways); one pathway refers to the involvement of a 
nurse specialised in diabetes mellitus; 
• Physical therapist and occupational therapist (all pathways); 
• Recreational therapist (one pathway); 
• Social worker (three pathways); 
• Dietician (two pathways); 
• Podiatrist (one pathway). 
No distinction between the different phases is made related to team composition. 
In one pathway the supply of a physio-amputee school is foreseen. 
7.2.2.7 Intensity of therapy 
All rehabilitation programmes foresee physical therapy once a day during inpatient 
rehabilitation. Concerning outpatient rehabilitation no intensity of therapy is discussed.  
7.2.2.8 Type of therapy 
During the pre-operative phase, all pathways include informing patients and their 
relatives, in an inpatient setting. 
The care on the day of intervention is focused on monitoring the physical status of the 
patient and wound healing. 
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In all pathways, physical and occupational therapy is starting in the post-operative phase, 
in an inpatient setting. One pathway mentions rehabilitation therapy activities 
performed by nurses. 
All post-acute and maintenance phases contain pain control, stump modelling and march 
training as most important goals. A multidisciplinary team is taking care of the medical 
and paramedical follow-up. 
The phases after the post-operative phase are performed in an inpatient and/or an 
outpatient setting. 
7.2.2.9 Expected outcomes and the use of outcome measurement tools 
The main outcome for the pre-amputation phase is having an informed and well-
prepared patient, who is fit for surgery. 
On the day of the intervention, all critical pathways include pain control and stump 
modelling as the main goals. Patient’s physical and mental status are continuously 
monitored. 
One program indicates that day of discharge may depend on wound-healing and stump 
status. Another pathway lets the day of discharge depend on the patient’s progression 
based on a physical assessment. 
7.2.3 Conclusion 
In literature, many descriptions of the use clinical pathways or rehabilitation programs 
for lower extremity amputations, were detected. Only four pathways were obtained for 
analysis and comparison. 
All pathways start in the pre-operative phase. All pathways make use of a 
multidisciplinary team, consisting in all programs of physicians, physical therapists, 
occupational therapists and nurses. Social workers and dieticians are also team-
members, but not in all pathways. Physical therapy is given daily during inpatient 
rehabilitation, but the exact amount of time of therapy is not explicitly noted in all 
pathways.   
The duration and content of the rehabilitation process described in the 4 clinical 
pathways differs. But this can be explained by the fact that each pathway only covers a 
part of the disease trajectory. Acute, post-acute and maintenance post-acute phases 
differ between the 4 pathways, as do the outcome measurements. Only 1 program 
included long-term follow-up until 18 months post-operatively. In only 1 pathway, 
prosthetic training is included, without giving concrete details. In the other 3 pathways, 
there is no report on prosthetic training or adaptation of prostheses. Perhaps, they only 
provide the prosthetic training in an outpatient setting.  
7.3 MULTIPLE SCLEROSIS (MS) 
7.3.1 Methodology 
The objective of the search was to find clinical pathways for rehabilitation in case of 
multiple sclerosis, used in different countries.  
The search algorithm on the website of the American Academy of Physical Medicine 
and Rehabilitation was performed by the subheadings Legislative, Business and Clinical 
Pathways and Multiple Sclerosis (N=23). 
In the PubMed search the keywords rehabilitation, multiple sclerosis, critical pathway, 
clinical pathway, integrated care pathway and care map were used. (See Appendix to 
chapter 7) 
Cochrane library search algorithms contained the keywords clinical care pathway, 
multiple sclerosis, critical care pathway and care pathway. (See Appendix to chapter 7) 
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Search on the website of the national library of health of the U.K. was performed 
through ‘protocols & care pathways’ and ‘multiple sclerosis’ (N=0). 
Different experts were contacted to ask whether they had a clinical pathway for 
rehabilitation in multiple sclerosis, and were willing to provide it. E-mail addresses were 
obtained trough the publications found by the literature search (N=9), through the 
website of RIMS (rehabilitation of multiple sclerosis - Europe) (N=22), the website of 
the department of health of the UK (N=3), and through the website of the National 
multiple sclerosis society of the USA (N=1). Personal contact with professionals in 
Belgium took place (N=1). 
Results of the searches were screened by title and/or abstract. The search algorithms 
were double checked by a second reader to avoid selection bias, and results were 
discussed with professionals of the CZVand department of PMR. 
7.3.2 Results 
During the search on the website of the American Academy of Physical Medicine and 
Rehabilitation, 4 publications (see Appendix to chapter 7) were considered as relevant. 
Full text of all articles was scanned. 
In the PubMed search 7 articles (see Appendix to chapter 7) were identified as relevant. 
Full text of all articles was scanned. 
In the Cochrane library and on the website of the national library of health in the U.K., 
no relevant publications were detected. 
Through contact with professionals, both by e-mail or personal contact, only 2 clinical 
pathways for rehabilitation for multiple sclerosis were received. 
Only the two clinical pathways obtained via expert contact were apt to be analysed and 
compared. 
7.3.2.1 Patient characteristics 
Both pathways describe a multidisciplinary path for inpatients, for acute/post-acute or 
maintenance therapy. 
7.3.2.2 Delay after onset of MS 
Delay after onset of pathology wasn’t described in either of them.  
7.3.2.3 Method of identification of patient needs 
The pathways are different related to the methods of identification of patient needs; 
one pathway uses a psychological questionnaire, composed by the local team members, 
concerning expectations/satisfaction. The other uses functional tests (Barthel, FIM, ESS) 
and consultation of the patient to discuss feasible objectives. 
7.3.2.4 Conditions to start rehabilitation 
Conditions to start the clinical pathway were rather functional in one pathway 
(identification of areas of potential functional improvement involving 2 or more 
disciplines, patients must be able to undertake an intensive therapy, definition of a 
clearly defined set of functional objectives which aim at reducing their degree of 
disability and/or handicap), and rather time-based in the other (minimum 3 weeks of 
admission). 
7.3.2.5 Duration of rehabilitation 
Length of stay was 3 weeks, and every single week was described separately in both 
clinical pathways. 
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7.3.2.6 Involved professionals 
A difference between both paths is also that the medical staff consists of a neurologist 
and a specialist in physical medicine and rehabilitation in one; in the other, they only 
mentioned the involvement of a neurologist. Apart from this difference, involved 
professionals are similar. 
Concerning the controlling system (signing of joint procedures,…) of the pathways, 
solutions of both described pathways are also different: by developing the first pathway, 
it was felt appropriate to introduce a key-worker system, with the key-worker acting as 
the coordinator for the patient’s clinical pathway. The other pathway doesn’t mention a 
control system yet, but professionals are working out a control mechanism on PC. 
7.3.2.7 Intensity of therapy 
Intensity of therapy was not described in one path, and varied from 2,5 up to 4 h/day in 
the other. 
7.3.2.8 Type of therapy 
Type of therapy was similar in both pathways: physical therapy, vocational 
therapy/occupational therapy, speech and language therapy, (neuro-)psychological and 
social support. 
7.3.2.9 Expected outcomes and the use of outcome measurement tools 
In both pathways expected outcomes were identified by setting goals, and adjusting 
them if needed. In one pathway, goals are set according the RAP-profile (rehabilitation 
activity profile), but goals were not further described in detail, in neither of the 
pathways. 
Method of outcome measurement was described with Barthel Index, FIM and ESS in 
one pathway. The other path described outcome measures, only for the last phase 
(phase of discharge): RAP (rehabilitation activity profile)-goals and the psychological 
questionnaire concerning expectations/satisfaction.  
7.3.3 Conclusion 
Very few concrete clinical pathways for rehabilitation of multiple sclerosis were found 
trough literature search and contact with (inter)national experts. Few experts use a 
concrete clinical pathway, or are eager to communicate it.  
Only two clinical pathways for rehabilitation of multiple sclerosis (Belgium – UK) were 
withheld and a comparison of both showed great similarity in objective and method of 
development. Both paths are focused on process and are patient centred, and are 
comparable in patient characteristics, type of therapy,  length of stay and involved 
professionals (apart from the fact that involvement of a specialist of physical medicine 
and rehabilitation was described in only one path). Main differences were found in the 
method of identification of patients’ needs, and conditions to start the pathway.  
Due to extreme variability and unpredictability in multiple sclerosis, rehabilitation still 
seems to be mainly based on clinical experience and expert opinion. 
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7.4 SPINAL CORD INJURY (SCI) 
7.4.1 Methodology 
The objective of the search was to find clinical pathways for rehabilitation after spinal 
cord injury, used in different countries.  
Literature search was started with a consultation of the website of the Belgian and 
Dutch Clinical Pathway Network w, followed by the website of the American Academy 
of Physical Medicine and Rehabilitation, was followed. Twenty-five papers (1994-2002) 
about clinical pathways for spinal cord injury were identified. Three papers described in 
detail a clinical pathway for SCI for the acute phase. One of these clinical pathways 
started in the acute phase and went over in the post-acute phase. 
The Protocols & Care Pathways Specialist Library of the NHS National Library for 
Health x were also consulted but this link did not contain any clinical pathways for SCI. 
The Pubmed database was explored using the keywords critical pathway and spinal cord 
injuries. This search resulted in 7 publications. Two of them were relevant. (See 
Appendix to chapter 7) 
Google was searched by the algorithm (Critical Pathway) OR (Clinical Pathway) OR 
(Integrated care Pathway) AND (Spinal Cord Injury). We only found one paper of 
interest which was included yet after consultation of the AAPM&R website.  
All search algorithms were double checked by a second reader to avoid a selection bias. 
After the literature search, more than 60 clinical pathway experts in different countries 
were contacted and  asked to forward information on the content of clinical pathways 
for spinal cord injury (See Appendix to chapter 7). Experts were contacted in Belgium, 
The Netherlands, the United Kingdom, France, the US, Australia and Switzerland.  
Authors of the selected scientific articles were also contacted. Besides this, 36 
international colleagues were contacted by the “Centrum voor Verplegings- en 
ziekenhuiswetenschap, Leuven”. Members from ISCoS (International Spinal Cord 
Society), AFIGAP (Association Francophone Internationale des Groupes d’Animation de 
la Paraplégie) and DuFSCoS (Dutsh Flemish Spinal Cord Society) were contacted as 
well. At last some direct colleagues in Physical Medicine and Rehabilitation who are at 
work in different foreign countries, were asked for information. In total 66 emails were 
sent of which 21 answered (21/66).  Six colleagues let us know that in their hospital no 
clinical pathway is used for spinal cord injury (UK, Australia, USA and Belgium). One 
person sent an irrelevant answer (USA). Seven colleagues referred to guidelines they 
use. However these guidelines are no real clinical pathways (USA, UK, Zwitserland and 
the Netherlands).  One person referred to an interesting article which was already 
detected during the literature search (Prague). From New Zealand a clinical pathway 
“Halovest” was sent. From Switzerland (Sion) we received one clinical pathway 
concerning the post-acute phase after SCI. Two e-mails came from centres where the 
development and implementation of a clinical pathway for SCI is in progress (France, 
UK). One person referred to a general clinical pathway for inpatients on a neurological 
rehabilitation facility, not specifically for spinal cord injury.  
                                                
w  http://www.uzleuven.be/ebm/kp 
x  http://www.library.nhs.uk/pathways/searchResults.aspx?searchText=rehabilitation&tabID=288 
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7.4.2 Results 
Four clinical pathways for spinal cord injuries which were useful for the comparative 
study, were withheld. Two clinical pathways concerning the acute phase after spinal 
cord injury were available in literature (USA). One clinical pathway about the post-acute 
phase came from Switzerland. One clinical pathway started with the acute phase and 
went over in the post-acute phase (USA). The clinical pathways were analysed and 
compared.  
7.4.2.1 Patient characteristics 
All concerned inpatient treatment in a multidisciplinary setting. One included only non-
ventilatory dependent tetraplegia, one only paraplegia, one only cervical or high thoracic 
SCI and one did not mention the type of SCI.  
7.4.2.2 Delay after onset of SCI 
Three of the pathways describing the acute phase after SCI, started immediately after 
onset of the lesion. One pathway describing the post-acute phase, started 5 weeks after 
injury. The other rehabilitation pathway did not mention time of onset after injury.  
7.4.2.3 Method of identification of patient needs 
Concerning the pathways limited to the acute phase of SCI, all of the patients required 
intensive care based on patient’s type of injury and neurological status.  All of the 
patients were monitored by technical and laboratory exams.  One pathway also 
mentioned the use of two outcome tools, made by the interdisciplinary team itself.  
Concerning the pathways focusing on the post-acute phase, discharge goals and care 
pathway were reviewed with patient and family. 
7.4.2.4 Conditions to start rehabilitation. 
One pathway mentioned medical criteria such as haemodynamic stable patient and no 
acute medical interventions, but also functional criteria such as the ability to sit up and 
participate in therapy 3 consecutive hours for 3 days.  
The other pathways did not mention a condition to start. 
7.4.2.5 Duration of each phase of the clinical pathway / length of stay 
Concerning the pathways related to the acute phase of SCI, different phases before and 
after spinal stabilisation were described.  Two of them specified the first 24 hours after 
injury in detail.  One of them considered the first 5 weeks after injury.  The two others 
did not specify time/objectives for the patient to be ready for exit of the path. 
No information on duration of the whole rehabilitation programme was given.  
Concerning the pathways related to the post-acute phase of SCI, one pathway 
described 3 different phases; delay after injury was not mentioned.  The first involved 
preparing to sit up, and considered 30 days.  The second involved sitting up and 
considered 53 days. The third phase involved preparing discharge and did not mention a 
specific length of phase. In total, length of stay was more then 85 days.  
The other pathway described 4 different phases and started 5 weeks after injury. Each 
of these phases was continued for 6 days. In total, length of stay was 24 days. 
7.4.2.6 Involved professionals  
All three acute pathways considered the usual emergency team, the nutritionist and 
social counselling. In one pathway, the rehabilitation specialist was asked in consult.  
Another also asked the rehabilitation specialist in consult and treatment by a 
multidisciplinary rehabilitation team (physical and occupational therapist, nurse and if 
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necessary a speech therapist) was started. In the other pathway, only a multidisciplinary 
rehabilitation team was mentioned without the rehabilitation specialist One pathway 
also included the chaplain, the case manager, the sex therapist, the urologist and 
enterostomal therapist.  
In both pathways describing the post-acute phase of SCI, a rehabilitation specialist, a 
physical therapist, an occupational therapist, a registered nurse and psychosocial 
counselling were involved in all the phases of the rehabilitation programme.  One of the 
pathways mentioned the involvement of a urologist, an enterostomal therapist, an 
assistive technologist and a case-manager. 
7.4.2.7 Intensity of therapy 
Only one pathway for the post-acute phase described 2 hours of physical therapy each 
day, as well as academic classes 3 hours/week.  
For the other pathways no intensity of therapy was mentioned. 
7.4.2.8 Type of therapy 
Considering the acute phase of SCI, the content of therapy was not described in case of 
the involvement of a multidisciplinary rehabilitation team.  
Considering the post-acute phase of SCI, in one case the goals for each phase and each 
therapist were formulated. In another case only the goals for each phase without 
specifying the therapist, were formulated. 
7.4.2.9 Expected outcomes and the use of outcome measurement tools 
In the acute phase of SCI, an outcome measurement tool was used once, developed by 
the multidisciplinary team concerning prevention of skin breakdown and calories intake 
per day.  This team also developed a checklist focusing on haemodynamic stability, 
respiratory system, neuro/skeletal system, skin, bowel, bladder, sleep, communication, 
psychosocial activity and ADL, nutrition and education. The two others did not use 
specific tools, though mentioned medical criteria to continue to the following phase.  
In the post-acute phase of SCI, in one pathway FIM was used. To go to a next phase, the 
patient must score a certain amount of points for each of the criteria. 
The other rehabilitation pathway contained three phases. The first phase considered the 
preparation to sit up.  For the second phase, the expected outcome was sitting up in a 
chair. The third phase was finished when the patient was ready for discharge.  No 
specific criteria or tools were mentioned.  
7.4.3 Conclusion 
The use of clinical pathways after SCI is widely considered as useful.  In general, clinical 
pathways for SCI could have a number of benefits although we need to be careful with 
the interpretation of the results.  
It appears to be a difficult task to obtain a detailed description of pathways for 
rehabilitation after SCI.   
Search based on literature and international contacts, delivered lots of non-specific 
guidelines and only 4 concrete pathways. The latter were included for further analysis. 
Two pathways are related to the acute phase (>USA), only one is related to the post-
acute phase (>Switzerland) and one is related to the acute as well as the post-acute 
phase (>USA).  
All of the acute pathways, described the first 24 hours in detail.  For the post-acute 
phase, no specific pattern was followed, as one described phases by time and another by 
functional criteria. All of the pathways included physical and occupational therapy and 
discharge planning from the beginning, though only one pathway described intensity of 
the therapy (2hours/day of physical therapy and 3hours/week academic classes) during 
the post-acute phase. The content of therapy was not specified.  Inclusion of the 
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rehabilitation specialist was mentioned in two of the acute clinical pathways within the 
first 24 hours but in all the pathways for the post-acute phase. The use of an outcome 
measurement tool made by the interdisciplinary rehabilitation team itself was once 
mentioned. One study mentioned the use of the FIM as outcome tool. No further 
standardised tools were included for evaluation.  
7.5 TOTAL HIP REPLACEMENT (THR) 
7.5.1 Methodology 
Pubmed was searched using the Mesh terms total hip replacement and critical pathway. 
This resulted in 29 articles, of which 15 were related to the aim of the search. The 
authors who described the implementation/evaluation of a clinical pathway were – if 
possible - contacted and asked if the pathway could be made available. No pathways 
were passed on. 
On the website of the NHS 3 critical pathways concerning total hip replacement were 
detected. 
A search via www.aapmr.org (terms: care pathway and orthopaedics) resulted in one 
relevant publication on the benchmarks of occupational therapy within orthopaedic 
critical pathways. 
Most of the assessed critical pathways, were found through expert contact of the 
“Centrum voor Ziekenhuis- en Verplegingswetenschap” of Leuven. Using their contacts, 
two more pathways were obtained from NHS hospitals in the UK, one German 
pathway, two North American pathways and one Australian. 
Contacts in Belgium resulted in 1 pathway for Belgium. 
All the pathways were analysed for length of stay, therapies given to the patient, 
involved professionals and the milestones set for the patient. 
7.5.2 Results 
A total of 10 pathways describing rehabilitation after total hip replacement, were 
selected. In Figure 7.2, the geographical origin of the pathways is shown. 
Figure 7.2: Geographical origin of clinical pathways for rehabilitation after 
total hip replacement. 
Origin Country Number of pathways 
United Kingdom 5 
Germany 1 
Europe 
Belgium  1 
America USA 2 
Oceania Australia 1 
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7.5.2.1 Patient characteristics 
The patients included in the pathways are patients who had an elective total hip 
replacement. 
Eight acute clinical pathways are dealing with the immediate inpatient care after surgery. 
One pathway (from the UK) describes an inpatient rehabilitation service as well as an 
outpatient rehabilitation service. The Belgian pathway only considers the post-acute 
phase during hospitalisation. It describes the care in a rehabilitation facility after 
discharge from the orthopaedic ward. 
7.5.2.2 Delay after THR 
Six of the nine acute clinical pathways mention the start of therapy on the first day after 
surgery. In three pathways rehabilitation starts on the day of surgery. 
One pathway describes rehabilitation in the post-acute phase after total hip 
replacement. No information is given on the delay after total hip replacement, it is 
defined as starting after discharge from the acute care setting. 
7.5.2.3 Method of identification of patient needs 
Eight of the ten pathways describe a pre-admission assessment of the patient.  The 
assessment tools mentioned in one pathway are nursing assessment, fall risk 
assessment, thrombosis risk assessment, wound healing risk assessment, discharge risk 
assessment, Norton score and patient special needs assessment. Two other pathways 
use a questionnaire or a check list for pre-admission assessment without giving detailed 
information on the criteria. Seven of the nine pathways describe the involvement of a 
physical therapist before admission. Five out of the eight pathways have an occupational 
assessment as well. One pathway even describes the possibility of a pre-admission home 
visit. 
In all pre-admission assessments the surgeon and a nurse are involved. 
7.5.2.4 Conditions to start rehabilitation 
Total hip replacement is the only inclusion criterion. No other in- or exclusion criteria 
are mentioned. 
7.5.2.5 Duration of rehabilitation 
The length of stay in the acute care facility (= orthopaedic ward) ranges from 3 to 11 
days. The pathway with a length of stay of 3 days contains an outpatient rehabilitation 
service which includes a home care program with multidisciplinary rehabilitation. This 
program lasts 7 days.  
The end of the acute phase is discharge from the acute care facility.  
At discharge, all pathways mention physical therapy as an outpatient rehabilitation 
service. In the pathways from the UK home-based occupational therapy is also supplied 
if necessary. Different discharge destinations are possible. The pathways do not mention 
criteria for discharge to a rehabilitation centre.  
One post-acute pathways starts after discharge from the orthopaedic ward. The length 
of stay in the rehabilitation centre varies between 23 and 40 days. 
7.5.2.6 Involved professionals  
Concerning the involved professionals, we conclude that all pathways contain a physical 
therapist. Eight of the ten pathways include occupational therapy. Other therapists 
mentioned are a social worker, a recreational therapist and a speech therapist. 
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7.5.2.7 Intensity of therapy 
None of the pathways gave information on the amount of therapy in hours a day. All 
pathways describe daily therapy. No information is given on therapy during the 
weekends. 
7.5.2.8 Type of therapy 
All pathways contain physical therapy. Physical therapy includes mobilisation, isometric 
exercises and ambulating with a walking aid. Eight of the ten pathways include 
occupational therapy.  The content of the therapy varies between pathways: supplying 
the necessary walking aid, ADL-assessment, kitchen assessment, stair climbing… 
7.5.2.9 Expected outcomes and the use of outcome measurement tools 
In Figure 7.3 a detailed overview is given of the milestones needed to be reached at 
discharge. In general we conclude that ambulating independently with a walking aid, be 
able to climb stairs and be able to perform ADL independently are the milestones 
needed to be achieved for discharge. 
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Figure 7.3: Benchmark of discharge criteria after total hip replacement 
 Length of Stay Physical Therapy discharge criteria Occupational Therapy 
discharge criteria 
Outpatient rehabilitation services? 
Belgium 23-40 March with 1 elbow crutch 
March 400 m 
Walk stairs 
Active flexion, extension and abduction of hip 
ADL independently 
Hip ergonomy 
No information 
Lakes US 5 Knows home exercise program 
Able to ambulate independently with safe gait with 
crutches/walker on level surface and stairs 
Correct total hip precautions 
Proper use of ADL-equipment 
Self care independent 
Independent transfers 
Discharge to appropriate level of care, with 
appropriate level of care 
St John’s US 4 No information No information DC: home, home care, rehabilitation centre, 
LTAC, ECF, home with community referral. 
Germany 6 Walks partially independent 
Stair climbing 
Full weight bearing 
Able to perform car transfer 
Not involved Physical therapist at home 
Australia 7 Ambulating independently using walking aids 
Able to perform safe hygiene needs 
Not involved No information 
UK Airedale 6 Able to mobilise independently using appropriate 
walking aids 
Able to negotiate stairs. 
Understands precautions to be taken following hip 
replacement 
Able to dress independently using 
appropriate aids. 
Services/ aids in place to enable safe 
discharge to take place 
Isle of Wight 
UK 
11 No information No information No information 
London UK Acute phase: 3 
(rehabilitation facility) 
Post-acute phase: 7 
(home-based) 
Acute phase: transfers independently bed to chair; 
Independently mobile with frame/elbow crutches; 
attempt stairs 
Post-acute phase: Mobile independent with aid, ascend 
and descend stairs safely with aid, able to mobilize 
outside home 
Acute: not involved 
Post-acute phase: transfers 
independently, able to prepare a 
light meal 
No information 
Peterborough 
UK 
7 Discharge checklist Discharge checklist Physical therapy 
Rotherham 7 Physical therapy assessment of sitting, mobilise with 
elbow crutches, stair climbing 
 
Transfers, kitchen and dressing 
practice. 
No information 
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7.5.3 Conclusion 
Clinical pathways in the acute phase after total hip replacement, are widely used. Most 
of them start with an extensive pre-admission assessment. In 8 of the 10 pathways 
described above, an occupational therapist as well as a physical therapist are involved. 
Only 2 pathways (Australia and Germany) work without an occupational therapist. The 
duration of daily therapy sessions is never mentioned. There is very little information 
available on the type of therapy in the post-acute phase. The Belgian pathway describes 
the post-acute phase and one pathway of the UK gives information on the home-based 
therapy provided by an outpatient team including a physical therapist, an occupational 
therapist and a nurse. 
Multidisciplinary rehabilitation after total hip replacement is used world wide in the 
acute phase after surgery. Very little information is available on the continuation of  
rehabilitation programmes after discharge from the acute care facility. 
7.6 STROKE 
7.6.1 Methodology 
A scan of the published literature was performed to collect information on clinical 
pathways for stroke rehabilitation. 
Pubmed was searched using the MeSH terms “critical pathways”, “cerebrovascular 
accident” and/or “rehabilitation” (N=64). Cinahl was searched using the MH terms 
“critical path” and “stroke patients” (N=4). The NHS Library y  was explored for 
“stroke” within the category of “Protocols & Care Pathways” (N=3). The website of 
the American Academy of Physical Medicine and Rehabilitation was also searched on 
“clinical pathways” and “Cerebrovascular Accident (Stroke)” (N=43). The CVZ was 
asked if clinical pathways for stroke rehabilitation were available in the archives. Grey 
literature (Google) was searched using the keywords “managed care”, “stroke” and 
“rehabilitation”, “integrated care” and “stroke” . 
7.6.2 Results 
In total, 7 relevant clinical pathways were selected for further analysis (See attachment). 
As demonstrated in Figure 7.4, detailed description of clinical pathways was only found 
for pathways developed in 3 countries: UK, US and Belgium. This might influence the 
findings during analysis. Another important remark is the fact that, although a lot of 
guidelines for rehabilitation practices during the post-acute phase of stroke are 
published, specially clinical pathways for the acute phase of stroke were found and only 
two clinical pathways for the post-acute phase of stroke were found. 
All pathways were developed and applied at an individual hospital level. For most 
pathways it was mentioned that they were developed by a multidisciplinary team 
consisting of physicians, nurses, physical therapists, occupational therapists, speech 
therapists and social workers. Evidence of best practices combined with professional 
standards and existing infrastructure were the basis to formulate a consensus on 
practice represented in the clinical pathway. Half of the pathways are process focused, 
half of the pathways are outcome focused. 
The goals of developing clinical pathways were timely interdisciplinary coordination, 
reducing practice variations, quality improvement, facilitation of discharge planning, 
promoting cost-effective resource use and reducing length of stay. 
                                                
y  www.library.nhs.uk/pathways/  
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Figure 7.4: Countries in which selected clinical pathways were developed. 
ORIGIN COUNTRY NUMBER OF PATHWAYS 
U.K. 4 EUROPE 
BELGIUM 1 
AMERICA U.S. 2 
7.6.2.1 Patient characteristics 
All pathways were developed for stroke patients. Five covered the acute phase of the 
disease trajectory. Two covered the post-acute phase. 
7.6.2.2 Delay after stroke 
Clinical pathways for the acute phase of stroke start on day 1 after stroke. The clinical 
pathway for the post-acute phase starts later because of the condition of medical and 
neurological stability before applying the clinical pathway. 
7.6.2.3 Method of identification of patient needs 
Patient needs are identified by a multidisciplinary assessment. All involved professionals 
performed a specific part of the assessment. In some pathways the assessment is done 
by use of validated outcome measures (FIM, Barthel Index, National Institute of Health 
Stroke Scale Measures, Duke Mobility Scale). In other pathways assessment is 
performed using criteria defined within the development team. In all pathways the 
results of the assessment are discussed with the patient as well as with his/her family. 
7.6.2.4 Conditions to start rehabilitation 
In the pathways for the acute phase the focus is on multidisciplinary assessment rather 
than on the start of therapy. Moreover, in two pathways for the acute phase no therapy 
is started yet. In the other pathways rehabilitation therapy is started if the need for 
rehabilitation could be demonstrated by the results of the assessment. For these 
pathways, the day on which therapy starts, ranges from 3 days to 1 week after start of 
the pathway. In one pathway the start of therapy differs per type of therapy: dietician 
treatment starts on day 1, equipment such as a wheelchair and cushions are provided 
on day 3, speech therapy starts on day 3 and physical as well as occupational therapy 
start on day 4. 
In the pathways for the post-acute phase, therapy is started after the multidisciplinary 
assessment is finished. 
7.6.2.5 Duration of rehabilitation 
If mentioned, the pathways for the acute phase focused on the process, take maximum 
7 days. In the pathways for the acute phase focusing on outcomes, duration depends 
once on the discharge outcomes reached and once on the completion of the 
assessment. 
The duration of rehabilitation in one pathway for the post-acute phase is +/- 4 weeks, 
depending on the goals reached. In the other pathway for the post-acute phase which is 
process focused, duration of the hospital stay is estimated on 8 weeks. These 8 weeks 
include 4 phases each of 2 weeks. 
7.6.2.6 Involved professionals 
The composition of the multidisciplinary team is very comparable between all pathways. 
In every pathway the multidisciplinary team is consisted of: 
• A physician 
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• A nurse 
• A physical therapist 
• An occupational therapist 
• A speech therapist 
• A dietician 
This multidisciplinary team is involved during the assessment as well as during therapy. 
In some pathways a psychologist is involved. In half of the pathways a social worker is 
involved. Only in 2 of the pathways the involvement of a specialist in rehabilitation is 
explicitly mentioned. 
7.6.2.7 Intensity of therapy 
Intensity of therapy was never mentioned. 
7.6.2.8 Type of therapy 
In the cases where the start of rehabilitation therapy is included in the pathway for the 
acute phase, it concerns always physical therapy, occupational therapy and speech 
therapy. 
Type of therapy or involved professionals are not defined in one pathway for the post-
acute phase. Instead of this, specific intervention goals in different domains are listed. An 
example for the domain of activities of daily living: patient has baseline skills in feeding, 
hygiene/grooming and dressing. This makes it easier to implement this pathway in 
different organisations with typical activities per type of professional. The other pathway 
for the post-acute phase contains specific goals directly linked to a type of professional. 
Goals change over the four phases. In each phase physical therapy, occupational therapy 
and speech therapy are offered. 
7.6.2.9 Expected outcomes and the use of outcome measurement tools 
Based on the results of the assessment, treatment goals are identified. In one of the 
pathways it was explained that goals were determined by stroke severity, number and 
degree of impairments, expected outcome, pre-morbid functional status, and 
patient/caregiver attributes or needs. For each therapeutic intervention short term 
goals and estimated time to achieve these goals were defined in advance. 
Only in two pathways the same assessment tool is used at the beginning and at the end 
of the pathway. 
In one pathway four categories of outcomes are identified: 
• Patient discharge outcomes 
• Patient clinical outcomes 
• Patient satisfaction outcomes 
• Final Program outcomes 
Assessment of clinical outcomes is used to determine rehabilitation goals and 
performed by use of: 
• National Institute of Health Stroke Scale Measures (Stroke deficits) 
• Orpington Prognostic Scale Measures (Stroke severity) 
• Barthel Index; FIM; Instrumental Activities of Daily Living (ADL) 
• Fugl-Meyer; Duke Mobility Scale (Motor function) 
• Geriatric depression scale (Depression) 
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• Medical Outcomes Study Short Form Health Survey (Health status and 
quality of life measure) 
Assessment of discharge outcomes is done at the end of the pathway process. 
Discharge outcomes include criteria focusing on patient safety and continuity of care 
during hospitalization and the patient's ability to successfully transit to the next level of 
care whether it be home, rehabilitation- or skilled nursing facility. The discharge 
outcomes are individualised to assist the patients in achieving their highest potential. 
Examples: Patient performes bed to chair transfers, demonstrates ability to perform 
care at home, demonstrates understanding of risks for injury, safety measures and use 
of adaptive equipment. 
7.6.3 Conclusion 
“The earlier rehabilitation is started the better the recovery” as one of the principles of 
rehabilitation of stroke patients 138 is represented in existing clinical pathways. Except 
for two, the obtained clinical pathways concern the acute phase of stroke. 
Intensity of therapy is described in none of the pathways. Duration of rehabilitation is 
difficult to consider because each pathway only covers a part of the disease trajectory 
(acute or post-acute phase). 
Identification of patient’s needs are always based on a multidisciplinary assessment. In 
some pathways this assessment is done by use of validated outcome measures. In other 
pathways this assessment is done by use of criteria defined within the multidisciplinary 
development team. The results of this assessment are used to define rehabilitation goals 
or to evaluate expected outcomes. 
Pathways for the acute phase are very comparable related to delay after stroke, 
involved professionals and type of therapy. 
One of the pathways for the post-acute phase is special because involved professionals 
and type of therapy are not integrated. Instead of this, specific intervention goals in 
different domains are listed. Besides, this pathway prescribes medical and neurological 
stabilisation before its start. 
Stroke management involves the expertise of several disciplines, which can result in 
poor coordination or inefficiencies in patient treatment. This can be avoided by the use 
of clinical pathways which ensures that important areas of treatment are not 
overlooked and unnecessary delays are prevented. 
However, the effectiveness of the use of clinical pathways could not be confirmed yet. A 
reason can be that the development of clinical pathways is based on the premise that 
patients will have predictable recovery, whereas stroke patients show considerable 
variability in timing, nature, and order of recovery. Other explanations can be the 
dependence on external influences such as accommodation and personal support. 139 
Anyway, there is currently insufficient supporting evidence to justify the routine 
implementation of care pathways for acute stroke management or stroke rehabilitation. 
140 
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Key points 
• There are only few clinical pathways available for rehabilitation of lower 
extremity amputation, multiple sclerosis and spinal cord injury. 
• A lot of clinical pathways exist for rehabilitation of total hip replacement 
and stroke, but they are mostly limited to the acute phase of the disease 
trajectory. 
• Characteristics of the available pathways are: 
Only part of the disease trajectory is covered and there is no information 
about duration of the whole rehabilitation process; 
Intensity and content of therapy are mostly not mentioned; 
The involvement of a multidisciplinary team is nearly always mentioned; 
Outcome measures are not commonly used; 
Some pathways focus on outcome criteria, other focus on time-related steps 
of the rehabilitation process; 
• The selected clinical pathways are difficult to compare. Variability can not 
be confirmed nor rejected. 
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8 INTERNATIONAL COMPARISON 
8.1 GENERAL INTRODUCTION 
This part of the research focuses on a search for international experiences with the 
reorganisation of the rehabilitation sector. As rehabilitation is organized differently for 
children and adolescents (age <17 years) and for adults (age >17 years), we focus on the 
adults. 
The aim of this chapter is to describe experiences in the (policy) choices made in 
organising the musculosceletal and neurological rehabilitation in a selection of countries. 
The organisation of any health care sector has to be understood in general, against the 
background of historical policy choices. Within the practical constraints of this research, 
the study contextualises the organisation of the rehabilitation sector within the overall 
health care system. Rehabilitation approaches develop within the features of insurance 
models, competency domains of central and decentralised agencies and local problems 
of health care provision. 
8.1.1 Research questions in this part of the study 
• How does a selected sample of countries organise and finance (post-
acute) musculoskeletal and neurological rehabilitation? 
• What are the current health service debates and organisation models 
proposed and developed for the post-acute musculoskeletal and 
neurological rehabilitation sector? 
• Are there any specific quality initiatives taken related to the 
organisation of the post-acute musculoskeletal and neurological  
rehabilitation sector? 
• Can anything be learned about the organisational choices made in 
different countries for the current Belgian debate on post-acute 
musculoskeletal and neurological rehabilitation?  
• What choices are made for some of the selected pathology groups? 
8.2 METHODS 
8.2.1 Selection of the countries 
Of course, the practical constraints of the research limited the number of countries to 
be compared. The selection of the countries, was based on criteria related to the health 
care system, developments in the rehabilitation sector, previous research experience in 
rehabilitation and an endorsement of the selection by the external expert group.  
Countries were selected based on the role of the state, the role and model of health 
insurances (private, public, mixed models) and knowledge about ongoing debates in the 
reorganisation of the rehabilitation sector. A selection was made of countries 
developing their health systems in a more North European tradition, a more south-
European tradition, and countries in which insurers are taking over an important role as 
catalysts in the organisation of health services   
A decision was made to focus on a description of the rehabilitation sector in: The 
Netherlands, France, Sweden, Germany and the US. 
8.2.2 Peer-reviewed journals 
A first step, aiming at describing the organizational models of rehabilitation for the 
selected countries, consisted of searching the Medline database (through PubMed).  
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A general search was done the last trimester of 2005 and the first trimester of 2006 
using the related meshterms: 
"Organization and Administration"[MeSH] OR "Professional Review 
Organizations"[MeSH] OR "Organizations, Nonprofit"[MeSH] OR "Health Planning 
Organizations"[MeSH] OR "Health Maintenance Organizations"[MeSH] OR "Health 
Care Economics and Organizations"[MeSH] OR "Managed Care Programs"[MeSH] OR 
"Risk Adjustment"[MeSH] OR "Organizational Case Studies"[MeSH] OR "Health 
Expenditures"[MeSH] OR "European Union"[MeSH]) 
AND 
("Rehabilitation"[MeSH] OR "rehabilitation"[Subheading] OR "Rehabilitation 
Nursing"[MeSH] OR "Rehabilitation Centers"[MeSH] OR "Rehabilitation of Speech and 
Language Disorders"[MeSH] OR "Rehabilitation, Vocational"[MeSH] OR "Activities of 
Daily Living"[MeSH] OR "Treatment Outcome"[MeSH]) 
For each country a more specific search was done introducing search terms for multiple 
sclerosis, spinal cord injury, total hip replacement, stroke and lower extremity 
amputation (see Appendix to chapter 8). 
8.2.3 Comments 
Taking into account the research question (specific organisational information on the 
rehabilitation sector) this search strategy is not offering a lot of relevant results. The 
medical peer reviewed journal databases mainly focus on clinical studies, far less on 
specific health services studies. The MeSH terms seem not always adequate to pinpoint 
particular organizational or policy issues. As a result, very little information can be 
obtained about the organization and health services models in the selected countries. It 
would be of no added value to deploy “selection of evidence” tables, because the 
selections steps (title and abstracts) already showed that a “circumstantial” approach 
would be needed. All the details of this approach can be found in the Appendix to 
chapter 8. 
For the pathology groups, some information was found resulting from a search in the 
medical peer reviewed databases. Again, the majority of the articles focuses on 
treatment and care, not organisational or policy issues. One exception to be quoted, is 
Germany for which more (local language) articles could be found. 
An additional search in the CIRRIE-database (Center for International Rehabilitation 
Research Information and Exchange) gave similar results, without much added value for 
our particular research questions. 
8.2.4 Other information sources 
Factual information had to be gathered based on informal contacts within the sector, as 
most information in peer reviewed journals is dealing with clinical issues. Due to the 
lack of relevant (descriptive) information on organisational models in the peer reviewed 
journals, this part of the study is heavily relying on work prepared by WHO-health 
systems observatory (in particular the HIT-reports), a particular issue of the “journal of 
health economics” on the health benefits basket in different countries, on reports from 
professional organizations and on public information from administrative authorities. 
The information gathered draws also to a large extent on informal and personal 
communications with people (research institutes, administrators) from the countries 
studied.  
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8.3 THE NETHERLANDS  
8.3.1 Health care organisation in general 
The Dutch health care system is characterized by some fundamental policy changes 
since the end of the 1980’s141. In general terms, and due to problems both of serving the 
population and of financing (cost containment), the system is trying to make the shift 
towards a more flexible, demand oriented and market driven model. Policy makers are 
less imposing the particular organization regimes, but are creating the frameworks of a 
welfare state in which providers and the public is offered more flexibility in using and 
providing health care. The system reform is often identified as a movement from a 
“public regulated system” towards a “regulated market model”. The recent shift 
towards “market oriented models” implies a shift of the steering power from the public 
to the private sector. 
The health care system changes are built on the assumption that more market forces 
will enable a more efficient and effective health care system, and especially a more 
flexible system that is able to handle the fast changing heath care needs and demands of 
the public. The health care system changes aim at improving the quality whilst also 
controlling public expenditure. 
8.3.2 Health insurance 
Since the mid 1990’ two major insurance regimes affected the use and right to medical 
and social care: de ziekenfondswet (ZFW) en de Algemene Wet Bijzondere 
Ziektekosten (AWBZ) The ZFW and AWBZ provided for benefits in kinds, while the 
AWBZ also provides for cash benefits.  
• Treatment and services available under ZFW are (in general terms): 
medical and surgical treatment (including limited number of sessions 
for physiotherapy and speech therapy); obstretic care, dental care, 
pharmaceuticals, non psychiatric hospital admissions; aids and 
appliances; transport, maternity care and care in an audiology centre; 
costs for genetic testing, haemodialysis, services for patients with 
chronic recurring respiratory problems, rehabilitation, and services of 
a thrombosis prevention unit. 
• The underlying principle of AWBZ is that people should continue to 
live in their homes as long as possible, whether they receive care at 
home or in an institution: For the AWBZ seven distinct functions are 
defined: domestic help, personal care, nursing care, supportive 
guidance (helping in the organization of daily life), activating guidance, 
treatment, and accommodation 
Since January 2006 a new, mandatory national health system, imposes individuals to 
purchase private health insurance. A standardized basic coverage (Basisverzekering) is 
guaranteed for all citizens by means of the Ziekte-Verzekerings-Wet (health care 
insurance law) (ZVW):  
• Medical care, including hospitalization (up to 365 days) and specialists;  
• Dental care for children (under age 18);  
• Specialist dental care and dentures for adults; 
• Pharmaceuticals;  
• Maternity and postnatal care for up to ten days after childbirth;  
• Ambulance and transportation costs; and  
• Some medical and paramedical rehabilitation services.  
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Supplemental plans are available on an individual basis or collectively via an employer 
plan or similar group arrangement. Insurance companies will not be required to accept 
all applicants for supplemental insurance. Companies are free to determine the scope of 
coverage and premium levels for supplemental policies 
The “wet maatschappelijke ondersteuning” (WMO) (law societal support) will replace 
the AWBZ .A clear separation in the overall insurance model will be made between 
chronic conditions and temporary conditions. The medical and paramedical parts of the 
AWBZ will in the future be transferred to the ZFW.142 143 The WMO will be mainly 
guaranteeing social support coordinated by the local communities. 
8.3.2.1 Health care policy making and organisation  
The historical changes in the Dutch health care system can be characterized as a 
movement towards territorial decentralization, and in the last decade a movement 
towards integration and coordination of the different levels of the health care providers. 
The Dutch system holds to a model of centralized supervision, but operational 
responsibilities in health and social care are delegated to the local and regional 
authorities.  
The ministry of health, welfare and sport (VWS) sets out the health, health care and 
social care policies, together with the minister. Local authorities bear joint responsibility 
and play a complementary (local) role. 
Regional networks of municipal public health services take up the care on preventive 
level and health promotion (among other public health tasks). 
Primary care is centralized around family physicians that play a role as gatekeepers. 
Secondary care is mainly provided in hospitals. These hospitals have both inpatient and 
outpatient services. The 9 university hospitals, regionally distributed, play a role as 
“leading” hospitals for specialist medical interventions.  
In the 1990’s measures were taken to bridge the (organizational and financing) gap 
between outpatient and inpatient care, by means of “transmural” (integrated) care: a 
mechanism to coordinate and organise continuity of care for the patients. These 
initiatives developed as “projects”, most of the time focused on specific groups of 
chronic patients, with intermittent acute care needs. However, the financing system did 
not facilitate an easy implementation of a smoothly functioning transmural (or 
integrated) care system.  
The most important part of residential social services consists of nursing homes and 
homes for the elderly. Residential homes are particularly established for those people 
who are not able or feel unsafe to live independently at home. A distinction has to be 
made between somatic nursing homes (disabled people needing multidisciplinary 
monitoring and treatment) and psycho-geriatric nursing homes (for people with 
dementia).  
Admissions to residential care have decreased in the last years, because of transmural 
initiatives (e.g. day care centres) on the care side and improvement of availability of 
home care services. 
8.3.2.2 Financing 
The hospitals were financed through a fixed budget system. The problems with waiting 
lists culminated in 1997 in measures making additional money available to reduce 
unacceptable waiting times.  
In 2005 a new hospital financing system was introduced by law: the “diagnosis-
treatment-combination” (Diagnose Behandel Combinaties (DBCs)), a DRG-like system 
describing all products and procedures provided in hospitals.z  DBCs are defined as the 
whole set of activities (diagnostic and therapeutic interventions) of the hospital and 
medical specialists from start till discharge, using the ICD-10 classification. A patient can 
                                                
z  http://www.minvws.nl/dossiers/dbc/ 
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enter in a DBC-trajectory by referral of his general practitioner (GP) or a medical 
specialist. The introduction of the DBC financing model goes hand in hand with an 
extended registration system. 
A DBC treatment trajectory can take one day up to one year. A treatment trajectory is 
ended at the end of the year, in case the treatment is stopped or in case a patient starts 
a different dbc (e.g. the inpatient trajectory is stopped when the patient starts an 
ambulatory treatment; an ambulatory trajectory is then started).  
DBCs distinguish between list A (prices fixed by the National Health Tariffs authority) 
and list B (an fixed part and a part of the prices negotiated by Sickness Funds and 
hospitals). DBC’s are used as a framework for price negotiations between health 
insurers and hospitals. Agencies were created to manage the implementation and follow 
up of the DBC financing model aa 
Congruent with a market driven approach, major efforts are now being put into the 
development of performance indicators. These performance indicators are mainly seen 
as a quality tool, and a facility for consumers to support informed choices on the health 
care market. The development of these performance indicators is still in an early stage, 
although a lot of debates are taking place on the conceptual level. 
• The Dutch health care system is characterized by territorial 
decentralisation. 
• A market-driven approach has been introduced (purchaser-provider). 
• Integration of care and networking of health care organisations is 
stimulated. 
• The “Ziekteverzekeringswet” insures for medical expenses. 
• The AWBZ used to insure for exceptional medical expenses and long term 
care. 
• The financing of medical activities in hospitals is based on “Diagnose 
Behandel Combinaties”, and is performance related. Extensive 
registration is set up. 
8.3.3 The organization of the rehabilitation sector 
(See also Appendix to chapter 8 (1.8.2.2)) 
8.3.3.1 The underlying conceptual ideas 
The Dutch rehabilitation “logic” differentiates between different levels on a continuum 
from “general and simple” toward “specialised and specific”. In conceptual terms a 
differentiation is made between (a) simple rehabilitation (b) general multidisciplinary 
rehabilitation (c) specialized target (pathology) group oriented multidisciplinary 
rehabilitation and (d) highly specialized rehabilitation (“topreferente”). bb 
For relatively “simple” rehabilitation a referral is needed from the medical specialist to 
the physical therapist. In the case of complex issues, a medical rehabilitation specialist 
becomes in charge of the patient.  
A “complex” situation is generally assessed as a medical condition in which the risk of 
long term impairment or handicap is real. For specific cases the rehabilitation physician 
will mobilize a multidisciplinary team in case of discharge of the patient to a home 
setting. 
                                                
aa  http://www.dbconderhoud.nl/ 
bb  http://www.revalidatie.nl/index_3.htm 
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8.3.3.2 Rehabilitation facilities 
Rehabilitation is organized in acute hospital settings as well as in 24 Rehabilitation 
Centres throughout the country cc  and a part in nursing homes. In both cases, the 
service can be in- or out-patient dd. Of the 24 Dutch Rehabilitation Centers, 14 are 
connected to University Hospitals (“Academiseringsovereenkomst”) and have an 
agreement to do research and organize teaching. They are considered to be “top 
reference centres”.144 
24 regional rehabilitation centres and hospital departments offer specialized 
rehabilitation servicesee.  
Most Dutch hospitals have a policlinic function for rehabilitation medicine, in which a 
staff of physical therapists, occupational therapist and social workers is employed. These 
services operate generally in close collaboration with acute intramural rehabilitation 
departments. 
Rehabilitation hospitals/centers are established for longer term intensive rehabilitation. 
Their activities are falling under the “cure” compartment (ZVW). However for some 
categories they currently still provide rehabilitation falling under the “care” 
compartment (AWBZ), which is generally offered in nursing facilities.  
Nursing facilities can also provide intramural and policlinical rehabilitation services. 
Somatic nursing homes (verpleeghuizen) are for disabled people in need of continuous 
multidisciplinary monitoring, care and treatment. The nursing homes aim in particular at 
an older population of patients, that are not eligible for a policlinical treatment or for 
which the intensive treatments in a rehabilitation clinic is judged as being not 
opportune. Moreover, the bed-capacity of the rehabilitation centres is too limited to 
accept this older patient group. But the rehabilitation activities in the nursing homes 
should also focus on reactivation. The somatic nursing homes have a multidisciplinary 
staff consisting of physiotherapists, occupational therapists, speech therapists and 
psychologists. Certain nursing homes offer policlinical services, generally focusing “day 
care”, more than on active rehabilitation. 
Recently, a lot of attention has been paid to the integration and coordination of facilities 
in order to provide more continuity of care for the patient (“ontschotting van de zorg”) 
One of the most important area’s in the context of this project, is the development of 
networks for stroke, more recently labeled as stroke services (see infra). 
8.3.3.3 Indication setting 
Patients in rehabilitation institutions need an indication setting145 for a multidisciplinary 
intensive approach, (for diagnostics, advice or treatment)  
The criteria used for indication setting are based on:  
• the expected level of recovery;  
• the multiplicity of the (expected) impairments or handicap, combined 
with the complexity of the rehabilitation goals put forward, taking into 
account the life-course stage and the premorbid level of the patient;  
• the learning capacity and training capacity of the patient  
• the potential of a patient to live in a regular (adapted) housing and 
living situation. 
The indication setting is developed according to a standardized model (SAMPC 
(somatic) and/or RAP (mobility)), but is not using scales on a systematic basis. The 
indications for treatment by a rehabilitation specialist are confined to disorders of the 
musculoskeletal system or the nervous system (including cognition, communication and 
                                                
cc  www.revalidatie.nl 
dd  www.dbconderhoud.nl/informatie/categoraal 
ee  http://www.brancherapporten.minvws.nl/object_document/o329n397.html  
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behaviour), that are so complex as to make specialized knowledge indispensible, or that 
tend to become permanent. E.g. physical rehabilitation of myocardial infarction or 
COPD (chronic obstructive pulmonary disease) belongs to the responsibility of the 
cardiologist, respectively pneumologist; in severe cases the advice of a rehabilitation 
specialist can be obtained. The indication has to be approved by the health insurer. 
Patients with complementary private insurance have (depending on the type of 
insurance) the right for more insured physiotherapy in private physiotherapy practices. 
For the upcoming reforms, four indication categories will be distinguished for the 
activities falling under ZVW: (a) diagnosis, diagnostic test in complement to the initial 
diagnosis (b) temporary co-treatment, (c) treatment as part of a recovery trajectory (d) 
continuous specific care. Other categories already exist with the AWBZ framework, for 
which nothing will change. It has to be said that it are only proposals. Before 1 january 
2007, nothing will change 
8.3.3.4 Financing reforms in rehabilitation 
(See also Appendix to chapter 8 (1.8.2.2)) 
For the rehabilitation in specialized rehabilitation centres and rehabilitation units of 
general hospitals, 47 DBC’s 146 are in the process of being defined in 2006, but are not 
yet endorsed by the government. The negotiations and identification of these DBC’S are 
particularly difficult. It will probably be foreseen that top reference centres get a higher 
price for their activities. One of the debated points is also how to discount for 
differences in seniority or educational level of the staff. 
DBC’s are conceptualised as “treatment trajectories”. As different rehabilitation 
facilities can be involved in the treatment of a patient during a rehabilitation period, the 
financing model funds for periods of registered activities from the DBC-lists within the 
facilities. It has also to be registered whether it is the first rehabilitation treatment or a 
“continuation” after the first treatment was ended. 
7 main diagnostic categories are distinguished (locomotor apparatus, amputation, brains, 
neurology, spinal cord injury, organs, chronic pain and psychic disorder (and one 
particular DBC for multidisciplinary interaction). It should be noted that the 
classification into a certain DBC is only based on medical diagnosis and does not imply a 
functional assessment.  Separate DBC’s are created for polyclinical rehabilitation and 
rehabilitation for children. Within these head categories about 45 detailed categories 
are identified. The details of the activities and the subclassification is still under 
negotiation at this stage. 
The consultations or therapeutic acts of the medical specialist are coded in 10 separate 
declaration categories. Each time a certain professional (speech therapist, manual 
therapist…) performs some activities with/for a certain patient, these are registered in a 
separate code. It can be “face-to-face” activities (actual treatment by physiotherapist, 
speech therapist, psychologist…) or “non- face-to-face” activities (such as report 
writing, team discussions, adaptation of a brace...) of minimal 10 minutes duration. 
Certain specific rehabilitation nurse acts (e.g. decubitus care) are registered by means of 
a therapy registration number. The activities are called “College Tarieven 
Gezondheidszorg-activities” as each hospital receives a yearly adjusted budget calculated 
on different factors. Although at the beginning of the rehabilitation episode a rough 
estimation of therapy duration and intensity has to be made by the rehabilitation 
specialist, at the end of the therapy the amount of accomplished sessions is refunded. 
As such, the system closely resembles a fee-for-service system. 
Rehabilitation therapy has to imply a multidisciplinary (two or more therapists) setting 
in a rehabilitation centre. Monodisciplinary therapy can only be taken into account if it 
concerns a special therapy which is not available on regular basis outside the 
rehabilitation centre. 
From 1 January 2008 onwards, the 24 rehabilitation centres will be operating according 
to the DBC model (be it that no negotiated part B will be implemented). Until then 
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they are financed in terms of reported rehabilitation treatment hours (RBU Revalidatie 
Behandeluren)ff. 
A model of function-oriented financing for intramural health care under AWBZ is put in 
place since 2005 for inpatient long term care-facilities. Providers will be financed on a 
budget calculation taking into account the “functions” provided (functiegerichte 
bekostiging) The health care policy makers try to stimulate the health care providers to 
take into account the particular regional needs of the population, and to develop social 
and health care arrangements (intramurale zorgarrangementen) combining a set of 
“functions” adapted to these needs. A more fundamental financing reform is prepared 
(to be introduced in 2007) based on the “level of care” offered (calculated on the 
average number of hours of care and treatment for a certain level of severity). 15 levels 
of care will be differentiated, and a patient will be indicated for a certain level of care.  
Some aspects of rehabilitation will be taken into account in care facilities, but it will 
mainly be “maintenance” rehabilitation. Baskets of care (“zorgzwaartepakket”) will be 
identified related to the characteristics and care needs of the patiënt. The care baskets 
differentiate between a spectrum of long term intensive support and shorter time 
recovery needs, but do not deal with the (para)medical aspects147. For each specific 
basket a (maximum) price will be set.148  
8.3.4 Quality in rehabilitation 
The formal procedures to develop quality assurance are since the reforms of the health 
care system based on “performance indicators”, formal audits of the centres and quality 
management incentives based on registration.  
Reflections started on the principles for the development of “rehabilitation treatment 
frameworks” (revalidatie behandelkaders: formerly identified as quality profiles). They 
are used as frameworks within which treatment-programmes on the level of the 
facilities have to be identified, The frameworks are intended as quality and accreditation 
instruments and try to incorporate the reflection on DBC’s and performance indicators. 
A rehabilitation treatment framework is developed as a set of minimal conditions to be 
met when providing rehabilitation activities. It will be used as a tool for quality audits. 
Frameworks have been developed for cognitive rehabilitation, cancer rehabilitation, and 
rehabilitation for pain149.  These rehabilitation frameworks have to be developed 
according to a standard template and follow a predefined working procedure. The 
frameworks currently available, only have the status of “discussion papers”.  
8.3.4.1 Performance indicators 
The development of performance indicators of medical rehabilitation facilities is still in 
its early stages, and seems to be a difficult exercise.  
In 2000, it was decided in a consensus meeting between stake-holders (government, 
insurance companies, patient organizations…) to develop performance-indicators for 
rehabilitation care, in order to simplify comparison between different settings for 
insurance companies as well as for patients.  
In 2004 a so called “basic set” of performance indicators has been developed150. Nine 
dimensions were identified, along the quality lines of structure, process and outcomes: 
satisfaction, patient safety, effectiveness, timeliness, efficiency, transparency, 
collaboration, competency and competencies development and research and teaching. 
In 2005 the rehabilitation institutions had to start registering on an experimental basis 
for these indicators. In april 2006 a first digital report has been published comparing 
rehabilitation facilities on the results for the basic set of indicators. The reporting is 
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aimed to communicate to the main collaborating institutions of the rehabilitation 
centres 144.  
The aim of the quality approach is to develop and implement a set of 20 outcome 
measures in 2009. Some further work has to be done to further develop the system for 
specific patient groups. The development of the indicators is a collaborative exercise of 
universities, rehabilitation physicians and research units, funded by VWS. 
In the framework of the development of integrated care for stroke patients (see infra) 
some particular propositions are made for 11 performance indicators for integrated 
stroke care. These indicators will be used in the “benchmark reports ketenzorg-CVA”. 
After an evaluation of pilot-initiatives of integrated care in stroke (edisse-study), 
integrated stroke care was introduced in 23 dutch regions. For this new initiative, 19 
indicators were used in order to assess the performance of the networks151. These 
performance indicators have yet no formal endorsement as a quality instrument.  
 
• The Dutch rehabilitation concept differentiates 4 levels of rehabilitation on 
a continuum: “general and simple” “general multi-disciplinary” 
“specialised and specific” and “top reference”. 
• Rehabilitation is organized in acute hospital settings as well as in 24 
Rehabilitation Centres throughout the country and partly in nursing 
homes. Fourteen rehabilitation centres have the status of “top-reference” 
centre (link with universities). 
• Patients in rehabilitation institutions need an indication setting. 
• The rehabilitation sector will be financed in the DBC model in 2008. Until 
then the financing is based on an activity based model.  
• “Function-oriented” financing for intramural health care under AWBZ is 
in place for inpatient long term care-facilities. A further financing reform is 
prepared including the “level of care” offered (calculated on the average 
number of hours of care and treatment for a certain level of severity). 
• The quality approach in rehabilitation will have to fit the DBC financing 
and performance model. A “basic set” of performance indicators is being 
developed and registered. “Rehabilitation treatment frameworks” are 
intended as quality and accreditation instruments. They describe the set of 
minimal conditions to be met when providing rehabilitation activities. 
8.3.5 Example: Stroke 
In recent years, a lot of “project based” attention has been paid to the organisation of 
facilities for people with stroke. Different pilot initiatives have been launched to 
guarantee better coordinated and integrated care between acute, post-acute, and home 
care arrangements (CVA-ketenzorg). The “Commissie CVA-Revalidatie”, a working 
group of the “Nederlandse Hartstichting” (www.hartstichting.nl), recommended in 2001 
“stroke services” (conceptualized as integration of rehabilitation activities) as the best 
way to take care of stroke patients, based on the opinion of the experts of the working 
group. Apart from the networking, they advised to assure continuity of care by 
transmural patient notes and/or by a transmural nurse. 
The concept of stroke unit is used for a specific neurology department providing 
(sub)acute treatment within the hospital. On average people stay between 10-14 days. 
About 80% of the hospitals have such a stroke unit. ‘Specialised rehabilitation stroke 
units’ are part of rehabilitation centres, aiming at rehabilitation for independent living. 
The duration of stay can be up to six months. A ‘nursing rehabilitation stroke unit’ is a 
specialised department in nursing-facilities, most of the time rehabilitating people that 
are probably not returning home. There are only few units in each region. Some care 
institutions for the elderly have some specific units for elderly stroke patients. As the 
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Dutch system has opted for a regional approach, every region has a specialized 
rehabilitation unit, accepting stroke patients: there are no national reference centres.  
Depending on the medical condition of the patient, there are several options for 
referral. In case of a hospital treatment, the first week is focusing on stabilizing the 
medical condition. From the second week, the multidisciplinary needs-assessment 
should have started. This needs assessment is the basis on which referral is prepared.152  
An important part (about 40%) of the stroke patients admitted in the hospital is 
returning home. About 32% is referred (temporarily of definitive) to a nursing facility. 5-
13 % of patients that stayed in a hospital is referred to a rehabilitation centre. About 20 
% of this group is still in the centre after 6 months. A vast majority of the patients is 
referred home after the post acute phase. Some of these patients will need additional 
medical and care support. Another group cannot immediately be referred home and are 
transferred to a nursing home or rehabilitation facility for further rehabilitation. The 
referral is organised on a regional basis as far as possible. Some people for which no 
progress is expected will be transferred to nursing homes only. The rehabilitation 
strategy in these facilities has a different purpose. For this referral, chains of care have 
been identified in which the regional collaboration between different centers is 
stipulated. The major aim of these chains is to shorten the length of stay in acute 
settings, to improve the problems with waiting lists, and to realize a more cost efficient 
care of stroke patients.  
Within the regions, regional coordination agreements (afstemmingsafspraken) are made 
in order to realize the chain of care model. In the EDISSE study (Evaluation of Dutch 
Integrated Stroke Service Experiments) 153 three experimental stroke services were 
analysed in depth with respect to costs, health effects, quality and organisation of care, 
and compared to three reference regions representing current standard care for stroke 
in the Netherlands. EDISSE was a non-randomised non-controlled observational study. 
In all “stroke service” experiments, hospitals, nursing homes, rehabilitation centres, 
general practitioners and home care worked together in order to provide co-ordinated 
care. The practical organisational design of the experiments varied considerably.) Two 
major problems to realise good transmural continuity of care, were waiting lists e.g. for 
nursing homes and on the other hand the fact that many agreements had to be made 
between the partners before good networking was possible. 
For the particular issue of stroke it wa sobserved that all of services have professional 
staffmembers with specific training in stroke rehabilitation However, the rehabilitation 
centres can not guarantee a presence of specifically trained personnel in stroke 24-
hours a day, since the rehabilitation centres are also dealing with other pathologies. 
Further reflections on organisational networks and integration of care services of 
stroke patients have lead to the development of a methodology to benchmark the 
initiatives on integrated stroke care management. These initiatives hold the 
coordination in acute, post-acute and long term phases.  Benchmarking is considered as 
a potential tool to assess quality and outcomes of the care offered. Based on 
experiences in the quoted Edisse study and CBO-innovation initiatives in health care (so 
called CBO-doorbraakprojecten, some of them coached by “kwaliteitsinstituut 
gezondheidszorggg ), lead to a benchmark study. Measures included measures about 
structure characteristics of the region in which a network was active, Questionnaires of 
the members of the organisation(s) and patients and informal carers satisfaction. The 
benchmarking model is very closely related to ideas about performance approaches. 
However, the authors of the report state that further analysis is needed on the 
indicators used for benchmarking networks of care. Moreover, benchmarking requires 
particular efforts and commitment of the organisations involved, to participate in the 
benchmarking activities151  
A different pilot-project related to the development of networks of care and the 
benchmarking, focuses on the development of data-information and management 
models adapted to the networks of care (cva keteninformatiesysteem CVA-KIS). This 
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system develops a dataset to be used to register data about patient characteristics and 
rehabilitation activities in the networks of care. The system is not only intended to 
register data, but also to support health care providers in the workflow. As the 
identification of the data needed is based on a Delphi technique, some indications can 
be found on what the professionals think what is needed to register. In general terms, a 
better registration of the patients co-morbidities, secondary diagnoses and a clearer 
registration of the rehabilitation aims per facility is considered as necessary 154.  
As the indication rules for transfer between facilities are not fixed, it is hoped for that 
the benchmark-reports will lead to a more comparable and uniform approach between 
regions for patient referal.  
The use of outcome scales. 
The discussion about the use of outcome scales is of current interest, but not very 
developed. At this stage one recommends at least the use of the Barthel-index. In order 
to assess and discuss the therapeutic aims of the patient, some professionals suggest to 
use the Canadian Occupational Performance Measure (COPM), or the AMDAS Stroke-
unit discharge guideline, to assess the rehabilitation potential of the patient155 , 156 Since a 
lot of efforts are going to the development of DBC’s, the debates of the use of scales id 
focusing on ICD-9, ICF and Barthel (and especially on how to develop an efficient 
registration of all these scales, and make them useful tools). 
• Stroke is particularly interesting example for its initiatives on developing 
networks of care. 
8.3.6 Example: Lower extremity amputation 
The total group of amputations constitutes only a minor part of the combined out- and 
inpatient rehabilitation in the Netherlands: 2% of outpatient and 6% of inpatient 
rehabilitation for adults (2003)157. About 3300 major amputations of the lower limb 
occur in the Netherlands66, 158 .Pernot et al.65 have estimated the average rehabilitation 
period for persons with a lower limb amputation at 35 weeks. There are no 
rehabilitation centres playing a role as reference centre.  
The largest part of people with a LEA (about 40%) are referred to a nursing facility. 
Another part is directly referred home, and continues multidisciplinary rehabilitation in 
a policlinic of a hospital or a rehabilitation facility. Only a minority of the group (10-
15%) starts a clinical rehabilitation in an inpatient rehabilitation setting 158. 
There are no fixed indication rules for the referral to one or another setting. As a 
general principle, the patients’ choice is the primary stimulus for a service. The 
indication is generally also affected by the physical condition, the motivation and the 
learning capacities of the patient. It is generally accepted that the functional outcome 
can be assessed two weeks after the event, by taking into account the age, motivation 
and learning potential and the one leg equilibrium. Especially the older people (75-80+) 
prefer to return as soon as possible in their own region or at home. This choice is 
largely influenced if partners (family or friends) have difficulties to visit a hospital or 
rehabilitation setting 158. 
Admission to an inpatient rehabilitation setting generally is foreseen about 10 days after 
the surgical intervention. The admission to a nursing facility takes about 10 to 20 days. 
Wound care is an important issue in the timing of referral. 
In a nursing facility, about 30% receives a prosthesis, in a rehabilitation facility this 
proportion is about 85%. Prosthesis rehabilitation training is offered in nursing facilities, 
hospitals and rehabilitation settings. But for more elaborated prosthesis rehabilitation, 
people are generally referred to a rehabilitation center. There is no specific 
rehabilitation program for people without a prosthesis. Small scale research gives 
indications of variations in the prescription of prosthetics. Policy makers are urging to 
develop a clinical guideline with more clear criteria for prescribing a prosthesis, and a 
draft guideline has recently been developed.159  
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There is no consensus on the use of outcome scales in rehabilitation, and different 
scales were used in different Dutch regions. The Sickness impact profile (SIP-68) scale 
and the Groningen Activity Restriction Scale (GARS) 160 timed up and go test (TUG) 
Barthel score en de FIM are used. The one leg equilibrium scale is often used. There is 
however no indication if these scales are used systematically in all the centres 
• Prosthesis rehabilitation training is offered in nursing facilities, hospitals 
and rehabilitation settings. For elaborated prosthesis rehabilitation, people 
are generally referred to a rehabilitation centre. 
• There are no fixed indication rules for the referral to one or another 
setting. 
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8.4 FRANCE 
8.4.1 Health care organisation in generalhh 
The French health care system is a centralised mixed system combining elements of 
various organizational models: 
• It is a publicly funded system characterized by freedom of choice and 
unrestricted access for patients and freedom of practice for 
professionals; 
• The organizational model is built on health insurance funds and strong 
state intervention. it is complex and pluralistic in its management, with 
co-management by the state and the health insurance funds. 
• It combines public and private health insurance, which finance the 
same services by the same providers for the same populations; 
• it combines public and private care, including private for-profit 
hospitals; 
8.4.1.1 Health insurance 
The financial management of health care in France is mainly regulated through the 
statutory health insurance as a branch of the wider social security. It covers the entire 
population of France. The health insurance system, offers wide-ranging reimbursement 
in the fields of preventive, curative, rehabilitative, and palliative care. 
There are three main schemes within the statutory health insurance system: a general 
(employees in commerce and industry and their families), an agricultural scheme for 
farmers and their families and a scheme for self-employed people. In 2004 an insurance 
fund was established specifically for dependent elderly people. In 1999 universal health 
insurance coverage (CMU) was established on the basis of residence in France (99.9% 
coverage for medical expenses). 
The health insurance is compulsory and covers all households regardless of health 
status, income, number of persons, etc. It provides a somewhat uniform field of 
reimbursement, with the “basket of goods and services” covered by the insurance funds 
being identical for all the statutory schemes, and a same reimbursement rate for the 
three main insurance schemes (since 2000).  
Health benefit catalogues are drawn up at national level with the whole range of goods 
and services reimbursed by the statutory scheme. The reimbursement of goods and 
services depends on their inclusion in defined lists, identified through advice of ad hoc 
scientific commissions and agencies, such as the former National Agency for 
Accreditation and Evaluation in Health Care (ANAES)- the current haute autorite de 
santé (HAS), checking for the effectiveness and/or safety of these procedures and the 
conditions under which they need to be per formed 
More selection is occurring in the insured services delivered by private sector 
profession in their own practices or in private for-profit hospitals. Services dispensed in 
public hospitals or private not-for-profit hospitals are mainly the subject of implicit 
definition since they were paid for by a global budget.  
8.4.1.2 Health care policy-making and organisation 
The French health care system is a very centralized model, with an important role for 
the regions. Regions are responsible for the factual organization and execution of health 
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care policy, while the central authorities define the policy and operational framework. 
(see Appendix to chapter 8) 
8.4.1.3 Financing 
The financing model is subject to important reforms. The Social Security Act of 2003 
(Loi de financement de la sécurité sociale, LFSS) changed the inpatient acute care 
funding rules, but implementation is still in progress. The nomenclature for physicians’ 
procedures, the CCAM, applies from that date to both private and public hospitals. The 
reform will also change the remuneration schemes of inpatient and outpatient care.  
• Services provided in inpatient or outpatient acute care will be financed 
through a payment-per-case system for all hospitals (700 Groupes 
Homogènes de Malades (GHM), considering co-morbidities and a 
nationally fixed tariff (Groupe Homogène de Séjours, GHS).  
• Outpatient procedures will be paid on a fee-for-service basis 
• Organ retrieval and emergency services by annual lump sum payments.  
Physicians are al ways paid separately and directly on a fee-for-service basis, except in 
public hospitals, where tariffs include specialists’ salaries. 
• France has a publicly funded system characterized by freedom of choice 
and unrestricted access for patients and freedom of practice for 
professionals. 
• France has a compulsory insurance system, but a large proportion of the 
population has private (complementary or supplementary) insurance. 
• France is a centralized model, but has delegated a lot of operational 
responsibilities to the regions. The “regional hospital agencies” (ARH) are 
responsible for hospital planning (for both public and private hospitals), 
financial allocation to public hospitals and adjustment of tariffs for private 
for-profit hospitals. 
• The SROS (Schéma Régional d’Organisation Sanitaire) is the regional 
planning tool for health care provision. The SROS provides the regional 
hospital agencies (ARH) with a framework for granting authorizations, 
approving proposals submitted by institutions and negotiating contracts. 
• Services provided in inpatient or outpatient acute care will be financed 
through a payment-per-case system for all hospitals (700 Groupes 
Homogènes de Malades (GHM), corrected for co-morbidities and a 
nationally fixed tariff (Groupe Homogène de Séjours, GHS). 
8.4.2 The organisation of the rehabilitation sector 
8.4.2.1 The underlying conceptual ideas 
Rehabilitation is conceptually organised around three levels of care161, 162 
• The specialized level of care has to answer very specific needs of a 
particular group of patients within a region. At this level specialised 
“reference” centres are identified, in charge of advanced medical and 
paramedical care. These services fall under the responsibility of a 
physician, and medical and paramedical team with specific 
competencies for the pathology 
• A second level is created for high needs or specific care needs 
requiring particular competences. This level is typically foreseen for 
the non-complex neurological pathologies (such as MS and stroke) and 
for geriatric care. 
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• The “low” level is created for general multidisciplinary rehabilitation 
and medical care, generally attached to hospital services and typically 
foreseen for short term rehabilitation, often in close collaboration 
with the SSR. 
A specific regulation of 1997 defines five functions of technical and support tasks for 
continuous care or rehabilitation:  
• limit the impairments through rehabilitation,  
• somatic and psychological rehabilitation through intensive treatment 
or teaching compensatory techniques, education of the patient (and 
his peers),  
• follow up in after care and control of pain 
• taking initiatives for reintegration in society.  
These principles have to be realised through the development of a continuity of care 
model (filières de soins).  
The organization of the rehabilitation sector has a clear regional orientation. Four 
geographical levels are distinguished, conceptually closely related to the notion of 
“filiéres de soins”. They aim at serving people as close as possible to their home, 
integrating them into daily life as far as possible: 
• The interregional or regional level: on the interregional level services 
are responsible for highly specialised care for pathologies with low 
incidence/prevalence (e.g. burn units, visual deficits or auditive 
deficits), but for which specific technology and infrastructure is 
needed. 
• On the regional level, specialised centres, using particular 
technologies, having an adapted infrastructure and competences but 
for which also the idea of accessibility for people of the region is taken 
into account. 
• The “intermediate” level, is defined as the less specialized 
rehabilitation services, clearly serving the people from a geographically 
near area. It are services not requiring very specific technologies or 
infrastructure. 
• The local level (niveau de proximité) is the alternative form of hospital 
services, offering medical and rehabilitation care at home. 
The regulations “soins de suite et de readaptation” (SSR) form the framework for 
middle-long term rehabilitation services (moyen sejours) are as follows.  As a general 
principle, the SSR aim at patients coming from acute or post-acute settings or other 
SSR, and are primarily aimed at social reintegration for those people in need of a global 
medical-rehabilitation for deficiencies or impairments, in need of a medical follow up, or 
in need of functional rehabilitation. They are conceptualized as the “in-between-
services” between acute hospital environments and the home care setting (or long term 
care facilities). There are “general” SSR and SSR specializing in geriatry, cardiology and 
nutrition163 . The agenda for the SSR is centrally set by means of circular letters 
(circulaires) (lettre circulaire DH/EO4/97 n°841 du 31 décembre 1997 relative aux 
orientations en matière d'organisation des soins de suite ou de réadaptation ; la  lettre 
circulaire DHOS/03/DGAS/AVIE n°2003-257 du 28 mai 2003 relative aux missions de 
l’hôpital local (notamment dans son paragraphe « Développer l’hospitalisation en soins 
de suite et de réadaptation »). In 2005 HAS/ANAES has published a report on the state 
of the art of SSR, in which the roles and missions of different services are clearly 
described.  
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8.4.2.2 Rehabilitation facilities 
Rehabilitation can take form in intramural settings (hospitals, specialized rehabilitation 
and nursing facilities), in ambulatory form (day hospitals) or in home care, depending on 
the clinical status of the patient. The most important post-acute facilities are university 
based rehabilitation units, general hospital rehabilitation units and rehabilitation centresii 
• The mission of MPR (medicine physique et réadaptation) in university 
hospital centres is focused on teaching, research and expertise highly 
specialised rehabilitation and has to participate in networks of care.  
• MPR services within hospitals are polyvalent rehabilitation services not 
necessarily involved in highly specialised rehabilitation   
• Rehabilitation centres are specialised and polyvalent facilities often 
reference centres for specific pathology groups, and also expected to 
participate in networks of care. Teaching and research can be part of 
their mission 
Due to historical reasons, France has an uneven geographical distribution of 
rehabilitation centers. For this reason units for rehabilitation in acute hospitals (both in 
Centres Hospitaliers, and almost always in Centres Hospitalier Universitaires) play an 
important role in rehabilitation in the different regions. They focus on the medical and 
paramedical issues of rehabilitation.  
The services for medical rehabilitation (medicine physique et réadaptation MPR) are 
specialized rehabilitation units generally linked to hospitals, and often with a day care 
function.  
The reforms prepared in the mid 1990 aim at guaranteeing a regional, needs based 
approach, and developing a more smooth patient flow. Through the “filières de soins”, 
these hospital services are urged to collaborate with other inpatient and home care 
facilities, for other dimensions of rehabilitation care. Through these models, one hoped 
to reduce lengths of stay in inpatient settings, manage the issue of waiting lists, and 
coordinate the services offered to the needs of the patients.  
An important rather new “French” development is the development of the “hôpital a 
domicile”, delivering medical and rehabilitation services, for people returned home. Not 
all regions have this service available, but it is a type of service that is developed more 
and more.  
For those people unable to (immediately) return home after the post-acute phase, 
different types of long term-care facilities are available: (Unités de soins de longue 
durée, maison d'accueil spécialisée (MAS) foyer d'accueil médicalisé (FAM) and 
« établissement hébergeant des personnes âgées dependants », (EHPAD)).  
8.4.2.3 Indication setting in rehabilitation 
For some types of treatment, such as physiotherapy and spa treatment, the prescription 
from a physician does not provide the status for reimbursement. Coverage by statutory 
health insurance is subject to the prior authorization (entente préalable) of the 
physicians advising the health insurance funds, after examination of the patient’s case 
history and a possible interviewing of the patient. However, France is not using a 
systematic model of indication setting: the indication setting is left to the clinical 
authority of individual physicians.  
8.4.2.4 Financing of the institutions 
Rehabilitation facilities are falling under the hospital financing regulations. Public and 
most private non profit hospitals receive a prospective global budget defined by AHR 
(taking into account historical budgets, relative costs per DRG and priorities in the 
                                                
ii   http://www.anmsr.asso.fr/anmsr00/crf/intro.html 
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SROS). Individual hospitals and the AHR work according to a model of contracting, 
defining the tasks and commitments of the hospital (quality of care, efficiency, 
activities,..) Private hospitals have a topic oriented billing system, independent of the 
fees to paid for the physicians. As a result, prices do vary enormously per region and 
between hospitals. 
8.4.3 Quality 
The “charte de qualité en medicine physique et de réadaptation” is used as a formal 
quality agreement and as a complement to different regulations defining the constituent 
norms of rehabilitation services. But this agreement is mainly limited tot a formal 
statement. 
In general one could say that France is mainly reflecting on the conceptual and 
“principles” level about quality. Several documents are being prepared, but no real 
quality models or indicators as a collective instrument are implemented. The principles 
proposed are not to be considered as quality tools in the technical meaning of the 
word. 
The quality policies and approaches in rehabilitation are getting inspiration from the 
CARF accreditation methodology. A working group has been developing criteria for 
rehabilitation care for different “locomotor” pathologies (“Critères de prise en charge 
en médecine physique et de readaptation”).162 The text of the working group is 
considered as an important reference document in France for the rehabilitation 
approach for different pathologies.  
The infrastructural and equipment characteristics of the facilities (as a condition for 
quality rehabilitation) are being summarised toojj  
Different “circulaires” have been developed identifying the expected level of quality and 
the norms for treatments (e. g. Circulaire  n° 2004-280 du 18 juin 2004 relative à la 
filière de prise en charge sanitaire, médico-sociale et sociale des traumatisés crânio-
cérébraux et des traumatisés médullaires ; Circulaire  n° 2003-517 du 3 novembre 2003 
: relative à la prise en charge des accidents vasculaires cérébraux) ;  
Rules of accreditation apply to the institutions providing Rehabilitation Care. The 
ANAES- “manuel d’accréditation des établissements de santé”, (with a chapter on SSR) 
sets some organizing principles, and focuses on patients rights. It also introduces the 
idea of using functionality scales, but this issue has to be developed further 
For the institutions providing SSR as a segment of their activity, a specific section in the 
accreditation reports offers an overall appreciation of these services. The accreditation 
is however not using specific indicators.  
In general, accreditation is used to be more structure oriented, but slowly quality 
standards started to be integrated. Most of the emphasis has been on hospital acquired 
(nosocomial) infections, there are some specific norms (process oriented) and 
objectives. However, real quality assessment tools are not used yet. 
In order to develop follow-up systems, some regions very recently started to develop 
(epidemiologic) registration systems, including a follow up of patients. 
Rehabilitation is conceptually organised around three levels of care: a specialized level 
for very specific needs of a particular group of patients within a region. A second level is 
created for high needs or specific care needs requiring particular competencies. The 
“low” level is created for general multidisciplinary rehabilitation and medical care, 
generally attached to hospital services and typically foreseen for short term 
rehabilitation. 
                                                
jj  http://www.syfmer.org/referentiel/qualite_mpr/syfcharte04.html 
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• The organisation of the French rehabilitation sector has a clear regional 
orientation. Four geographical levels are distinguished: interregional, 
regional, intermediate and local level. 
• The regulations “soins de suite et de readaptation” (SSR) form the 
framework for middle-long term rehabilitation services. 
• Rehabilitation can take form in intramural settings (hospitals, specialized 
rehabilitation and nursing facilities), ambulatory (day hospitals) or home 
care, depending on the clinical status of the patient. 
• France is not using a systematic model of indication setting: the indication 
setting is left to the clinical authority of individual physicians. 
• Rehabilitation facilities are falling under the hospital financing regulations. 
• France is mainly reflecting on the conceptual and “principles” level about 
quality. Several documents are being prepared, but no real quality models 
or indicators as a collective instrument are implemented. 
8.4.4 Example: Stroke  
The approach of stroke rehabilitation fits into the model of the SSR (“soins de suite et 
de réadaptation”). The organisation model should hold the notion of integrating the 
activities of different services and developing “chains of care”.  
A circular letter (“circulaire”) was endorsed in november 2003 for the treatment and 
rehabilitation for people with stroke (Circulaire n°2003-517 du 3 novembre 2003 
relative à la prise en charge des accidents vasculaires cérébraux). The circular letter 
describes the formal conditions, and creates opportunities within the SROS, to develop 
facilities for taking care of stroke patients close to home (hôpitaux de proximité).  
An Anaes-study has focused on the different aspects of treatment of stroke patients. 
The study focuses on clinical guidelines, including post-acute rehabilitation164 This report 
is not paying a lot of attention to organizational matters in stroke rehabilitation, except 
that some infrastructural issues are mentioned. A major recurrent recommendation is 
that networks of care services have to be developed in order to provide integrated 
care. 
In August 2005 the HAS-ANAES has launched an evaluation tool-kit for assessing the 
scope of care offered for stroke patients. The tool-kit aims at supporting the services in 
doing auto-evaluations and improving the quality of care. It is supposed to steer the 
future quality assessments of stroke services. 
8.4.5 Example: Multiple Sclerosis 
Rather recently, an assessment has been made analyzing the state of the art of MS-
related topics in France 165 
As is the case in many other countries, MS and the particular needs of MS-patients, 
make the organisation of rehabilitation for this group of patients a particular issue In 
general terms the treatment and follow up of MS patients in France is very 
heterogeneous.  
Only in few regions, specific initiatives have been set up to coordinate the treatment 
and care of MS-patients. Since 2001, some regional networks are formally recognized as 
MS-care networks (“reseau de soins sclerose en plaques (SEP)”), and others are in 
preparation. The major network-aim is to offer different kinds of (para)medical and 
social care in a coordinated way, as close as possible to the patient.  
Some regions are (at this stage) not covered at all by a formal network of care. 
Moreover, there is a great disparity between the existing networks in the number of 
participating patients. The operational conditions of these networks are very dissimilar, 
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for professional participation as well as the patient inclusion, as there are no common 
indication standards. 
Inpatient care and support is generally offered in specialized hospital units for short 
stays. Long term specialized inpatient facilities exist, but are very few in number, leading 
to particular problems for MS patients with very severe complications. There are 
currently 5 centres for long term stay for highly dependent ms patients with specific 
medical and paramedical needs (offering about 230 beds). Experts confirm that the need 
for this kind of facilities is a lot bigger, but no precise epidemiological estimates are 
available (ms patient organizations claim that 2000 of these beds should be available to 
answer the needs). 
Other centres have developed units for MS-patients within their general neurological 
functions. The capacity of the centres varies enormously, some offering 1 to 2 beds, 
while others have about 60 beds available for MS patients. The average period of stay is 
between 2 and 6 weeks. 
The coordination of medical care is generally in the hands of a private or hospital based 
neurologist (neurologue de proximité), having to play a role in the network of carers 
(réseau). The hospital settings vary, as not all hospitals have a neurology department. It 
can however happen that some of these hospitals hire the services of a neurologist, 
doing the follow-up of the patients. Many neurologists in France have a private practice 
within the hospitals (des attachés). 
Some university hospitals (Dijon, Rennes) organize themselves inspired by a Canadian 
specialized model of clinical practice for MS. During a whole day, and in collaborative 
practice with different physicians, the whole spectrum of problems of different MS 
patients is assessed. These centres also try to work in networks of care. 
More common forms of multidisciplinary follow-up (medico-social) of ms-patients are 
found in regional hospitals (generally funded through proper means of the hospital and 
private gifts).  
For assessing the status of MS patients, the Expanded Disability Status Scale (EDSS, also 
named Kurtzke scale) is used, measuring 8 functional domains and enabling the 
neurologist to give a Functional system score. The scoring scale is mainly used as tool 
to assess the severity of the condition of the patient, and mainly as a clinical tool to 
assess the progress of ms. The scores are also used as an informal indication setting 
tool for offering particular health care services. 
8.4.6 Example : Spinal Cord Injury 
France has no really integrated approach of the rehabilitation of people with spinal cord 
injuries. However recently particular concerns are developed on the organization of 
care.  
A circular letter (Circulaire DHOS/SDO/01/DGS/SD5D/DGAS/PHAN/3 B n° 2004-280 
du 18 juin 2004) focuses on the organisation of care for patients with SCI and TBI, with 
a particular attention on necessary care and the demand for continuity of care. The 
SROS (schéma régional d'organisation sanitaire) should provide in foreseeing the 
necessary conditions. 
The "Académie Nationale De Médecine” has formulated recommendations on the 
rehabilitation of SCI patients166. The main line of reasoning is that specific and 
specialised rehabilitation centres are needed in the French rehabilitation landscape. The 
“Académie” recommends to develop a territorial map and a list of reference centres for 
the French territory. The Académie recommends to create 12 reference rehabilitation 
centres, with a maximum of 3 or 4 for the Ile the France and neighbouring departments. 
The recommendation is however not clear on the criteria used to make this 
recommendation. 
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8.5 GERMANY 
8.5.1 Health care organisation in general 
A fundamental aspect of the German health care system is the sharing of decision-
making powers between the federal government, the individual states (Länder), and 
designated self-governmental institutions. Responsibilities are delegated to membership 
based, selfregulated institutions of payers and providers. These institutions adopt the 
status of quasi-public corporations and guarantee the financing and delivery of benefits 
outlined in the legal framework of the statutory health insurance. They are involved in 
financing and delivering health care. 
As is the case in many other countries, the role of private parties is penetrating the 
organisational principles of the health care model. 
8.5.1.1 Health insurance 
In the Statutory Health Insurance (SHI), (covering 88% of the population), sickness 
funds, their associations and associations of SHI-affiliated physicians and dentists 
negotiate on the insured care. The most important body in the benefit negotiations 
between sickness funds and physicians concerning the scope of benefits is the Federal 
Joint Committee. Based on the legislative framework the Committee issues directives 
relating to all sectors of care. 
Citizens have a free choice of sickness funds. Employees with a gross monthly income 
not exceeding a certain amount (€3.862 in 2004) are mandatory to have a membership 
in a sickness fund. Higher income levels can opt out. Private insurance companies 
provide health insurance policies that are substitutive or supplementary to the SHI.  
The autonomous sickness funds are organized on a regional and/or federal basis. They 
are obliged to raise contributions from their members and to determine the 
contribution rate necessary to cover expenditures. Their responsibilities include 
contracting, negotiating prices, quantity and quality assurance measures. Services 
covered by such contracts are usually accessible to all fund members without any prior 
approval by the fund, except for preventive spa treatments, rehabilitative services and 
short-term home nursing care that require an indication setting. 
A risk structure compensation scheme is in place which prevents the sickness funds to 
refuse people at a higher risk for health care services. Members and their dependents 
are entitled for the benefits: prevention of disease, screening for disease, emergency and 
rescue care and treatment of disease. In the latter category ambulatory care, care by 
allied health professionals and certain areas or rehabilitative care are included. 
Ambulatory care is only described in generic terms whereas care by allied health 
professionals is more elaborated. These services that are reimbursed by the SHI are 
linked to indications and therapeutic targets and need to be prescribed by a physician. 
167 
8.5.1.2 Health care policy making and organisation 
The legislative authority regulates the procedures with which the contractual partners 
determine the scope of SHI services. The “Federal Joint Committee” issues directives 
about adequate and cost-effective medical interventions for the insured persons. In the 
Länder as well as in the federal government, a department of health is installed, although 
not always as a distinct ministry. The sickness funds have a central position in the health 
insurance system.  
The sickness funds are obliged to collect contributions from their members. In return 
these funds negotiate prices, quantities and quality with providers on behalf of their 
members. 
Health care delivery in Germany is typified by a clear delineation between public health 
services, ambulatory care and hospital care. The ‘strict’ legal and financial delineation 
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between the different sectors hampered the integration of hospital and ambulatory. The 
Reform Act of SHI 2000, enhanced by reforms in 2002 and 2004, enabled (by means of 
incentives) the implementation of models of integrated care. 
See Appendix to chapter 8. 
8.5.1.3 Financing 
In 2000 the Australian system of diagnosis-related groups (DRGs) was adopted as the 
basis for developing a German DRG hospital financing system. the development of a 
DRG catalogue is seen as a starting point towards a more explicitly benefit catalogues 
where all approved interventions are listed and grouped around the relevant diagnoses. 
The Institute for the Payment System in Hospitals (InEK) is intended to support the 
introduction and the further development of the DRG sys tem. The Institute defines the 
DRG case groups, maintains the DRG system, and its severity classification system, 
develops of a coding directive The Institute is also responsible for the calculation of 
DRG cost weights and individual adjustments with in the DRG system. 
A catalogue lists all procedures (services) performed in hospitals in accordance with 
respective clinical diagnoses. The DRG system also constitutes the catalogue of services 
and benefits covered by the SHI scheme for inpatient care. The inclusion of new health 
care ser vices in the DRG system is made available at the beginning of each year. (based 
on ICD 10) 
• The German health care system shares decision-making powers between 
the federal government, the individual states (Länder) and designated self-
governmental institutions. Responsibilities are delegated to membership 
based, selfregulated institutions of payers and providers. 
• All employees below a given income level must subscribe to an 
independent not-for profit sickness fund. Individuals above that income 
level have the right to opt out and arrange private coverage (a minority of 
the population). The role of the sickness funds is publicly regulated. 
• The sickness funds have a central role. Sickness funds contract for health 
care services and negotiate prices, quantity and quality assurance 
measures. 
• Hospital care is outlined by federal legal framework. Planning and 
regulation are done at Länder level, resulting in variation in offer among 
the different Länder. 
• The Australian system of diagnosis-related groups (DRGs) was adopted as 
the basis for developing a German DRG hospital financing system. 
8.5.2 The organisation of the Rehabilitation sector 
8.5.2.1 The underlying conceptual ideas 
Rehabilitation is defined as a multidisciplinary team approach adapting to the patient’s 
needs. During the recovery period, these needs vary resulting in different goals in 
different phases. A distinction is made between medical, vocational and social 
rehabilitation.  
Because of the historical formal segmentation between hospital care, rehabilitation care 
and ambulatory care, delays or inconsistencies occur(ed) in the referral for further 
rehabilitation. As mentioned earlier since 2000-2004 models of ‘Integrierte Versorgung 
(integrated care model) ’were set up for heart failure and hip joint replacement. The 
SHI, care providers and hospitals develop agreements to organise the full range of 
services, from acute care to the completion of rehabilitation period168. 
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Patients older than 70 years are less eligible to these models and are referred to 
geriatric rehabilitation. Geriatric rehabilitation is a special category of rehabilitation in 
Germany offering less intense rehabilitation compared to the other models.169 
Figure 8.1: The 'Phasenmodell' in neurorehabilitation (BAR, Die 
Bundesarbeitsgemeinschaft für Rehabilitation, 1999) 
Specifically, for neurorehabilitation a conceptual ‘Phasenmodell’ was developed to 
streamline the thinking about rehabilitation services. The model distinguishes 6 phases 
(see Figure 8.1). The patient may not go through all phases neither pass them in 
chronological order. In Phase A, the acute treatment is the major priority. As soon as 
the patient is medically stable, the first rehabilitation interventions can take place. Phase 
B is a phase in which the patient still may need intensive care support and has not 
reached a sustained phase of full consciousness. If the patient evolves to a condition 
enabling active participation in the rehabilitation process and where significant 
improvement for his functional independency can be expected, the patient will move to 
Phase C: a period of intensive rehabilitation where supervision of nurses and medical 
staff is still needed. If no improvement is expected, it will be decided to transfer him to 
a long-term nursing care setting (Phase F).  
If no further nursing support is needed but improvement is still expected, the patient 
will then continue to Phase D.  
Phase A trough phase D is organised in different types of intramural settings. Acute 
hospitals have the necessary technical equipment and expertise to support the patient in 
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his life-threatening condition. For Phase B, services need to have an intensive care unit 
or can call upon immediate access to a hospital in the direct neighbourhood. In practice 
these inpatient settings can be: acute hospitals, specialised clinics in neurology or 
general rehabilitation clinics. 
Patients in Phase C are still hospitalised and treated in a rehabilitation centre or 
specialised clinic, as they require supervision of nursing care and medical treatment or 
follow up. Phase D patients can be helped in an inpatient or outpatient service. Patients 
in Phase E are mostly cared for in an outpatient setting. Phase F patients expect no 
recovery and have high functional dependency and are supported in long-term care 
settings with nursing support.  
The “bundesarbeitsgemeinschaft fur rehabiliation” has developed recommendations for 
the organisation of neurological and musculoskeletal rehabilitation kk  But these 
recommendations focus mainly on the clinical approach of the patients (in certain 
phases of their disease within organizational formulas).  
Other reflections started on the development of “mobile rehabilitation” trying to bring 
rehabilitation services to the home. The focus of these reflections is mainly geriatric 
rehabilitation. ll 
8.5.2.2 Rehabilitation facilities 
Medical post-acute rehabilitation is mainly offered in specialised rehabilitation clinics, 
although out-patient and part-time in-patient care has considerably grown. Within the 
past decades changes were implemented in the organization of rehabilitation, mainly 
trying to ensure smooth patient flows, and offering rehabilitation services at home 
(integrated care). Moreover, the insurance negotiations have had a major impact on the 
provision models of services as insured parties receive different rehabilitation benefits 
depending on the insurance type. 
The rules for providing and financing social services are regulated at federal level. The 
social code book (Sozialgesetzbuch, SGB) forms the core of the legislation. Regulations 
relevant for rehabilitation are mostly found in volume 5 and 9 of the SGB. 
• Several research networks are established to clarify (among other 
research themes) the role of different services in this rehabilitation 
process but no definite conclusions can be drawn from these 
studiesmm.  
8.5.2.3 Indication setting  
In daily practice, approvals for admission to rehabilitation facilities are needed by the 
insurance companies. 
Early rehabilitation in hospital obtained a new legal basis with the Sozialgesetzbuch IX 
(SGB IX) of 2001,. In § 39 section 1 SGB V, early rehabilitation was for the first time 
explicitly described as part of hospital treatment. However, the German system is still 
seeking ways to optimise the use of rehabilitation facilities and looks for standardised 
models of indication setting. Currently a lack of generally accepted indication criteria for 
early rehabilitation services is experienced and the aims, objectives and methods need 
to be specified.  
Based on Delphi methodology a group of interested experts from different fields and 
backgrounds to achieve an interdisciplinary consensus in terms of conceptual definitions 
and terminology for all early rehabilitation care services in the acute hospital was 
developed. Examples of typical cases from the various fields of early rehabilitation care 
were identified and described. Furthermore, the report points out a number of other 
                                                
kk  http://www.bar-frankfurt.de/Empfehlungen.BAR?ActiveID=1083 
ll  http://www.dvfr.de/pages/static/1834.aspx 
mm  http://www.gesundheitsforschung-bmbf.de/_media/forschung_in_der_rehabilitation-englisch(1).pdf 
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problems in the area of early rehabilitation care, which have yet to be solved.170 In a 
position paper, indication guidelines were presented by a group of German experts 171. 
In the conceptual model for neurorehabilitation the Barthel Index is used as an 
indication setting tool to discriminate between phase B, C and D). ([0-30]=B; [35-
65]=C; [70-100]=D 
8.5.3 Quality in Rehabilitation 
Germany has a longer experience with imposed “external” quality assurance initiatives 
in medical rehabilitation. Quality assurance programmes have been routinely 
implemented for most inpatient rehabilitative indications, and are characterized by their 
comprehensive approach 172. This is most of the time imposed by private insurance 
companies or sickness funds. In 1994 the German statutory pension insurance 
developed a model of quality assurance in rehabilitation, that was imposed in 1998. It is 
based on indicator tools relating to structural, procedural as well as outcome quality 173 , 
174 The statutory health insurance has imposed quality assurance models, trying to 
guarantee effective and efficient rehabilitation. By developing clinical practice guidelines 
specific to rehabilitation, the pension insurance is the only sector of the German health 
system in which quality evaluation is carried out on the basis of clinical practice 
guidelines. The quality assurance programs are intended to impact on the allocation of 
patients as well as the financing of the rehabilitation services. So far, this is the first and 
only health care sector that has included the use of evidence-based practice guidelines 
into quality assurance activities.174 However, corresponding to the relative paucity in 
rehabilitation research there is no sufficient evidence for a lot of the therapeutic 
interventions. Accordingly, guidelines in rehabilitation will -initially- consist of a mixture 
of evidence- and consensus-based recommendations. There are many initiatives by the 
providers of rehabilitation as well as the scientific medical societies to develop and 
implement rehabilitative clinical practice guidelines, e. g. the guidelines programme of 
the BfA (Federal Insurance Institute for Salaried Employees), which is aimed at 
developing rehabilitation process guidelines for selected indications (mainly vocational 
rehabilitation), the guidelines activities of the VDR (Federation of German Pension 
Insurance Institutes), and the input of the "Guidelines" commission of the DGRW 
(German Society of Rehabilitation Science)175. Since 1998, the German Federal Pension 
Insurance for Salaried Employees (BfA) has funded several research projects aimed at 
developing clinical practice guidelines for medical rehabilitation. The elaboration of 
standards is aimed at avoiding over-provision, under-provision or misdirected provision 
of care and, simultaneously, at ensuring that quality assured treatment is offered to the 
rehabilitees. Also, it is intended to increasingly implement evidence-based medicine in a 
sector of the health system in which research has so far been underrepresented. The 
guidelines are since 2005 being integrated into the BfA's quality assurance system. Using 
a standardized protocol, therapeutic processes for individual disorders were evaluated 
as to whether they were evidence-based. After successful implementation of the 
program, a substantial reduction of practice variation among rehabilitation institutions is 
hoped for. For that reason, comparative quality analyses are the focus of the quality 
assurance programmes. In the context of the Quality Assurance Programme for 
Rehabilitation provided by the German statutory health insurance, the structural quality 
of 18 neurological rehabilitation units was assessed. It is argued that Assessing the 
structural quality of rehabilitation units on the basis of defined standards allows for a 
benchmark between units as well as for improvements within the individual units. 176 
These comparative analyses have shown that centres with little experience with 
severely affected rehabilitation patients achieve on average lesser effects on somatic 
functional and psychosocial levels177, 178. The external pressure to develop quality 
assurance, and the increased competition for patients between rehabilitation centres 
have lead to the development and research on more effective and efficient rehabilitation 
models. 
For outpatient rehabilitation facilities, quality assurance programmes are under 
development. 
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Currently, rehabilitation centres face the problem of treating patients from different 
health insurance companies. Sometimes different proofs of quality have to be 
demonstrated, leading to a large overhead and administrative cost 179 Efforts are now on 
their way to guarantee a convergence of the different quality assurance programs180 
Reflections have started to take form on the quality of services and quality assurance 
programs in integrated care. 
Recent efforts are made to refine the standards used in the quality assurance programs. 
Some projects are focusing on the study of the structural standards for inpatient rehab 
units treating patients for musculoskeletal, cardiac, neurological gastroenterological, 
oncological, pneumological and dermatological diseases. The aim of these projects is to 
distinguish between basic criteria that every inpatient rehab setting has to fulfill, and the 
more specific structural characteristics of each of the rehabilitation specialisms. Relevant 
structural criteria were defined in expert meetings by means of a modified Delphi-
technique with five inquiries. 199 "basal criteria" and "assignment criteria" were defined. 
The criteria are grouped in two domains: general structural characteristics (general 
characteristics and equipment of rooms; medical/technical equipment; therapy, 
education, care; staff) and process-related structures (conceptual frames; internal quality 
management; internal communication and personnel development). The structural 
standards are applicable to units for musculoskeletal, cardiac, neurological, oncological, 
gastroenterological, dermatological and pneumological rehabilitation181  These projects 
are in this stage mainly research and/or pilot projects. 
Integrated care models are being developed for rehabilitation, taken into account 
phases of rehabilitation. A conceptual model has been developed for neurological 
rehabilitation 
• In Germany, medical post-acute rehabilitation is mainly offered in 
specialised rehabilitation clinics, although outpatient and part time 
inpatient care has grown considerably. 
• Approvals for admission to rehabilitation facilities by the insurance 
companies are needed. 
• Quality assurance programmes have been routinely implemented in 
rehabilitation, most of the time imposed by private insurance companies 
or sickness funds. The statutory health insurance has imposed quality 
assurance models. Quality assurance programs are intended to impact on 
the allocation of patients as well as the financing of the rehabilitation 
services. 
• Patients older than 70 years are less eligible to these models and are 
referred to geriatric rehabilitation. Geriatric rehabilitation is a special 
category of rehabilitation in Germany offering less intense rehabilitation 
compared to the other models. 
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8.5.4 Example: stroke and neurological rehabilitation 
The organisation of neurological rehabilitation has been described in the paragraph 
“underlying conceptual ideas”. Additionally it is worth mentioning that early 
rehabilitation in neurology (phase B) is mainly carried out in specialised neurological 
hospitals and in rehabilitation hospitals and, very rarely, in general hospitals. 
8.5.5 Example: LEA and THR 
The conceptual reflection in terms of a “phasenmodell” is not used for Rehabilitation 
after orthopaedic surgery, implying that individual needs are far less considered. In the 
acute phase, patients stay in the acute hospital. The duration of the inpatient stay is 
mainly defined by the prospective payment system based on the RDRG’s. 
 Patients are discharged home or to a rehabilitation hospital for further training. In the 
latter situation, the period is defined under ‘Anschlussheilbehandlung (AHB)’ and refers 
to the period directly after acute hospitalisation.  
An approval by the health insurance companies prior to admission is necessary. The 
initial length of stay approved is 3 weeks. A prolongation of inpatient stay can be 
requested by the physician and needs to be approved by the health insurance company 
before it is granted. Patients discharged home may use rehabilitation services at home 
or in a system of outpatient services.  
In general, the rate of total hip replacements (THR) in Germany can be considered as 
one of the highest in Europe, next to France and Switzerland. In 2003, estimations were 
made at 145-183 THPs per 100.000 habitants in Germany compared to 66-90/100.000 
and 101-132/100.000 for Italy and the United Kingdom respectively.182 The average 
length of stay in the acute hospital was 14,1 days in 2005.183 International comparison on 
the average LOS after THR revealed that this is longer than hospitals in the UK and US. 
A longer pre-operative hospitalization and the admission to the intensive care unit as a 
general practice rule were suggested as explanations for these higher LOS in 
Germany.184 After a stay in the acute hospital patients are mainly referred to 
Anschlussheilbehandlung (AHB), which is a service of inpatient rehabilitation following 
an acute hospital stay. On average, the AHB-LOS is 15,7 days.183 As mentioned earlier, 
the German health care system is characterized by the sectoring system between acute 
hospitals and rehabilitation services. Recent health-policy measures were implemented 
to facilitate enhanced collaboration between both sectors by introducing integrated 
health care plans [Integrierte Versorgung]. The implementation occurs over several 
phases and THR is one of the first indications using this type of health care plan. 
However, data on the effects of the integrated health care plan for THR on LOS were 
not found. 
The incidence of lower extremity amputations in Germany is estimated at 230-
660/100.000 habitants for diabetes patients and 2-9/100.000 for non-diabetes 
persons.185, 186  No significant changes were observed in the incidence for the period 
between 1990-1998. More recent data were not found. The average total length of stay 
in the acute hospital and rehabilitation centre was 9,8 months.187 In the group of 
patients with complications, the average LOS was 19,9 months. No distinction was 
being made between the LOS in the acute hospital and the LOS in the rehabilitation 
unit. Additionally, it was not clear if only the inpatient rehabilitation was considered or 
whether it concerned the total rehabilitation period, inpatient as well as outpatient. As 
only one source was found on the care trajectories of patients with amputations of 
lower extremity, generalization of the findings is jeopardised.  
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8.6 SWEDENnn 
8.6.1 Health care organisation in general 
The Swedish health care sector has undergone several important reforms during the 
past decades. Generally, national reforms that have had an impact on the health care 
system have focused on three broad areas: the responsibilities of provision of health 
care services, priorities and patient’s rights in health care and cost containment.  
8.6.1.1 Health insurance 
The social insurance system is managed by the Swedish Social Insurance Agency. No 
basic or essential health care or drug package is defined within Swedish health care. 
Insurance is mandatory. It covers individuals’ expenditures for health care and 
prescribed drugs.  
There are direct, small fees for medical attention payable by patients; these fees are in 
the form of flat-rate payments. County councils have been able to determine their own 
user charges for hospital and primary care within the national framework since 1991. 
This practice has resulted in increased and differentiated patients’ fees. Ceiling amounts 
are defined on the total amount that any citizen must pay in any 12-month period. The 
ceiling for individual co-payments for prescribed drugs is separated from the other 
health care services.  
In 2002, a new fee system was introduced for care of the elderly and the disabled. The 
purpose is to ensure that all individuals have a certain amount of money to cover living 
expenses (a reserve sum) once all fees are paid. For elderly and the handicapped, and 
depending on the level of service and care, together with the number of hours of 
assistance accorded per month, each municipality sets its own fee schedule in 
accordance with nationally determined reserve sums and maximum fees. 
The market for voluntary health insurance is growing. One of the reasons is the long 
waiting lists for elective treatment under the county councils. The main benefit of having 
supplementary insurance is that it allows quick access to a specialist in ambulatory care 
when necessary. Another benefit might be the possibility of jumping waiting lists for 
elective treatment. 
8.6.1.2 Health care policy making and organisation  
The Swedish health care system is organized on three levels: national, regional and local. 
Health and medical care is separted into three levels:  
• regional health care  
• county health care  
• primary health care (health centres) 
Hospitals are mostly independent public facilities. The degree of privatization in 
hospitals varies among counties. There are nine regional hospitals, some 70 county and 
provincial hospitals and just over 1000 health centres.  
More than half of Sweden’s county councils and regions are currently planning to 
change the structure of their health care organisation. The main elements of the 
changes involve a combination of extended primary care and specialised hospital care, 
which is to be concentrated and centralised. Technological developments, competence 
requirements and cost efficiency are steering the development, so that hospitals and 
clinics focus on certain specialties or operations. 
For highly specialized care, Sweden is divided into six large medical care regions, within 
which the county councils cooperate to provide the population with highly specialized 
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care. The highly specialised centres are university hospitals. The regional hospitals treat 
all the rare and complicated diseases and injuries. The counties that do not have a 
regional hospital have agreements with the counties that have the highly specialized 
care. 
The high degree of decentralisation is seen as an important feature of the health care 
system, but is also questioned because of some inefficiencies. Especially the 
differentiation in health care approaches between the counties is considered as a 
problem. A committee is currently reviewing the structure of government and the 
division of responsibilities and is due to report in 2007. There is a strong case for 
reducing the number of county councils to perhaps half a dozen or fewer. Some 
commentators would go further, eliminating that layer of government entirely and 
shifting responsibility for the hospital sector to the central government (similar to 
Norway). 
8.6.1.3 Financing 
The Funding of the Swedish health care system comes from County and local 
(municipal) taxes, and parish taxes (about 2/3), Central government grants to counties 
about (1/10) Patient fees (2%) and Mandatory payroll tax from employers and 
employees  (about a quarter) 
Most county councils introduced in the 1990’s some form of purchaser-provider model, 
whereby the traditional system of fixed annual allocations to hospitals was to some 
extent abandoned. The main features of shift were: separation of production and 
financing; resource allocation to health districts in relation to the needs of the 
population; and introduction of public competition between health districts (purchasers) 
and hospitals (providers). Most county councils have decentralized a great deal of the 
financial responsibility to health care districts through global budgets. Special purchasing 
units, normally headed by an elected committee of local politicians, have been formed 
with the task of formulating the requirements which should be made of the hospitals by 
the county councils and of evaluating quality and prices. Resource allocation principles 
vary among the county councils. A small group of about five county councils continues 
to develop per-case payment with expenditure ceilings for some services (primarily 
hospitals) and capitation models for primary care.  
As a purchaser the County Council must make agreements to purchase the appropriate 
levels and volumes of care from competing providers. As providers, the hospitals, care 
centers, doctor and practitioners compete for business and have operational 
responsibility for providing care to the agreed upon levels and volumes, with payment 
either on a DRG (Diagnosis Related Group) basis or on some kind of per capita 
payment, often supplemented by some performance-related provisions. The extent of 
DRGs and other classification systems varies among regions and county councils. Per 
case reimbursements for outliers, such as complicated cases that grossly exceed the 
average cost per case, may be complemented by per diem payments Payment is made 
according to results or performance.  
Contracts are often based on fixed prospective per case payments, complemented with 
price or volume ceilings and quality components. DRGs are the most common case 
system with respect to short-term somatic care. Primary health care providers are 
usually paid through global budgets. 188 
The DRG-based financing models replaced the fixed-budgets models after huge critique 
on increasing waiting list and debates on the accountability of the use of the budgets. At 
one point attempts were made to give all the hospitals equal reimbursement per 
treatment but this goal – stressing competition on equal terms –resulted in big deficits 
for a number of hospitals. In response, purchasers in Swedish county councils decided 
to accept paying some hospitals a little more and some a little less than the national 
standard. After an early and intensive “market negotiation period” the market policy 
turned increasingly to longer-term and more cooperative contracts to define relations 
between hospitals and the county councils, because of the changing health care 
landscape. At first the reforms enjoyed uncritical support by a broad spectrum of 
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stakeholders. Gradually participants in the reform process recognized inherent tensions 
among the goals of the reform, conflicts between reform programs and fundamental 
social and political values, unrealistic assumptions about the effects of competition, 
technical and organizational obstacles to implementation, and threats to interest 
groups189.  
• Sweden has a public health care model, going through important reforms 
in the last two decades. 
• Insurance guarantees universal coverage: services included are not 
specified. 
• Free choice of provider is guaranteed, but some referral is required in 
special care if patients choose a provider outside the county council. 
• The Swedish health care system is organized at three levels: national, 
regional and local. 
• The county councils play a major role in organizing and financing health 
care. The county councils have the overall responsibility for all health care 
services delivered, and have authority over hospital structure. County 
councils and regions are currently planning to change the structure of 
their health care organization involving a combination of extended 
primary care and centralization of specialized hospital care. 
• For highly specialized care, Sweden is divided into six large medical care 
regions, within which the county councils cooperate. 
• County councils determine their own user charges for hospital and 
primary care. Ceiling amounts are defined on the total amount paid in any 
12-month period. 
• There are global budgets for the counties. The DRG-based financing 
models replaced fixed-budgets models after huge critique on increasing 
waiting list and debates on the accountability of the use of the budgets. 
•  Most county councils introduced some form of purchaser-provider model. 
Special purchasing units on district level have been formed with the task to 
formulate the requirements which should be made of the hospitals by the 
county councils and to evaluate quality and prices. 
• Resource allocation principles vary among the county councils. 
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8.6.2 The organisation of the Rehabilitation sector 
8.6.2.1 The underlying conceptual ideas 
In Sweden rehabilitation is a concept including all medical, psychological, social and 
work-related measures to help sick and injured to regain conditions for an improved 
life. Different institutions are responsible for different areas, but it are mainly the local 
social and health services that are getting the prime responsibility to organize 
rehabilitation.  
The county councils are responsible for patients until they are fully medically treated, 
more specifically until they no longer require hospital care. After this phase, the 
physician (together with staff from social care services, other outpatient services and 
the patient) develops a care-plan designed to achieve further rehabilitation. Once the 
patient is fully medically treated and a care-plan has been developed, responsibility for 
the patient is transferred to the municipality.  
The responsibility for home nursing and rehabilitation lies between the county councils 
and the municipalities, which causes tensions.  
The municipalities are responsible when people need rehabilitation without 
hospitalization: generally maintenance training (conscious training to prevent loss of 
function and to maintain or improve the functions of the individual) 
The counties, however, are responsible for discharged patients to have a carefully 
arranged plan of rehabilitation. All patients who need it, have a continuing rehabilitation 
plan, no matter who has the responsibility. But, it is difficult to make a clear delimitation 
between rehabilitation in the health system (counties) and maintenance training and 
prevention of loss of function in the social system (municipalities). A gradual shift from 
the specialised rehabilitation at hospitals to the rehabilitation that is normally carried 
out in the municipalities appears to be taking place. Between the two sectors a grey 
area in which patients can get jammed insofar as none of the rehabilitative bodies accept 
responsibility for the rehabilitation of a given patient. The delimitation between the two 
sectors (in connection with the obligation to continue or to start training) are typically 
related to the discharge from hospitals.  
The collaboration and the division of labour between hospital and health and social care 
units vary from municipality to municipality and from one hospital department to 
another. 
8.6.2.2 Rehabilitation facilities 
The Swedish rehabilitation facilities do cover the range from acute hospital facilities, 
over specialised units within the hospitals, inpatient and outpatient hospital services, 
specialised rehabilitation centres and long term care facilities. 
The county-wise organisation makes it almost impossible to sketch a clear picture on 
how these facilities play a role in the rehabilitation landscape. There are great local 
variations in the numbers of beds and rehabilitation practices.  
Collaboration between services has been suggested as a means to increase effectiveness 
and reduce costs especially in the care and rehabilitation of long-term illness. In Sweden, 
a special legislation named SOCSAM was introduced in 1994, enabling financial 
collaboration between governmental and municipal authorities for crossing the 
boundaries between medical rehabilitation and social welfare related rehabilitation. But 
the development of really integrated seamless care is still to be debated.  
In the more recent period the debate on coordination of care was partly driven by 
county council cost containment. There are considerable problems in the “grey area” 
where responsibility moves from county councils to municipalities. The municipalities 
claim that patients are now sent home “quicker and sicker” because counties have a 
financial incentive to discharge them as early as possible. Municipalities are sometimes 
unable to provide necessary medical care and they have no direct access to medical 
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facilities. The counties counter that municipalities are not providing enough elderly or 
long-stay beds and claim that one in ten hospital beds is still occupied by someone who 
is medically ready to be discharged and who should be treated in primary care or at 
home. In 2004, a committee delivered recommendations on improving the boundary 
between health and social care, and proposed putting a greater responsibility on 
municipalities to provide integrated social and health care while giving them the ability 
to hire their own doctors if they feel that the counties are not allocating enough 
physician time to municipal home care (SOU, 2004). 
8.6.2.3 Financing rehabilitation 
The financing of the post-acute stroke rehabilitation centres is organised in a fixed 
budget system. (contrary to the acute sector that is financed on a DRG-system). 
Purchaser-provider negotiation decide on the amount of care there will be offered for 
the budget. The budget includes infrastructure; e.g hospital beds, cleaning etc, staffing, 
extra examinations (such as a new MR examination), training equipment for use at the 
hospital.  
Specifically for  rehabilitation, a Nordic European pilot study (in which Swedish teams 
participate) aims at integrating functional status measures based on ICD-10 coding, 
(including a critical analysis of ICF, FIM, FRG, AN-SNAP). The project aims at 
developing a method to measure activity and participation of the patient on special care. 
But a real wide scale implementation of the ICF is not realised yet. For ICF to become 
used more widely there is a consensus that more developed guidelines are needed as a 
complement to the classification. 
There Nordic work group is also developing reflections on how to link between acute 
inpatient care and rehabilitation and will develop a proposal for rehabilitation in 2007. 
There is yet no link with the current NordDRG systemoo.. 
8.6.3 Quality 
The National Board of Health and Welfare issued a set of regulations on quality issues 
for all health services to develop continuous quality improvement. The regulations 
emphasize on monitoring and quality-improvement measures focusing on technical 
quality and safety and issues related to the people for whom health services are 
intended.  
The National Quality Registers are used as supportive tools for analyses of the medical 
quality and outcomes in specific parts of the healthcare system. The national quality 
registers mainly cover highly specialised care provided at hospitals, whilst primary health 
care largely lacks joint follow-up systems. Standardised patient questionnaires are used 
and Safety problems and shortcomings in care are registered, e.g. by the Medical 
Responsibility Board, Patient Insurance Fund, and in the National Board's Risk Database. 
Data from National Health Data Registers can be used to monitor health care 
utilisation, morbidity and mortality on a population level.  Some 40 national health care 
quality registers, are developed each containing data on health care outcomes and 
treatment for a large number of categories of illness. These registers serve as a 
knowledge base for continuous improvement.190, 191   
Although the prerequisites for monitoring the quality of care in Sweden are good, 
further development of models and methods for performance assessment are needed. 
Sweden has for instance no databases and quality indicators in primary care and care for 
many chronic diseases and psychiatric disorders. Hence, the quality of services cannot 
be defined for a large proportion of health services delivered. 
In 2001, the National Board of Health and Welfare, jointly with the Federation of 
Swedish County Councils and the Swedish Association of Local Authorities started a 
reflection on a comprehensive and coherent system for review and for exchanging and 
maintaining information within treatment and care. Part of the exercise also focussed on 
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the development of Quality Indicators. Quality indicators will be used to assess and 
compare the results of treatment and care, and for reviewing operations. Quality 
indicators should give all stakeholder insight into health care practice.  
The model is similar to that used in Dutch health care systems, and very much related 
to performance indicators. 
However, the Swedish quality pilot projects pay a lot of attention to the needs at 
population, group an individual levels. A lot of attention is now going into the 
development of a registration, in which individual needs are assessed through scales or 
rating systems.  
In rehabilitation issues, the future assessment will focus on functionality and will be 
compared to identified targets set in different stages. The electronic registration system 
of needs and targets, aims at providing documentation for decision-making on treatment 
and care, for reviewing and studying outcomes and as such as a quality tool at various 
levels (individual, operational, regional and national levels). 
• In Sweden, the organizational model of rehabilitation takes into account 
the level of specialisation and the needs of the population to provide 
rehabilitation care. 
• Related to the important role of primary care, it is sometimes difficult to 
make a clear delimitation between rehabilitation in the health system 
(counties) and maintenance training and prevention of loss of function in 
the social system. 
• Rehabilitation facilities cover the range from acute hospital facilities, over 
specialised units within the hospitals, inpatient and outpatient hospital 
services and specialised rehabilitation centres to long term care facilities. 
• General regulations for health care emphasize on monitoring and quality-
improvement measures focusing on technical quality and safety, and issues 
related to the people for whom health services are intended. National 
Quality Registers are used as supportive tools for analyses of the medical 
quality and outcomes in specific parts of the healthcare system. Reflections 
started on developing a model of quality indicators for the health care 
sector. 
8.6.4 Example: Lower Extremity Amputation 
According to the Swedish National Board of Health and Welfare (SNBHW), more than 
3000 patients undergo amputation annually in Sweden. The amputation rate increases 
with age, and most amputations are performed on patients over 60. After the operation 
some follow-up treatment, and some extensive rehabilitation and nursing care has to be 
organised. Sweden has no standard approach for this rehabilitation after LEA. 
Rehabilitation for LEA is offered in regional and University rehabilitation units. In 
general it are only those people for which prostheses are matched, that are referred to 
rehabilitation centres. Most of the (especially older) groups remain short time at the 
rehabilitation unit of the hospital, before returning home.  
An older study 192 retrospectively scrutinized medical records of patients underwent 
major lower limb amputation during 1980-82 were. The records showed 131 
amputations were performed in 106 patients at the district hospital and 22 amputations 
on 17 patients at the local university hospital, referral centre, altogether 57 men and 66 
women. Of the amputees 47 per cent were older than 80 years. Final amputation level 
was above-knee in 61 per cent of the patients treated at the district hospital. For 
patients who came from and eventually returned to their own homes the mean hospital 
stay amounted to 184 days (postoperative deaths excluded). After amputation 26 
patients were trained to wear a prosthesis and 16 of these used the prosthesis 2 years 
after amputation.. 
A more recent prospective study 193 described the overall treatment and outcome of 
patients who underwent major LEA. The study took place over a five year period in the 
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Health Care District of North-East Skane, Sweden for about 190 patients. Prostheses 
were delivered to 43% of all patients with primary amputations. These patients spent a 
median of 13 days at the orthopaedic clinic. 55 days at the rehabilitation unit. 
A retrospective study 194 analysed medical and nursing records of 45 patients who had 
undergone LEA at Uddevalla General Hospital. Hospitalization, rehabilitation and 
nursing-related data related to subjects alive after 6 months were compared with data 
concerning those deceased during hospital stay and within 6 months after amputation. 
The aetiology of the diagnosis leading to the LEA was cardiovascular disease in the 
majority of cases. The most common amputation level was below the knee. The 
patients surviving after 6 months had permanent problems in the area of nutrition, 
elimination, skin ulceration, sleep, pain and pain alleviation. The patients who died 
during the hospital stay had problems in all these areas. 
8.6.5 Example: strokepp 
Although the organisation models can differ per county, rehabilitation of stroke patients 
is organised according to an overall general approach in Sweden The general approach 
follows the process outlined in the Evidence based national guidelines for stroke care, 
issued by the Swedish Board of Health and Welfare. The board monitors the quality of 
care and whether the correct measures are taken to implement the guidelines. 
A vast majority of the stroke patients are discharged home. Depending on their needs 
the rehabilitation process is continued in ambulatory form at hospitals in case of 
comprehensive needs. If the patient is referred to a nursing home, the rehabilitation is 
continued at a low level by the paramedical staff attached to that facility. For those 
patients directly returning home from a stroke unit, and needing further rehabilitation, 
the health services of the municipalities are taking charge of the rehabilitation. 
A smaller group (around 9% of the total) of stroke patients is referred to post-acute 
inpatient rehabilitation units within the hospitals. That can be general mixed 
neurological rehabilitation units (serving both TBI (about 25%) and stroke (about 60%)) 
or general geriatric rehabilitation units. 
The quality approach in stroke rehabilitation is supported by a tradition of stroke 
registrationqq .The steering committee for “Riks-Stroke”, frames and outlines quality 
indicators reflecting structure, process and outcome. All hospitals in Sweden admitting 
patients with acute stroke (85) participate since 1998. Annually, each hospital receives a 
written report in which the local results are compared with the national data and with 
comments and suggestions on improvements for the care. Data collection includes 
information on the patient's gender, age, history of previous stroke, life situation prior 
to the current stroke and level of mobility and need of assistance in three ADL 
functions, namely dressing, bathing, and going to the toilet. Items related to acute care 
include, the time from the onset of symptoms to admission to hospital, type of 
department to which the patient is admitted (medical, neurological or geriatric), 
whether or not the unit has organized stroke care (stroke unit), the patient's level of 
consciousness on admission, whether or not a CT-scan was done, and, in patients who 
died, whether or not an autopsy was done. In addition, drug treatment during the acute 
phase has been added since 1998. Items registered at discharge included: the duration of 
the acute admission to hospital; diagnosis of the stroke subtype, the patient's status at 
discharge (alive or dead), details of further management (at home or in an institution) 
and whether or not they required further care in an institution. A 3-month follow-up of 
the patients is included 195. 
Results from Riks-Stroke show that women, in comparison with men, are more often 
living in institutions three months after stroke. Women also less often receive 
secondary stroke prevention.196 , 197 
                                                
pp  the information is based on a personal communication of Prof. Katharina Stibrant Sunnerhagen, Insitute of 
Neuroscience and Physiology - Rehabilitation Medicine The Sahlgrenska Academy Göteborg University, 
SWEDEN 
qq  www.riks-stroke.org 
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Research using the stroke register has demonstrated that there are wide variations 
between hospitals in the proportion of patients admitted to a specialised acute stroke 
unit (more than one quarter of all stroke patients do not receive care in a stroke unit), 
variations in secondary prevention (Wide variations in the use of oral anticoagulants in 
stroke patients with atrial fibrillation, between hospitals), but also between counties and 
health care regions and in the proportion of patients in institutional care at 3 months. 
198 , 199, 200  
A separate registration initiative for inpatient rehabilitation has been initiated by the 
Swedish Association of Rehabilitation and Physical Medicine. This registration focuses 
on all aspects related to inpatient rehabilitation activities and patient profiles. The 
purpose of the register is to improve the quality of care for the persons and has been in 
work since 1998 with annual reports. The register is now transferring to a web based 
modality, where the unit can get momentary feed back on the data entered. The data 
include demographics, mismanagement during the stay (falls, UTI, pressure sores etc), 
available rehabilitation resources, identification of functional limitations according to the 
ICF, ADL function, rehabilitation plan, quality of life etc and a follow up at one year 
checking the follow up of the rehabilitation plan. 
8.7 US 
8.7.1 Health care organisation in general 
Health care policy in the US is based on completely different principles than the 
European welfare regimes. Especially the health insurance logic is not based on the well-
known European variants of solidarity based Bismarck or Beveridge state insurance 
models. It is precisely this health insurance model that has a major impact on the 
organisation of health services.  
8.7.1.1 Health insurance  
The types of health insurance are group health plans, individual plans, workers' 
compensation, and government health plans such as Medicare and Medicaid.  
About 2/3 of the American population is privately insured, often through collective 
employers insurances. The benefit packages are the result of negotiations and premiums 
paid. About one quarter of the population is insured through public programmes, 
especially focussing on elderly and poor people (Medicaid, Medicare). Some public 
insurances aim at particular groups (children, military personnel, agricultural sector,…). 
These last programmes will not be discussed. 
A large part (about 70%) of the inpatient rehabilitation services is organised in the 
context of medicare payment policy, which is to a large degree operating under control 
of the federal government.  
FEE-FOR-SERVICE  
Health insurance can be classified into fee for-service (traditional insurance) and 
managed care. Both group and individual insurance plans can be either fee-for-service or 
managed care plans.  
Fee-for-service plans traditionally offer greater freedom when choosing a health care 
professional. In a Fee-for-service model the insurance company reimburses the doctor, 
hospital, or other health care provider for all or part of the fees charged. A premium is 
paid and there is usually a yearly deductible (an amount specified by the terms of the 
insurance policy), which means benefits do not begin until this deductible is met. After 
the person has paid the deductible the insurance company pays a portion of covered 
medical services.  
MANAGED CARE 
In Managed care plans (for both groups and individuals) a person's health care is 
managed by the insurance company. Managed care refers primarily to a prepaid health 
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services plan, often limiting a patient to health care professionals listed by the managed 
care insurance company. Approvals are needed for some services, such as visits to 
specialist doctors, medical tests, or surgical procedures. The highest level of coverage is 
only guaranteed for services from providers affiliated with their managed care plan.  
The following are types of managed care plans: 
• Health Maintenance Organization (HMO) 
• Preferred Provider Organization (PPO) 
• Point of service (POS) 
Health Maintenance Organization (HMO) is a type of health care plan where members 
pay a flat monthly rate to have access to a specified group of medical professionals. 
Members are limited to this group of participating providers and must see a primary 
physician to have access to any specialized medical service. HMOs are usually associated 
with specific geographical areas. It is actually a form of health insurance combining a 
range of benefits in a group basis. A group of doctors and other medical professionals 
offer care through the HMO for a flat monthly rate with no deductibles. However, only 
visits to professionals within the HMO network are covered by the policy. All visits, 
prescriptions and other care must be cleared by the HMO in order to be covered. A 
primary physician within the HMO handles referrals. 
The HMO is the primary provider of managed care, and it does so in four basic models 
sharing one important feature: the health care providers may not bill patients directly 
for services rendered, and must seek any and all reimbursement from the HMO. 
A PPO combines the benefits of fee-for-service with the features of an HMO. If patients 
use health care providers from a PPO network, they will receive coverage for most of 
their bills after a deductible and, perhaps a copayment, is met. 
A PPO contracts with individual providers and groups to create a network of providers. 
Members of a PPO can choose any physician they wish for medical care, but if they 
choose a provider in the PPO network, their co-payments—predetermined fixed 
amounts paid per visit, regardless of treatment received—are significantly reduced, 
providing the incentive to stay in the network. No federal statutes govern PPOs, but 
many states do regulate their operations.  
Point of service systems (POS) is actually an integrated form of HMO and PPO. It is an 
insurance model in which the benefits are dependent on the role of a gatekeeper, that 
authorizes wheter certain health services can be used. The model is based on a model 
of network health care providers. If the patients chooses a provider outside this 
network, a higher out-of pocket part will be paid.  
MEDICARE/MEDICAIDrr 
Medicare is a programme under the U.S. Social Security Administration that reimburses 
hospitals and physicians for medical care provided to qualifying people over 65 years 
old, for some younger individuals who have disabilities and for people who have end-
stage renal disease. Enrolled individuals must pay deductible and co-payments, but much 
of their medical costs are covered by the program. Medicare is less comprehensive than 
some other health care programs, but it is an important source of post-retirement 
health care. Medicare is divided into three parts. Part A covers hospital bills, Part B 
covers doctor bills, and Part C provides the option to choose from a package of health 
care plans. 
Medicaid is a program funded by the federal and state governments, which pays for 
medical care for those who can't afford it. It reimburses hospitals and physicians for 
providing care to qualifying people who cannot finance their own medical expenses.  
Supplemental insurance covers expenses that are not paid for by a person's health 
insurance. 
                                                
rr  http://www.cms.hhs.gov/ 
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Health care policy making and organisation. 
Health care is provided by a diverse array of entities:  
• nonprofit health care provider (generally hospitals) operated by local 
or state governments, religious orders, or independent nonprofit 
organizations.  
• for-profit health care providers (hospitals), which are usually operated 
by large private corporations.  
There are many outpatient clinics which may be operated by any of the above 
organizations or may be a partnership of health care professionals (essentially a large 
medical or dental group). There are some health care professionals who individually, or 
in a group, practice for personal profit. 
The provision and consumption of health and social care, is very much affected by the 
health insurance model, and the schedule of benefits it guarantees. Centres for 
medicare and Medicaid provide health care services for people falling under respective 
categories:  
• Health care policy in the USA is based on completely different principles 
than the European welfare regimes. Public and private insurance only 
covers about 85% of the population. 
• Some groups have access to publicly financed programmes: Medicaid 
serves the poor, Medicare serves the severely disabled and people above 
65. 
• Services depend on the type of insurance coverage. There are different 
models of health insurance. 
• The insurers (of which the federal government is the largest) are the 
purchasers of health care services. The provision depends on negotiations. 
• Health care is provided by both for profit and non-for profit and public 
facilities. 
8.7.2 Rehabilitation 
8.7.2.1 The underlying conceptual ideas 
On the policy level, there is very little explicit conceptual reflection on the content and 
organisation of rehabilitation, as the organisational model is generally “left to the 
market”. However, some implicit ideas can be found when looking at the different 
facilities playing a role in rehabilitation. 
8.7.2.2 Rehabilitation facilities 
The following settings provide postacute care rehabilitation services:  
• Acute inpatient intensive rehabilitation services  
• Skilled nursing units (facility with a subacute unit) 
• Skilled nursing facility (nursing homes) 
• Inpatient rehabilitation facilities  
Acute intensive rehabilitation is provided under the general or direct supervision of a 
physician and is intended to help the physically or cognitively impaired patient to 
achieve or regain his/her maximum potential for mobility, self-care, and independent 
living in the shortest possible time. Acute inpatient intensive rehabilitation services are 
covered services only when provided to a patient admitted to an acute care bed. It 
generally is offered in a section of a hospital which is licensed to provide skilled nursing 
services for longer periods of time than the usual hospital stay. 
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Skilled nursing units (SNU) are based in hospitals, either housed inside the hospital or in 
a separate building. They typically provide only short term care and rehabilitation 
services. The skilled nursing unit does not have a separate license because it is part of a 
licensed hospital. They are sometimes called Step-Down Units, to reflect the fact that 
patients are moved there subsequent to the original hospital stay, once hospital level 
care is no longer required. These units provide sub-acute care, a level of care "between 
hospital and home". This form is also offered in skilled nursing facilities. It is care for 
patients of all ages who have been discharged from a hospital but need rehabilitation or 
complex medical services for recuperation before they can return home. Specialized, 
short term services may include extensive wound care, cardiac or stroke rehabilitation, 
intensive rehabilitation following joint replacement, multiple fracture or trauma 
rehabilitation, medically complex care and pain management. The goal of subacute care 
is to prepare patients to return home after restoring their mobility and independence. 
Nursing Homes - also called Residential Health Care or Skilled Nursing Facility: is the 
general term for facilities offering long term nursing care. A freestanding SNF is a 
nursing home that provides skilled nursing care and is not attached to a hospital. A 
hospital-based SNF is a unit of an acute care hospital, and does not fall under the group 
of nursing home facilities.  
Residents are admitted from their homes, other health care facilities and hospitals. It 
provides multi-disciplinary care to maintain residents at their highest functional level. A 
skilled nursing facility can serve for those who need short-term care following a hospital 
stay or long-term nursing supervision because of health issues or disabilities. Each 
facility defines its own level of care; not all facilities accept residents with complex 
medical problems. 
• SKILLED NURSING FACILITIES (SNF) are licensed to provide 
twenty-four hour nursing care. Skilled nursing facilities are required to 
provide medical, rehabilitative and personal care. 
• SKILLED NURSING FACILITIES - DISTINCT PART (SNF-DP) are 
skilled nursing facilities, which are a distinct part of an acute care 
hospital. In general, persons are admitted to these units from the 
acute care units of hospitals. 
• SKILLED NURSING FACILITIES-SPECIAL TREATMENT PROGRAM 
(SNF-STP) are skilled nursing facilities with a special treatment 
program such as providing treatment to the mentally ill. 
Inpatient rehabilitation facilities (IRF) can be independent or hospital based, but the vast 
majority (about 80%) is hospital based. IRFs provide intensive rehabilitation services—
such as physical, occupational, or speech therapy—in an inpatient setting. Beneficiaries 
generally must be able to tolerate and benefit from three hours of therapy per day to 
be eligible for treatment in an inpatient rehabilitation facility. Medicare is the principal 
payer for IRF services. 
To qualify as an IRF for Medicare payment, facilities must meet the Medicare conditions 
of participation for acute care hospitals and must meet all of the following additional 
criteria: 
• have a preadmission screening process to determine that each 
prospective patient is likely to benefit significantly from an intensive 
inpatient rehabilitation program; 
• have close medical supervision by a physician with experience or 
training in rehabilitation; 
• have a director of rehabilitation, with training or experience in 
rehabilitation of patients, who provides services in the facility on a full-
time basis; 
• provide 24-hour rehabilitation nursing; 
• use a coordinated multidisciplinary team approach; 
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• expect significant practical improvement for patients; 
• have realistic goals for treatment aims; and 
• each year, have no fewer than 75 percent of all patients admitted with 
1 or more of 13 specified conditions. 
The 75 percent rule allows inpatient rehabilitation facilities to admit 25 percent of cases 
without the specified diagnoses, so IRFs may treat some cases with diagnoses not 
compliant with the rule without financial penalty. The purpose of this 75% rule is to 
ensure that IRFs are primarily involved in providing intensive rehabilitation services. ss 
The diagnoses included in the 75 percent rule, were also known as the Healthcare 
Financing Administration–10 (HCFA–10) These criteria were redefined in 2004 in the 
CMS conditions  (Stroke, Brain injury, Amputation, Spinal cord, Fracture of the femur, 
Neurological disorders, Multiple trauma, Congenital deformity, Burns: The original 
HCFA condition “polyarthritis” was redefined as: Osteoarthritis (After less intensive 
setting);  Rheumatoid arthritis (After less intensive setting) Joint replacement (Bilateral, 
Age ≥85, Body mass index ≥50) and a seperate condition Systemic vasculidities (After 
less intensive setting). 
This change contributed to the reduction in the volume of patients admitted to IRFs. 
The most common rehabilitation condition for Medicare beneficiaries in 2004 was joint 
replacement, followed by stroke and hip fracture. 
8.7.2.3 Indication setting 
For IRF one of the Medicare conditions is that a preadmission screening process to 
determine that each prospective patient is likely to benefit significantly from an intensive 
inpatient rehabilitation program. The purpose of prior authorization is to validate that 
the service requested is medically necessary and meets criteria for reimbursement. 
Prior Authorization does not automatically guarantee payment for the service; payment 
is contingent upon passing all edits contained within the claims payment process; the 
recipient’s continued Medicaid eligibility; and the ongoing medical necessity for the 
service being provided. Prior Authorization requires a written initial physician 
certification upon admission to Intensive Rehabilitation Services. 
Medicare-medicaid agencies operate with interqual criteria.tt  InterQual Criteria are sets 
of clinical indicators, that consider the level of illness of the patient and the services 
required The criteria are grouped into 14 body systems, and there are 3 sets of criteria 
for each body system: Intensity of Service, Severity of Illness Discharge Screens. 
Intensity Severity Discharge (ISD) Level of Care Criteria are used to determine the 
appropriateness of admission, continued services, and discharge, across the continuum 
of care. ISD uses objective, clinical indicators to determine the proper level of care, 
based on the patient's severity of illness and service requirements, and to suggest an 
appropriate care setting 
8.7.2.4 Financing in rehabilitation 
The Balanced Budget Act of 1997 mandated use of a prospective payment system (PPS) 
to pay for Medicare patient stays at inpatient rehabilitation facilities (IRFs) and stated 
that payment amounts should accurately reflect changes in IRFs’ patient case mix.  
The Centers for Medicare and Medicaid Services (CMS) implemented the Inpatient 
Rehabilitation Facility (IRF) Prospective Payment System (PPS) beginning on January 1, 
2002. Before January 2002, Medicare paid IRFs under the Tax Equity and Fiscal 
Responsibility Act of 1982 (TEFRA), on the basis of their average costs per discharge, 
                                                
ss  for details see http://www.cms.hhs.gov/InpatientRehabFacPPS/LIRFF/list.asp#TopOfPage 
http://www.cahf.org/public/consumer/medicare.php 
tt  http://www.interqual.com/IQSite/about/history.aspx 
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up to an annually adjusted facility-specific limit. As of 2002, these facilities are paid 
entirely at prospective payment system (PPS) rates. uu 
Under this PPS, IRFs are compensated for providing inpatient rehabilitation care based 
on a pre-determined amount per case according to the patient’s impairment, age, level 
of function and co-morbid conditions. Patients are assigned to one of more than 300 
case-mix groups (CMGs) based on their characteristics—a diagnosis that requires 
rehabilitation, functional status, cognitive status, age, and comorbidities—as recorded in 
the IRF patient assessment instrument. 
Payments to IRFs are also adjusted to account for additional costs due to certain 
facility-level characteristics, namely costs due to geographic wage index differences, 
rural location, and low-income patients. 
The unit of payment in the IRF PPS is a Medicare-covered hospital stay, beginning with 
an admission to the rehabilitation hospital or unit and ending with discharge from that 
facility. Each case will be classified into a Case Mix Group. The IRF PPS utilizes a patient 
assessment instrument (IRF PAI), to classify patients into distinct groups based on 
clinical characteristics and expected resource needsvv . The FIM data set, measurement 
scale and impairment codes incorporated or referenced in the IRF PAI. This payment 
will be increased for outlier cases. Also, short-stay transfer cases will receive a payment 
for each day in the hospital plus a case-level payment equal to one-half of one day’s 
payment. But research already demonstrated the necessity to refine the instrument to 
predict costs.201 , 202 , 203 
Providers of skilled nursing services must comply with both the Prospective Payment 
System (PPS) eligibility criteria and the Medicare technical eligibility criteria. The PPS 
criteria are focused on the resources used in the care of the resident. The basic 
principles of PPS are comparable to those for IRF. The PPS reimbursement is an all-
inclusive per diem rate. This rate is predetermined, adjusted for geographic differences 
in labour costs and case-mix. Adjustment for case-mix is based on the Resource 
Utilization Groups (RUGs). RUG is a system identifying 53 groups based on patient 
characteristics (e.g. presence of medical conditions and ADL score) and service useww.  
A rather important discussion at the beginning of this century, lead to an assessment of 
payment adequacy of the IRF. 204 The major emerging issues from this assessment were: 
it is very difficult to assess who needs intensive rehabilitation in an inpatient setting, and 
maybe there is an opportunity to transfer people faster to other types of rehabilitation 
setting, for the follow up (outpatient, homecare, SNF) but it lacks clear tools to assess 
whether patients are treated in an appropriate setting. This issue of access and transfer 
is considered as an important one, though as rehabilitation can also be offered in other 
types, and less expensive facilities. The introduction of the new PPS seems to indicate 
that the length of stay within the IRF’s continues to reduce, while the medical outcomes 
remain comparable. Interesting is that the introduction of the PPS clearly lead to an 
increase in cost per case. 
                                                
uu  http://www.washingtonwatchdog.org/documents/fr/01/au/07/fr07au01-17.html 
vv  http://www.cms.hhs.gov/InpatientRehabFacPPS/04_IRFPAI.asp#TopOfPage 
ww  http://www.physiciansnews.com/business/804campbell.html 
http://www.medpac.gov/publications/other_reports/Sept06_MedPAC_Payment_Basics_SNF.pdf 
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8.7.3 Quality 
An overview of quality and outcome measures for rehabilitation can be foundxx. 
The Federal Agency for Healthcare Research and Quality (AHRQ) of the Department 
of Health and Human Services is responsible for measuring the quality of health care in 
the United States. Since 2003, a yearly report, ‘the National Healthcare Quality Report‘, 
has been issued on quality of services. At this stage, the clinical conditions discussed in 
the reports are not specifically linked to rehabilitation (e.g. cancer, diabetes, end-stage 
renal disease, HIV and AIDS, mental health) but it is intended to update the set of 
measures.  
Quality of care in rehabilitation is not uniformly assessed across the United States and a 
variety of measurements is in use. The American Academy of Physical Medicine and 
Rehabilitation suggested five performance measurements which are focused on the level 
of the setting or the health care professional and are organized by external institutesyy   
The Commission on Accreditation of Rehabilitation Facilities (CARF), accredits the 
services of an organization based on preset standards. These differ by pathology (e.g. 
spinal cord, brain injury) and facility (e.g. hospital, outpatient). In total, 23 different 
programs are identified in the area of medical rehabilitation for which accreditation can 
be requested. Medical Rehabilitation programs include treatments for people who have 
had a stroke, brain or spinal cord injury, or pain that cannot be controlled by 
medication alone. Medical rehabilitation also includes return-to-work programs or 
occupational rehabilitation, which helps people regain skills they need so that they can 
return to work after an injury or illness. An organization seeking accreditation for a 
medical rehabilitation program must demonstrate the following: 
• Service design and delivery that focus on the needs of the persons 
served. 
• Assignment of designated, qualified, competent personnel to provide 
medical rehabilitation services. 
• Program accessibility and designation of space for the provision of 
medical rehabilitation services. 
• Accomplishment of predicted outcomes. 
• Partnership with the persons served in decision making and the 
development of goals. 
• A system of accountability that measures the success of the medical 
rehabilitation program by evaluating the outcomes achieved by the 
persons served. 
• External communication to a variety of stakeholders regarding 
program performance. 
The organization is asked to demonstrate to a survey team conformance to standards 
highlighting the organization's values and approaches in these areas. CARF standards are 
developed and revised through a series of panels, national advisory committees, focus 
groups, and field reviews: 
• Core values and mission. 
• Input from the persons served and other stakeholders. 
• Individual-centered planning, design, and delivery. 
• Rights of the persons served. 
                                                
xx  http://www.emedicine.com/pmr/topic155.htm 
yy  http://www.aapmr.org/hpl/perfmeasure/pmr.htm 
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• Continuity of care. 
• Quality and appropriateness of services. 
• Leadership, ethics, and advocacy. 
• Planning and financial management. 
• Human resources. 
• Accessibility. 
• Health and safety. 
• Outcomes management and performance improvement. 
• Infrastructure management 
The Ambulatory Care Quality Alliance (AQA) provides a list of 26 quality indicators for 
peer review between settingszz.  
The Joint Commission on Accreditation of Healthcare Organizations provides different 
core measure sets. Organizations enlisted in the program are enabled to compare their 
own performances with their peers. On the level of the health care professional, two 
performance measures are suggested. First, there is the ‘Centers for Medicare and 
Medicaid Services – Physician Voluntary Reporting Program’. A list of 16 measures is 
asked to be reported which serve as a base for comparison between peers.   
The ‘Physician Consortium for Performance Improvement’ which is part of the 
American Medical Association selected 96 performance measures on 17 clinical topics. 
As with the other systems, the variables are selected from electronical patients’ records 
and entered in a uniform database. Registered members have privileged access to the 
database to compare their own data with blinded grouped data from their peers. 
As mentioned before, many other institutes provide similar services and are mainly 
based on the sample principle of comparison between peers. 
                                                
zz  http://www.aqaalliance.org/performancewg.htm 
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• In the US, different facilities provide post-acute care rehabilitation 
services: Acute inpatient intensive rehabilitation services; Skilled nursing 
units (facility with a subacute unit); Skilled nursing facility (nursing homes); 
Inpatient rehabilitation facilities.  
• The vast majority of IRF’s are hospital based. 
• To qualify as an IRF for Medicare payment, facilities must meet Medicare 
conditions of participation for acute care hospitals and some additional 
criteria of which the most important is to have a preadmission screening 
process to determine that each prospective patient is likely to benefit 
significantly from an intensive inpatient rehabilitation program. Medicare 
IRF should have no less than 75 percent of all patients admitted with 1 or 
more of 13 specified conditions. 
• A prospective payment system (PPS) is used to pay for Medicare patient 
stays at inpatient rehabilitation facilities. IRFs are compensated for 
providing inpatient rehabilitation care based on a pre-determined amount 
per case according to the patient’s impairment, age, level of function and 
co-morbid conditions. The unit of payment in the IRF PPS is a Medicare-
covered hospital stay (from admission to discharge). 
• For skilled nursing services the basic principles of PPS are comparable to 
those for IRF.  
• The IRF PPS utilizes a patient assessment instrument (IRF PAI), to classify 
patients. 
• Some initiatives exist on quality measures, but Quality of care in 
rehabilitation is not uniformly assessed across the United States and a 
variety of measurements is in use. 
• The Commission on Accreditation of Rehabilitation Facilities (CARF), 
accredits the services of an organization based on preset standards. 
8.7.4 Example: Stroke  
Accurate information on the current systems in stroke rehabilitation is difficult to 
obtain because the different health care providers, private and public, are not equally 
sharing their information 205.  
Post-acute care can be provided by home health agencies (HHA), skilled nursing 
facilities (SNF), inpatient rehabilitation facilities (IRF) or long-term care hospitals.206 
HHA mainly provides therapy, nursing care and assistance from home health aides207. 
The main difference between IRF and SNF is the intensity of rehabilitation. Patients are 
eligible to be admitted in an IRF if they can sustain 3 hours of therapy while in SNF less 
intensive therapy is provided. Long-term care settings are focused on the provision of 
nursing care or constant supervision. 
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FIGURE 8.2: USA: DECISIONS ON DISCHARGE DESTINATION FROM ACUTE STROKE CARE SERVICES INVOLVE THE CLINICAL EVALUATION208 AS WELL AS SOCIAL INDICATORS 
OF THE PATIENTS209 
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The majority of the patients are discharged home (50,3%, 2000), followed by discharge 
to skilled nursing facility (21,0%).210 However, also factors as geographical availability and 
the relationship between acute setting and IRF or SNF have been found to play a 
significant role in the decision on the patient being transferred to a SNF or IRF207 The 
regional distribution of use of various types of post-acute care also shows much 
variation over the country. 
For Medicare beneficiaries (not pathology specific), the use of SNF is the highest in 
West North Central, (61,8 discharges per 1000 beneficiaries in 1997) and the lowest in 
Middle Atlantic.211 For IRF, the highest use was measured in West North Central, the 
lowest in Pacific. For stroke, different referral patterns were found across the country. 
For example, in 1998, 74,5% of the Medicare patients who suffered a stroke were 
admitted to a SNF or IRF while this was 62,6% in East and West South Central.212 It was 
suggested that these differences were caused by several forces: practice styles, supply of 
services and local regulatory practices.  
The median length of stay in inpatient rehabilitation setting (SNF and IRF combined) was 
16 days in 2001 and significantly lower than in 1994 (26 days).213 Additionally, large 
differences are found between the different systems of health care providers. A 
comparative study between IRF of the Veteran Affairs (VA) versus non-VA IRF revealed 
a higher length of stay, a higher functional outcome and lower community discharges in 
the VA-system.214 Financial incentives to decrease the length of stay over time are 
considered as one of the main drivers behind this phenomenon. Ottenbacher et al.213 
found that this was accompanied with an increase of mortality in the post-discharge 
period. The authors could not pinpoint an explanation for this finding. The discharge 
destination from inpatient rehabilitation settings are mainly to the community (67%) or 
to a long-term facility care (12%).215  
The presence of various health care systems and different stakeholders and agencies 
results in fragmented health care delivery leading to suboptimal treatments and 
inefficient use of resources.216 The American Stroke Association’s task force recognized 
this problem in a recent report217 , 218 and formulated recommendations to establish a 
more ‘integrated system coordinating patient access to the full range of activities and 
services associated with stroke prevention, treatment and rehabilitation,…’ A general 
recommendation was that a stroke system should ensure effective collaboration 
between agencies. Also a standard approach in stroke care was recommended as well 
as performance measures on process and outcome of care should be identified. 
However, the recommendations lack the concrete suggestions how to establish such 
stroke systems.219 In the meantime, it was suggested that international comparative 
research in stroke rehabilitation could offer opportunities to study different care 
systems in the efficiency220.  
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8.7.5 Example: Spinal Cord Injury 
In general terms, the care trajectory after the acute event of a spinal cord injury (SCI) 
goes through acute care into rehabilitation and further back into the community or to a 
setting of chronic care.  
No indications were found on the eligibility of acute hospitals to admit SCI patients. 
However, due to the status of emergency, patients may mainly be transferred to acute 
hospitals providing tertiary or high secondary services, the so called ‘referral hospitals’. 
These can provide care to patients with multi-system failure or in need of neurosurgery. 
The rehabilitation phase mainly follows subsequently the stay in the acute care setting. It 
is expected that the SCI patients will be mainly transferred to IRF settings. All IRF 
settings are eligible to admit SCI patients as there are no legislations in place which 
preset criteria. Moreover, SCI belongs to the list of 13 diagnostics eligible for the 75% 
rule in the PPS regulation implemented by CMS for IRFs.221   
On the other hand, there are initiatives to facilitate rehabilitation settings to specialize 
in programs for SCI patients. First, there is the program of the Rehabilitation Services 
Administration, currently funded by the National Institute on Disability and 
Rehabilitation222 It focuses on the development of a comprehensive service delivery 
system for patients with a spinal cord injury which also included a long-term follow after 
inpatient stay. In 1970, a first model spinal cord injury system (MSCIS) was granted. 
Since then, the number of hospitals that were offered support to further develop this 
integrative system was increased to 16 centers nationwide. Support is provided for five 
years. After each half a decade all hospitals need to reapply for this type of support.  
This program also includes a collaborative national database on demographics and 
outcome after rehabilitation as well as information on follow-up status. Currently, data 
are available on 30.532 subjects222 and one of the major strengths is the standardized 
collection of patient-related and injury related information.223 The mean length of stay 
(LOS) in the acute care unit was 18 days in 2003 (most recent complete data). This 
represented a small increase since 1997 where the mean was 13 days. In most years, 
the LOS of patients with tetraplegia do not differ much with the average LOS of 
patients with paraplegia (19 days vs. 16 days, respectively). Mean LOS in rehabilitation 
was measured at 45 days. In 1974, this was 115 and has declined since then. In contrast 
with the acute stay, large differences are found in average LOS between tetraplegic and 
paraplegic patients. The mean LOS of patients with tetraplegia was measured at 51 days 
while patients with paraplegia had a mean LOS of 36 days in the rehabilitation unit.224  
Accreditation can be considered as a second initiative to facilitate rehabilitation settings 
to provide a specialized, integrative program. In total 90 centers are certified by CARF 
fulfilling the requirement in excellence of practice.aaa  
The discharge destination after the rehabilitation phase is mainly the private residence 
(88.1% (NSCISC data) and 92% [3]) followed by nursing home (4.1%).  
Besides the MSCIS, no other information on establishing formal networking across 
settings was found. The trajectory of care is mainly driven by the freedom of choice, 
moderated by insurance regulations. In a system of ‘fee for service’ the patients have 
more complete freedom to choose their own providers of care. In models as ‘Managed 
Care Organizations’, ‘Health Maintenance Organizations’ and ‘Point of Service 
Organization’ the policyholder is limited in choosing health care providers by the list of 
preferred providers determined by the insurer. 
                                                
aaa  . http://www.carf.org 
196 Musculoskeletal & Neurological Rehabilitation KCE reports 57  
 
8.7.6 Example: Total Hip Replacement 
Prior to the introduction of the pre-paid system, patients undergoing total hip 
replacement remained in the acute hospital until they could be discharged home. Due 
to the increasing financial pressure on acute settings, leading to a reduction of length of 
stay, referral to inpatient rehabilitation services increased significantly as functional 
recovery was not established in the acute hospital.225 , 226 Rehabilitation is offered in 
various facilities: inpatient rehabilitation facilities (IRFs), Skilled Nursing Facilities (SNFs) 
or long-term care hospitals (LCTH).  
Currently, referrals to post-acute facilities are not regulated and there are no criteria 
implemented defining patients eligible for particular services. Decision-making on 
discharge disposition is made by the physician in the acute hospital. In most cases, a 
discharge planner will be involved assuring a smooth transition into post-acute care 
setting. Percentages of patients being discharged to one of the post-acute services vary 
between 33% 227 and 58%228, mainly depending on the age of the studied group. 
However, the specific destination is more influenced by non-clinical factors. In a recent 
study by Buntin et al.207 availability of the post-acute facility as well as the network of 
the acute hospital were better predictors for discharge destination than any clinical 
indicator. 
As service delivery varies largely between these post-acute facilities, it is expected that 
outcome will vary considerably. Recent studies showed superior outcomes for patients 
admitted to IRFs in comparison to SNF-patients.229 , 230 The hypothesis is made that this 
is due to the more intensive rehabilitation programs in the IRFs. The average length of 
stay varies between 10 days and 13 days mainly dependent on the need for revision 
surgery and age.231 , 232, 233  
8.8 INTERNATIONAL COMPARISON  
8.8.1 A basic schematic comparison of the different countries 
Based on the information gathered we tried to schematically synthesise the organisation 
of musculoskeletal and neurological rehabilitation for the five different countries. As can 
be expected, we do not claim that these schemes cover al details and nuances. They are 
made as a tool for a quick comparison, and as a stepping stone for the 
recommendations in the final chapter. 
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8.8.1.5 USA, 
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8.8.2 Summary assessment 
The organisation of rehabilitation facilities has to be understood against the background 
of historical policy choices in organisation, financing and health insurance issues, 
economic constraints and societal values and preferences of the entire health care 
system.  
(Policy-)Reflections on the organisation of the rehabilitation sector, are being linked to 
conceptual issues about the role of rehabilitation. Policymakers are aware that more 
clear conceptual delineation of issues related to rehabilitation, is needed to streamline 
the health care organisation. 
A well-defined framework for developing trajectories of care and integration of health 
services is not to be found in the countries studied. Although, it becomes apparent that 
similar reflections are taking place in order to realise an optimal use of the different 
kinds of health care services.  
The debate about organising rehabilitation services is mainly focussing on the clear 
identification of the roles of services playing a role in acute care and treatment, 
rehabilitation and long term care.  
In the different countries similar types of health services are identified as playing a role 
in rehabilitation. In general terms a distinction is accepted between different types of 
rehabilitation (related to the purposes and the patients (medical) needs).   
The important challenge for most countries is now to identify timeslots for each phase 
and each type of rehabilitation care needed in these time slots. The criteria put forward 
to define the use of the facilities depend on the local availability of services, the 
rehabilitation purpose and the medical needs of the patient 
All the countries studied struggle to translate the different dimensions of rehabilitation 
targets in organisational facilities. A clear trend is emerging however:  rehabilitation 
policies focus on a clear delineation between the content (and intensity) of 
rehabilitation, the phases of rehabilitation and the aims of rehabilitation interventions, in 
order to identify the roles or organisations and providers. Moreover, these roles have 
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to be identified in the logic of “trajectories of care” with “phases” and fitting in 
organisational “networks” or “chains of care”. 
Some countries try to conceptually differentiate between “general rehabilitation”, 
“general multidisciplinary rehabilitation”, “complex multidisciplinary rehabilitation”, and 
“top reference multidisciplinary rehabilitation”. This distinction is based on the 
particular needs of the patients. Organisations and providers are being identified to fulfil 
tasks on this gradients. The planning of these centres is ought to be fitting with 
geographical and epidemiological characteristics. The functioning of these different types 
of facilities should be adapted to the logic of rehabilitation trajectories” in “networks” 
or “chains of organisations” 
In all countries it can be observed that some centres function as “reference centres” for 
specific pathologies. They develop specific competences and knowledge related to 
specific disorders. However, these centres are not exclusive to a certain pathology. 
Neither does it mean that other centres cannot service similar pathology groups, 
especially if a limited number of rehabilitation centres serve a region. All centres offer 
rehabilitation support for different types of musculoskeletal and neurological problems 
(with maybe as a sole exception for MS). 
In some countries the access to rehabilitation is controlled through the aims of 
rehabilitation. In Germany and the Netherlands, aged groups have a bigger chance to 
have a different facility providing (less intensive) rehabilitation. 
Other facilities, can provide a certain level of medical and paramedical rehabilitation, but 
focus more on the longer term social aspects of rehabilitation. They mainly play a role 
in the provision of (inpatient or ambulatory) support for those who are unable to live 
independently. 
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9 RECOMMENDATIONS FOR ORGANISATION 
OF POST-ACUTE MUSCULOSKELETAL AND 
NEUROLOGICAL REHABILITATION IN 
BELGIUM 
9.1 INTRODUCTION 
9.1.1 Synthesis of the key points formulated during the study of the 
organisation and financing of musculoskeletal and neurological 
rehabilitation 
The principal goal of this project is an assessment of the conventions 7.71 and 9.50. The 
analysis of the conventions 7.71 and 9.50 which include the financing of rehabilitation 
activities in a limited number of rehabilitation facilities, was extended with an analysis of 
K-nomenclature which includes a separate part of financing of rehabilitation activity. As 
for musculoskeletal and neurological rehabilitation specific facilities exist for hospitalised 
patients, an analysis of the financing of a hospital stay (Specialised beds for 
musculoskeletal S2 and neurological disorders S3) completed the study. 
The current organisation of musculoskeletal and neurological rehabilitation in Belgium 
lacks transparency and clinical coherence. Several parallel payment systems exist which 
are mostly based on historical factors instead of criteria concerning patients’ 
rehabilitation needs and goals.  
One system is linked to hospital stay in specialised beds (Sp beds) for diagnosis and 
treatment of musculoskeletal (S2) and neurological disorders (S3). This financing system 
covers basic care needs and limited rehabilitation services.  
Other systems are specifically linked to rehabilitation activities and concern mainly 
nomenclature (K, M and R) and rehabilitation agreements (also called conventions). 
These systems are fee for service systems. The different payment systems overlap 
significantly and can be combined. Price setting for each unit of payment, as well as per 
hour of therapy depends on the system and is mainly based on historical facts. There 
are no clear criteria for patient referral to the different types of rehabilitation 
organisations and the only characteristic on the limitative lists is the medical diagnosis. 
Patients’ rehabilitation needs and goals are not formally assessed, neither are there 
criteria justifying an inpatient treatment.  
The rehabilitation trajectory is often driven by the access of the different organisations 
to the different payment systems. 
There is no systematic central and detailed registration of data concerning the 
performed rehabilitation activities. There is no accreditation system and only very 
limited formal quality control. 
Current rehabilitation practice in Belgium shows a large variability concerning duration 
of the rehabilitation programmes (expressed as a number of treatment sessions), type 
of therapy (mono- versus multidisciplinary) as well as payment system (M- or K-
nomenclature, 9.50 or 7.71 convention), at least for the five studied pathologies (LEA, 
MS, SCI, stroke and THR). The variability in rehabilitation programmes might be rather 
explained by the type of organisation regionally available and by the related payment 
system than by patient’s rehabilitation needs and goals, because except for medical 
diagnosis, no patient referral criteria are available. The study of clinical pathways for 
these pathologies, yielding only limited information (see chapter 7), could confirm nor 
reject the variability in clinical practice. 
A definition of rehabilitation was developed within the conceptual framework of the 
WHO International Classification of Functioning, Disability and Health (ICF). This 
conceptual definition has to be made operational in due time, by means of a patient 
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classification system (Figure 9.1). ICF can already be used as a conceptual framework for 
an outcome model but the application of ICF in clinical practice and for financing 
purposes only fits long term vision. 
Figure 9.1: Principles of an ideal Patient Classification System 
Outcome measures, outcome models and patient classification systems exist but are 
not explicitly linked. 
The implementation of ICF as an outcome model depends on its compatibility with 
measures used in rehabilitation and the improvement of its applicability. 
FIM and Barthel Index are tools measuring level of dependence related to activities of 
daily living. The results of this measurement can be used to estimate workload, but 
neither FIM nor Barthel Index measure rehabilitation needs. 
In Belgium only MVG-RIM2 includes functional items. It could be considered to use the 
MVG-RIM2 as an intermediate profiling tool of post-acute rehabilitation, using the 
“fingerprints”. However, the necessary reluctance is needed: MVG-RIM is not a tool 
enabling to score for paramedical (occupational therapy, physical therapy, 
psychology,…) activities, neither to monitor or assess the effectiveness of therapy or 
different aspects of rehabilitation activities. It could be an option to validate MVG-RIM2 
with other instruments currently tested in other countries even though MVG-RIM2 will 
at the earliest be implemented in Belgium in 2008. 
Organisation and financing of rehabilitation was analysed in five countries. All countries 
are struggling with these issues and developing new solutions. 
In The Netherlands rehabilitation is organised within 4 levels and patients need an 
indication setting. There is basic set of performance indicators as well as a rehabilitation 
treatment framework, intended as quality and accreditation instrument. 
In France rehabilitation is conceptually organised around three levels of care and has a 
clear regional orientation. There is no systematic model of indication setting. 
Medical post-acute rehabilitation in Germany is mainly offered in specialised 
rehabilitation clinics, although outpatient and part-time inpatient care grows 
considerably. Approvals by the insurance companies for admission to rehabilitation 
facilities are needed. Quality assurance programs intend to impact on the allocation of 
patients as well as the financing of the rehabilitation services. 
In Sweden rehabilitation is organised at county level, taking into account the level of 
specialisation and the population’s needs. The rehabilitation has a clear orientation on 
home and ambulatory care, but a differentiation is made between at least two levels of 
facilities. The quality assessment is stimulated by both national health care agencies and 
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rehabilitation professionals. Registers are an important support tool in this quality 
approach. 
In the US different facilities provide post-acute care rehabilitation services. A 
preadmission screening process is needed within Medicare as  stays in a Medicare 
inpatient rehabilitation facilities (IRF) are funded by a prospective payment system. The 
unit-of-payment is a Medicare covered hospital stay. Patients are classified with a patient 
assessment instrument (IRF PAI). Quality of care is not uniformly assessed, although 
efforts are made to develop a quality approach based on registration. Services can be 
accredited by the Commission on Accreditation of Rehabilitation Facilities (CARF) 
based on preset standards. 
In this and the following chapters the organisation and financing of musculoskeletal and 
neurological rehabilitation in Belgium is discussed. This discussion is based on the input 
of national experts and elements from literature described in previous parts. Several 
models are proposed and recommendations applicable to the Belgian context are made. 
9.1.2 Optimising the organisation and financing of post-acute musculoskeletal 
and neurological rehabilitation in Belgium 
The current organisation and financing of musculoskeletal and neurological rehabilitation 
in Belgium requires an important revision. The conventions 9.50 and 7.71 have to be 
revised and elaborated in the context of an overall strategic vision on rehabilitation in 
the Belgian health care approach. In their current form the conventions do not 
differentiate enough from, or offer added value to K-nomenclature.  
Belgian health care services are in general characterised by a wide accessibility and 
affordability by a universal social security system. The development of a vision on the 
organisation and financing of rehabilitation services and facilities should fit in this 
tradition.  The new conceptual approach of rehabilitation should be built on the 
interaction between financing, organisation and quality of rehabilitation services (Figure 
9.2). A line of reasoning developed in this chapter, takes these issues into account.  
Figure 9.2: Interaction in policy making 
Similar to international debates, Belgium needs to develop an explicit conceptual 
framework for the organisation of musculoskeletal and neurological rehabilitation. It is 
proposed to develop a stratified rehabilitation model in which the roles of rehabilitation 
organisations can be identified, taking into account characteristics of patients’ needs, 
disease trajectories, rehabilitation goals and epidemiological and geographical needs. 
Resource allocation must become more transparent and related to the effective service 
delivery for particular patient characteristics. 
Necessary interaction for 
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9.2 ORGANISATION OF POST-ACUTE MUSCULOSKELETAL 
AND NEUROLOGICAL REHABILITATION 
9.2.1 An organizational model for post-acute musculoskeletal and neurological 
rehabilitation in Belgium: different options.  
Four dimensions are important when developing an organisational model for 
musculoskeletal and neurological rehabilitation: 
• the phase (parts of the disease trajectory): acute, post-acute and 
chronic. We stick to a generalised division in three phases. For each 
particular pathology more detailed schemes can be developed 
(examples were given in the chapter international comparison phased 
model neurology, Dobkins model for stroke) 
• the setting: inpatient versus ambulatory.  
• the idea of a mono- or multidisciplinary approach is related to human 
resources issues 
• the complexity of the rehabilitation needs and goals and thus of the 
required rehabilitation activities: simple or complex. 
Since the study of other countries (see chapter 8) yielded no single organizational 
model, and since each model has advantages as well as disadvantages, several options 
will be given for the organization of musculoskeletal and neurological rehabilitation in 
Belgium. The policy options discussed in this chapter only consider the post-acute 
phase. Post-acute rehabilitation cannot be isolated from rehabilitation in the acute and 
chronic phase. The organisation and financing issues there are particular, and to far 
from the initial goal of this project. 
9.2.1.1 A Stratified Rehabilitation Model 
The conceptual stratified rehabilitation model for the post-acute phase is developed as a 
support tool for organising rehabilitation. Moreover, it tries to translate and optimise 
the existing informal organisation of musculoskeletal and neurological rehabilitation in 
Belgium. 
Figure 9.3 visualises the ideas underlying this conceptual model. 
This rehabilitation model is organised around three differentiated types of rehabilitation 
services, taking into account patients’ rehabilitation needs and goals: 
• General rehabilitation services 
• Specific rehabilitation services 
• Highly specific rehabilitation services. 
The services of the different rehabilitation levels funtion in a collaborative way throug a 
clearly structured network. Between the different centres can be referred depending on 
the phase of the trajectory and when necessary considering geographical factors. 
Two criteria are used for separating the levels in this structure: 
• complexity of rehabilitation needs and goals 
• incidence and prevalence of consequences of health conditions. 
The implementation of this model thus requires a systematic assessment of patients’ 
rehabilitation needs in the acute phase of the disease trajectory. It is recommended to 
keep in mind the framework of the International Classification of Functioning, disability 
and health (ICF) while performing this assessment. The value of this framework is 
generally accepted in rehabilitation medicine from a clinical point of view. However, it 
should be noted that ICF currently is not ready yet to be used as an organizational and 
managerial tool. The assessment should be based on diagnosis, required intensity of 
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care, rehabilitation needs and goals as well as on personal and environmental criteria. 
The assessment has to be repeated periodically and can result in a transfer of an 
individual to another type of organisation within the network. 
This assessment is a crucial tool to assign a patient to a rehabilitation programme, which 
in turn is decisive for the referral to a certain type of rehabilitation organisation. Each 
rehabilitation facility offering rehabilitation programmes, will receive an adapted funding. 
Budget allocations can be more transparent and logic, and adapted to the resources 
required to offer a rehabilitation programme. 
Of course, the assessment has to be perfomed by an objective but specialised 
professional. Several options exist. This assessor could  either be the treating 
rehabilitation specialist in the acute phase, the rehabilitation specialist in the post-acute 
phase, a representative of the insurance organism, a completely independent party, or a 
collaboration between two or three of these parties. In chapter 8 several examples will 
be given in the studied countries. The better the PCS is conceived, the better chance 
there is for objectivity in the assessment. 
The rehabilitation needs and goals will lead to a mono- or a multidisciplinary approach 
as is mentioned in the comments on the definition of musculoskeletal and neurological 
rehabilitation. 
Another dimension is the complexity of the rehabilitation needs and goals. 
Short-term (or temporary) rehabilitation needs and goals are considered as simple. 
For example: rehabilitation in case of simple sport injuries, or after total hip, knee or 
shoulder replacement. 
Long-term (or permanent) rehabilitation needs and goals are considered as complex. 
For example: rehabilitation in case of spinal cord injury or multiple sclerosis. 
Rehabilitation needs and goals in case of a health condition which often causes 
important long-term functional impairments but can partially recover such as stroke, 
Guillain-Barré syndrome and multiple trauma, are also considered as complex. 
The model also takes into account options for hospitalised (inpatient) or ambulatory 
(outpatient) rehabilitation services. However, it is not clear yet neither in literature (See 
chapter 3), nor among experts in what conditions one can choose for hospitalised or 
ambulatory settings. This dimension is not visualised in the model. 
The implementation of this model will require the implementation of an elaborated 
quality or performance assessment instrument, measuring at least the clinical patient 
outcomes of the rehabilitation process. An accreditation system could be an alternative 
(see CARF in the US). 
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Figure 9.3: a) Stratified Rehabilitation Model: Post-acute Phase; b) 
Visualisation of the dimension complexity of rehabilitation needs and aims; 
c) Visualisation of the dimension mono-disciplinary and multidisciplinary 
rehabilitation. Note: the dimension “hospitalized and ambulatory” is not 
visualized  
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GENERAL REHABILITATION SERVICES 
As demonstrated in Figure 9.3: general rehabilitation services can be provided in the 
acute phase of the disease trajectory, in the post-acute phase after medical stabilisation, 
as well as in the chronic phase for maintenance rehabilitation or follow-up activities. All 
these organisations deliver services to patients with simple rehabilitation needs and 
goals. Besides, acute organisations assess patients with complex rehabilitation needs. 
Based on this assessment, patients can be referred to specific or highly specific 
rehabilitation services.  
The final referral decision is  made by the assessor as described above. 
The general services can offer both mono- as well as a simple multidisciplinary 
rehabilitation. Mono-disciplinary rehabilitation services can be delivered by one or more 
(‘multi-mono’ or ‘simple multi’) individual therapists (working independently of each 
other), but belonging to a multidisciplinary team, part of a multidisciplinary organisation. 
This contrasts with multidisciplinary rehabilitation, which is offered by an 
interdisciplinary collaborative team. bbb  In the general level, this multidisciplinary 
rehabilitation is less complex than in the specific and highly specific level. 
These services will be provided in an ambulatory, outpatient setting. In case of a 
preceding acute care phase, inpatient services can be provided too (at the start of the 
rehabilitation process). 
SPECIFIC OR HIGHLY SPECIFIC REHABILITATION SERVICES 
Patients selected on clearly defined criteria for complex rehabilitation needs and goals, 
are only referred to specific or highly specific rehabilitation services. Patients affected by 
consequences of health conditions with a high incidence or prevalence, have access to 
specific rehabilitation services (e.g. stroke), whereas patients affected by consequences 
                                                
bbb  Note that therapy at home, delivered by an individual therapist, is called “home therapy” and is 
monodisciplinary. Post-acute rehabilitation is offered in a rehabilitation organisation, where a multidisciplinary 
team offers therapy in a coordinated way. In the post-acute phase, the team can offer multidisciplinary 
therapy, or one of the team members can offer monodisciplinary therapy, depending on the needs and goals 
for an individual patient. 
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of health conditions with a low incidence or prevalence have access to highly specific 
rehabilitation services (e.g. spinal cord injury).  
(Highly) specific rehabilitation services are always provided by a multidisciplinary team 
at least composed of a physician specialised in rehabilitation and one type of therapist. 
These services can be provided in a hospitalised or ambulatory setting. 
Referral between organisations providing specific and highly specific rehabilitation is 
possible and is based on a re-assessment with the same tools as used for the assessment 
at the start of the post-acute phase. 
Facilities offering specific and highly specific services need more resources, because they 
will offer more intense and complex rehabilitation programmes. A prospective payment 
system with a closed-end budget is preferred, calculated on different components, and 
allowing a transparent price setting considering different elements needed for providing 
rehabilitation services. The budget allocation has to be supported by the use of 
performance or quality monitoring (see next paragraphs on financing and quality). 
Research and/or academic functions can be integrated at all levels as long as the 
necessary academic support is available or can be organised separately. Anyway, funding 
of research should be clearly separated from the funding of the rehabilitation process. 
The critical condition to use a stratified rehabilitation model in the post-acute phase, is 
the availability of (an) assessment tool(s) to support patient referral (patient 
classification system). Clear criteria to distinguish the different types of organisations 
are essential. The advantages of this model are that a differentiation of rehabilitation 
supply is possible. Patients with complex needs and goals, will receive tailored 
specialised care which would be an excess utilisation of services for patients with simple 
needs and goals.  
9.2.1.2 Variants of the post-acute stratified rehabilitation model 
A first variant of the previously described model focuses on target populations or 
pathology groups (Figure 9.4). In this model a distinction can be made between: 
• General rehabilitation services for simple rehabilitation needs and 
goals 
• Reference rehabilitation services for complex rehabilitation needs and 
goals as a consequence of one specific health condition . 
Elements of this variant can be found in some countries (e.g. the USA), where separate 
rehabilitation facilities are created exclusively for Spinal Cord Injuries. However, none 
of the countries studied, organise their services model exclusively on target groups. 
Probably because this would require an exponential growth in resources (facilities, 
infrastructure, equipment, human resources) allocated to rehabilitation. In our basic 
model these groups would be treated in highly specific centres.  
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Figure 9.4: pathology specific variant 1 
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A second alternative conceptual model differentiates reference centres based on 
“functional” impairment (motor, cognitive,…) rather than a specific health condition 
(Figure 9.5). This model fits into the logic of e.g. centres for “vocational” or “cognitive” 
rehabilitation. This model of post-acute rehabilitation was not found in any of the 
countries studied, although one could argue that Sweden is paying a lot of attention to 
vocational reintegration.  
Figure 9.5: Function specific variant 
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9.2.1.3 Pathology specific trajectory based rehabilitation model 
Another variant of a health services model would be a pathology based approach for all 
phases of the disease trajectory (Figure 9.6). The referral to different strata of services 
is based on the assessment of (rehabilitation) needs and goals. This model is 
implemented in Belgium for patients with Multiple Sclerosis. In the U.S., the U.K., and in 
one Belgian and Swiss centre this is the organisation model for spinal cord injuries. 
Trauma centres in Germany can be compared to this model as well as the Dutch stroke 
networks. 
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As is the case in the basic variant, both mono- and multidisciplinary approaches can be 
organised, and services can be offered in inpatient or ambulatory settings. 
Figure 9.6: Pathology specific trajectory based  
 
9.2.1.4 Stratified rehabilitation model: Goal oriented 
Another option is to consider several organizational levels according to the final goal of 
the rehabilitation: back to work or not (Figure 9.7). It actually refers to one of the 
principles used in Belgium in the federal “Rijksfonds voor Sociale Reclassering van de 
Mindervaliden” or former “Fonds Maron”. (see chapter 5) Within the Fund a main 
distinction was made whether the person to take in charge would be able after the 
treatment to restart work or not.   
Figure 9.7: Goal oriented model 1 
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Some elements of this model can be found in the German geriatric rehabilitation model, 
and –also for the older age groups, in the somatic nursing homes in the Netherlands. 
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However, one can certainly not say that countries are exclusively orienting their post-
acute rehabilitation on goal oriented models. 
9.2.1.5 Managed Care Rehabilitation Model 
In a managed care model (Figure 9.8) as currently applied in the U.S., a patient’s health 
care services utilization is managed by the insurance company. Insurance authorization 
is needed for some services. The highest level of coverage is only guaranteed for 
services from providers affiliated with their managed care plan. Some ideas of this 
model can be found in the German and the Dutch models. Germans are members of 
sickness funds buying in services and the Dutch model of insurance is also based on a 
provider-purchaser model. In these countries this managed model is much more 
embedded in a welfare state logic than in the U.S. (See chapter 8). 
The principle of contracting health care providers is not applied yet in Belgium and 
would require a fundamental shift in the health services approach. However, the 
principles of managed care could also be implemented in Belgium for example by 
insurers of working accidents or traffic accidents. 
Figure 9.8: Managed care model for rehabilitation 
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9.2.1.6 Recommended conceptual rehabilitation model 
The first proposed stratified rehabilitation model in the post-acute phase is considered 
as the best option. It would require an optimisation of the current informal organisation 
model of musculoskeletal and neurological rehabilitation in Belgium. 
Moreover, the principles are comparable to rehabilitation models in the Netherlands, 
Germany, France and Sweden.  
The model presented in Figure 9.3 fits best. First, the existing rehabilitation 
organizations apply for a payment system according to one of the three levels (general, 
specific, highly specific). Compared to the current Belgian reality we assume that most 
organisations with a convention 7.71 are comparable to highly specific rehabilitation 
services.  
The current situation is far less clear for the specific level. The differentiation between 
organisations with a convention 9.50 and organisations only reimbursed via K-
nomenclature is very confuse, due to the important overlap in the patient target groups 
as well as in the price for the item-of-service. Organisations with a 9.50 convention 
come closest to the concept of a specific centre, those with nomenclature to general 
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rehabilitation. However, some of these might be competitive as a specific or even highly 
specific organisation. 
Clear requirements have to be set at the specific and highly specific levels on expected 
performances and on human resources, infrastructure and equipment. Patient target 
groups need to be redefined in order to avoid overlap.  
The number of specific and highly specific organisations needs to be based on 
epidemiologic and geographical data. Follow up through systematic central registration 
will be necessary in order to avoid eventual under- or oversupply.   
9.2.2 A Patient Classification System (PCS) to support the referral process 
The conceptual stratified rehabilitation model should be supported by a patient 
classification system. 
Criteria related to diagnosis, required intensity of care, rehabilitation needs and goals as 
well as personal and environmental factors, are needed to refer patients to a certain 
type of organisation in a stratified rehabilitation network (see chapter 3).  
Ideally one should strive for a PCS supporting patient referral (clinical decision making) 
as well as resource allocation and quality assessment 100 (see chapter 3). 
• One common tool for both purposes makes it easier to respect the 
desired interaction between the resource allocation process and the 
rehabilitation services; 
• Only one registration is required; 
• Technical and financial efforts will result in benefits on both domains. 
Figure 9.9: Principles of an ideal Patient Classification System (for detailed 
information on this figure see chapter 3) 
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The comments of consulted international experts (chapter 3) illustrate both the 
potential value of such a PCS but also the doubts on the compatibility of both goals 
(clinical and managerial) when looking at the existing scales. 
Some observations on existing PCS: 
• ICF can serve in the mapping of the results of technical, clinical and 
health-status measurement tools. However, the scope of ICF is much 
broader than the areas relevant for clinical use, and it does not assist 
the clinician in selecting the most salient aspects of functioning to 
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assess, or the specific instruments to use in that assessment for a given 
individual. The ICF Core Sets are expected to offer a solution for this 
problem but problems are still remaining234, 96, 235, 236, 117. Moreover, ICF 
does not meet a number of basic requirements for scientific 
classification due to a lack of a clear definition for all the components. 
It is not clear yet how researchers will handle this obstacle. ICF can 
currently be used as a conceptual framework but the operational 
application of ICF is still experimental.  
• Most other patient classification systems that were found only support 
resource allocation (see infra). 
The PCS currently used for resource allocation in some countries (For example: IRF-
PAI, AN-SNAP, CRAFT) were extensively discussed in chapter 3. 
They typically include 3 parts:  
• medical diagnosis (impairment category) 
• estimation of functional disability  
• registration of additional factors that typically influence the 
rehabilitation process like co-morbidities, age or social factors. 
FIM-FRG (developed in the USA; led to IRF-PAI, AN-SNAP and to some principles in 
the German classification system etc.) uses FIM to estimate functional disability for 
inpatient post-acute rehabilitation and explains 30 % of variance of costs within the 
American Inpatient rehabilitation system23, 22. Although only covering some aspects of 
ICF, this is a first step in predicting and controlling resource allocation for in-hospital 
post-acute rehabilitation. As additional factors in this system, impairment codes, age and 
co-morbidities are used. 
The already existing PCS for managerial purposes have some disadvantages.  
Some PCS like IRF-PAI are only applicable for inpatient or for outpatient rehabilitation 
and do not cover the whole continuum of rehabilitation care. AN-SNAP (developed in 
Australia based on FIM-FRG) is an exception (see chapter 3); moreover it is specifically 
developed for smaller countries in order to avoid that some PCS-classes contain only 
few patients.  
PCS for hospitalised patients include the results of tools which measure level of 
independence concerning ADL (FIM). These results are rather an indicator for burden 
of general nursing care and do not indicate rehabilitation needs. Patient groups within 
these PCS are homogeneous for resource needs during a hospital stay (e.g. Length Of 
Stay (LOS)) but not for resource needs for rehabilitation. During the development of 
FIM-FRG (and subsequently IRF-PAI and AN-SNAP), these “mistakes” were made 
voluntarily, because no other measurement tool except FIM had been sufficiently 
validated for almost all diagnostic categories in rehabilitation care (which is necessary 
for financial purposes). The option to use LOS (and not therapy intensity) as an 
indicator for resource allocation was taken because regarding therapy needs, practices 
and opinions among rehabilitation specialists are divergent (as we also demonstrated in 
chapter 6 and 7) and evidence in the literature is still scarce23, 22.  
The countries currently using these PCS systems are aware of the difficulties 
mentioned, and research is going on to develop a managerial system based on ICF. 
Moreover, efforts are made to make sure that this new system will fit with the financing 
systems already in use.  
These PCS are often expensive tools and require investments in software applications 
and probably also in hardware. Even an existing PCS should first be validated in the 
Belgian context and no Belgian data are available till now. 
As already outlined in chapter 4, the validation of a PCS available in other countries 
could go hand in hand with a validating exercise of the existing Belgian registration 
system MVG-RIM2, which also includes some measures of level of independence 
concerning ADL, for inpatient rehabilitation managerial purposes. 
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9.2.3 Planning of rehabilitation services 
9.2.3.1 General rehabilitation (mono-disciplinary and simple multidisciplinary): bottom-
up 
To ensure accessibility at this level, no restrictions should be set on the number of 
organisations. General rehabilitation services should be provided geographically 
widespread (bottom-up approach). It could be considered to allow these organisations 
to admit patients with complex needs in the chronic phase, as these people do not 
always have easy access to adapted temporary intensive rehabilitation (e.g. in nursing 
homes).  These services can be delivered by the departments of Physical Medicine and 
Rehabilitation, present in most of the acute hospitals. 
9.2.3.2 Complex multidisciplinary rehabilitation: top-down 
Decision-makers should define the number of organisations needed based on 
epidemiological data and evidence about intensity, content and duration of rehabilitation 
therapy. As this information is not yet available in Belgium, it is currently not possible to 
plan in such a way. An epidemiological monitoring of musculoskeletal and neurological 
disorders and a follow up of the developments in rehabilitation sciences is necessary. 
For this last purpose, an international research collaboration is recommended.  
Planning of rehabilitation services requires a central database in which data of delivered 
services and activities as well as patients’ profiles are registered, in order to dispose of 
relevant information concerning musculoskeletal and neurological rehabilitation in 
Belgium. 
Besides musculoskeletal and neurological rehabilitation, other types of rehabilitation 
(e.g. cardiac and pulmonary rehabilitation) should be considered while planning 
rehabilitation services in order to increase efficiency. These types of rehabilitation might 
be  offered in a comparable administrative framework with similar infrastructure and 
equipment. 
9.2.3.3 Estimation of the number of needed rehabilitation services for the five selected  
pathologies 
As mentioned earlier, in Belgium there is no central registration of rehabilitation 
activities or patient profiles. 
In order to estimate the need for rehabilitation services an attempt is made to define 
the number of patients needed to be treated within these facilities, at least for the five 
selected pathologies in this study. 
These data need to be interpreted with very great caution as they are based on 
incidence and prevalence figures obtained by extrapolation of other countries (Chapter 
2), completed by Belgian expert opinion and some RIZIV/INAMI data.  
There are some specific aspects in the Belgian context making that a model of services 
supply cannot be merely copied in Belgium. Here is referred to Belgium as a federal 
state with different regions and communities. Distances are small but the population 
density is very high as compared to other European countries. 
The aim of this estimation is merely to give an idea on how to start, and the services 
supply should be corrected where necessary in the future, based on exact data once 
they are available. 
This estimation is based on the incidence/prevalence as developed in Chapter 10, Figure 
10.5. 
The report of the Ministerial subgroup for locomotor and neurological rehabilitation131 
is also taken into account as this is the result of a reflection process and dialogue 
between different Belgian stakeholders, during more than a year of discussion and 
dialogue.  
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TOTAL HIP REPLACEMENT 
The assumption is that 85% of the patients with THR have only temporary and simple 
rehabilitation needs, wich can usually be covered by monodisciplinary treatment. About 
15 % of the patients are considered as fragile (mostly after traumatic hip fracture) or 
present with polypathology (e.g. rheumatoid arthritis, stroke or polyneuropathy). These 
patients may need a simple multidisciplinary approach. 
The required rehabilitation activities in patients with THR can be provided by general 
rehabilitation services, present in most of the acute hospitals. The overall incidence of 
patients with THR in Belgium was  16.599 in 200446. In the Study of prof. Closon of the 
Sp facilities they account for 26% of the hospital stays24. 
 
LOWER EXTREMITY AMPUTATION 
The incidence of LEA is difficult to estimate in Belgium as in literature it is not always 
specified which amputation levels are included. In the Sp-study by prof. Closon LEA 
accounts for only 3 % of the hospital stays24. The majority of LEA is due to vascular 
disease (82%), mostly in diabetic patients. A minority are traumatic (9%) or oncological 
(9%)237. In other studies the percentages of vascular causes are often even higher. About 
half of the patients with LEA are fitted with a prosthesis66. Patients who are not fitted 
with a prosthesis can usually be treated in general rehabilitation services (except e.g. for 
bilateral above knee amputation). 
Based on literature, expert opinion and RIZIV/INAMI data the assumption is that in 
Belgium there are about 600 new prosthesis patients each year. Of these prostheses, 
the proportion above knee/below knee is approximately 50/50%. 
The majority of the LEA needing a prosthesis can be treated in specific services. In 
order to admit 30 new LEA patients per centre per year maximum 20 specific centres 
are needed. 
The patients with above knee amputation, associated problems (traumatic or 
oncological etiology) and younger age, with broader rehabilitation goals, can even need 
highly specific services. Technology has become very specialised and the indication for 
expensive knee mechanisms such as microprocessor knees should depend on the 
decision of a highly specialised multidisciplinary team. For the small number of patients 
(maximum 10 %) with highly specific needs (associated problems, high technology needs, 
pelvic level of amputation for traumatic or oncological reasons), 2 to 3 centres are 
sufficient which need to collaborate with the specific centres in the network. For 
reasons of efficiency the highly specific centres could combine the specific function for 
the own region. 
SPINAL CORD INJURY 
The incidence of spinal cord injury in Belgium is estimated between 1 and 3/ 100.000 / 
year. Nearly all present with complex rehabilitation needs. These patients need 
treatment in highly specific services. 
This means that there are about 200 new SCI patients per year in Belgium (100-300). 
Considering, as is defined in the report of “the Ministerial subgroup for locomotor and 
neurological rehabilitation”, that a total critical mass of minimum 30 patients/day and 30 
new patients per year is needed this brings us to a total of three or four centres for 
Belgium. This still means 1 centre for 2.500.000 inhabitants whereas abroad there 
usually is one centre for 4 to 6.000.000 inhabitants (e.g. UK and France 12 centres, 
Denmark 2 centres). 
These highly specific centres need to work in collaboration with a network of specific 
centres, for instance if the distance to the highly specific centre would be to important 
for ambulatory treatment. 
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STROKE 
In Belgium there are about 19 000 new stroke patients per year (incidence 185/100 
000/year). Half of these occur after the age of 75 and only 25 % before the age of 65. 
According to the gold fist rule of Fortune and Wenn238 approximately 1/3 dies, 1/3 
recovers and 1/3 presents with permanent disability (n= 6300). Of these about half is 
younger then 75, and even less are younger then 70. A considerable number of the 
elderly patients can be treated in general services or in geriatric services. 
About 15 % of stroke patients need rehabilitations services in order to obtain the 
predefined rehabilitation goals (n= 2860). As the incidence of this pathology is quite 
high, these services can be provided by specific services in function of the complexity of 
the rehabilitation needs and goals. In chapter 10 is described how protocols for 
standard patients within the different pathology groups were developed. The mean 
length of stay was estimated at 16 weeks. A specific subgroup needs highly specific 
services: the (mostly hemorrhagic) younger patients whose clinical profile is rather 
comparable with that of TBI patients than with ischemic stroke patients. 
In the Sp-study of Prof. Closon24 stroke patients account for 28 % of the inpatients. In 
chapter 5, 16 % of K nomenclature cases is coded 101A (cerebral lesions with 
neurological deficit) and 64 % of the cases of the 9.50 conventions concerns the group 
A2 (Acquired para- or tetraplegia or Brain injury that causes severe neuromotor 
impairments or speech- and language impairments or other severe neuropsychological 
impairments). 
The report of “the Ministerial working group for locomotor and neurological 
rehabilitation”131 states that ‘locoregional rehabilitation centres’, where stroke patients 
ought to be treated in the model they propose, minimum 60 new patients should be 
admitted yearly and 30 patients should be treated daily. The assumption is that a very 
important part of these patients will be stroke patients. 
Based on all these data the estimated number of specific facilities for stroke is between 
25 and 30. However, these data are based on minimum numbers of patients. Of course 
a larger critical mass creates opportunities for a better cost/benefit relation and 
increased efficiency. For the estimation of the needed number of highly specific services 
for stroke patients, data on the incidence of other acquired brain injuries such as 
traumatic brain injury (TBI) are needed, as the patients in this small stroke subgroup will 
probably be partly comparable to this pathology group. 
 MULTIPLE SCLEROSIS 
The crude incidence for MS in Belgium is estimated at 4/100 000/year, meaning 400 new 
patients per year. The prevalence is about 10 000 patients. The assumption was made 
that 10 % of these patients need a hospitalisation during 4 weeks and 1/6 of the patients 
need ambulatory rehabilitation. The first part should be organised in a highly specific 
service. The ambulatory treatment can additionally be provided in specific services 
organised in a network around the highly specific services. 
It is assumed that 2 to 3 highly specific services are needed, as well as about 25 to 30 
specific services. As a reference, in Denmark there are 2 centres for about 7000 MS 
patients. 
 CONCLUSION 
Most of these estimations need to be interpreted with extreme caution, due to the lack 
of real data and the many assumptions and extrapolations that have been made.  
Registration of data should be started as soon as possible by means of a patient 
classification system as described in chapter 3 and in a second phase the estimation can 
be corrected where necessary. 
The planning of the different levels of services supposes the organisation of a network 
through which the patient can be transferred in function of the rehabilitation phase and 
his rehabilitation needs and goals. 
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Summarised, at the level of general rehabilitation planning is not necessary as it is 
assumed that these services can be delivered by the departments of PM&R, present in 
most of the acute hospitals. 
At the level of specific rehabilitation, the number of needed services is between 20 and 
maximum 30. Of course, these specific centres can deliver service to the different 
pathologies. The geographical repartition should take into account the population 
density which varies to an important extent in Belgium. In The Netherlands there are 
for instance 24 centres spread over the country for a population that is 1/3 higher than 
in Belgium. 
Due to low incidence of some pathologies, the highly specific centres should combine 
different pathology groups (for instance SCI, complex amputations, multiple trauma, 
burns and TBI). Some specialised and expensive functions, equipment and infrastructure 
can be shared by different patient groups, for instance a driving simulator, a treadmill 
with body weight support or equipment for functional electrostimulation. The estimated 
number for Belgium is between 3 and 5 centres. 
9.2.4 Evidence based practice: need for research 
Another important issue is the principle of good clinical practice in terms of intensity, 
content and duration of a rehabilitation programme. Unfortunately, up to date only little 
evidence is available concerning these factors. Rehabilitation interventions must be 
evidence based and have a proven added value to achieve the defined goals. 
The variability in clinical practice and clinical pathways (see Chapters 6 and 7), is related 
to a lack of scientific evidence to support clinical decisions in rehabilitation. This is the 
main weakness of rehabilitation. 
For this reason a research program, preferably in an international collaboration, is 
needed in rehabilitation lining up with studies on the effectiveness and quality of 
rehabilitation activities. Similar programmes are being launched in The Netherlands, 
Germany and North-European countries. 
9.3 MEASURING QUALITY: A REQUIREMENT FOR POST-
ACUTE REHABILITATION. 
One of the important issues for the near future is developing tools to assess and 
support the appropriateness of payment and coverage policies. For rehabilitation, a 
specific agenda will be needed on the development of quality systems. It is 
recommended to reflect on and develop quality (and/or accreditation) systems in 
rehabilitation for the different phases in the disease/illness trajectory. These phases have 
particular characteristics and different purposes. As mentioned earlier: acute care is a 
rather discrete event with a clear beginning and end. Post-acute care refers to the 
period of care that follows an acute event. Chronic care is defined by long-term, 
ongoing treatment. Patients needing post-acute care may require ongoing, chronic care, 
because of pre-existing conditions or as a result of the severity of the acute event. The 
integration of the phases is relevant when developing quality systems for the 
rehabilitation sector as a whole. Developing quality indicators and quality measures for 
post-acute rehabilitation should therefore be done against the background of the 
rehabilitation trajectory. 
At first, considerations have to be made about outcome measures, as these measures 
can have a place in clinical practice, in research or in policy questions. This distinction 
has to be kept in mind when developing a system, especially since many instruments are 
available. The different purposes should however be built on a common trunk. When 
developing a useful quality measurement system the measures (“what?”) should be 
aligned to the purposes (“why?”). Policy issues (and needs) are not the same, even 
necessarily in line with, clinical or research issues. This conceptual quality framework 
should have primarily a policy relevance. 
The lack of evidence about the effectiveness of post-acute care use is a particular 
problem for developing quality indicators or measures. The measurement of ‘added 
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value’ or outcome of a rehabilitation process is rather difficult because a lot of 
independent variables influence this outcome. Besides the identification of rehabilitation 
needs and goals other factors need to be taken into account to select appropriate 
intervention strategies: 
• Patient and environment related factors, such as age, motivation, social 
situation or profession (contextual factors)  
• Disease related factors, such as nature and course of the disease, 
individual variability throughout the disease course, age at disease 
onset, availability of disease modifying agents, disease stage. 
Some fundamental work still has to be done, also because of the lack of uniform 
outcome measures in rehabilitation. It is currently almost impossible to assess 
systematically the outcomes of rehabilitation as existing instruments measure functional 
status in different ways. The available patient assessment instruments make it difficult to 
identify whether similar patients are treated across different settings.  
The reflection on outcome measures within a quality approach should as much as 
possible line up with the current efforts being done to use and implement the ICF 
framework (as is the case internationally). It is recommended to choose as much as 
possible those instruments falling within one of the dimensions of ICF. Outcome 
elements not covered by the ICF framework (e.g. quality of life, satisfaction) and end 
points such as mortality should not be forgotten. These other dimensions have to be 
developed at longer time notice and international collaboration is needed on this issue. 
Moreover, many of the measures identified as potentially important in understanding 
quality of post-acute care, are not included in existing administrative data. It lacks 
objective and other (e.g. quality of life, integration) measures as well as global and 
disease specific process measures. Existing data sets may serve a variety of purposes, 
but currently do not include information needed to measure post-acute care quality and 
outcomes. They do not contain information needed to adequately measure the quality 
of care within and across post-acute care settings. 
Several countries are currently trying to develop and implement quality and 
performance measurement and try to connect it (at least the outcome measures) to the 
financing of the post-acute and long term rehabilitation. It is recommended to analyse 
these efforts and make an assessment on how performance and quality measurement 
could be integrated in the Belgian (post-acute) rehabilitation model. An analysis of their 
methods to develop quality systems for daily practice, in a context of limited scientific 
evidence would offer an added value.  
At short notice, it will not be possible to develop a quality system able to determine 
whether post-acute care has successfully maximized a patient’s function, allowing return 
to the most independent living environment, and reintegration into prior activities and 
lifestyle. This question should be dealt with on middle term. In a first stage, a model 
“light version” for a quality measurement system could be prepared, at least to compare 
activities, patient profiles and maybe some functional outcomes. The tool should enable 
a comparative analysis of post-acute facilities as a “benchmark”. It will offer a basis to 
debate profiles and (in due time) outcomes of activities of post-acute facilities.  
The “light” instrument should at least measure functional level, (some) pathology-
specific elements, some additional measures for risk adjustment (social characteristics, 
co-morbidity, …), and some items concerning patient’s perception. A longitudinal 
method would be ideal using an admission instrument and a follow up instrument for 
each patient, in order to compare base-line functioning and follow up function of each 
patient in different phases of the rehabilitation process (compare the Swedish registers). 
At short notice a cross sectional approach (e.g. an adapted MVG-RIM2) might the most 
feasible approach to get some basic quality indicators. 
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Key Points 
• Belgium needs to develop an explicit conceptual framework for the 
organisation of post-acute musculoskeletal and neurological rehabilitation. 
• It is proposed to develop a stratified rehabilitation model in which the 
roles of rehabilitation organisations can be identified, taking into account 
characteristics of patients’ needs, disease trajectories, rehabilitation goals 
and epidemiological and geographical needs.  
• The stratified rehabilitation model rehabilitation is organised around three 
differentiated types of rehabilitation services, taking into account patients’ 
rehabilitation needs and goals: general rehabilitation services, specific 
rehabilitation services, highly specific rehabilitation services. 
• The conceptual stratified rehabilitation model should be supported by a 
patient classification system: a systematic assessment of patients’ 
rehabilitation needs in the acute phase of the disease trajectory (PCS), 
within the framework of an outcome model as ICF. 
• Two criteria are used for separating the levels in this structure: complexity 
of rehabilitation needs and goals, and incidence and prevalence of 
consequences of health conditions.  
• An equitable geographical distribution of general rehabilitation services 
should be pursued (bottom-up). 
• A maximum of 20 to 30 rehabilitation centres are estimated to be 
necessary at the specific level; and 3 to 5 at the highly specific level. 
• Alternative options for the stratified rehabilitation model are given. 
• An epidemiological monitoring of musculoskeletal and neurological 
disorders and a follow up of the developments in rehabilitation sciences is 
important. Central registration of delivered services and activities is 
necessary. Based on these data, the proposed estimation of centres and 
services can be refined in the future if necessary. 
• Quality evaluation is an important part of every organisational/financial 
structure. Basic data registration is a first step to evaluate the 
rehabilitation process. In the Netherlands and Germany, quality and 
performance indicators are used, even without the use of a formal patient 
classification system (PCS). In the US, an accreditation system is available 
(CARF); according to experts a European accreditation system is under 
development.  
220 Musculoskeletal & Neurological Rehabilitation KCE reports 57  
 
10 COSTS, REVENUES AND RIZIV/INAMI 
EXPENDITURES FOR POST-ACUTE 
MUSCULOSKELETAL AND NEUROLOGICAL 
REHABILITATION 
10.1 INTRODUCTION 
In this chapter, we explore the possibility of calculating costs and revenues of five 
relevant pathologies. The analysis is based on the five pathologies selected in chapter 2 
and examined in chapter 6 and 7.   
Because of the limited evidence-based literature available on post-acute rehabilitation, 7 
experts were asked to propose a rehabilitation protocol for an average patient with 
one of the five selected pathologies and some sungroups. Expert opinion was also used 
to estimate Belgian incidence of rehabilitation needs per pathology when no other 
information was available.  
It should be stressed that these proposed rehabilitation protocols are subjective 
estimates and not scientifically proven to be “ideal”: e.g. the experts’ estimates of the 
average duration or average number of sessions per week showed a large variation. 
However, the methodology has also been used in a recent part of the HealthBASKET 
study by the European Commission239, in case no other possibilities were available to 
estimate costs and revenues. 
Consequently, estimates of costs and revenues as presented in this chapter and in the 
following chapter should not be interpreted as precise estimates of costs and revenues 
in the actual situation, with the current rehabilitation practices, nor of the precise costs 
of the standard rehabilitation protocols as defined by the experts. More precise 
estimates would require data from more rehabilitation centres (cf infra) and better data 
on the multidisciplinary rehabilitation activities in the five selected pathologies.  The 
methodology does illustrate, however, some possible weaknesses of the current 
reimbursement system for rehabilitation and its possible effects in terms of generating 
discrepancies between costs and revenues. The protocols are examples of –according 
to the experts- rehabilitation requirements for an ‘average’ patient. For these 
rehabilitation paths, costs and revenues under the current reimbursement system are 
calculated. The figures will not be indicative of the actual costs, revenues and 
RIZIV/INAMI expenditures to be expected in practice but give an indication of the 
order of magnitude of costs, revenues and expenditures for these protocols. From this, 
inferences are made about the likely effects of the current reimbursement system. 
Policy decision should not be based on the actual value of the estimates. 
10.2 METHODS 
In this chapter we calculate costs, rehabilitation centre revenues and RIZIV/INAMI 
expenditures for the post-acute phase of the following pathologies (already examined in 
previous chapters): total hip replacement (THR), amputation of a lower extremity with 
prosthesis (LEA), spinal cord injury (SCI), stroke and multiple sclerosis (MS), THR, LEA 
and SCI were further subdivided into subgroups.   
For THR two subgroups were made in the post-acute phase. The assumption is that the 
“standard” THR patient can be helped with (monodisciplinary) treatment in the acute 
phase. The first subgroup in the post-acute phase comprises patients presenting with 
“polypathology”. Polypathology refers to pathology with clear functional impairments 
such as stroke, polyneuropathy, Parkinson's disease or rheumatoid arthritis. The second 
subgroup are the “fragile” patients needing a more extensive multidisciplinary treatment 
than provided by the standard THR rehabilitation protocol. Mostly this group consists 
of trauma patients.  
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In the LEA group the first subgroup consists of transtibial (below knee (BK)) 
amputations and the second subgroup of knee disarticulations and transfemoral (above 
knee (AK)) amputations. 
The SCI group is divided in function of the level of lesion: paraplegia or tetraplegia. For 
MS and stroke there are no further subgroups. For LEA subgroup AK, SCI both 
subgroups, stroke and MS a distinction was made between rehabilitation during 
hospitalization and ambulatory rehabilitation. For THR only a hospitalization phase was 
considered. As shown in Figure 10.1, this amounts to 13 distinct categories, of which 8 
inpatient and 5 outpatient categories. 
Figure 10.1: Pathologies considered in the cost, revenues and expenditures 
analysis 
Pathology Main Groups Pathology Subgroups 
Polypathology hospitalisation THR 
Fragile hospitalisation 
hospitalisation Above knee 
ambulatory 
LEA 
Below knee hospitalisation 
hospitalisation Paraplegia 
ambulatory 
hospitalisation 
SCI 
Tetraplegia 
ambulatory 
hospitalisation MS 
ambulatory 
hospitalisation Stroke 
ambulatory 
Because insufficient evidence on good rehabilitation practice was found in literature, a 
group of 7 experts was invited to estimate the most optimal rehabilitation path for each 
of the five pathologies and their subgroups.  
Information of experts has been used in other studies when little or no other 
information was available. The experts are physicians specialised in rehabilitation 
medicine, six of them with a background of physical and rehabilitation medicine and one 
with a neurology background. They are professionally active in the different Belgian 
regions (Flanders, Wallonia and Brussels) and in university as well as non-university 
rehabilitation centres. The experts worked in a very constructive way but insisted 
unanimously on the fact that a lot of assumptions were made at different levels 
(duration of therapy, intensity and type of therapy, setting, …) and that the estimations 
based on the developed “standard” protocols might be very different from the real 
needs, since to their knowledge little information is available in the literature. Also, 
according to the stratified rehabilitation model (chapter 9), patients should be referred 
to different levels of rehabilitation services in function of their rehabilitation needs and 
goals, as defined by means of a patient classification system (Figure 9.9) (cfr. Chapter 9). 
The standard protocols as defined by experts consensus only took the pathology into 
account. However, there seemed to exist a  consensus on the protocols as developed 
during the meeting and summarised by the researchers. The methodology was as 
follows.   
First, the experts determined a reference rehabilitation path for an ‘average’ patient.  
This reference treatment specifies: 
• the number of weeks treatment is needed 
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• the number of hours per week a rehabilitation specialist is involved  
• the number of sessions per week of paramedical input (subdivided into 
individual and group (4 individuals) rehabilitation activities and into the 
type of discipline involved (e.g. physical therapy, occupational therapy, 
speech therapy, social work, sports therapy, nursing and psychology). 
An example of the reference treatment path for THR with polypathology requiring 
multidisciplinary treatment is presented in Figure 10.2 
Figure 10.2: Treatment path for an average patient with THR and 
polypathology 
Hospitalization in a rehabilitation centre  
Number of days  25     
Number of weeks 3.6     
Medical input hours/week total hours per stay   
Rehabilitation specialist 0.75 2.7   
      
Paramedical input hours/session number of sessions 
per week 
total hours per 
stay 
Multidisciplinary treatment  5 20.09 
  Individual 1    
  Group sessions (4 patients/group) 0.5    
        
Fractions     
Physical therapist 60%    
Occupational therapist 30%    
Speech therapist 0%    
Social worker 10%    
Sports therapist 0%    
Nurse 0%    
Psychologist 0%    
10.2.1 Calculation of costs 
Allocating operating costs, depreciations and overhead costs is relatively complicated.  
Nine different rehabilitation centres were asked to fill in a template in order to provide 
data on : 
• Medical and paramedical staff  
• Operating expenses, depreciations and overhead 
• Surface area of the rehabilitation centre (inpatient ward and 
rehabilitation rooms) 
• Annual activities, i.e. number of sessions K20, K30, K60, M and 
concention 9.50 
Four different rehabilitation centres returned the template: one was incomplete and 
could not be used for the analysis, three were used to calculate cost.  The other 
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centres were contacted again in order to know why they did not collaborate.  The 
following reasons were given: anonimity insufficiently guaranteed, data difficult (or 
almost impossible) to collect, more time (and resources) needed. 
In a first step total operating costs (excluding wages) and depreciation costs of the 
rehabilitation centre and general overhead costs were allocated to the inpatient ward 
and the rehabilitation rooms using their respective surface areas. Then, total annual use 
of rehabilitation rooms was calculated by adding up the different number of sessions, 
each multiplied by their respective duration (e.g. 5000 sessions K60 generate 10000 
hours).  This procedure yields the total number of hours per year that the rehabilitation 
rooms are used.  Dividing operating costs, deprecations and overhead costs allocated to 
rehabilitation rooms by their annual use (measured in patient hours) leads to an 
overhead costccc per patient hour: 12.44 Euro/hour in centre 1, 15.62 Euro/hour in 
centre 2 and 25.51 Euro/hour in centre 3.  The variables and numbers used in this 
calculation are reported in Figure 10.3 
Figure 10.3: Allocation of overhead costs to a patient hour of rehabilitation 
in three centres (Euro) 
 Centre 1 Centre 2 Centre 3 
Overhead cost rehabilitation centre 1 392 780 1 427 224 1 481 330 
Surface area Hospitalization ward 1 806 885 1 836 
Surface area rehabilitation rooms 637 847 1 160 
Overhead cost allocated to Hospitalization ward 1 029 657 729 365 907 969 
Overhead cost allocated to rehabilitation rooms 363 122 697 858 573 361 
Activities rehabilitation rooms (total number of hours) 29 194 44 675 22 474 
Overhead cost rehabilitation rooms per patient hour 12.44 15.62 25.51 
Multiplying these overhead costs per hour by the number of hours of rehabilitation 
activity according to the protocols yields an allocated overhead cost for every patient in 
a specific pathology.  Depending on the scenario (€ 15/hour, i.e. relatively close to the 
overhead costs of centre 1 and centre 2 or € 25/hour, i.e. relatively close to the 
overhead costs of centre 3), allocated overhead costs account for 26%-27% of total 
costs (scenario 1) or 36%-38% of total costs (scenario 2). 
Secondly, personnel costs were calculated. Using annual wage cost (seniority of 15 
years) for medical and paramedical input and accounting for the number of working 
hours per year, it is possible to calculate the cost of one hour of medical and 
paramedical (subdivided into 7 categories) input. This wage cost should also be 
considered as approximative; it was calculated based on the average of the 3 
rehabilitation centres that returned information. It does not take the employment of 
students or junior doctors, who receive a lower or no wage, into account. The 
consequence of this approach is that personnel costs may be overestimated. One of the 
three centres did confirm working with students or assistants. For medical specialists, 
cost per hour is estimated based on the annual wage cost at a university hospital, where 
physicians are salaried. It should be noted that in non-university settings physicians are 
usually self employed. The cost of medical input for the hospital is therefore lower but 
this cost is not a good representation of the opportunity cost of one hour of medical 
input. The cost of medical input in a non-university centre underestimates the real 
opportunity cost. It can be argued that the conditions for using wages of medical 
specialists at university hospitals as an estimate for opportunity costs are not met, but 
unfortunately it is the best proxy we have. Therefore, the salary of physicians working 
in a university setting was considered as the best proxy for the real cost. These annual 
wage costs and costs per hour (assuming 1626ddd hours of work per year) are reported 
                                                
ccc  In the following tables, the concept ‘overhead costs’ includes operating costs (excluding wages), depreciation 
and overhead of the rehabilitation centre. 
ddd  Taking into account working hours per week, public holidays, holidays. 
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in Figure 10.4. Concerning the wage cost of the speech therapist it should be noted that 
for this exercise the cost of a therapist with an “A1” degree was used whereas there 
are also speech therapist with a university degree. So in the future a possible increase in 
this cost should be taken into account. 
Figure 10.4: Annual wage costs and costs per hour of human resources 
inputs (Euro) 
 Annual cost Cost per hour 
Medical input 
  
Rehabilitation specialist 120 402 74.05 
Paramedical input   
Physical therapist 63.840 39,26 
Occupational therapist 49.497 30,44 
Speech therapist 49.497 30,44 
Psychologist 63.840 39,26 
Social worker 49.497 30,44 
Sports therapist 63.840 39,26 
Nurse 49.497 30,44 
Combined with the number of weeks, hours per week and sessions per week specified 
by the reference rehabilitation path (protocol) total staff costs can be calculated for the 
selected pathologies and their subgroups.   
10.2.2 Calculation of revenues and RIZIV expenditures 
The theoretical revenues and RIZIV expenses of the centres providing on average 
rehabilitation services according to the protocols defined by the experts are estimated 
by applying the current reimbursement mechanisms for musculoskeletal and 
neurological rehabilitation in Belgium to the rehabilitation protocols of the five 
pathologies under consideration. Given that different pathologies can be treated within 
different reimbursement systems (K30/K60 nomenclature, convention 9.50 and/or 
convention 7.71), three scenarios were built to estimate the range of likely revenues 
associated with the rehabilitation protocols.  
Currently, THR can only be reimbursed by means of K30/K60 nomenclature. 
Moreover, a royal decree for the implementation of a K45-nomenclature for large joint 
replacement is waiting for publication. A K45 will probably be worth €46.62 and 
represents a session of 90 minutes.  
All other pathologies can be treated either by K30/K60 or by a 9.50 convention. With 
the exception of LEA below knee, all pathologies included in the 9.50 convention can in 
principle also be treated in a 7.71 centre. We should note that the K30/K60 system is 
insufficient to finance the entire treatment path as defined by the experts for LEA above 
knee, SCI, MS and stroke, as more sessions are needed for these pathologies than 
reimbursed by the K30/K60 system (limited to 60 or 120 sessions depending on the 
pathology).  
The revenues are calculated using the full price of the K30/K60 nomenclature, 
convention 9.50 and convention 7.71. The full price covers the reimbursement tariff and 
the patient out-of-pocket payment. We used the tariffs that are applicable since January 
2007. An overview of the tariffs applied to the five pathologies in the three (or less if 
some systems are not applicable) reimbursement systems is provided in the Appendix 
to chapter 10. 
It should be noted that for some items in the protocol, no precise reimbursement tariff 
could be identified. For example, if a patient gets one individual session of 2 hours and 
one group session of 1 hour per day, this can only be charged to the RIZIV/INAMI as 
one K60 (or R60 in convention 9.50), as centres can charge only one K60 per patient 
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per day. No specific reimbursement exists for group sessions. Therefore, group 
sessions are in principle reimbursed as individual sessions. For example, a group session 
of 2 hours is charged at one K60 per patient in the group.  
For pathologies that are treated in a convention 7.71 centre, the number of hours per 
session became less relevant (from the sponsor’s point of view), in the sense that all 
hospital sessions are reimbursed through a day lump sum and ambulatory sessions 
between 1 and 3 h as a half day lump sum and sessions between 4 and 6 hours as a day 
lump sum. We did have to choose, however, between the tariffs we applied for a half 
day or day rehabilitation, as the lump sums differ significantly between the 7.71 
convention centres. For all pathologies except MS we applied an average lump sum of all 
centres of €119 per day of hospital treatment, €56 per half day ambulatory treatment 
and €103 per day ambulatory treatment. For MS, which is particularly treated in 2 
specialised centres with higher lump sums, the average lump sum of these 2 centres was 
used. 
10.2.3 Extrapolation to the Belgian population 
From the unit costs, revenues and expenditures for the protocols of the five 
pathologies, we estimated the total costs, revenues and RIZIV expenditures for Belgium 
by means of extrapolation. For the extrapolation, we needed an estimation of the 
number of patients needing treatment for each selected diagnosis group. This is 
summarised in Figure 10.5.  
Figure 10.5: Incidence of multidisciplinary rehabilitation requirements in 
Belgium for 5 selected pathologies 
Pathology   Incidence 
Total Hip Replacement   16.599 
THR polypathology needing multidisc rehab Hospitalization 830 (5%)  
THR fragile needing multidisc rehab Hospitalization 1.660 (10%) 
Lower Extremity Amputation   1.200 
LEA below knee needing multidisc rehab Hospitalization 300 (20%) 
LEA above knee needing multidisc rehab Hospitalization 300 (20%) 
  Ambulatory 300 (20%) 
Spinal cord Injury   200 
SCI (para) needing multidisc rehab Hospitalization 100 (50%) 
  Ambulatory 100 (50%) 
SCI (tetra) needing multidisc rehab Hospitalization 100 (50%) 
  Ambulatory 100 (50%) 
MS   10.000 
MS needing multidisc rehab  Hospitalization 1.000 (10%) 
MS needing multidisc rehab  Ambulatory 1 500 (15%) 
Stroke   19.000 
Stroke patients needing multidisc rehab Hospitalization 2.850 (15%) 
  Ambulatory 2.850 (15%) 
To calculate these incidences, data from chapter 2 were taken into account. When 
more information was needed, Belgian experts in the specific field under consideration 
were contacted and for LEA some RIZIV/INAMI data were used. 
The incidence of THR in Belgium46 was 16 599 in 2004. Experts in the field of THR 
estimated the percentage of fragile patients 10% (mostly the THR due to trauma) and 
the percentage of patients presenting with polypathology 5%. 
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Rommers237 found an incidence of LEA in the Netherlands of 19/100.000. He also states 
that about half of the patients are fitted with a prosthesis66. Based on other literature 
data as described in chapter 2 and on data of the RIZIV/INAMI we estimate the 
incidence in Belgium somewhat lower. (RIZIV/INAMI data: number of AK amputations 
in 1995: 653, in 1998: 614; BK amputations in 1995: 448, in 1998: 489; number of 
evaluation prostheses for BK provided in 2005 and 2006: 272 and 303; number of 
evaluation prostheses for AK provided in 2005 and 2006: 213 and 282). Combining 
these data, the number of LEA for Belgium is estimated at 1200/year. About 50% of the 
patients are fitted with a prosthesis, almost as much for AK as for BK. This means 300 
patients for subgroup 1 as well as for subgroup 2, when patients deserving a prosthesis 
are taken into account for post-acute multidisciplinary rehabilitation, and patients 
without prosthesis are assumed to follow monodisciplinary treatment. 
The estimated incidence of SCI in Belgium based on literature (chapter 2) is between 1 
and 3/100000. This seems to be confirmed by a newsletter of ISCoS (International 
Spinal Cord Society) in December 2006. A European survey was performed, using a 
questionnaire that was sent to experts in 21 European countries. The results showed a 
mean incidence of SCI of 1,75/100000. So we estimate the number of new cases in 
Belgium at 200/year, 100 paraplegics and 100 tetraplegics. 
For MS the number of new cases in Belgium yearly is estimated at 400. The prevalence 
in Belgium, which in this case is relevant as it concerns a progressive disorder, is 
estimated at 10 000 (see chapter 2). Based on Belgian expert opinion, it is assumed that 
+15% of the patients need continuous ambulatory rehabilitation, which means 1500 
patients. Based on information of the FOD/SPF Volksgezondheid, Santé Publique 
(Technical Cell), it was estimated that each year 10% of the MS patients need 
hospitalization. These numvers are in line with the Flemish study published in 1998 by 
Carton et al240. 
Concerning stroke we estimate the number of new patients at 19 000/year (see chapter 
2). According to the gold fist rule of Fortune and Wenn238, approximately 1/3 dies, 1/3 
recovers and 1/3 presents with permanent disability. Of these patients only half is 
younger than 75 years and even less are younger than 70 years. Part of these patients 
goes directly to a nursing home and part of them can be treated in a geriatric ward. So 
it is assumed that only about 15% of all stroke patients need post-acute rehabilitation 
services, which brings us to 2860 patients yearly. This assumption was confirmed by the 
real data of a Belgian expert centre (Stroke Unit discharge). 
Especially for ambulatory rehabilitation, the percentages of patients needing 
multidisciplinary rehabilitation are highly uncertain. To account for this uncertainty, a 
beta distribution was applied to each of these percentages. This is the accepted 
distribution for uncertain proportions. The upper and lower limits are essentially 
arbitrary, as there are no data in literature or from centres that can provide a clue to 
the ranges. The lower limit was therefore arbitrarily set at a rehabilitation need of 50% 
of the point estimate and the upper limit at 130% of the point estimate. The point 
estimate itself was defined as the mean of the beta distribution. 
During the Monte Carlo simulation of the costs, revenues and expenditures for Belgium 
as a whole, values are chosen at random from these distributions. This eventually leads 
to total cost, revenue and expenditure estimates with a probabilistic distribution. 95% 
confidence intervals were constructed around the point estimates based on the Monte 
Carlo simulations. The analyses were performed in @risk version 4.5.5. 
Because these five pathologies obviously do not cover the entire population in need of 
multidisciplinary rehabilitation, it was assumed in the extrapolation that these five 
pathologies cover about 75% of the total hospitalization costs and 60% of the total 
ambulatory care costs for multidisciplinary rehabilitation. This is consistent with the 
figures in chapter 2 for hospital rehabilitation and with the reported case-mix of two 
non-university rehabilitation centres in Belgium. To account for the uncertainty 
associated with this 60%, a beta distribution was applied to this variable, with an 
arbitrary lower limit of 30% and an arbitrary upper limit of 78%. The mean of the 
distribution was set at 60%. 
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10.3 RESULTS 
10.3.1 Costs  
Figure 10.6 summarises for each pathology group the number of rehabilitation days (in 
case of hospitalization), of rehabilitation sessions (in case of ambulatory rehabilitation) 
and the number of weeks treatment is needed according to the experts’ protocol. Using 
theoretical hourly wage cost of medical input and of the various paramedical inputs 
combined with total number of hours medical and paramedical input (accounting for the 
different wage levels and their respective fractions of participation to a session), 
theoretical cost of medical staff, costs of paramedical staff and total staff costs were 
calculated. These numbers represent the actual personnel costs that would be incurred 
by a rehabilitation centre following the rehabilitation path as proposed by the expert 
meeting.  It should be stressed that these calculated staff costs only include the cost for 
rehabilitation activities specified by the protocols. For hospitalised patients, hotel 
services, nursing activities etc. are not included in these protocols and hence not 
included in the total costs reported in the following tables. 
The total costs of rehabilitation activities for the various pathologies (i.e. the cost to 
treat one patient according to the specified path), including personnel and overhead 
costs, are presented in Figure 10.7.  
Figure 10.6: Staff costs of rehabilitation protocols of five selected pathologies 
(Euro) 
 According to expert 
protocol 
Calculated staff costs 
  Days (hosp) or 
sessions (amb) 
Weeks Cost 
medical 
staff 
Cost 
paramedical 
staff 
Total staff 
costs 
     
THR polypathology 25 3.57 198 718 916 
THR fragile 7 1.00 56 201 257 
LEA BK  28 4.00 444 1 630 2 075 
LEA AK, Hospitalization 70 10.00 1 111 5 095 6 206 
LEA AK, ambulatory 20 10.00 370 1 853 2 223 
SCI (paraplegia), 
Hospitalization 175 25.00 3 702 16 166 19 868 
SCI (paraplegia), ambulatory 60 20.00 740 2 713 3 454 
SCI (tetraplegia), 
Hospitalization 273 39.00 5 776 24 911 30 687 
SCI (tetraplegia), ambulatory 78 26.00 1 203 3 484 4 687 
MS, Hospitalization 28 4.00 592 2 555 3 147 
MS ambulatory 104 52.00 1 925 4 646 6 571 
Stroke, Hospitalization 112 16.00 2 370 7 075 9 445 
Stroke, ambulatory 120 60.00 2 221 5 360 7 581 
In addition sensitivity analyses with a different number of sessions (deviations of +25% 
and -25% of the reference path proposed by the expert meeting) and different wage 
levels (+10% and -10% of the reference wage level) were performed. Details on these 
sensitivity analyses are reported in the Appendix to chapter 10. 
KCE reports 57 Musculoskeletal & Neurological Rehabilitation 228 
 
Figure 10.7: Costs to the rehabilitation centre of the different rehabilitation protocols for 5 selected pathologies (Euro) 
 
According to expert 
protocol Calculated staff costs 
Allocated overhead costs according 
to duration of rehabilitation activity  
(2 scenarios: € 15/hour and € 
25/hour) 
Calculated total costs 
(staff + overhead) 
  
Days (hosp) 
or sessions 
(amb) Weeks 
Cost medical 
staff 
Cost 
paramedical 
staff 
Total staff 
costs 
Hours 
rehabilitation 
activities 
Allocated 
overhead  
(€ 15/hour) 
Allocated 
overhead  
(€ 25/hour) 
Total cost  
(if overhead 
is € 15/hour) 
Total cost  
(if overhead 
is € 25/hour 
THR polypathology 25 3.57 198 718 916 23 342 569 1 258 1 485 
THR fragile 7 1.00 56 201 257 6 96 159 352 416 
LEA BK  28 4.00 444 1 630 2 075 50 750 1 250 2 825 3 325 
LEA AK, Hospitalization 70 10.00 1 111 5 095 6 206 153 2 288 3 813 8 494 10 019 
LEA AK, ambulatory 20 10.00 370 1 853 2 223 55 825 1 375 3 048 3.598 
SCI (paraplegia), Hosp. 175 25.00 3 702 16 166 19 868 497 7 453 12 422 27 321 32 290 
SCI (paraplegia), amb 60 20.00 740 2 713 3 454 85 1 275 2 125 4 729 5 579 
SCI (tetraplegia), Hosp 273 39.00 5 776 24 911 30 687 775 11 627 19 378 42 313 50 065 
SCI (tetraplegia), amb 78 26.00 1 203 3 484 4 687 114 1 706 2 844 6 394 7 531 
MS, Hospitalization 28 4.00 592 2 555 3 147 80 1 193 1 988 4 340 5 135 
MS ambulatory 104 52.00 1 925 4 646 6 571 156 2 340 3 900 8 911 10 471 
Stroke, Hospitalization 112 16.00 2 370 7 075 9 445 230 3 450 5 750 12 895 15 195 
Stroke, ambulatory 120 60.00 2 221 5 360 7 581 180 2 700 4 500 10 281 12 081 
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10.3.2 Revenues and RIZIV expenses for the rehabilitation protocols under 
current reimbursement rules 
The results of the calculations of the centre revenues and RIZIV/INAMI expenses 
corresponding to each rehabilitation protocol are presented in Figure 10.8: . The table 
shows the revenues per treatment protocol and the RIZIV/INAMI expenditures 
according to the current reimbursement mechanisms. As most rehabilitation 
programmes can be financed through different mechanisms three scenarios are 
presented, 
In addition, the theoretical future revenues for THR under the not yet implemented 
K30/K45/K60 system were calculated (results not in table but described in text). The 
royal decree for the implementation of the K45-nomenclature is waiting for publication. 
A K45 is worth €46.62 and represents a session of 90 minutes. (Note that, according to 
the described protocols, only 15% of all THR deserve multidisciplinary rehabilitation 
(THR combined with polypathology or in fragile patients)). 
For comparative purposes, the total costs borne by the rehabilitation centres for each 
rehabilitation protocol, assuming an overhead cost of €15/hour, are presented in Figure 
10.8: . This comparison shows that for all rehabilitation paths in all reimbursement 
systems, except for ambulatory rehabilitation for MS, the theoretical costs are higher 
than the revenues. For the ambulatory rehabilitation protocol for MS, revenues under 
convention 7.71 are higher than theoretical costs.   
Under the future K30/K45/K60 system, the revenues for the treatment of THR 
polypathology becomes €839.16 and for the treatment of THR fragile €233.10. 
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Figure 10.8: Revenues and RIZIV expenses of standard rehabilitation protocols for five selected pathologies under current reimbursement 
rules (Euro) 
Pathology  Setting 
Centre revenues per treatment protocol 
(total treatment period) according to 
current reimbursement mechanisms 
RIZIV expenses per treatment protocol (total 
treatment period) according to current 
reimbursement mechanisms 
Total costs borne by 
centres applying the 
protocol 
    K30/K60 
Convention 
9.50 
Convention 
7.71 K30/K60 
Convention 
9.50 Convention 7.71  
THR                
THR 
polypathology  Hospitalization 1 119   1 007   
1 258 
THR Fragile  Hospitalization 311   280   
352 
LEA          
LEA BK Hospitalization 1 368 1 368  1 231 1 231  
2 825 
LEA AK Hospitalization 3 419 3 419 6 545 3 077 3 077 6 545 8 494 
  Ambulatory 311 885 1 120 280 832 1 090 3 048 
SCI          
SCI (para)  Hospitalization 7 459 8 159 16 303 6 714 7 414 16 303 
27 321 
  Ambulatory 0 2 469 3 360 0 2 378 3 269 4 729 
SCI (tetra)  Hospitalization 7 459 11 327 25 466 6 714 10 582 25 466 42 313 
  Ambulatory 168 3 377 4 368 168 3 259 4 250 6 394 
MS                
MS  Hospitalization 1 368 1 368 3 663 1 231 1 231 3 663 4 340 
MS  Ambulatory 3 264 6 682 11 440 2 960 6 038 11 283 8 911 
Stroke                
Stroke  Hospitalization 5 470 5 470 10 472 4 924 4 924 10 472 12 895 
  Ambulatory 2 492 6 113 6 720 2 293 5 781 6 539 10 281 
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10.3.3 Extrapolation of costs, revenues and expenditures to the entire 
rehabilitation population in Belgium 
Figure 10.9 presents the results of the extrapolation of the theoretical costs, revenues 
and expenditures per treatment protocol to the entire patient population in need of 
multidisciplinary rehabilitation services in Belgium. The five pathologies were assumed 
to account for 75% of hospital post-acute rehabilitation and 60% of ambulatory 
rehabilitation (see 10.3.3). 
For revenues and expenditures again three scenarios are presented, one for each 
possible financing system. A scenario gives the results of a situation where all services 
for all pathologies are financed through one specific financing system, either K30/K60, 
convention 9.50 or convention 7.71. For example, the revenues and expenditures in the 
convention 9.50 scenario are the revenues and expenditures obtained if all treatments 
of all patients with the pathology are reimbursed within a convention 9.50. In reality a 
mix of the three systems exists but as we have no data on the proportion of treatments 
for each of the pathologies reimbursed through the different financing systems, we 
could not simulate the actual revenues and expenditures if everyone would follow the 
protocols. 
Note that the total expenditures presented for convention 9.50 and 7.71 (last row in 
the table) are incomplete. They do not cover the reimbursement of rehabilitation 
services for THR, as this pathology cannot be reimbursed through one of these 
conventions. Likewise, rehabilitation for LEA below knee cannot be financed through 
convention 7.71. For K30/K60 nomenclature, the current reimbursement rules preclude 
full reimbursement of some rehabilitation protocols. That is the reason why, for 
instance, the expenditures for SCI (paraplegia) ambulatory are zero. According to the 
protocols, the maximum number of treatment sessions allowed for this condition (120) 
is already needed during the period of hospitalization. As a consequence, there is no 
reimbursement left for ambulatory sessions according to the current reimbursement 
rules. This incompleteness for all scenarios implies that the total estimated expenditures 
and revenues are lower than the actual revenues and expenditures respectively 
associated with the rehabilitation protocols. The difference with the total centres’ costs 
(added in the last column of the table for comparative purposes) will therefore be less 
pronounced in reality than in this theoretical exercise. 
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Figure 10.9: Total costs, revenues and expenditures for the entire rehabilitation population in Belgium (Euro) 
Pathology  
All centres' revenues according to current 
reimbursement mechanisms if protocols are 
followed (per year) 
RIZIV expenditures per treatment protocol 
(per year) according to current 
reimbursement mechanisms 
All centres' cost 
according to 
protocols (per year) 
   K30/K60 
Convention 
9.50 
Convention 
7.71 K30/K60 
Convention 
9.50 
Convention 
7.71  
THR                
THR 
polypathology  Hospitalization 
928 614 0 0 835 843 0 0 1 043 847 
THR Fragile  Hospitalization 
515 897 0 0 464 357 0 0 584 554 
LEA   
       
LEA BK Hospitalization 
410 256 410 256 0 369 270 369 270 0 847 434 
LEA AK Hospitalization 
1 025 640 1 025 640 1 963 500 923 175 923 175 1 963 500 2 548 053 
  Ambulatory 
93 240 265 635 336 000 83 925 249 525 326 940 914 422 
SCI  
       
SCI (para)  Hospitalization 
745 920 815 875 1 630 300 671 400 741 355 1 630 300 2 732 105 
  Ambulatory 
0 246 900 336 000 0 237 840 326 940 472 857 
SCI (tetra)  Hospitalization 
745 920 1 132 730 2 546 600 671 400 1 058 210 2 546 600 4 231 339 
  Ambulatory 
16 750 337 720 436 800 16 750 325 942 425 022 639 355 
MS   
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MS  Hospitalization 
1 367 520 1 367 520 3 663 000 1 230 900 1 230 900 3 663 000 4 339 834 
MS  Ambulatory 
4 895 385 10 023 585 17 160 000 4 439 685 9 056 385 16 924 440 13 365 918 
Stroke   
       
Stroke  Hospitalization 
15 589 728 15 589 728 29 845 200 14 032 260 14 032 260 29 845 200 36 750 132 
  Ambulatory 
7 101 117 17 421 537 19 152 000 6 534 765 16 476 477 18 635 580 29 302 206 
Total (/0.75) Hospitalisation 
28 439 327 27 122 332 52 864 800 25 598 140 24 473 560 52 864 800 70 769 732 
Total (/0.60) 
(95% 
confidence 
interval) Ambulatory 
20.177.487 
(M€13.29 – 
M€34.49) 
47.158.962 
(M€31.11 – 
M€80.70) 
62 368 000 
(M€40.81 – 
M€106.72) 
18.458.542 
(M€12.06 – 
M€31.36) 
43.910.282 
(M€28.71 – 
M€74.81) 
61 064 870 
(M€40.32 – 
M€103.08) 
74.491.264 
(M€48.61 – 
M€127.18) 
TOTAL 
(95% 
confidence 
interval)  
48.616.814 
(M€41.73 – 
M€62.93) 
74.281.294 
(M€58.23 – 
M€107.82) 
115 232 800 
(M€93.68 – 
M€159.58) 
44.056.681 
(M€37.95 – 
M€58.57) 
68.383.842 
(M€48.29 – 
M€89.38) 
113 929 670 
(M€92.69 – 
M€158.07) 
145.260.996 
(M€118.24 – 
M€198.30) 
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Figure 10.10: Graphical presentation of the uncertainty around the point 
estimates of aggregate costs, revenues and RIZIV/INAMI expenditures for 
musculoskeletal and neurological rehabilitation in Belgium (revenues per 
payment system incomplete, see 10.3.3.) 
Mean values and confidence intervals around cost, revenues and expenditures estimates
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The point estimates of total costs, expenditures and revenues in Figure 10.9 (last row) 
show that all three reimbursement systems are insufficient to cover all theoretical costs 
for all rehabilitation services if the rehabilitation protocols would on average be 
followed. On a disease-specific level, revenues are found to be higher than costs under 
convention 7.71 for ambulatory rehabilitation of MS. For all other pathologies and 
systems, theoretical costs are systematically higher than revenues. Note that for 
convention 9.50 and convention 7.71 rehabilitation for some pathologies is not included 
in the estimates for revenues or expenditures while they are included in the estimates 
of costs. If these pathologies would, as in reality, be financed through another 
mechanism the revenues/expenditures would increase.  
In the new –although not yet implemented- K30/K45/K60 system, total revenues would 
be €696 461 and €386 923 for THR polypathology and THR fragile respectively. The 
impact on the total revenues for all centres across all pathologies is about €474 000. 
These point estimates do not take uncertainty in our estimates into account. The 
uncertainty is large, however, because we could not rely on data registrations for the 
estimation of the percentages of patients in need for multidisciplinary rehabilitation, 
especially not for ambulatory treatments.  
Figure 10.10 presents the confidence intervals around the point estimates of the 
aggregate costs, revenues and RIZIV/INAMI expenditures for Belgium. The intervals 
represent the uncertainty around the point estimates associated with the assumptions 
about the prevalences of ambulatory rehabilitation in all five pathologies and about the 
percentage of ambulatory rehabilitation services covered by these 5 pathologies.   
The confidence intervals are large for all values, which means that the uncertain 
variables in our model have an important effect on the estimates.  
The most important determinant for the estimates turned out to be the estimated 
percentage of ambulatory care covered by the five selected pathologies. In the base case 
analysis, this was assumed to be 60%. The higher the percentage is, the lower the total 
costs, revenues and expenditures will be. The second and third most important factors 
are the assumed percentage of patients with MS and stroke needing ambulatory 
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rehabilitation. The higher these percentages are, the higher the total costs, revenues 
and expenditures will be.  
10.3.4 Discussion 
Without giving too much weight to the actual cost figures because these are based on 
(incomplete) data from a small number of centres, four major findings can be drawn 
from our analyses. Although estimates of costs and revenues should not be used for 
policy decision, the merit of the developed methodology is that it reveals certain 
weaknesses in the current reimbursement mechanisms for rehabilitation. In the 
following paragraphs, explanations for the main findings are sought. 
10.3.4.1 Aggregate revenues versus aggregate costs 
A first finding is that, for all pathologies taken together, none of the reimbursement 
systems (K-nomenclature or conventions) covers the total aggregate costs (last row in 
Figure 10.9). Possible reasons for this finding can be related to the methodology used 
for calculating costs and revenues (points 1 and 2 hereunder) or to the specific features 
of the reimbursement systems (point 3). 
Methodological reasons for the difference between costs and revenues might be: 
1. Costs are overestimated 
The cost estimates are based on the cost structure of 3 rehabilitation centres in 
Belgium. This is not a representative sample of the entire rehabilitation supply in 
Belgium. Estimates of unit costs, both for personnel and overhead, might be exagerated 
relative to the costs of other centres. For example, personnel costs for one hour of 
therapy are based on the annual wage cost of a professional therapist and an assumed 
number of working hours. The personnel costs presented are hence estimates of the 
costs in case no students or assistants would be deployed to do part of the 
rehabilitation treatment as defined in the expert-opinion based protocols. If students or 
assistants are deployed and if the number of working hours per year is underestimated, 
the costs will be lower than the costs presented in this chapter. The impact of 
overstimation of personnel costs is important, as personnel costs are about 80% of the 
total estimated rehabilitation costs. This applies for all pathologies. 
Overestimation of costs might also be due to the use of expert panels consisting of 
rehabilitation physicians to develop rehabilitation protocols. These experts may have 
overestimated the number of individual sessions and/or underestimated the number of 
group sessions in the rehabilitation protocols. If the number of individual sessions is 
overestimated or the number of group sessions underestimated, actual costs will be 
lower and come closer to the revenues. 
2. Revenues are underestimated 
The amount of money paid for therapeutic services to patients hospitalised in a Sp-unit 
through the day price (“ligdagprijs”) is not included in the calculations of the revenues. It 
was impossible to include this in the estimates because no information is available on 
the percentage of this amount that can be attributed to the five pathologies under 
consideration in case the protocols would be followed. The impact of this exclusion is 
that the revenues in all financing systems are underestimated. It is unlikely, however, 
that this has a major impact on the estimates, as these amounts are spread over all 
patients receiving multidisciplinary rehabilitation in hospital.  
Another possible reason for underestimation of revenues, in particular in the K30/K60 
system, is omission of the revenues generated by the first “diagnostic” evaluation. This 
activity can be charged in the K30/K60-system. The bias generated by this omission is 
likely to be small, as the costs of this act were also not included in the cost estimates 
for the rehabilitation centre and revenues generated by the act are small compared to 
the total revenues generated by the rehabilitation path. The omission of this cost item 
will hence have a downward effect on both cost and revenue estimates. 
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If 1 and 2 do not explain the difference between aggregate costs and revenues, -which is 
unlikely given the almost certain overestimation of personnel costs- the explanation of 
the finding might be related to the reimbursement system: 
3. The current reimbursement rules might insufficiently reflect the actual cost and cost 
structure of rehabilitation services. This would imply that -if the protocols that describe 
rehabilitation needs for five pathologies would on average be followed by all treatment 
centres in Belgium- the rehabilitation sector as a whole would work with deficits.  
In practice, centres will try to avoid deficits. Different mechanisms exist to reduce the 
difference between costs and revenues on the level of rehabilitation centres. First, 
potential deficits can be reduced by changing the case-mix of patients treated. Our 
assumptions on case-mix were based on estimates of experts on the percentages of 
patients in each pathology group needing multidisciplinary rehabilitation. Obviously, the 
difference between costs and revenues is larger for some pathologies than for others. 
This may induce an incentive towards treating more patients for which revenues are 
relatively closer to costs. 
Second, patients can be treated less intensively than described in the expert opinion-
based rehabilitation protocols. The provision of rehabilitation services can be driven by 
the financing system. For instance, according to the rehabilitation protocols a SCI (tetra) 
patient needs 3 hours of individual rehabilitation treatment and one hour of group 
treatment per day during hospitalisation. In the K-nomenclature, however, only one 
K60 (corresponding to 2 hours of therapy) can be charged per day. Consequently, an 
incentive for providing only 2 hours of therapy is created by this reimbursement system, 
whereas 3 hours are needed according to the experts.  
10.3.4.2 Revenues versus unit costs of ambulatory MS rehabilitation 
A second finding of our study is that for each of the ideal rehabilitation protocols 
revenues are lower than theoretical costs, except for ambulatory rehabilitation of MS 
under convention 7.71. The reason for this different result for ambulatory MS 
rehabilitation is related to the inherent nature of the reimbursement system under 
convention 7.71. For “MS ambulatory” the protocol defines a rehabilitation need of 1 
hour individual treatment and 1 hour group treatment two times a week during 52 
weeks. In convention 7.71 every session between 1 and 3 hours is charged at the same 
lump sum, meaning that 3 hours of treatment generate the same revenues as 1 hour of 
treatment. The costs as defined by the protocol borne by the rehabilitation centre 
relates to 1.25 hours of treatment only (1 hour group session with 4 patients implies 
that 0.25 hours are allocated to each patient in the group), while the reimbursement is 
the equivalent of a reimbursement for 3 hours of treatment.  
For the other pathologies, revenues were not higher than costs under convention 7.71. 
This is due to the fact that the lump sum per day for the 2 MS 7.71 centres (centre 1 an 
2 in chapter 5) is higher than the lump sum in other 7.71 centres that also treat other 
pathologies.  
10.3.4.3 Revenues for ambulatory versus hospital rehabilitation 
A third finding of our study is that the aggregate revenues for ambulatory care 
significantly exceed the aggregate revenues for post-acute rehabilitation in hospital if the 
rehabilitation protocols are on average followed. This is the case at least for convention 
9.50 and convention 7.71, not for the K-nomenclature (note that revenues under K-
nomenclature are incomplete for several pathologies in the protocol). However, there 
is no significant difference between the costs of hospital rehabilitation and ambulatory 
rehabilitation if we take uncertainty about the percentage of ambulatory care covered 
by the 5 pathologies (60%) into account.  
If we focus on the absence of a significant difference between hospital and ambulatory 
rehabilitation costs and the presence of a significant difference for hospital and 
ambulatory rehabilitation revenues/expenditures, we can draw a number of conclusions 
related to the financing systems for rehabilitation in general. The discrepancy can again 
be attributed to the inherent financing rules under conventions 9.50 and 7.71. In 
convention 9.50 1 hour individual therapy and 1 hour of group therapy per session is 
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“charged” in the current simulations at a rate for R60, which is actually the 
reimbursement of 2 hours of therapy. The costs, however, are calculated on the basis of 
1.25 hours of therapy. Similarly, in convention 7.71 every session between 1 and 3 
hours is charged at the same lump sum, meaning that 3 hours of treatment generate the 
same revenues as 1 hour of treatment (cf supra). As the ambulatory rehabilitation paths 
for stroke and MS are relatively long compared to the rehabilitation path in 
hospitalisation and as both pathologies are important determinants of the total revenues 
estimates, this weakness of the current financing system weighs relatively more heavy 
for ambulatory care than for hospital care. This implies that a difference is found 
between revenues for hospital and ambulatory rehabilitation that is not found between 
costs of hospital and ambulatory rehabilitation. It can be concluded that the relatively 
large difference between revenues of ambulatory rehabilitation and hospital 
rehabilitation is hence artificial and caused by the rules of the financing system. A 
reimbursement system that better ressembles the cost structure of rehabilitation 
services is  necessary. This could imply, for instance, the implementation of a specific 
reimbursement rule for group sessions. 
The absence of a significant difference between hospital and ambulatory rehabilitation in 
the K-nomenclature is due to the limitation of reimbursement to 60 or 120 sessions 
depending on the pathology. Hence, the protocols are only partially covered by the 
reimbursement system based on the K-nomenclature. 
10.3.4.4 Budget actually spent to rehabilitation versus estimated budgets 
Finally, the budget spent to musculoskeletal and neurological rehabilitation in 2004 is 
highly similar to our estimates of aggregate expenditures if all rehabilitation protocols 
would be followed and if convention 9.50 would apply for all pathologieseee. This does 
not apply to the situation where all rehabilitation activities would be financed through 
the K-nomenclature. The latter finding is related to the limitations imposed on the 
number of reimbursable sessions in the K-nomenclature. The protocols, as defined by 
the experts, are incompletely reimbursed under the K-nomenclature. Some sessions, 
although considered necessary, are not reimbursed. Convention 9.50, on the other 
hand, allows reimbursement of complete rehabilitation protocols, be it at a reduced 
tariff if certain limits are exceeded. The fact that the budget spent in 2004 ressembles 
the estimated expenditures in convention 9.50 if the protocols are followed, may mean 
that the optimal rehabilitation paths are currently on average followed, although there 
might also be discrepancies between pathologies that level each other out. On the 
other hand, one might argue that the experts defined their current practice as the 
‘optimal’ practice. The method of using expert opinion has the inherent weakness that it 
might induce a bias.   
We tried to test the hypothesis that protocols are biased by comparing part of the 
actual staff (rehabilitation specialists and physical therapists) dedicated to treat stroke 
patients in two rehabilitation centres with the need (according to the protocols) for 
rehabilitation specialists and physical therapists to treat their reported number of stroke 
patients. Actually available staff varied from approximately 50% of the needed staff 
(according to the protocols) to 75% of the needed staff. 
A number of simulations were performed to investigate the budgetary impact of a 
number of scenarios. 
In Figure 10.11 protocol staff costs for treating one patient (stroke hosp or stroke amb) 
and costs for the Belgian population were calculated, assuming that total duration and 
the number of sessions were a fraction (50%, 60%, 70%, 80%, 90% and 100%) of the 
numbers specified in the protocol (the 100% column is equal to the protocol). Total 
costs for treating the entire population are now closer to the payments centres would 
receive according to current reimbursement mechanisms if protocols are followed (see 
the column “All centres' revenues according to current reimbursement mechanisms if 
                                                
eee  Note that the expenditures for rehabilitation after THR (necessary for only 15% of all THR patients) should 
be added to the total expenditures estimates for convention 9.50, as this rehabilitation will have to be 
reimbursed in some way or another; if not by convention 9.50, it will have to be by other financing 
mechanisms. This will slightly increase the aggregate expenditure estimate for convention 9.50.  
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protocols are followed (per year)” according to current reimbursement mechanisms 
(Figure 10.9). 
Figure 10.11: Protocol staff costs for treating one patient (stroke hosp or 
stroke amb) and costs for the Belgian population per year, when duration 
and number of sessions in the protocol vary (Euro). 
  Assumption: duration and sessions as percentage of protocol 
  50% 60% 70% 80% 90% 100% 
            
Total staff costs stroke hosp 4 722 5 667 6 611 7 556 8 500 9 445 
Total staff costs stroke amb 3 791 4 549 5 307 6 065 6 823 7 581 
            
All centres' personnel cost according 
to protocol (per year, for the entire 
population) stroke hosp 13 458 816 16 150 579 18 842 343 21 534 106 24 225 869 26 917 632 
All centres' personnel cost according 
to protocol (per year, for the entire 
population) stroke amb 10 803 603 12 964 323 15 125 044 17 285 764 19 446 485 21 607 206 
Figure 10.12 presents results, assuming that the actual amount of individual sessions is 
smaller that specified in the protocol (Baseline). Two variants are presented: one in 
which half of the individual sessions (according to the protocol) are replaced by group 
sessions and a second alternative where all individual sessions are replaced by group 
sessions. Note that no “group tariff” exists, so staff costs were lowered to account for 
the group sessions. Both staff costs for treating one patient (stroke hosp and stroke 
amb) as well as cost per year for treating the entire population are presented. Again, 
costs for the protocols come closer to revenues if part of the individual sessions are 
replaced by group sessions. 
Figure 10.12: Protocol staff costs for treating one patient (stroke hosp or 
stroke amb) and costs for the Belgian population per year, when the amount 
of individual sessions in the protocol is replaced by more group sessions 
(Euro). 
  Assumption 
  Baseline 50% Ind --> group All Ind --> group 
Individual sessions stroke hosp 2 1 0 
Group sessions stroke hosp 1 2 3 
Individual sessions stroke amb 1 0.5 0 
Group sessions stroke amb 1 1.5 2 
        
Total staff costs stroke hosp 9 445 7 086 4 728 
Total staff costs stroke amb 7 581 5 973 4 365 
        
All centres' personnel cost according to 
protocol (per year, for the entire population) 
stroke hosp 26 917 632 20 196 147 13 474 661 
All centres' personnel cost according to 
protocol (per year, for the entire population) 
stroke amb 21 607 206 17 024 374 12 441 543 
In the following chapter, the financing possibilities and financial consequences of the 
different rehabilitation models described in chapter 9 are presented. 
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Key points 
• Because of the limited evidence-based literature available on post-acute 
rehabilitation, 7 experts were asked to propose a rehabilitation protocol 
for an average patient with one of five selected pathologies. Expert opinion 
was also used to estimate Belgian incidence of rehabilitation needs per 
pathology when no other information was available. Data from 3 
rehabilitation centres were used to estimate costs of these rehabilitation 
needs. Due to the limitations of this methodology, estimates of costs and 
revenues as presented in this chapter should not be used for policy 
decisions. The merit of this methodology is that it reveals certain 
weaknesses in the current reimbursement mechanisms for rehabilitation.  
• For a given rehabilitation protocol for each of the five pathologies 
examined, theoretical costs are higher than revenues, except for 
ambulatory rehabilitation for MS in convention 7.71. The exception for MS 
can be explained by the specific reimbursement conditions of the two 7.71 
centres specialized in MS (higher lump sum than other 7.71 centres and no 
separate tariff for sessions of less than 3 hours) and the long duration of 
ambulatory rehabilitation in this patient group. 
• Aggregate revenues for ambulatory rehabilitation in Belgium are higher 
than for hospital rehabilitation. This relationship was not found for the 
costs of ambulatory rehabilitation and hospital rehabilitation. This pointed 
towards an artefact in the estimates of the revenues caused by the rules of 
the current financing system. More specifically, the absence of a separate 
tariff for group sessions induces higher revenues than costs for group 
sessions. 
• Aggregate revenues for rehabilitation services in each of the 
reimbursement systems are insufficient to cover theoretical aggregate 
costs. This can be explained by methodological weaknesses of the study 
(overestimated costs or underestimated revenues) and/or to the fact that 
the current reimbursement system does not reflect the cost structure of 
rehabilitation services. The real difference between costs and revenues will 
moreover depend on the actual case-mix. 
• One illustration of this inadequate reflection of the cost structure in 
current reimbursement rules is the reimbursement of a maximum of 2 
hours of treatment per day in the K-nomenclature and convention 9.50. 
For some pathologies (especially during the initial phase of rehabilitation, 
see the proposed protocols during hospitalization) more than 2 hours of 
treatment per day is needed.  
• The limited number of sessions and the limited duration of sessions in the 
K-nomenclature is insufficient to cover the therapeutic needs of patients 
with very complex rehabilitation needs, such as spinal cord injury. 
• The budget spent to musculoskeletal and neurological rehabilitation in 
2004 highly resembles the estimates for aggregate expenditures if all 
rehabilitation protocols would be followed and if all activities would be 
reimbursed through convention 9.50. On the one hand, this may mean 
that the optimal rehabilitation paths are currently followed on average, 
although there might also be discrepancies between pathologies that level 
each other out. On the other hand, this may mean that the protocols are 
based on current practices rather than on rehabilitation needs. 
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11 OPTIONS FOR FINANCING POST-ACUTE 
MUSCULOSKELETAL AND NEUROLOGICAL 
REHABILITATION IN BELGIUM 
11.1 INTRODUCTION 
No good arguments can be developed to maintain the current financing mechanisms in 
their actual form (Conventions 9.50 and 7.71, K-Nomenclature, see description of 
Belgian system in Chapter 5). The implicit logic of these existing financing systems has to 
be fine-tuned. A clear distinction between the different systems is necessary. 
As in many other countries, a closed-end budget with a prospective financing system is 
preferable if we aim at keeping control over the rehabilitation budget (for typology of 
financing see Chapter 5). Internationally (see Chapter 8) a tendency exists to integrate 
different components of financing rehabilitation into one reimbursement package. Some 
countries are evaluating this option, others have already implemented such a system. 
The reimbursement package is allocated based on the relative weight of homogeneous 
groups of patients classified by means of a Patient Classification System (PCS). 
For example: In the U.S. individuals in Inpatient Rehabilitation Facilities are classified in 
Cost Management Groups (IRF-PAI) and payments are done per discharge. Individuals in 
Skilled Nursing Facilities are classified in the Resource Utilisation Groups - III (MDS-
PAC) and payments are done per diem.  
11.2 OPTIONS FOR FINANCING MECHANISMS 
Based on the literature search and expert opinion, no ideal system is implemented yet. 
In an international context, most financing models try to integrate different components 
of financing rehabilitation into a lump sumfff approach as far as possible. For each type of 
rehabilitation organisation, budgets are being allocated to homogeneous groups of 
patients included in a PCS. 
11.2.1 Advantages and disadvantages of different payment mechanisms. 
In Chapter 5 of this report different types of financing mechanisms were classified 
according to a typology model for provider payment mechanisms in health care.123  This 
typology model classifies payment systems according to two dimensions: fixed versus 
variable systems and retrospective versus prospective systems. Advantages and 
disadvantages as well as (perverse) incentives created by a number of payment systems 
were discussed.  In addition this model showed that the unit of payment also has an 
important impact on the classification (and the associated incentives) of a financing 
system.   
In the following sections a limited number of elementary payment mechanisms will be 
proposed and discussed briefly (for a more elaborate discussion we refer to the 
typology model presented in Chapter 5). 
11.2.1.1 Fee for service 
An advantage of a fee-for-service (FFS) is that the number of activities and the amount 
of payment are closely linked. Consequently, a FFS generates incentives for a sufficient 
amount of quality care (provided that marginal revenue exceeds marginal cost) and 
production will probably increase.  However, a fee-for-service mechanism requires well-
defined and measurable activities (e.g. diagnostic or therapeutic activities). 
                                                
fff  The term ‘lump sum’ which will frequently be used in the following sections is intended as a micro concept, 
i.e. it refers to a fixed payment for a given rehabilitation path (protocol) and not to a fixed (annual) budget for 
a rehabilitation centre (macro interpretation). 
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A disadvantage is that a FFS provides incentives for supplier induced demand (SID), 
especially combined with excess supply, and may lead to overconsumption and higher 
than expected costs for the sponsor, i.e. there is a substantial risk of exceeding the a 
priori defined budget.  
In order to avoid this, specific measures are possible such as fixing the total number of 
activities or an a posteriori price calculation according to the number of activities so 
that centres exceeding their a priori target level of supplied care (or budget) get 
financially punished. 
11.2.1.2 Lump sum 
The main advantage of a lump sum payment system per protocol is that it creates 
incentives for cost containment.  From the point of view of the sponsor it facilitates 
controlling total payments and for the supplier total budget for a particular treatment is 
clearly known.  Moreover a lump sum system allows to allocate budgets for essential 
activities in complex rehabilitation that are difficult to register (e.g. coordinating 
activities and interdisciplinary discussions).  
However, it does not give financial incentives to provide high quality services.  On the 
contrary, suppliers may be induced to provide a suboptimal level of care and may try to 
select good risks in order to avoid financial losses.  Therefore implementation of such a 
mechanism should go hand in hand with accountability, quality control and a reliable 
PCS.  
11.2.1.3 Mixed payment mechanism 
A mixed payment system combines a FFS with a fixed component (lump sum).  The 
advantage of a mixed system is that it combines the characteristics of both FFS and lump 
sum.  It contains the advantages (and disadvantages) of both into a blended system that 
dampens the undesired incentives of each of the extreme mechanisms.  It can be 
constructed as a linear combination of the lump sum (i.e. fixed payment) that would be 
received to treat a particular patient according to the protocol and the FFS payment 
scheme for that patient.  Suppose a particular treatment can be financed using a FFS or 
a fixed payment :    
 : fee = cost per session (in FFS)
 : number of sessions (in FFS)
Total payment FFS : 
Total fixed payment for treatment : 
Payment mixed system : (1 )       with 0 1
F
n
nF
FP
MS FP nFα α α= + − ≤ ≤
 
The parameter  can be considered as the weight (fraction) of the fixed payment in 
total payment : if  = 0 the formula collapses into a FFS payment and if  = 1 it equals 
the fixed payment; FP is a fixed, lump sum part of the payment and (1-)nF is the 
variable part, depending on the number of sessions.  Varying  allows to stress either 
the FFS component or the fixed component and their respective advantages and 
incentives.   
A hypothetical example of total and marginal payments of a FFS, lump sum to finance a 
particular protocol and two mixed systems ( = 0.25 and  = 0.80) are depicted in 
Figure 11.1 and Figure 11.2.  It is clear that in the mixed system institutions with relative 
high numbers of high cost patients are less penalised than in a lump sum mechanism.  
On the other hand, incentives for overconsumption are smaller compared to a FFS 
system. 
It is clear that a high share of fixed payment is more indicated in case of relatively high 
fixed costs, whereas a high share of FFS payment is better indicated in case of a 
relatively high proportion of variable costs – in order to reduce the financial risk for the 
provider.  However if the provider can relatively easily influence the number of 
activities, this ‘advantage’ of reduction in financial risk for the provider, must be weighed 
against the ‘disadvantage’ of potential excess utilisation of the service. This disadvantage 
would not show up in case of fixed funding, but the latter may have the disadvantage 
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that providers are not strongly encouraged to supply a sufficient amount of care to their 
patients.  
Figure 11.1: Total payment 
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Figure 11.2: Marginal payment 
11.2.1.4 Variants of units of payment 
The classification of a payment as lump sum or FFS also depends on the unit of payment 
(e.g. a fee per discharge, per episode, per year, capitation payment… (see chapter 5)) 
11.2.2 Options for financing of the stratified rehabilitation model 
For the stratified rehabilitation model (see 9.2.1.1) several options for reimbursement 
will be discussed. For each level, two budgets will be calculated: (1) the budget that 
would be required to cover all costs of the centres offering rehabilitation services 
(assuming that the treatment protocols presented in the previous chapter are on 
average followed) and (2) the budget that corresponds with the amount the 
RIZIV/INAMI could spend on the three levels if it works with a fixed budget of €82 625 
881 (i.e. the budget spent in 2004)(see chapter 5) for musculoskeletal and neurological 
rehabilitation (i.e. budget-neutral resources)  
The starting point is a stratified model with the five studied pathologies attributed as 
follows: hospital rehabilitation for MS and hospital and ambulatory rehabilitation for SCI 
in the highly specific level, ambulatory rehabilitation for MS, hospital and ambulatory 
rehabilitation for stroke and LEA in the specific level, THR in the general level. (The 
general level consists of pathologies requiring only monodisciplinary or simple 
multidisciplinary rehabilitation services, such as THR, recovering strokes and a number 
of orthopaedic cases like shoulder rehabilitation, chronic back pain,…).  
For the calculation of the budget to be allocated to the different levels of the stratified 
organisation model under the restriction of total-budget neutrality, it is assumed that 
the share of the pathology in the 2004 budget is equal to the share of the pathology 
costs in the total costs for the entire population if the rehabilitation protocols would be 
followed, as calcualted in Figure 10.9. 
One reimbursement option is a uniform financing system for all levels within the 
stratified model. However, differences in complexity (higher in the (highly) specific level) 
and predictability (lower in the general level due to higher variability in case-mix) of 
rehabilitation activities, favour differentiation in financing mechanisms, as is shown in 
Figure 11.4. 
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11.2.2.1 General rehabilitation services (simple rehabilitation needs) 
Because of the lower predictability of rehabilitation activities due to an expected high 
case-mix variability, a lump sum payment system is less convenient for general 
rehabilitation services.  A lump sum payment would bear high (financial) risk on 
providers which could lead to a policy of risk selection and attempts to redirect high 
cost patients to other institutions.  On the other hand, it could be argued that an 
increase in scale (i.e. a sufficient or number of patients) reduces the variance and the 
risk for the rehabilitation centres.  However it is anything but clear whether Belgian 
(general) rehabilitation centres have a sufficient scale in order to reduce the financial 
risk from a lump sum payment adequately. 
Therefore the financing mechanism for general rehabilitation services (simple 
rehabilitation needs), could be fee for service, or a mixed system with relatively high 
weight of the FFS component. The service is a rehabilitation activity performed by one 
or more types of professionals in a mono- or (simple) multidisciplinary way. 
If only one professional is involved (mono-disciplinary rehabilitation, strictu sensu no 
rehabilitation (see chapter 1) since only one discipline is involved), a therapy specific fee 
is provided (e.g. physical therapy, occupational therapy, psychology, speech therapy...). 
If different types of professionals are involved (multidisciplinary rehabilitation) two 
options are possible. 
• A first option is a common fee covering different disciplines 
(multidisciplinary fee). The payment is made to the team and team 
members will have to bargain on the distribution. 
• A second option is a system in which every therapeutic (or medical) 
discipline gets a separate fee as mentioned for mono-disciplinary 
rehabilitation.  
If all costs of the general rehabilitation services are supposed to be covered by the 
reimbursement system, the RIZIV/INAMI should keep about €49 million available for 
reimbursement of the general rehabilitation services. This is the difference between the 
extrapollated total costs of rehabilitation services as calculated in Figure 10.9 and the 
total costs associated with the 4 pathologies classified in the specific and highly specific 
level. In case of a budget neutral operation relative to 2004, about €28 million should be 
reserved for this level. 
11.2.2.2 Specific and highly specific rehabilitation services (complex rehabilitation needs) 
Since the number of pathologies to be treated in specific and highly specific 
rehabilitation services is smaller and pathologies are relatively clearly defined, a lump 
sum or mixed payment system (with relatively high weight of the lump sum component) 
might be easier to implement and less contestable than in the general rehabilitation 
services. 
Therefore, for highly specific rehabilitation services, the proposed financing mechanism 
could be based on a lump sum per treatment protocol. The lump sum can be paid by 
means of different units-of-paymentggg. Alternatively, a mixed system may be chosen 
with a relatively higher weight for the lump sum. In this mixed system as well, the 
payment is done per treatment path, which boils down to a payment per capita with a 
fixed component (the lump sum) and a variable component. 
As the number of centres providing highly specialised rehabilitation services will 
probably be very limited, an alternative financing system might be a fixed budget per 
rehabilitation centre. The amount of this so-called “envelope” can be determined by the 
case-mix of the centre. Again, a good PCS is indispensable to determine the case-mix. 
For the specific rehabilitation services, a mixed system with a relatively lower weight for 
the lump sum is an option, as this level is characterised by a somewhat larger number of 
pathologies and less complex rehabilitation needs than the highly specific level.   
                                                
ggg  If the unit-of-payment is the activity then it becomes a fee-for-service 
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The first option is a lump sum covering all components of rehabilitation (e.g. diagnostic 
and therapeutic activities, coordination and interdisciplinary activities, infrastructure and 
equipment). Especially for the highly specific services this is preferable. In case of 
inpatient rehabilitation this lump sum may even cover components related to hospital 
stay (e.g. general nursing care, hotel services, infrastructure and equipment) as is the 
case in other countries (chapter 8).  
Other options hold different financing mechanisms per component of rehabilitation 
services. These might be considered for the specific services. 
• FFS for measurable diagnostic and therapeutic activities, lump sum for 
coordination and interdisciplinary activities, infrastructure and 
equipment. This option leaves the flexibility needed until more 
evidence is available for identifying an effective and efficient 
rehabilitation programme adapted to patients’ rehabilitation needs and 
goals. 
• FFS for measurable diagnostic and therapeutic activities; fee per 
discharge for coordination and interdisciplinary activities and a lump 
sum for infrastructure and equipment. The fee per discharge creates a 
financial incentive to admit new patients. This mechanism supposes an 
accountability obligation and quality control. 
If the budget spent by the RIZIV/INAMI is supposed to cover all costs of rehabilitation, 
the budget needed is about €84 million for the specific rehabilitation services and €12 
million for the highly specific services. In a budget neutral scenario, where the fixed 
budget is supposed to be equal to the budget spent in 2004 (€82 625 881), the budget 
needed is €48 million for the specific services and €7 million for the highly specific 
services. This is under the assumption that the levels as defined in this model are limited 
to the pathologies mentioned in each level and no other pathologies would resort in 
these levels. If the levels are expanded with other pathologies, the budgets –both the 
cost-covering and budget-neutral budgets- will increase. Figure 11.3 presents the 
budgets per pathology and per level for the different levels of the stratified rehabilitation 
model. For the total budgets per level, the 95% confidence interval limits are also 
presented. Especially for the general level, this interval is large.  
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Figure 11.3: Budgets for the stratified rehabilitation model  
 Cost covering budgets  
Budget neutral 
budgets* 
Level 1: highly specialized services   
MS hospitalization 
4 339 835 2.468.540 
SCI (para) hospitalization 
2 732 105 1.554.048 
SCI (para) ambulatory 
472 858 268.966 
SCI (tetra) hospitalization  
4 231 339 2.406.827 
SCI (tetra) ambulatory  
639 355 363.672 
Total cost level 1  hospitalization 
11 303 278 6.429.416 
Total cost level 1 ambulatory  
1 112 213 632.638 
Total cost level 1  
12 415 491 
(M€12.10 – M€12.67) 
7.062.053 
(M€5.15 – M€8.60) 
Level 2: specialized services   
LEA below knee, hospitalization  
847 434 482.029 
LEA above knee, hospitalization  
2 548 053 1.449.358 
LEA above knee, ambulatory  
914 422 520.132 
MS ambulatory  
13 365 918 7.602.666 
Stroke hospitalization 
36 750 132 20.903.836 
Stroke ambulatory 
29 302 206 16.667.382 
Total cost level 2, hospitalization 
40 145 620 22.835.223 
Total cost level 2, ambulatory 
43 582 546 24.790.180 
Total cost level 2 
83.728.165 
(M€71.16 – M€93.88) 
47.625.403 
(M€36 – M€53.89) 
Level 3: general rehabilitation 
services 
49.117.340 
(M€31.85 – M€98.81) 
27.938.425 
(M€21.04 – M€41.39) 
* obtained by multiplying the share of the costs of the rehabilitation protocol for the pathology in 
the total extrapollated costs for the entire rehabilitation sector (€145 million) to the budget of 
2004. 
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Figure 11.4: Financing mechanisms 
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Note: the dimension “hospitalized and ambulatory” is not visualized  
11.2.3 Options for financing variants of the post-acute stratified rehabilitation 
model 
Four variants of the post-acute stratified rehabilitation model were suggested in the 
previous chapter. The pathology-specific variant focuses on target populations or 
pathology groups.  
11.2.3.1 Pathology specific variant 
Since the basic level of this variant (general rehabilitation services) is similar to the 
general level of the stratified model (i.e. relatively low predictability of rehabilitation 
activities due to an expected high case-mix variability) the suggested financing 
mechanism is also similar: FFS or a mixed system with a relatively high weight of the FFS 
component. The second level (pathology specific rehabilitation centres) is characterised 
by centres treating relatively homogeneous patient groups.  Therefore a lump sum or a 
mixed system with a relatively high weight of the lump sum component can be 
defended. 
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Figure 11.5: Budgets needed for all pathologies in a pathology-specific 
stratified organisation model (variant 1) 
 Budget that covers all costs 
of the centres (€) 
Budget that presumes 
budget-neutrality 
compared to 2004 (€) 
THR    
Hospitalization 
1 628 401 926 251 
Ambulatory 
0 0 
Total 
1 628 401 926 251 
LEA 
  
Hospitalization 
3 395 487 1 931 387 
Ambulatory 
914 422 520 132 
Total 
4 309 909 2 451 519 
SCI 
  
Hospitalization 
6 963 444 3 960 875 
Ambulatory 
1 112 213 632 638 
Total 
8 075 656 4 593 513 
MS 
  
Hospitalization 
4 339 835 2 468 540 
Ambulatory 
13 365 918 7 602 666 
Total 
17 705 753 10 071 206 
CVA 
  
Hospitalization 
36 750 132 20 903 836 
Ambulatory 
29 302 206 16 667 382 
Total 
66 052 338 37 571 218 
Budget left for general 
services 
 27.012.174,63 
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 presents the required budgets for financing all specific pathology reference centres 
(variant 1) for the 5 pathologies we examined for the entire Belgian population. One 
difficulty in this model is that it is unknown whether the 5 selected pathologies 
represent all pathology-specific centres that should be foreseen. If not, the budget 
allocated to general services will decrease and be allocated to additional pathology-
specific centres. 
Figure 11.5: Budgets needed for all pathologies in a pathology-specific 
stratified organisation model (variant 1) 
 Budget that covers all costs 
of the centres (€) 
Budget that presumes 
budget-neutrality 
compared to 2004 (€) 
THR    
Hospitalization 
1 628 401 926 251 
Ambulatory 
0 0 
Total 
1 628 401 926 251 
LEA 
  
Hospitalization 
3 395 487 1 931 387 
Ambulatory 
914 422 520 132 
Total 
4 309 909 2 451 519 
SCI 
  
Hospitalization 
6 963 444 3 960 875 
Ambulatory 
1 112 213 632 638 
Total 
8 075 656 4 593 513 
MS 
  
Hospitalization 
4 339 835 2 468 540 
Ambulatory 
13 365 918 7 602 666 
Total 
17 705 753 10 071 206 
CVA 
  
Hospitalization 
36 750 132 20 903 836 
Ambulatory 
29 302 206 16 667 382 
Total 
66 052 338 37 571 218 
Budget left for general 
services 
 27.012.174,63 
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11.2.3.2 Function specific variant 
Variant 2 of the organisational models differentiates reference centres based on 
“functional” impairment.  Regarding a possible financing mechanism for this variant, the 
characteristics of both levels are similar to those of the previous variant. Consequently 
the suggested mechanisms are identical: FFS or a mixed system with a relatively high 
weight of the FFS component for the general rehabilitation services and a lump sum or a 
mixed system with a relatively high weight of the lump sum component for the 
reference centres. 
Since in Belgium no information is available on rehabilitation patients at the functional 
level, and since for the 5 selected pathologies the subdivision according to functional 
impairment is not known, budget allocation cannot be specified. 
11.2.3.3 Pathology specific trajectory based rehabilitation model 
The 3rd variant presented in chapter 9, is the trajectory based model in which centres 
treat certain pathologies during the whole trajectory of care, namely acute, post-acute 
and chronic phase.  Since the “general rehabilitation services” level of this variant has 
characteristics similar to those of the general level of the stratified model, the suggested 
financing mechanism for this level (with high case-mix variability) is FFS of a mixed 
system with a relatively high weight of the FFS component. The pathology specific 
rehabilitation centres will treat relatively homogeneous groups of patients, therefore a 
lump sum or a mixed system with a relatively high weight of the lump sum  component 
is suggested. 
The protocol proposed for the 5 pathologies was limited to the post-acute phase, and 
did not include the acute and chronic phase. Budget allocation for the subacute phase 
equals variant 1. 
11.2.3.4 Goal oriented model 
The goal-oriented model (variant 4) is based on the final goal the patient should attain: 
back to work or not.  Depending on the homogeneity of patient groups the payment 
mechanism could be rather lump sum (in case of relatively homogenous patient groups) 
or rather fee for service (in case of relatively heterogeneous patient groups) oriented.   
The proportion of patients in the 5 pathologies for which this goal possibly can be 
reached is unknown. 
11.2.3.5 Managed care model 
The last model (managed care model) emphasizes the role insurers can play in 
negotiating prices with providers. Insurance companies and sickness funds bargain with 
providers over volume, prices, quality and numerous other stipulations.  Hence, the 
budget is determined by these negotiations.  
Key points 
• Every payment mechanism has advantaged and disadvantages and may 
generate perverse incentives. 
• FFS, lump sum and a mixed system were discussed. 
• For the proposed organisational rehabilitation models, the general level is 
characterised by a relatively high case-mix variability. A reimbursement by 
a FFS or a mixed system with relatively high weight on the FFS 
component seems most appropriate for this level.  
• For levels treating more homogeneous patient groups (specific or highly 
specific level, pathology specific level, function specific level, pathology 
specific centres) a mixed system with a relatively high weight on the lump 
sum or a fixed budget for the rehabilitation centre (envelope) seems 
appropriate. 
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12 HOW CAN A REHABILITATION MODEL BE 
IMPLEMENTED IN BELGIUM: A REFLECTION 
12.1 INTRODUCTION 
People suffering from musculoskeletal and neurological impairments belong to a specific 
group requiring tailored care. Inspiration for an implementation approach for the 
rehabilitation model in Belgium can be found in the way Ontario (Canada) developed 
and implemented changes in post-acute rehabilitation care. Likewise, we will propose 
suggestions for a stepwise development and implementation of changes in the Belgian 
post-acute rehabilitation care.  
12.2 THE EVALUATION AND SELECTION OF A 
CLASSIFICATION/ASSESSMENT TOOL FOR 
REHABILITATION CARE IN ONTARIO, CANADA 
Ontario has been working on the development of an integrated funding model for 
rehabilitation. This work has been hindered by a lack of a general agreement on the 
patient classification system and assessment tool to be used for rehabilitation. A group 
of experts from different fields has been mandated to evaluate and recommend the 
implementation of a classification and assessment tool used for different purpose: 
inpatient and outpatient resource allocation, quality indicators, outcome measurement 
and care planning. 
See Appendix to chapter 12. 
12.3 STEPWISE DEVELOPMENT, VALIDATION AND 
IMPLEMENTATION OF CHANGES IN POST-ACUTE 
REHABILITATION MEDICINE IN BELGIUM. 
Rehabilitation services have to manage the rehabilitation process in an efficient way. 
Patients should be referred to the right rehabilitation services whenever necessary and 
according to their rehabilitation needs and goals. 
The transition through phases and different levels of service should be guaranteed by 
use of a patient classification system, implying continuity of care from acute over post-
acute to chronic care.  
Development, validation and implementation of changes in post-acute rehabiliation 
medicine in Belgium will next described in four steps (see Figure 12.1). 
12.3.1 First step: Identification of a patient with rehabilitation needs and goals 
The identification of a patient with rehabilitation needs and goals is necessary in order 
to initiate a rehabilitation trajectory. Moreover, from an organisational and financing 
point-of-view data are needed in advance about the number of patients needing a 
rehabilitation program. Therefore, the theoretical definition proposed in the first 
chapters of this study, has to be tested in the field to see whether practically all aspects 
necessary to organise rehabilitation in practice are included. 
12.3.2 Second step: Selection of an appropriate functionality tool  
As has already been extensively been discussed, a patient classification system implying a 
functional assessment is necessary in order to refer the patient within the stratified 
rehabilitation model. 
A Steering Committee mandated by the Public Authorities should select one (or more) 
assessments tools, while a PCS, integrated in a outcome model is under development 
(see Chapter 3). The selected tools should be adapted to the Belgian context. 
Continuity from acute over post-acute to chronic care should be taken into account. 
The Committee could validate the tools in use in other countries in the Belgian context, 
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and define an appropriate set of data to collect in Belgium. In this validation exercise, 
existing Belgian registration systems like MVG-RIM2 can be taken into account (see 
chapter 4). Also, a cross-validation with ICF core-sets can be an option (see chapter 3). 
Next, a pilot registration system could be implemented, testing the feasibility of the 
proposed data set in the Belgian rehabilitation context.  
12.3.3 Third step: Introduction/Development of a patient classification system 
and eventually a financing system 
Until now, the link between the assessment tools and the financing of rehabilitation has 
not been thoroughly examined. Studies on the integration of the rehabilitation tools in 
the financing system have been undertaken in some countries (Australia, United States, 
Germany, Switzerland and Canada), followed by the introduction of the developed 
system in the financial system of the country (see chapter 3).  
As mentioned in Step 2 and in previous chapters of this study, an assessment tool will 
be important in order to determine the patient’s rehabilitation needs and goals for 
organisational and financing purposes as well as to orient him/her to the adequate 
clinical rehabilitation services. As outlined in chapter 3, nowadays it is not possible to 
find a classification tool that covers organisation as well as clinical purposes (much work 
is going on to develop such a system based on ICF). For organisational and financing 
purposes, patients characterized by a similar clinical profile and a comparable level of 
needed resources have to be classified in homogeneous groups. A pilot study should be 
launched focused on the choice of the patient classification system for organisational 
and financing purposes (and probably another one for clinical purposes) (see chapter 3). 
The ongoing international studies should be kept in mind, and as soon as they are 
available, new international developments in this field (based on ICF) should be taken 
into account. 
Also, a cost model has to be developed, taking into account the findings in chapter 10 
and 11 of this study. 
12.3.4 Fourth step: Results: Organization and financing of post-acute 
rehabilitation care. 
The PCS and financing model that will be the result of the study can then be 
implemented. This has to go hand in hand with measures assuring quality control. 
Thorough registration is needed in order to dispose of the necessary data to further 
plan rehabilitation services. 
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Federal Institutions Steps Actions
KCE report : Organisation and 
Financing of Musculosketal and 
Neurological Rehabilitation in 
Belgium
Publication and communication of the results
Developing, validating and 
implementing changes in post-acute 
rehabilitation medicine under the 
auspices of the Ministry of Public 
Announcement of Implementation of an evaluation tool and patient 
classification system for post-acute rehabilitation medicine.
Selection of the Steering Committee
Selection of the research team(s)
Step 1. Identification of 
patients with rehabilitation 
needs and goals
Test of the "theoretical" rehabilitation definition in the rehabilitation sector
Determination of the number of patients concerned by the theoretical definition
Step 2. Selection of an 
appropriate functionality tool
Steering Committee :  selection of possible assessment tools
Steering Committee :  validation of the selected tool in the Belgian context
Steering Committee :  proposition of a data set collection
Pilot registration system to test the feasibility of the selected assessment tool 
and the data collection
Step 3. 
Introduction/Development of a 
patient classification system 
and eventually a financing 
system
Selection of possible patient classification system
Validation of the selected system in the Belgian context
Proposition of a data set collection
Pilot registration system to test the feasibility of the proposed patient 
classification system
Development of a cost model
Simulations and financial propositions
Step 4. Results : Organisation 
and financing of post-acute 
rehabilitation medicine
Planification of  the rehabilitation activities in Belgium
Quality control and development of a registration system
Fixation of a budget  
Figure 12.1: Stepwise development and implementation of changes in post-acute rehabilitation medicine in Belgium. 
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13 CONCLUSIONS 
13.1 SUMMARY OF FINDINGS AND KEY-POINTS 
The aim of this project is to study the current RIZIV/INAMI conventions for 
“locomotor rehabilitation” and to propose models for the organization and financing of 
musculoskeletal and neurological rehabilitation in Belgium. 
The methodology consists mainly of scientific literature search. However, where 
scientific data lack they are completed with grey literature, data obtained from 
RIZIV/INAMI, FOD/SPF and sickness funds, national and international expert opinion, 
and expert meetings and surveys. 
Based on an extensive literature search, a conceptual definition of musculoskeletal and 
neurological rehabilitation is developed within the framework of ICF (with specifications 
on individual and outcome, services, professionals and organization). The conceptual 
definition in a next phase has to be made operational. This should be done by the use of 
a comprehensive outcome model that structures all relevant outcome measures,  and of 
a patient classification system which could ideally be used for resource allocation as well 
as clinical decision making. 
Five representative pathologies are selected for further study: THR, LEA, SCI, stroke 
and MS. As up to date there are no comprehensive epidemiological Belgian data 
available (due to a lack of systematic central registration of pathologies or delivered 
rehabilitation activities), epidemiological data for these pathologies are gathered 
following the above mentioned methodology. The following incidences are found: THR 
160/100.000/year (of which 15% are considered to need multidisciplinary rehabilitation: 
5% presenting with polypathology and 10% considered as fragile patients), LEA 
12/100.000/year (about half receive a functional prosthesis), SCI 2/100.000/year, stroke 
185/100.000/year (of which 15% need specialised rehabilitation services) and for MS an 
incidence of 4-6/100.000/year and a prevalence of 90/100.000/year (10% yearly need 
hospitalisation and 15% need continuous ambulatory treatment). 
Current Belgian clinical practice is investigated by means of a limited survey and 
compared to clinical pathways developed in several countries for the five selected 
pathologies. A great variance in rehabilitation practice is shown by the survey of nine 
Belgian medical rehabilitation specialists. This variance can be rejected nor confirmed by 
the study of the clinical pathways, as very few concrete data on the intensity and 
duration of rehabilitation are available in the detected pathways. 
A detailed description of the current organization and financing systems of 
musculoskeletal and neurological rehabilitaiton in Belgium shows that the organization 
and financing of musculoskeletal and neurological rehabilitation in Belgium lacks 
transparency and clinical coherence: several parallel payment systems exist but are 
mostly based on historical factors rather than on criteria related to patients’ 
rehabilitation needs and goals. 
One payment system is linked to hospital stay with specialised beds (Sp beds) for 
diagnosis and treatment of musculoskeletal (S2) and neurological disorders (S3). Other 
systems are linked to rehabilitation activities and concern mainly nomenclature (K, M 
and R) and rehabilitation agreements (also called conventions, general 9.50 and specific 
7.71). These systems are mainly fee for service systems. 
Several combinations and cumulations (parallel as well as sequentially) of the different 
payment systems are possible, inducing a very heterogeneous rehabilitation landscape in 
Belgium. The different payment systems overlap significantly. There are no clear criteria 
for patient referral to the different types of rehabilitation organizations and the only 
characteristic on the limitative lists is the medical diagnosis. There are no criteria 
justifying an inpatient treatment. Patients’ rehabilitation needs and goals are not formally 
assessed. Sp-beds are financed on a 7/7 days basis, discouraging weekends home. 
Neither is there reimbursement for travel expenses for weekends home. Moreover, 
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reimbursement for travel expenses is only provided for wheelchair bound patients and 
only for ambulatory treatment.  
A payment system for multidisciplinary follow up of patients with permanent functional 
impairments due to musculoskeletal or neurological disorders in the chronic phase, 
exists only for a very limited number of pathologies (such as neuromuscular disorders 
or cerebral palsy). 
The different rehabilitation organizations and Sp-beds are geographically relatively well 
spread, even though some corrections seem necessary. 
There is no systematic registration of data concerning the performed rehabilitation 
activities. There is no accreditation system and only very limited formal quality control. 
There is nomenclature for mono-disciplinary physical therapy and speech therapy, but 
not for other disciplines such as occupational therapy or psychotherapy. 
The RIZIV/INAMI expenditures for (multidisciplinary) musculoskeletal and neurological 
rehabilitation accounted for 0.38 % of the Healthcare budget in 2000 and 0.48 % in 
2004. In absolute figures the expenditure for musculoskeletal and neurological 
rehabilitation grew about 50 % over a five year period, 2000-2004 (from €57.340.095 to 
€87.361.509). K-nomenclature and  convention 9.50 changed significantly in 2004 and 
2006. It is too early to estimate the impact of these changes but there is a trend 
towards increased expenses for multidisciplinary K-nomenclature. 
Price setting for each unit of payment, as well as per hour of therapy, depends on the 
system, is not transparent and mainly based on historical facts. 
All financing mechanisms can be qualified as variable and prospective, generating similar 
incentives: increasing the number of units of reimbursement and decreasing the intensity 
of care (and the cost) within the unit of payment. In addition, an incentive for selecting 
good risks is produced. 
An international study of five countries has been performed: The Netherlands, France, 
Germany, Sweden and the US. Most countries are struggling with the organization of 
this sector and are involved in the search for a clear rehabilitation concept comprising 
patients’ needs, organizations for the different phases in the trajectory (acute, post-
acute and chronic) and continuity of care. Unfortunately, no country disposes of a 
ready-for-use model for post-acute rehabilitation. All countries define different levels of 
rehabilitation: basic, specialised and highly specialised. For example, SCI rehabilitation is 
nearly always assigned to the most specialised level of care, because of the very specific 
needs and low incidence. 
Several options for organizational models in the post-acute rehabilitation phase are 
proposed but the ‘stratified rehabiliation model’ is recommended. This model contains 
three levels: general rehabilitation services, specific and highly specific rehabilitation 
services, organised in a network. The criteria used for patient assignment to the 
appropriate level are: complexity of rehabilitation needs and goals, and incidence and 
prevalence of consequences of health conditions. The implementation of this model 
requires a systematic assessment of patients’ rehabilitation needs in the acute phase of 
the disease trajectory, which has to be repeated periodically and can result in a transfer 
of an individual to another level within the network. For this assessment a PCS is 
needed, preferably based on the ICF framework. At this point such a PCS is not 
available yet and further (international) research is needed in order to develop such a 
tool. Awaiting this, several patient data and current assessment measures can be 
combined (e.g. medical diagnosis and comorbidities, age, contextual factors and 
functional scales such as FIM or Barthel Index). Also, it is mandatory to start as soon as 
possible with a central registration system for patient profiles and delivered 
rehabilitation activities in order to dispose of real data concerning the needs in Belgium. 
As in many other countries, a closed-end budget with a prospective financing system is 
preferable if we aim at keeping control over the rehabilitation budget. In an 
international context, most financing models try to integrate different components of 
financing rehabilitation into a lump sum approach as far as possible. In case a PCS is 
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implemented, budgets are being allocated to homogeneous groups of patients included 
in a PCS, for each type of rehabilitation organization. 
The options for financing of the stratified rehabilitation model are the following. A FFS 
system (or mixed with high weight on FFS component) is proposed for the general 
rehabilitation services. For the specific and highly specific services a lump sum or mixed 
system with high weight on the lump component is recommended. At the highly specific 
level even an envelope payment system can be considered. 
In order to perform cost calculations, standard rehabilitation protocols are needed. 
Because of the limited evidence-based literature available on post-acute rehabilitation, 
seven experts were asked to propose a rehabilitation protocol for an average patient 
with one of the five selected pathologies. Expert opinion is also used to estimate Belgian 
incidence of rehabilitation needs per pathology when no other information was 
available. Data from three rehabilitation centres are used to estimate costs of these 
rehabilitation needs. Due to the limitations of this methodology, these estimates of 
costs and revenues should not be used for policy decisions. The merit of this 
methodology is that it reveals certain weaknesses in the current reimbursement 
mechanisms for rehabilitation.  
Aggregate revenues for ambulatory rehabilitation in Belgium are higher than for hospital 
rehabilitation. This relationship is not found for the costs of ambulatory rehabilitation 
and hospital rehabilitation. This points towards an artefact in the estimates of the 
revenues caused by the rules of the current financing system. More specifically, the 
absence of a separate tariff for group sessions induces higher revenues than costs for 
group sessions. 
For a given rehabilitation protocol for each of the five pathologies examined, theoretical 
costs are higher than revenues (except for ambulatory rehabilitation for MS in 
convention 7.71). Aggregate revenues for rehabilitation services in each of the 
reimbursement systems are insufficient to cover theoretical aggregate costs. This can be 
explained by methodological weaknesses of the study (overestimated costs or 
underestimated revenues) and/or to the fact that the current reimbursement system 
does not reflect the cost structure of rehabilitation services. The real difference 
between costs and revenues will moreover depend on the actual case-mix.  
One illustration of this inadequate reflection of the cost structure in current 
reimbursement rules is the reimbursement of a maximum of 2 hours of treatment per 
day in K-nomenclature and convention 9.50. For some pathologies (especially during the 
initial phase of rehabilitation during hospitalization) more than 2 hours of treatment per 
day is needed according to the proposed protocols.  
The limited number of sessions and the limited duration of sessions in the K-
nomenclature is insufficient to cover the therapeutic needs of patients with very 
complex rehabilitation needs, such as spinal cord injury. 
The budget spent for musculoskeletal and neurological rehabilitation in 2004 highly 
resembles the estimates for aggregate expenditures if all rehabilitation protocols would 
be followed and if all activities would be reimbursed through convention 9.50. On the 
one hand, this may mean that the optimal rehabilitation paths are currently followed on 
average, although there might also be discrepancies between pathologies that level each 
other out. On the other hand, this may mean that the protocols are based on current 
practices rather than on rehabilitation needs. Anyway, all these data have to be 
interpreted with great caution due to methodological difficulties as a consequence of 
the lack of real data for Belgium on the one hand and scientific data on good clinical 
practice in musculoskeletal and neurological rehabilitation. 
Based on the epidemiological data and the standard rehabilitation protocols the number 
of needed services at each level is estimated. It is assumed that general rehabilitation 
can be provided by the departments of PM&R present in most acute hospitals. 
Maximum 20 to 30 specific rehabilitation services are needed and between 3 and 5 
highly specific services. Of course, these different services can combine rehabilitation 
acitivities for different patient groups (e.g. stroke and LEA in specific services, SCI and 
TBI in highly specific services). 
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In order to implement the different recommendations made in this report, the following 
steps are proposed. First of all patients with rehabilitation needs and goals should be 
indentified based on the conceptual definition to test the conceptual definition in clinical 
practice. Systematic registration of the patients’ profiles and delivered rehabilitation 
activities, in a central database, should be started as soon as possible in order to allow 
for correction of the estimations mentioned above, based on real data. Then, a 
classification system should be developed in order to assign an individual to the 
appropriate level of rehabilitation services with regard to his rehabilitation needs and 
goals at a certain point in the disease trajectory. The currently existing rehabilitation 
services should be reoriented to respectively general, specific and highly specific 
services. A network permitting collaboration between the services of the different 
levels at the level of clinical activities as well as concerning research and education 
should be installed. Patient referral can then be realised within this network using the 
PCS. Finally, the appropriate payment systems need to be developed for the different 
levels as described above. Quality control should be implemented. 
13.2 COMPARISON WITH THE REPORT OF THE MINISTERIAL 
WORKING GROUP (PROF. HEILPORN): “NETWORK OF 
MUSCULOSKELETAL AND NEUROLOGICAL 
REHABILITATION” 
13.2.1 Introduction 
On demand of Minister R. Demotte a “working group” was composed of different 
stakeholders and experts within the whole rehabilitation sector, under the direction of 
Prof. A.Heilporn. A subgroup concerning musculoskeletal and neurological rehabilitation 
held 16 meetings between January 2005 and November 2006. The report was published 
in 2007. The activities of the Ministerial group took place in parallel with the KCE 
project 2005-18 HSR titled “Organisation and Financing of Musculoskeletal and 
Neurological Rehabilitation in Belgium”. 
The aim of the Ministerial subgroup was to elaborate a concrete proposal for the 
organisation of musculoskeletal and neurological rehabilitation in Belgium, based on the 
recommendations  as formulated in the policy note of the Minister and the report of 
the audit performed by Mr. Verhaevert of the budgetary commission of the 
RIZIV/INAMI (June 2004). 
The primary aim of the KCE project is to study the current RIZIV/INAMI conventions 
for ‘locomotor rehabilitation’. As financing and payment is very much related to 
organizational issues, the secondary aim of the study was to assess the organization and 
financing of musculoskeletal and neurological rehabilitation.  
13.2.2 Methodology 
The methodology of the KCE project was described earlier in this report throughout 
the different chapters. Summarised, the different issues were primarily approached in a 
scientific way by means of a thorough search of the available scientific literature. In the 
different steps of this project, evidence found in scientific literature was maximally used. 
Where evidence lacked, other sources were used such as grey literature, national and 
international expert opinion, expert meetings and surveys. Also, an exercise in analysis 
of costs and expenditures and some financial simulations were performed. 
The Ministerial Subgroup applied a completely different methodology. The 
developed ideas are mainly based on expert opinion and dialogue between the different 
stakeholders, members of the subgroup. For scientific data concerning for example 
epidemiology reference is made to the KCE project. 
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13.2.3 Included Pathologies 
The Ministerial subgroup, divided the disorders needing musculoskeletal and 
neurological rehabilitation into six groups with exclusion of children and adolescents 
who are treated as a separate entity. 
For the KCE study five representative pathologies were selected, accounting for about 
75% of inpatient rehabilitation and roughly 60% of outpatient rehabilitation. These five 
pathologies belong to five different groups of the Ministerial subgroup report, so only 
one subgroup (rheumatological disorders) is not represented in the analyses of the KCE 
study. 
Ministerial subgroup KCE study   
1. Amputations LEA 
2. Brain injury Stroke 
3. Spinal cord lesion and peripheral neurological disorders SCI 
4. Progressive neurological disorders MS 
5. Rheumatological disorders  
6. Orthopaedic disorders and multiple trauma THR 
In the report of the Ministerial subgroup factors related to rehabilitation needs at level 
of intensity and duration were taken into account in the description of the six different 
groups of pathologies. These factors are based on the number of functional systems 
involved (e.g. motor system alone or motor system and cognition) as well as the 
anatomical distribution of the functional impairments (e.g. number of limbs involved), 
referring to the ICF-domain “Body Structures and Functions”. Taking these factors into 
account, a distinction was made between patients whose rehabilitation needs can be 
answered by activities financed through ‘Nomenclature PM&R’ and patients for whom 
this nomenclature is insufficient to provide the necessary activities, again, in terms of 
intensity or duration. 
The KCE as well as the Ministerial subgroup referred to the necessity to take all ICF 
domains into account when defining rehabilitation needs of patients. However, a full 
classification system for patient referral based on ICF is still under development.  
The KCE did a literature search to find information on how to divide patients in need of 
musculoskeletal or neurological rehabilitation into distinct subgroups in funtion of 
organisation and financing. Of the described patient classification systems already in use 
in other countries, FIM-FRG and AN-SNAP were found to be the best. One of the 
limitations of these two systems is that they are based on assessment tools only 
evaluating ADL-activities. If one should aim at implementing FIM-FRG or AN-SNAP, a 
data-set of Belgian patients is necessary, so that the system can be validated for use in 
the Belgian context.   
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13.2.4 Comparison of the results and recommendations of both reports 
13.2.4.1 Organisational models 
Even though the methodology in both projects was very different, the main 
recommendations are very comparable. Both authors propose:  
• a model comprising three rehabilitation levels and functioning in a 
rehabilitation network structure 
• with patient referral to the appropriate level by means of an 
assessment tool. 
LEVELS OF REHABILITATION 
Apart from primary care (mono-disciplinary treatment), three levels of rehabilitation are 
proposed by both authors: 
Ministerial subgroup KCE study 
Basic rehabilitation in the departments of PM&R General rehabilitation serviceshhh 
Locoregional rehabilitation centres (LRC) Specific rehabilitation services 
Categorical rehabilitation centres (CRC) Highly specific rehab. Services 
However, the assignment of the pathologies to the appropriate level shows several 
differences between the two studies, summarised in the following table. It has to be 
mentioned of course that the Ministerial subgroup did not dispose of epidemiological 
data. The KCE proposals, which are limited to the five selected pathologies for the 
study (and not valid for the whole of the groups in the Ministerial subgroup report) are 
highlighted in violet italic characters. 
It has to be noted that in the proposals of the Ministerial subgroup a significant overlap 
exists between the basic levels and the LRC (e.g. for stroke patients). Also, it is 
proposed that in hospitals providing LRC, Basic rehabilitation should also be provided. 
CRC should provide LRC services for their own region.
                                                
hhh  Mono- or multidisciplinary treatment, delivered in an organisation where a multidisciplinary supply can be 
provided.  
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Tabel 13.1: Comparison between report of Ministerial workgroup and KCE-report: pathologies in each level of the rehabilitation model. 
 
 General/Basic Specific/LRC Highly spec./CRC 
Amputations BK (nomencl.) 
AK ; bilat.; BK + contralat. limb; (75 instead of 60 
sessions) 
upper limb  
LEA (without prosthesis; monodisciplinary) Most LEA in need of prosthesis Very complex needs (very small number) 
Brain Injury 1 system involved; temporary needs; motor system  and 
dicrete speech problems 
1 system involved; temporary needs; motor system  
and dicrete speech problems -  
Complex strokes with several deficits (motor + e.g. 
aphasia, bladder problems, cognition,..) 
TBI (in function of younger age, combined deficits, 
functional and socio-professional prognosis) 
Always advice of CRC for patients with behaviour 
problems treated in general level or LRC 
Stroke  (temporary needs) Permanent disability  
(15% of stroke-incidence) 
Very complex needs (e.g. socio-professional 
rehabilitation) and younger age (small number) 
SCI and periph. neurol. disorders Only motor system involved; always first consult in CRC >=2 limbs involved; paraplegia and tetraplegia if only 
motor system involved; always first consult in CRC 
>=2 limbs involved + other system; 
SCI  (AMB in 2nd level if geographically too far from third 
level to follow AMB in third level) 
HOS and AMB 
Progressive neurol.disorders Maintenance treatment (AMB) AMB in function of CRC program Complex rehabilitation in particular clinical situations 
MS  AMB HOS and AMB 
Rheumatological disorders Most rheumatological patients Educational and professional needs Complex rheumatological cases 
Orthopaedic disorders and multiple 
trauma 
Simple bone or joint lesions >=3 limbs involved; >=2 limbs + pelvis or trunk 
involved 
Very complex situation with other systems involved 
than orthopaedic (burns, respiratory deficit, bladder 
problem, neurolog. involvement…) 
THR all THR (85% mono; 15% multi)   
Children & adolescents Maintenance treatment More specialised Neurolocomotor specific and complex; HOS; research 
and education 
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ASSESSMENT TOOL 
In order to function, an objective PCS is needed to refer the patient to the adequate 
service level in the network, at the right time. Both authors refer to ICF as the 
framework of choice for a PCS in the future. The KCE report contains an extensive 
overview of the outcome measures, models and PCS currently used in other countries 
in musculoskeletal and neurological rehabilitation. At this moment, no such system or 
corresponding assessment instrument is ready for combined use for clinical as well as 
managerial objectives. Available PCS are mainly used for organisational/financing 
purposes, and in all these PCS, registration of the necessary data occurs at least at the 
beginning and at the end of the rehabilitation period. The KCE team proposes to start 
introducing one of the assessment instruments currently in use abroad within existing 
PCS for organisational/financing objectives: FIM or Barthel Index. At the same time, 
medical diagnosis, comorbidities, age and contextual factors (e.g. social situation) should 
be registered (e.g. at the beginning and at the end of the rehabilitation). The results of 
this data collection can already be used to refine the epidemiological data proposed in 
their study (and used to estimate number of services needed in Belgium). Next, a pilot 
study can be set up to validate the first results of this registration against data of RIM2 
and ICF-core sets; or to validate a PCS currently already in use other countries.  
The Ministerial subgroup proposes an application form combined with FIM as an 
evaluation instrument (“rehabilitation needs evaluation”), to be performed at the start 
and then every three months during the rehabilitation trajectory. 
AMBULATORY TREATMENT VERSUS HOSPITALISATION 
In the KCE report there are some limited data on inpatient versus outpatient therapy 
but no scientific rules to make the distinction were found on this topic in literature.  
The Ministerial subgroup separately treats the importance of ambulatory rehabilitation 
in the different phases of rehabilitation, as far as the personal and environmental factors 
of the patient permit discharge home. It is stated in the report that ambulatory 
rehabilitation encourages patients’ independence and quality of life and decreases 
hospitalisation cost. However, this implies sufficient nursing care in this setting, the 
organisation and financing of transport and cooperation with the general practitioner 
and primary care services. The Ministerial subgroup report underlines the importance 
of continuity of care and immediacy of the necessary services through the network. 
Concerning hospitalisation, the Ministerial subgroup proposes a new type of beds for 
hospitalisation in LRC and CRC: SpR-beds. 
Also, in this report criteria for qualifications of the medical staff are defined for the 
different levels. 
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13.2.4.2 Financial models 
For each rehabilitation level in the network, recommendations are made for an 
appropriate payment system. However, there are some significant differences in the 
recommendations between both reports. 
In the Ministerial subgroup the recommendations concerning organisation and financing 
are based on the actual payment systems (Nomenclature PM&R and Conventions) 
whereas the KCE research team discusses several theoretical options. 
The proposed payment systems are shown in the next table. 
 Ministerial subgroup KCE study 
General/Basic existing K-nomenclature (K30/K60, 
with for some pathologies a change in 
maximum number of sessions from 60 
to 75) 
fee for service  (FFS) or mixed with 
high weight on FFS component 
Specific/LRC a new R-nomenclature (R1 for 2 hours 
and R2 for 3 hours of treatment) 
lump sum or mixed with high weight on 
lump component 
Highly spec./CRC lump sum per day of treatment envelope  or lump sum  or mixed with 
high weight on lump component 
The KCE study comprises a detailed analysis of the current organisation and financing of 
musculoskeletal and neurological rehabilitation with budgetary data  in the period 2000-
2004, as well as a cost and expenditures calculation based on the estimated needs in the 
post-acute rehabilitation phase taking into account the developed stratified 
rehabilitation model, the epidemiological data on the five studied pathologies, and the 
‘standard rehabilitation protocols’ developed for these pathologies by an expert group. 
13.2.4.3 Number of services needed in Belgium 
In the KCE study an attempt was made, based on literature data, to estimate the 
number of needed rehabilitation services at the different levels, for the five studied 
pathologies. These data were also used for the calculation of the estimated 
expenditures in the proposed financial model. 
Both reports propose to supply basic/general rehabilitation in the departments of 
PM&R, present in most of the acute hospitals.  
The number of rehabilitation services of the second level is estimated in by the KCE 
team as (maximal) 20 to 30 and in the Ministerial subgroup report 23 for stroke, or 
about 30 for the whole of the musculoskeletal and neurological rehabilitation. This is 
very similar, although there are some differences between the 2 studies in the 
subgroups of patients assigned to this level. However, centres can be larger or smaller 
and should be geographically well spread. 
The report of Prof. dr. Heilporn mentions no estimations for the number of needed 
CRC and prefers to wait for the results of the KCE study. In the KCE report 3 to 5 
highly specific centres are recommended, combining different pathology groups. 
13.2.4.4 Quality and control 
Both reports stress the importance of quality control. 
The KCE report contains information on how quality control and accreditation is dealt 
with in the five studied countries, and proposes to restart evaluations of the 
rehabilitation organisations by a visitation committee. 
The Ministerial subgroup proposes a yearly activity report for the locoregional and 
categorical rehabilitation services, as well as a yearly inspection of these LRC and CRC. 
For basic services (PM&R) no control system is proposed, whereas a lot of patients are 
assigned to this level. 
The Ministerial subgroup also defines concrete (minimum) criteria for the LRC and 
CRC, based on the current situation and on expert opinion. 
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The KCE report provides epidemiological information which can in a second phase 
support the criteria as defined by the Ministerial subgroup. 
13.2.4.5 Implementation of the recommendations 
The KCE report proposes a four steps scenario for implementation of the 
recommendations, the Ministerial subgroup asks for transitional measures during a 
period of maximum six months. 
13.2.5 Conclusion 
The reports of the Ministerial subgroup “Network of musculoskeletal and neurological 
rehabilitation” and the KCE project 2005-18 HSR titled “Organisation and Financing of 
Musculoskeletal and Neurological Rehabilitation in Belgium” have to be considered as 
complementary. 
The applied methodology is very different. The Ministerial subgroup report is mainly 
based on the current Belgian situation and concrete proposals are based on the input of 
the different stakeholders, member of the group. In the KCE project the 
recommendations are based on an extensive search of scientific literature, of grey 
literature and where necessary completed with national and international expert 
opinion, expert meetings and surveys. The approach is more a conceptual one, that can 
serve as a basis for further implementation into practise. 
Despite the differences between both projects certain common conclusions can be 
drawn.  
A stratified rehabilitation model is proposed comprising three levels of rehabilitation 
services with increasing complexity of the rehabilitation needs. The services part of the 
different levels are organised in a network structure. The patient is assigned to the 
appropriate level in a particular phase of the rehabilitation trajectory by means of a 
patient classification system. The ideal framework for this assessment instrument is ICF. 
However, as no such tool is currently available it is by both authors recommended to 
start by using a combination of different tools, such as FIM. 
The KCE report also comprises analyses of the current financing systems as well as the 
proposed systems in the new model. The report of the Ministerial subgroup offers 
concrete (minimum) criteria for rehabilitation services on the one hand and 
propositions for payment systems for the different pathology groups on the other hand. 
The KCE report discusses different options for payment systems at the three levels. 
Taking into account both reports, the number of needed services seems to be 3 to 5 
for the most specialised level and between 20 and 30 for the second level. For the 
basic/general services no number was defined as they can be provided in the acute 
hospitals in the current departments of PM&R. 
Both studies recommend to (re-)introduce a yearly inspection of rehabilitation services. 
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